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Abstract 
This thesis describes the historical and functional evolution of British cQnmunity pharmacists 
showing the succession of a compounding role by a supply function with incumbent 
bureaucracy. Development of a role as advisors on prescription medication is reviewed and 
the potential benefit explored by reviewing patients' lack of understanding about their 
medication following advice from general medical practitioners. Although ethical directives 
and specific guidance could be identified for the application and use of additional labels, little 
was found for provision of verbal advice. 
No comprehensive research was found to describe the prescription medication advisory role 
of community pharmacists. The present thesis primarily addresses this lack of knowledge. 
For a total of 651/2 days between June 1988 and February 1989 the discussions of twenty of 
twenty four randomly selected community pharmacists which involved prescription 
medication were tape recorded, transcribed and the circumstances observed. For half this 
time a poster advertising community pharmacists' advisory service was displayed. 
Verbal advice was provided by the community pharmacist to 473 of 3519 individuals 
involved with prescription medication. Two types of community pharmacists were identified, 
proactive and reactive. Irrespective of type, a constant level of requests for advice was 
noted. Overall, display of the poster was not associated with any significant effect on the 
quantity of advice; however, it was associated with changes in the nature of advice with 
greater emphasis on 'Specific problem' and 'Side effects' over 'What is prescribed' and 'What 
to do with it'. Although reiteration of the prescribers' directions and verbalising additional 
label warnings accounted for the majority of verbal advice, qualitative analysis revealed an 
element of independent judgement. The sociological literature on the professions provides an 
understanding for the observations. It is argued that guidance for verbal advice provided in 
the British National Formulary may facilitate community pharmacists' prescription medication 
advisory role. 
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CHAPTER 1 INTRODUCTION 
1.1 Summary 
This chapter considers the general question, 'Who are community pharmacists? ' Specifically, 
what are their origins, who governs them or directs their activity and how their position in 
society is maintained. Also how many are there, how they are paid, and finally, what do they 
do? This short historical and functional account of community pharmacists (CPs) provides a 
general understanding which prepares the reader for an account of potential areas of concern 
regarding their activity. 
Briefly, the origins of CPs and general medical practitioners (GPs) are inexorably interwined. 
Both have a common ancestry in the apothecary of the 18th century. It was the orientation of 
apothecaries towards either diagnosis or drugs which resulted in a division of practice. Those 
who favoured diagnosis were the predecessors of todays GPs while medicine-orientated 
apothecaries became chemists or druggists and ultimately CPs. Some medicine-orientated 
apothecaries further diversified into manufacturing and wholesaling and developed the basis 
of todays pharmaceutical industry. Central to this discussion is the knowledge of 
compounding medications and the struggle between both orientations of practitioners over 
who would control the use of such knowledge. It was the additional drug knowledge which led 
to a widening of the medicine-orientated apothecaries' role, when it was noted that the 
provision of advice on medicines was in the public interest. In response to the recurrent 
threat of medical domination individuals with a medicine-orientation banded together to form 
the Pharmaceutical Society of Great Britain (The Society). Educational standards were 
imposed by the Society. In recognition, Government gave it right to manage registration 
which then became a prerequisite for practice. Although precluded from an industrial council 
role, The Society represented pharmacy in the development of legal restrictions governing 
the general public's access to medicines. The legal right to dispense became the powerbase 
of todays pharmacist, and they assumed the role of custodians of drugs In contemporary 
society. 
There has been a steady increase since the 1940s in the overall number of individuals in the 
United Kingdom choosing to become a member of the pharmacy profession (pharmacists). A 
steady decline in community pharmacy outlets and an increasing population has meant that 
the number of community pharmacies per head of population has decreased. However, this 
has not meant that the number of CPs per pharmacy has increased. In fact, the ratio in Great 
Britain has remained relatively constant with time. This discrepancy may be explained by the 
increasing number of pharmacists choosing a hospital based career in preference to one in 
the community. The picture for community pharmacy is further complicated by changes in the 
proportions of full- to part- time and female to male CPs such that part-time females are 
becoming a notable proportion of the workforce. Prescription dispensing by CPs is 
remunerated through an administrative structure within the National Health Service. For 
community pharmacy returns in 1988, the main period of data collection for this thesis, the 
Prescription Pricing Authority collated and determined the amount of remuneration on behalf 
of the Family Practitioner Committee which in turn acted in a managerial capacity for 
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Government. Community pharmacists must be conversant with a complex system of 
endorsing for full payment of dispensing services. Evidence from changes in preparation 
formulae indicates that compounding or preparing preparations has largely been superseded 
by the supply of manufacturers products. Although this has released CPs from a time 
consuming function, the act of supply has become increasingly structured to contend with 
clerical and monitoring functions. Coincident with a relatively static number of community 
pharmacies and CPs, the number of prescriptions dispensed in the United Kingdom has 
increased in excess of the population. This is due to a growth in the elderly population and a 
change in prescribing patterns. 
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1.2 Historical development of community pharmacy 
1.2.1 The origins of community pharmacy 
"The history of Medicine and Pharmacy is not a record of continuous human progress" George 
Edward Trease. 1 
From the earliest times there have been groups of individuals concerned with medicines. The 
sale and preparation of medical drugs derived from vegetable, animal and mineral products, 
the "materia medica", has been directly associated with physicians, herb-gatherers, drug- 
peddlers, apothecaries, spicers, pepperers, grocers, mercers, chemists, druggists, dispensers 
and most recently pharmaceutical industry and pharmacists. To understand the current 
relationship between CPs, the general public and relevant health care professions, it is helpful 
to examine the origins of Pharmacy in the context of those groups dealing with the materia 
medica and to describe the attempts of the medical profession (Medicine) to dominate the 
practice of preparing and selling medicines. Specifically the case of William Rose will be 
detailed. A flow diagram found at the end of this section (figure 1, page 20) traces the major 
relevant events. Specifically, it indicates whether groups of individuals compounded 
medicines, diagnosed or were involved in wholesaling. 
Although drug-traders existed earlier, it was not until the early part of the ninth century in 
medieval Islam that shops were run by educated and responsible apothecaries. The word 
apothecary is derived from the Greek apotheke or apotheca which originally meant a 
storehouse, but gradually came to mean a storehouse for specific commodities including 
drugs. At this time there was no clear legislation to prohibit the apothecary from diagnosing 
and the physician from compounding and dispensing. Specialisation was inevitable due to 
the expanding knowledge on drugs. 2 It was this enforced development which influenced 
Emperor Frederick II in the Kingdom of Sicily to pass legislation in 1231 and 1240 which; 
recognised the professional status of the apothecary, separated compounding from the 
practice of medicine, recommended a single formulary - the Antidotarium Salemitami, and, 
set educational standards and introduced a system of fixed scales of remuneration. 123 
Perhaps the first European title of interest for this thesis was that of 'spicer', used in the late 
12th century to identify a merchant who both dealt in drugs and prepared medicines in 
addition to a wide variety of spices and vegetable drugs. A similar function was associated 
with pepperers. However, the latter confined themselves entirely to ports such as London. 
Pepperers resembled present-day drug importers and wholesale produce merchants, while 
spicers became concerned with retail trade practised either from booths at fairs, or from 
permanent shops, which were the first English pharmacies., 
The name apothecary acquired a pharmaceutical meaning in England about the middle of 
the 13th century. During this time, the term spicer-apothecary might be used to describe a, 
spicer, an apothecary or a pepperer. On the 9th May 1345, the Fraternity of St Anthony was 
formed which brought together the earlier mysteries of spicer, pepperer and apothecary to be 
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replaced by the term grocer. By 1373 the name grocer was established and the Fraternity of 
St Anthony had evolved to become the mystery of Grocers or Grocers' Company which was 
given power by civic ordinance to search all spicers, and presumably apothecaries. That the 
name and associated spicer function of the apothecary persisted, points to an activity which 
was unique within this area of public service and retail enterprise. 
Aware of the dangers from the practice of medicine by totally unskilled persons, Parliament 
in England authorised the Privy Council in 1421 to make regulations restricting medical 
practice to those of adequate training. However, physicians were few in number, mainly 
ecclesiastical and practised among the rich; thus, the bulk of medical care continued to be 
conducted by surgeons, barbers, well-intentioned amateurs and fortune-seeking quacks. 
Although some apothecaries may have practised medicine as a sideline, most remained 
viable through the manufacture and sale of medical drugs. ' 
In 1518, during the reign of Henry VIII, Thomas Linacre founded the College of Physicians 
with the avowed aim to guard the profession from men "who profess physic rather from 
avarice than in good faith" This consolidated the power of the physicians, and in 1553 an Act 
provided them with the power to fine or have imprisoned "Poticaries who sell evil and faulty 
stuff" as well as to search apothecaries shops and to destroy any drugs which they regarded 
as inferior. The Act was not repealed until 1875.1 
Partially arising from such legal power, the practice developed whereby the physician would 
use rooms in 'his' apothecary's shop for consultation and would encourage the apothecary to 
see patients on his behalf. Physicians regarded the apothecary as an agent to increase their 
number of patients and relieve them of compounding duties, but who must be kept in an 
inferior position. Through contact with physicians, apothecaries acquired a supplementary 
knowledge of medical diagnosis. As the number of legally qualified medical practitioners was 
relatively small, many of the sick, especially in areas lacking a physician, turned to the 
apothecary for advice. Concurrently, physicians who had the knowledge were able to 
compound medicines, an activity central to the livelihood of apothecaries. Crossing of role 
boundaries contributed to rising tension between physicians and apothecaries. Under this 
climate of conflict, the compounding function of the apothecary continued to develop. 
By the 17th Century the term 'pepperer' has disappeared. London apothecaries who were 
founder members of the Grocers' Company had retained their-original identity. In 1607, the 
Grocers Charter was amended such that London apothecaries became a separate section 
within the Company. They were chartered in 1617 as the Worshipful Society of the Art and 
Mystery of the Apothecaries or Society of Apothecaries, with the power to make rules for the 
practice of members within seven miles of London. The Masters and Wardens of the Society 
were empowered to enter the premises of any persons, question them and prohibit from 
practice those found to be unskilful or Ignorant of their profession. The College of Physicians 
supported the granting of the charter because, as Atkins its president remarked, "they would 
be brought under the control of the College much more efficiently than while they were 
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members of the Grocers' Company': London apothecaries held a monopoly over their 
patrons, as it was illegal for other mysteries "to furnish, have, hold or keep an apothecary 
shop". 4 
By the end of the 17th century, the herbalist was becoming a botanist and as the demand for 
chemicals increased, the title 'Chemist' became associated with one who made and sold 
chemicals. An apothecary could describe himself as a chymist, a druggist, or a chemist and 
druggist. 
The early 18th century was important in the history of pharmacy as a turning point in the long 
struggle between prescribing apothecaries and dispensing physicians. The number of 
physicians was smaller than that of apothecaries who, under legal domination, had acquired 
a knowledge of diagnosis and treatment and were justifiably able to claim that they had the 
skills necessary for the additional practice of medicine. ' The full extent to which apothecaries 
practised medicine in the early years is, however, unclear. 5 
In 1696, the College of Physicians established a dispensary at Warwick Lane, London. Six 
years later, the Society of Apothecaries established an outlet nearby at Bishopgate, with the 
undertaking to provide and dispense medicines gratis to the poor for four years. It is 
important to this thesis that in 1687 the Society of Apothecaries had unanimously agreed to 
give advice free of charge to "all their sick neighbouring poor, when desired, within the City 
of London, or seven miles around" s 
Charges and counter-charges were made between the College of Physicians and the Society 
of Apothecaries. Apothecaries claimed that unqualified dispensers working under the 
guidance of physicians at Wardwick Lane had set up in competition against them; however, 
the main issue involved the allegation by physicians that apothecaries were prescribing and 
thus practising medicine in contravention of the Act of 1522. 
In 1703 the College of physicians took the apothecary William Rose to court for the supply of 
"medicines proper for distemper" to one John Seale, "a poor butcher", The Queen's Bench 
jury, realising that Rose had acted in accordance with accepted practice for the period, asked 
for a definition of 'practice'. Having defined 'practice' the law necessitated the conviction of 
William Rose. However, the judgement was reversed on appeal by the House of Lords. This 
was based upon the opinion that it was "in the public interest to allow apothecaries to give 
advice as well as to sell medicines' Thus, until the Act of 1815, apothecaries provided 
"advice gratis" and only charged for medicines. 146 
Only a new Act of Parliament could abrogate the legal status of London apothecaries. The 
London apothecary practising in 1704 could continue his business of the preparation and 
sale of medicines, or compete with the physicians on their own'ground. No exact figures are 
available to indicate how many changed to medical practice, but gradually the medically-' 
orientated apothecaries and physicians merged to become medical practitioners, and those 
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concentrating on medicines associated themselves with the emerging force of Chemists and 
Druggists. Medically-orientated apothecaries did not relinquish their trade in medicines easily 
and in 1795 founded the short-lived General Pharmaceutical Association of Great Britain 
which later unsuccessfully petitioned Parliament to limit the chemist and druggist to 
wholesale business. In response, the Association of Chemists and Druggists was founded in 
1802 which was successful in protecting members' interests, notably in the 1815 
Apothecaries Act. 
Over the next century the number of unqualified or ill-qualified practitioners of medicine 
necessitated a reform in both education and registration. With the passing of the 
Apothecaries Act of 1815, the Society of Apothecaries became responsible for training and 
registration, and a court decision in 1829 made it legal for such apothecaries to charge for 
their advisory skill. Importantly, the 1815 Act contained a clause making it clear that 
chemists and druggists could continue their trade "in buying, preparing, dispensing and 
vending of drugs, medicines and medicinal compounds, wholesale and retail" as it was before 
the passing of the Act. ' Further, Chemist and Druggist had acquired legal status without 
being subject to inspection by the Society of Apothecaries or any requirements regarding 
education or apprenticeships. Most apothecaries moved towards medical practice and the 
preparation and sale of medicines passed into the hands of chemists, druggists and those 
apothecaries who remained orientated towards medicines. Research and manufacturing 
industries, for example Allen and Hanbury's, later absorbed by Glaxo Laboratories Ltd, have 
their origins with those latter pharmacists. As a consequence, "the true origins of pharmacy 
are to be found in the trading community"' and those of the GP linked to the medically- 
orientated apothecary. 
The Association of Chemists and Druggists expanded and in 1829 became The General 
Association of Chemists and Druggists of Great Britain, which disbanded after obtaining a 
promise from the Chancellor of the Exchequer not to continue a duty on the lucrative 
manufacture and sale of soda water. For a decade chemists and druggists had little 
cohesion. However, they rallied in response to a Parliamentary Bill in 1841 which proposed 
that it should be an offence for chemists and druggists to recommend a simple remedy or 
advise on how a medicine should be taken and that they should be controlled by an 
independent body consisting largely of medically-orientated apothecaries. 
The Bill was successfully opposed, but the realisation that chemists and druggists were lucky 
to practice without fixed standards of education, training and examination prompted a 
general meeting on the 15th April 1841, at the Crown and Anchor Tavern in the Strand, 
London. It was resolved that a Pharmaceutical Society be formed and with the granting of a 
charter of Incorporation by the Queen in 1843, the Pharmaceutical Society of Great Britain 
became the official body holding and administering the register of its members. The 
Medicines Act of 1858 transferred the responsibility for medical training to the General 
Council for Medical Education and Registration and charged it with producing the first British 
Pharmacopoeia. It is significant that the first meeting of the general council resolved to 
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request the involvement of the Pharmaceutical Society in producing the British 
Pharmacopoeia, an action which went far in healing the rift between the physician and the 
chemist and druggist. 
By the late 19th Century, the title apothecary had disappeared. A medical education led to 
practice as physician or surgeon. By then, The Society had introduced the title pharmacists 
to further complicate those of chemist and druggist, a situation which persists to this day. 
This short account has followed the development of groups who have been involved in 
preparing and retailing medicines. Originally the physician held the knowledge for the 
preparation of medicines. With time, drug-traders evolved and the apothecary emerged as a 
compounder of medicines. Although spicers and pepperers became involved in the drug 
trade, the apothecary retained a unique involvement in the preparation of medicines. 
Attempts by physicians to dominate apothecaries by legal right of inspection lead to 
increased inter-professional contact and enabled apothecaries to absorb medical skills. It 
was this additional knowledge which led to a widening of the apothecarist's role when it was 
noted, and established by the Rose case, that the provision of advice on medicines was in 
the public interest. Medically-orientated apothecaries later amalgamated with the physicians 
and threatened those apothecaries orientated towards medicines who had joined forces with 
the emerging and powerful chemists and druggists. In response to the dangers of domination 
by the medical profession chemists and druggists plus functionally related apothecaries 
formed the Pharmaceutical Society of Great Britain. In the next section the historical 
development of community pharmacy is continued through the activities of its governing 
body, The Society. 
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Figure 1 
The historical development of community pharmacy 
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1.2 Historical development of community pharmacy 
1.2.2 The Pharmaceutical Society of Great Britain 
In this section, the further historical events predisposing the nature of the CP will be detailed 
through the guiding activities of The Society. 
Initially, most members of The Society believed its chief function was to protect their 
interests from outside interference; specifically, repeated threats of legislation that would 
have been inimical to their interests 789 Greater definition of the powers of The Society were 
sought in response to the threat of external control from the General Council, which, under 
the 1858 Medicines Act, had powers to examine and register persons practising medicine, 
and sought to similarly control Pharmacy. With the passing of a second Pharmacy Act in 
1868, The Society became the sole official examining body for persons seeking registration 
and assumed responsibility for registration of pharmaceutical chemists, chemists and 
druggists, assistants and apprentices. Legally, therefore, a person wishing to practise as a 
CP in Great Britain required registration with The Society. Similarly, registration is required 
with the Pharmaceutical Society of Northern Ireland (PSNI) which came into being by virtue 
of the Pharmacy and Poisons Act (Northern Ireland) in 1925. Currently, much of pharmacy 
activity is regulated by the 1954 Pharmacy Act. 
From the initiation of formal training, education has assumed a high profile. Results of 
examinations in 1941 were officially published, 10 a practice which continues to the present 
day. The minimum qualification for registration has evolved, with the result that a CP In 
practice may have one of three educational backgrounds, the Chemists' and Druggists' 
diploma, the Pharmaceutical Chemists' Diploma or a university degree. From 1970, a degree 
from an institution accredited by either The Society or the PSNI, and 12 months supervised 
practical experience became the minimum requirement. Presently, an unknown number of 
CPs are still in practice with the older qualifications. The, 16 schools of pharmacy must 
conform to educational requirements set out in The Society's Calendar, if their graduates are 
to be accepted for registration. The Society makes quinquennial visits to each School to 
grant approval subject to proof of appropriate standards and requires that courses cover 
three aspects of pharmaceutical sciences. These are; pharmaceutics which includes the 
microbiology, formulation, preparation, production and testing of medicines; pharmaceutical 
chemistry which deals with chemistry and the analysis of drugs and drug-containing systems 
and pharmacology or the Interaction between drugs and the living organism, " the latter topic 
having been included since 1935, , 
The following paragraphs detail four important court cases involving The Society which 
directly affect the practice of pharmacy in Britain. These cases are described in detail by 
. !., 
Holloway 9 and indicate the historical shackles which bind the activities of The Society. 
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First, the case of The Society versus The London and Provincial Supply Association Limited, 
which was considered by the House of Lords in 1880. Their decision that limited companies 
were not persons and could use the titles restricted by the Pharmacy Act of 1868, was a 
constant reminder that rectification could only be achieved by legislation. ' 
Second, in 1890, The Society unsuccessfully sponsored a Parliamentary Bill to prevent 
companies carrying on a chemists' business unless all the directors were registered 
pharmacists. These two cases are important as they opened the way for multiple ownership 
of pharmacies by non-pharmacists. ' 
Third, an injunction sought by Mr Jenkin was upheld in the High Court preventing The 
Society acting as an Industrial Council. The Retail Pharmacists' Union - later known as the 
National Pharmaceutical Association (NPA) - was formed as a direct result of this decision 
and undertakes some of these functions. As a result, the 1954 Pharmacy Act includes the 
directive "to maintain the honour and safeguard and promote the interests of the members in 
the exercise of the profession of phannacy". 12 1314 Thus, The Society has no direct ability to 
manipulate financial reward in order to influence practising CPs, rather, its sanctions are 
through registration to practice. 
Fourth, The Society sought to influence the nature of trade based on recommendations put 
forward in the Report on the General Practice of Pharmacy submitted to The Society's 
Council in July 1961. A motion was put to the Annual General Meeting of The Society in 
1965, requesting that "new pharmacies should be situated only in premises which are 
physically distinct, and should be devoted solely to (1) professional services, as defined... (2) 
non-professional services, as defined... and (3) such services as may be approved by the 
Council... ". 15 Subsequently, an injunction was sought by Mr R. C. M Dickson -a director of the 
Boots Pure Drug Co - claiming that the motion was outside the scope of The Society's 
powers and that, if implemented, would lead to a restraint upon trade. Although a Special 
General Meeting voted overwhelmingly by 5,020 votes to 1,336 for the motion, the High 
Court declared 'That it is not within the power, purpose or objects of the PSGB... to enforce or 
carry out .... the provisions of the motion... on the grounds that the said provisions are in 
restraint of trade". 16 The Court of Appeal and the House of Lords failed to reverse the High 
Court decision. 1718 Thus, ' The Society failed in its bid to influence the nature of community 
pharmacy trade. 
By their very nature people tend to protect and promote their area of expertise - their 
livelihood. Pharmacy had on the one hand gained recognition and legislative protection yet 
found itself constrained by the very mechanisms that gave is status. Recently the title Royal 
was conveyed to the Society and membership is now of the Royal Pharmaceutical Society of 
Great Britain (The Society) 19 with the letters MRPharmS to describe the title . 
20 The 
development of legal protection is detailed in the following section. 
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1.3 The development of legal restrictions governing access to medicines 
Restraint on the access of the general public in Great Britain to specific chemical substances 
can be traced back to the Arsenic Act of 1851, as 'the unrestricted sale of arsenic facilitates 
the commission of crime' The sale of arsenic was confined to "licenced sellers of poisons': ' 
Restriction continued with the 1868 Pharmacy Act introducing a poison list. A series of 
Poison Acts increased the number of substances listed for limited access. Notably, in 1933 
under the Pharmacy and Poisons Act, poisons were divided into two parts, defining in part 
one substances that could only be sold at pharmacies. A Poisons Board was created which 
replaced the system set up by the 1868 Pharmacy Act whereby The Society proposed 
amendments to the Schedule of Poisons. At this time The Society was empowered to 
establish a disciplinary body to reprimand offenders in courts of summary jurisdiction and 
not, as previously, in the civil courts. 
Similarly, The Penicillin Act of 1947 and the Therapeutic Substances Act of 1953 restricted 
the supply of antibiotics to pharmacies or from GPs. The Therapeutic Substances Act of 
1956 combined control of manufacture and supply but was replaced by the all encompassing 
Medicines Act of 1968 which also incorporated relevant sections of the Pharmacy and 
Poisons Act of 1933. Special consideration was given to drugs liable to abuse which 
culminated in the Misuse of Drugs Act 1971 and the 1986 Drug Trafficking Offences Act. It is 
through the prescription that the prescriber conveys instructions for dispensing to the CP. 
The latter Acts placed greater controls on prescription writing and drug storage for those 
substances open to abuse. 
The legal powerbase for those registered as CPs in Great Britain is currently derived from 
section 52 of the Medicines Act 1968. The Act defines certain substances as either a 
Prescription Only Medicine (POM), a General Sales List item (GSL) or, by default, a 
pharmacy medicine (P). Exemptions are made in section 55 for doctors, dentist and 
hospitals. Further restriction is enforced by the National Health Service Acts which require 
that the general public obtain medicines only from pharmacies if they are to be subsidised. 
The Society, in maintaining the register of pharmacists and having the power to de-register 
persons convicted of an offence, is able to exert considerable influence on the current 
practice of pharmacy. Offences are generally contraventions of The Society's Code of Ethics. 
This code brings together The Society's expectations of pharmacy practice under the 
relevant Acts. 
At this point it will be useful to examine the number of pharmacies and CPs who provide 
access to restricted substances. 
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1.4 Pharmacy demographics 
Records from 1940 indicate that the number of registered pharmacists resident in the United 
Kingdom has been steadily increasing (figure 2 [A]). During this period the availability of 
pharmacy outlets for the general public declined (figure 2 [B]), with the result that each 
pharmacy served progressively more members of the general public, until the 1980's when 
the trend appears to level out (figure 2 [C]). 
Figure 2* 
The number of pharmacists [A] and pharmacies [B] in the United Kingdom, 
population per pharmacy [C] by time 
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" References 11 21 22 23 24 25 26 27 Data for Great Britain respresents the number to the end 
of the calendar year. Data for Northern Ireland prior to 1985/6 was collected for the 12 month 
period ending Ist August. This was subsequently changed to 1st June. Calculations based on 
projected mid-year estimates of UK population. 
Concern over pharmacy closures prompted several studies during the mid to late 1970's 
which cited economic viability as the prime reason for closure. 28 29 Pharmacy demographics 
have been influenced by: the aggregation of GPs into practices in the 1960's and, more 
recently, into health centres; restrictions on opening a pharmacy 30 an increasing proportion 
of multiple compared with independent pharmacies 3132 33 34 The numbers of resident, 
registered pharmacists has increased (figure 3 [A]). However, the number who identify the 
location of their employment in the community (figure 3 [B]) initially decreased until the late 
1970's then rose slowly; a pattern which closely matched changes in the number of 
pharmacies (figure 4 [B]). In fact, the increase in overall pharmacy numbers can be 
accounted for by a dramatic expansion in hospital pharmacy employment (figure 3 [C]). 
Thus, the ratio of full-time CPs per pharmacy has remained relatively constant since surveys 
were undertaken (figure 4 [C]). 
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Figures 3 and 4* 
Number of registered resident pharmacists in Great Britain employed in 
community or hospital service by time 
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There have, however, been shifts in the proportions of part- to full- time and male to female 
CPs. It is known that the absolute number of part-time CPs increased in the sixties and 
seventies and levelled out in the eighties (figure 5 [B]). 
Figure 5* 
The percentage female [A] and part-time [B] pharmacists in community 
practice in Great Britain by time 
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The ratio of full-time CPs to pharmacies has remained static during this period. Thus, the 
total number of CP, full- plus part- time, to pharmacies has increased. Manpower surveys 
conducted by The Society 47 48 49 report the following ratios for the number of CPs to 
pharmacies; 1.32,1.49 and 1.82 corresponding to the years 1970,1974 and 1982 
respectively. Although the admission of females to the register was hotly debated 50 
evidence suggests that these changes may be due to increasing numbers of female 
pharmacists 45 46 possibly working part-time. 48 51 Since 1963 the "percentage of registered 
resident pharmacists identifying themselves as unemployed appears to have peaked in the 
late 1970's, when attention was drawn to the trend. 41 There is no evidence of involuntary 
unemployment. 
Studies of CPs have recorded age bands specific to those employed full- or part- time in 
community pharmacy (figure 6, page 27). 444552 Numbers of male and female or full- and 
part- time CPs in age bands is not available. Taking a 20 year span, there was a peak in the 
number of CPs in their early thirties reported in the study of 1969. Many of these individuals 
have remained in community pharmacy and are now in their early to late fifties. Currently 
there is an additional peak number of CPs in their mid-twenties. Pharmacists may have 
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varying educational backgrounds and experience in several branches of pharmacy, both of 
which are age dependent. If behaviour is related to education and experience, then the two 
current age peaks may represent separate groups for investigation. Empirical assessment of 
figure six provides a value of 50 years to divide the two groups. 
Figure 6* 
The percentage of community pharmacists in age bands by time 
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In summary, the number of CPs in the UK has increased. The trend for a net closure of 
pharmacy outlets until the late 1970s was reversed in later years. Reasons for this are 
complex and involve the distribution of general practice surgeries and legal restrictions on 
the siting of new pharmacies. There appears to be a current expansion in multiple ownership 
of pharmacies. In 1986 it was stated that "insofar as there is a general model, it is of a 
pharmacy in which there will be a single CP available at any one time". " Indeed, surveys 
have shown that the number of full-time CPs per pharmacy has remained constant. 
However, there are increasing numbers of part-time CPs. It is likely that females dominate 
this part-time workforce. In 1988, two peaks of age bands for practising CPs can be 
identified. That this is the case may indicate two distinct groups, therefore, investigations 
based on data collected at this time should use a figure of 50 years to divide CPs into 
separate age groups. 
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15 Remuneration 
1.5.1 The National Health Service 
The first section on remuneration briefly describes the structural evolution of the National 
Health Service relevant to remuneration of pharmaceutical services. This background 
introduces the second section which broadly describes the mechanism of payment in 
England and Wales. The reader will appreciate that CPs are salaried workers employed by 
Government. The complexity of the payment system will become apparent. This has a 
bearing on the central theme of this thesis, the advisory activities of CPs. 
Under the 1946 National Health Services Act, the Ministry of Health in England and Wales 
became fully responsible for GPs, pharmaceutical services, hospitals, local authority 
services, and mental health and hygiene. ' Almost overnight the CP became more important 
as with the Act medical practitioners ceased to dispense the medicaments they prescribed. 5 
Initially Pharmacy was included in the general practitioner service under the jurisdiction of an 
Executive Council which maintained a Pharmaceutical List of the names and business 
addresses of those persons undertaking to provide pharmaceutical services. Regulations 
defined the limited extent of medical or dental practitioners' pharmaceutical service 53 
Terms of service were also regulated by the Executive Council. The regulations in 1962 
made no specific stipulation requiring the provision of prescription medication advice (PMA) 
by the CP 54 However, provision was made for complaints from the general public through 
the Pharmaceutical Services Committee or Joint Service Committee, both of which reported 
to the Executive Council. A local Pharmaceutical Committee was created which dealt with 
inter-pharmacy disputes. 
The Service was eventually reorganised into a single management structure with the 
National Health Service Reorganisation Act 1973 and in Scotland by the National Health 
Services (Scotland) Act 1972. The National Health Services Act in 1977 consolidated the 
1946 and 1973 Acts and finally, an Act in 1980 extended the 1977 Act to allow alteration in 
the structure of the Service. The 1977 National Health Services Act, as amended, controls 
pharmaceutical services in England and Wales 55 Details are set out in Part One of the 
Fourth Schedule to the National Health Services (General Medical and Pharmaceutical 
Services) Regulations 1974. No specific stipulation requiring provision of information on 
ss PMA by the CP was made. 
The 1977 Act required District Health Authorities to set up Family Practitioner Committees 
(FPCs) with responsibility for pharmaceutical services. The Health and Social Security Act 
1984 amended the 1977 Act allowing the Secretary of State to establish 83 FPCs as special 
authorities 57 Upon receipt of a legally correct prescription form, CPs are contracted to supply 
the items requested. Recent regulations amended the terms of service such that CPs are 
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able to exclude or limit the supply of certain drugs and medicines. This created the 
medication "black List" 58 
The FPC, currently renamed as the Family Health Services Authority (FHSA), enters into a 
contract with individuals providing pharmaceutical services, prepares a list of names and 
addresses, operates statutory disciplinary arrangements, and administers the terms of the 
contract, including remuneration as defined in the Drug Tariff which is published by the 
Secretary of State. Increased power and autonomy came with Authority status in September 
1990. 
Pharmaceutical services in Scotland, like medical services, are still governed by the National 
Health Services (Scotland) Act 1972. A contract is made with one of the 15 Area Health 
Boards which are directly responsible to the Scottish Home and Health Department. There is 
no FPC. The Pharmaceutical General Council (Scotland) is the body recognised by the 
Secretary of State for Scotland as being representative of pharmaceutical contractors. 
Terms of service are similar to those in England and Wales. 
From the political perspective, since 1979, Government has been directed by a 
fundamentally anti-collectivist ideology which emphasises the social values of freedom, 
inequality and individualism 59 Anti-collectivists have argued that the collective force made 
up of individuals with freedom to choose within a market is essential to reveal inequality in 
service and, through the voting-with-their-feet principle, to generate incentives for innovation 
and improved service efficiency. This has manifested in the most recent structural changes 
to the NHS, fundholding GPs, hospital trusts and most recently the creation of autonomous 
District purchasers of services. By 1996, the latter locally defined bodies will purchase 
services from CPs. Whether this will be through the FHSA or a hybrid with the District 
purchasing authority is unknown 60 
.. __, 
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1.5.2 Community pharmacies 
Community pharmacists receive payment for dispensing services from a Government 
agency. As such, they are essentially salaried employees with an additional income from 
non-dispensing activities. In American, Boyd and colleagues 61 demonstrate the high 
percentage of CPs' time spent performing nonprofessional tasks. They suggest "that the time 
was not available under the present system to expand the pharmacists' professional 
activities". The following discussion demonstrates the complex nature of payment for British 
CPs. Negotiating this bureaucracy must inevitably detract from the time available for 
professional activities, such as that required for an advisory role. 
Under the National Health Services Acts 1946-77, payment to holders of a contract with the 
FHSA, to dispense items at a licenced premises on a general practitioner's prescription, is 
calculated by the Prescription Pricing Authority (PPA). In England, the Pharmaceutical 
Services Negotiating Committee (PSNC) discusses terms of payment with the Department of 
Health (DofH) on behalf of pharmacy contractors. Any agreements are operationalised by the 
PPA. 
Details of payment for dispensing prescriptions are set out in the monthly edition of the Drug 
Tariff. As data was collected for this thesis from 1988 to 1989, the September 1988 edition 62 
is considered. At this time, calculation of payments to the pharmacy contractor was 
determined by a formula consisting of: 
A. the cost of drugs, appliances and chemical reagents; 
B. plus an on-cost payment; 
C. plus a fee for bulk quantity; 
D. plus a professional fee; 
E. plus an 'essential small pharmacy' payment if applicable; 
F. plus a container allowance; 
G. plus a training fee; 
H. plus a broken bulk fee, if applicable; 
1. plus a fee for pharmacies operating on a "rota" basis to cover emergencies and which 
remain open in addition to the hours required In their contract; 
J. plus a fee for emergency supply of a prescription medicine; and, 
K. less a percentage based on the total amount remunerated. 
The principle of on-cost was introduced as a commercial payment to reflect that dispensing 
was both a commercial as well as professional activity. Initial postal surveys, 64 to define 
the expenses incurred by contractors, proved unreliable. From 1962 to the demise of the 
cost-plus contract 65 in 1989, periodic audits were conducted with a reported three percent 
error in generalisation 66 Notably, Jones 67 cites a newsletter of the Chemist Contractors 
Committee 68 which stated that one of the activities paid for in 1971 was the "handing out to 
patients the dispensed item; giving any verbal instructions as to usage etc" 
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In 1988, the pharmacy contractor was paid a professional fee of £1.30 for each of the first 
1,400 prescription items dispensed per month. The next 5,250 were paid at £0.61 per 
prescription and thereafter at a rate of £0.67. Additional professional fees are paid if a 
prescription item involves extra paper work or responsibility, as with Controlled Drugs, or 
requires aseptic dispensing, sterilisation extemporaneous compounding, the measurement of 
appliances and dressings, supply of oxygen or urgent dispensing. Each of these additional 
fees requires a suitable endorsement on the prescription. The author was unable to locate an 
official breakdown of the elements paid for by the professional fee. 
Pharmacies are required to forward dispensed prescriptions by the 5th day following the end 
of the month in which the supply was made. The processing of prescriptions by the PPA 
takes a finite time and drug wholesalers require payment by pharmacy contractors within two 
to four weeks. To obviate the cash flow problem pharmacy contractors receive an estimated 
sum plus any arrears at the start of each month. 
This account outlines the method by which payment is calculated for individual prescription 
items dispensed. In April 1985, National Health Service reimbursement was withdrawn for 
specific items. This created the so called 'Black list' or carte blanche. General practitioners 
were still able to prescribe such items; however, the cost was met by patients. 
Published figures are available from Government sources detailing both the cost of 
dispensing in the United Kingdom by pharmacies and by appliance contractors and the net 
ingredient cost taking into account the reduction based on the amount remunerated (figure 7, 
page 32)2.5 69 Both CPs and appliance contractors have contracts with the FPC to dispense 
prescriptions, the latter for specific non-drug products. As the numbers of dispensed 
prescriptions and associated prescription costs for CPs have been shown to account for over 
99% of the total, 7 figure seven, page 32, can be taken as representative of the economics of 
community pharmacy dispensing. It would appear that, over the last 15 years, the net cost of 
ingredients has been consistently just under 80% of the total cost of dispensing and the total 
cost of dispensing hovering around 11 % of total NHS health care expenditure. Net income 
from dispensing in relation to the net cost of ingredients has remained stable. Increases in 
absolute remuneration for dispensing may be accounted for by increasing inflation in 
conjunction with changes in the number of prescriptions dispensed. 
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Figure 7* 
Remuneration from dispensing in the United Kingdom compared to health 
care expenditure by time 
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In summary, this account of community pharmacy remuneration began with the 
Governmental structure managing pharmaceutical services. Since 1977 the FPC and after 
1990 the FHSA have provided the first level of management. The purchaser-provider 
philosophy is bringing about local variations in this structure. 
Payment for community pharmacy services is calculated on a cost-plus basis. Community 
pharmacists' livelihoods depend on accurate endorsing of prescription forms and prompt 
completion of accompanying documentation. It is implicit that endorsing and processing 
each item requires an intimate knowledge of the relevant application of the Drug Tariff. Time 
taken in this bureaucratic process is not available for other activities such as PMA. Net 
income from dispensing plus non-pharmaceutical sales funds CPs' salaries and maintains 
businesses. Remuneration from dispensing as a proportion of health care expenditure and 
overall dispensing costs has been stable since the mid 1970s. 
Having described who pays, how payment is calculated and how much is involved, the next 
section continues with the changing nature of dispensing and an account of how many and 
which drugs are dispensed. 
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1.6 The prescription 
1.6.1 Prescription dispensing 
This section provides evidence for a change in CPs' dispensing activities from small scale 
manufacturer or compounder to their current role as dispenser of pre-manufactured items. 
Although this may be seen as a decline in technical expertise, 70 the process of supply has 
become increasingly more structured. This aspect will be examined by placing the dispensing 
act in the context of supply using the link between prescriber and dispenser, the prescription. 
Having described the process of supply, the epidemiology of prescription dispensing will be 
investigated with a comparison of local and National figures. 
There has been a forced change in pharmacy dispensing. The dominance of the liquid 
dosage form which was compounded in the dispensary and could be easily manipulated to 
accommodate variations in prescribers' directions, has given way to prepacked dispensed 
medicines, usually in the form of the compressed tablet (figure 8). Preparation of the latter 
required more sophisticated, heavy-duty machinery and large scale manufacturing was 
clearly more cost-effective. The fundamental underpinning for pharmacy, small-scale 
manufacturing, was gone. As early as 1944, it was noted that Pharmacy's role might be "little 
more than an intelligent retail distribution of ready-made and centrally standardised 
products". 71 
Figure 8* 
Number of unique formulae for local compounding and industrial manufacture 
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33 
ý.. ýýi... t., w. crý. ': dý. ls tc.. w . tu: ýb s.. i-uw.. ýsT".: e= v`.. -. 
rýý" 
Pharmacists are currently seldom directed to compound medicines. Their role has changed 
to one of the retailing middle-man. To place dispensing in context, it is helpful to examine a 
strict set of procedures which are relevant to current pharmacy practice. To ensure safety 
and efficiency 90 CPs are encouraged to: 
1. Read the prescription carefully and check that it is complete and valid; 
2. Check that the dosage and directions are appropriate; 
3. Dispense the medicine; 
3.1. check any calculations; 
3.2. check the storage requirements; 
3.3. collect the container; 
3.4. write the label; 
3.5. prepare or select the medicine; 
3.5.1. Compounded extemporaneously; 
3.5.2. Weighed or measured from stock which has been previously 
compounded from basic ingredients on a small scale in the 
pharmacy; 
3.5.3. Weighed, measured or counted from stock purchased from a 
manufacturer; or, 
3.5.4. Supplied in a manufacturer's original pack. 
3.6. pack the medicine into the container; 
3.7. fix the label; and, 
3.8. check the finished product. 
4. Counsel the patient; 
5. Endorse the prescription and collect any fee; 
6. Dispose of the prescription; and, 
7. Make the appropriate records. 
This description reinforces the relatively minor role of compounding, and indeed the act of 
supplying pre-packed items. Notably, procedure four, to "counsel the patient", is a unique 
activity which is not under the umbrella term "to dispense the medicine". Procedures two, 
five, six and seven have a monitoring and clerical implication, to check, to endorse, to 
dispose, to record. Evidence for the increased bureaucracy of the dispensing process can be 
seen in subtle changes to the design of the 1988 FP1 0 prescription forms compared with its 
predecessor the 1963 ECI0. Additions include: a box which prescribers may use to indicate 
the number of days treatment; the letters NP which may be cancelled to avoid identifying the 
medication with a specific title; and a specific area entitled 'Pharmacist's pack and quantity' 
endorsement'. Community pharmacists must follow each monthly edition of the Drug Tariff 
and adhere to the current requirements in order to receive payment for dispensed 
prescription items. Space allocated specifically for endorsing testifies to an increasing 
commitment on the part of the CP to processing rather than compounding. This is further 
emphasised if the back of both prescription forms are compared. Since 1st June 1952, 
patients have been charged a levy in respect of each item dispensed. In 1963, a fee of £0.10 
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per form was charged with no exemptions. Form FP1 0 contains a multiple-category 
declaration section for exemptions. Community pharmacists are not directly liable for 
inaccuracies in the completion of the declaration but time is inevitably spent in servicing this 
aspect of the dispensing process. The 1st April, 1995 introduced even more complicated 
declarations to form FP10.91 
Procedure one of the supply process has more than a monitoring or clerical overtone. The 
1968 Medicines Act (section 1.3, page 23) dictates the manner in which a prescription must 
be written before a POM can be dispensed by a CP. The regulations restrict the prescriber 
and also place the CP in a gate-keeping position, a role which is reinforced as payment is 
based on adherence of all parties to the code. Briefly, a current prescription for a POM must 
have: 
1. The patient's name, address and age if under 12 years; 
2. The names and quantities of the medicaments to be supplied; 
3. Instructions for the patient; 
4. The prescriber's profession, address and signature; 
5. The date on which the prescription was written or signed; and, 
6. The proper name (designated on prescription forms as "NP" for Nomen Proprium). 
Certain substances are additionally controlled by the Misuse of Drugs Act 1971 and 
subsequent regulations 92 Prescriptions for Controlled Drugs must be indelibly written, signed 
and dated by a valid prescriber, individually recorded by the CP and include: 
1. A date not more that 13 weeks previously; 
2. The form of the medicine, whether tablet, capsule, injection etc; 
3. Strength of the preparation if appropriate; 
4. Dose to be taken; and, 
5. Total quantity to be taken in words and figures. 
In summary, it can be shown that compounding has largely been superseded by the supply of 
manufacturers' products. The act of supply has become increasingly burdened with clerical 
and monitoring functions and legal directives have positioned the CP as a custodian of drugs 
in society. It is emphasised that these activities will have a time element attached. However, 
time taken in compounding has also been released. Previous sections have shown that the 
number of pharmacies and CPs has slowly declined for a number of years, having only 
recently levelled out (figure 3, page 24 and figure 4, page 25). If the number of prescriptions 
dispensed has followed the same pattern, then, in a gross sense, CPs' prescription supply 
activities are likely to have remained static with time. In the following section, the number 
and type of prescriptions dispensed is examined. 
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1.6 The prescription 
1.6.2 The epidemiology of prescription dispensing 
Currently, about eight out of ten NHS patients who consult a family doctor are given at least 
one prescription as part of their medical treatment. The number of prescription items 
dispensed per head of population has risen from 4.5 to 8.8 items per year during the period 
1949 to 1993. In 1988 the figure was 7.5.93 Information on the number of prescriptions 
dispensed in the United Kingdom between 1949 and 1993 is provided in figure nine. Of all 
prescriptions, approximately six percent are dispensed by GPs In rural areas where 
pharmacies are not readily accessible. Figures for such dispensing are excluded from those 
cited. As shown, the number of prescriptions dispensed has more than doubled during this 
period. Although the reduction in compounding or preparation activities plus the advent of 
computerisation would offset time taken by increasing bureaucracy in supply, it Is likely that 
the increase in number of prescriptions has lead to an increasing emphasis on all aspects of 
dispensing. 
Figure 9* 
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Figures include prescriptions dispensed by CPs and appliance contractors, however, 
the numbers by the latter are said to be negligible in comparison to the former. 67 
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Numerous factors underlying the increase in the number of prescriptions dispensed have 
been suggested, including: 
1. increases in the overall population; 
2. changes in the populations' demographic structure, notably the rising proportion of 
elderly people; 
3. the development of radically new medicines; and, 
4. social factors such as raised public expectations. 
Of these factors the most numerically obvious is the increase in dispensing for the elderly, 
such as those of pensionable age, men aged 65 and over plus women aged 60 and over. 
The total number of prescriptions dispensed for this group increased from 98 to 176.5 million 
between 1978 and 1993 (figure 10, page 38). This represents an increase in prescriptions 
dispensed for each individual per year from 12.2 to 19.8 respectively. Figures for those who 
were chargeable fell from 5.5 to 2.2 items per person. Increases in dispensing for the elderly 
more than balanced decreases in other sections of the community. 25 
By 1988, there were approximately 2,300 pharmaceutical preparations available for 
prescribing and dispensing in various strengths and pack sizes in the United Kingdom. It is 
estimated that only 20% of this total were frequently dispensed 25 Dispensed items are 
classified therapeutically by the PPA for the DofH using the Drug Master Index and relevant 
appendices. 4 Figure 11, page 38, lists the percentage of preparations dispensed in Great 
Britain In each class for the years 1983 to 1989 ordered according to the number dispensed 
in 1988. One of the most striking features of prescription dispensing during this period has 
been the pronounced decrease in the frequency of prescribing for class one drugs, those 
acting on the central nervous system. The major component of this effect was the reduction 
in prescribing of sedatives and hypnotics, class 01(3), from 17,604,000 in 1983 to 10,882,000 
in 1989. A further feature concerned preparations acting on the respiratory system, class five, 
which showed a dramatic decrease in 1985, the year a 'limited list' or, 'Black list' was 
introduced. Specifically, remuneration for dispensing of expectorants and cough' 
suppressants was limited to a reduced number of products resulting in a drop in dispensed 
items from 10,358 in 1985 to 7,855 in 1986 s5 
In summary, the number of prescriptions dispensed in the United Kingdom has increased in 
excess of the population. The difference can be accounted for by the growth in the elderly 
population and a change in prescribing patterns. Examination of prescribing using the 
number of prescriptions dispensed in defined therapeutic classes indicates reductions in 
class five items and in class one items, specifically, ' sedatives and tranquillizers. ' 
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Figures 10 and 11 * 
Prescription items dispensed in England in age categories by time 
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1.7 Conclusion 
Concerning the general question 'Who are community pharmacists? ', it can be concluded 
that they are individuals working in the community who are primarily concerned with the 
dispensing of drugs. They are members of one branch of the generic occupation of 
Pharmacy. 
There is a long history of conflict between those individuals whose main concern is the 
medicinal product and those who diagnose medical problems for which medicines are 
considered appropriate therapy. The Rose case demonstrates that the provision of advice as 
a free service to the public may be a powerful argument in developing the roles of 
professional groups. Thus, acquisition of drug knowledge and the right to inform patients is 
central to the continued existence of Pharmacy. 
Through the necessity for registration in order to practise, community pharmacists are tied to 
the decisions of The Society. It follows that co-operation of The Society is a necessary 
prerequisite for any external influence on pharmacy practice. Legal rulings necessitate that 
The Society operates through its Code of Ethics in directing the practice of pharmacy. The 
Code of Ethics is, therefore, a major mechanism for influencing pharmacy practice. 
The role of CPs has changed dramatically this century from one based on the physical and 
practical skill of compounding to an arguably less technical activity of dispensing pre- 
manufactured preparations. The majority of pharmacists are trained to graduate level. On 
successful completion of the degree their breadth of knowledge on drugs is second to none, 
yet their legal responsibilities are primarily to dispense prescribed medication. The legislated 
restriction of the general public to community pharmacies for access to listed medication 
produces a dependence on Government backing for their continued economic prosperity. 
The legal right to dispense prescriptions, the cost of which is reimbursed by Government, is 
the CPs' current powerbase. In operationalising restraints on public access to medicines they 
are, in effect, salaried public servants with Government as their sole employer. 
Trends in both the number of full-time CPs and pharmacies have levelled out. Given net 
increases in the number of prescriptions written per head of population, increasing general 
population and the proportion who are elderly, the number of prescriptions dispensed per CP 
is likely to continue increasing. The effect on pharmacy practice will depend on recent - 
increases in the number of part-time CPs and the proportion of females. 
In the next chapter, a requirement for PMA and the response of occupations which are in a 
position to provide such information are considered. 
ýý. 
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CHAPTER 2 DESCRIPTION OF THE PROBLEM 
2.1 Summary 
"In policy analysis, the most creative calculations concern finding problems for which 
solutions might be attempted"- Aaron Wildavsky 96 
In chapter one it was argued that the provison of advice on medicines is an activity of public 
concern. Chapter two continues in section 2.2, page 42, by reviewing evidence affirming this 
activity as an area for development by Pharmacy. As predicted in chapter one, hostility 
towards the activities of pharmacists comes from GPs. Legal rulings are described which 
indicated a shared responsibility between CPs and GPs for dispensing and providing the 
correct PMA. The importance of dispensing compared with over-the-counter (OTC) and front- 
shop sales is described. 
If CPs have a role as advisors to the public, then fundamental questions must be asked. 
First, do the general public and patients perceive CPs as legitimate sources of advice? 
Limited evidence that they do is presented in section 2.3.1, page 44. Second, who is the 
patient's preferred source of PMA, the GP or CP? Qualified evidence is presented 
demonstrating a preference for the GP (section 2.3.2, page 45). Third, do patients want 
advice? A literature review is presented demonstrating a perceived need on the part of 
patients for more advice, yet a reluctance to ask advisors. The lack of feedback creates a 
breakdown In communication whereby patients' needs remain unmet. A potential mismatch 
in the category of advice provided by advisors and that perceived as required by patients Is 
first noted (section 2.3.3, page 46). This mismatch is explored in greater detail in section 
2.4.1, page 50, where studies of 'what the patients want to know' are reviewed. It is argued 
that advice may be categorised under headings of 'What to do with it', 'What is prescribed', 
and 'Specific problems'. A sub-category of 'Specific problems' with the heading of 'Side 
effects' Is specifically identified. Evidence is presented that patients require advice across 
this broad range of categories. This requirement is compared In section 2.4.2, page 53, with 
studies of the activities of advisors. Although the advisory activities of CPs and GPs Is 
difficult to ascertain, it is argued that is is likely to be low in comparison to perceived need, 
and also dependent on the category of advice involved. The disparity is at its greatest for the 
sub-category 'Side effects'. 
Unless advice can be comprehended by patients, is remembered and results in compliance 
with medication, then its provision is of limited value. Section 2.5.1, page 59, presents a 
review of the literature and demonstrates patients' lack of comprehension of both GPs' verbal 
advice and written advice in the form of prescription labels. Patients are said to be diagnosis- 
orientated when visiting GPs and medication-orientated when having a prescription 
dispensed. It is argued that the patients' medicine orientation presents the potential for CPs 
to remedy any failures in comprehension. That patients also fail to remember advice from 
GPs is demonstrated in section 2.5.2, page 65. However, this is of little consequence for their 
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prognosis providing they are still compliant with their medication. In the final section of this 
chapter (section 2.5.3, page 67), non-compliance is shown to be of the order of 50%. 
Relationships between compliance and structural variables, situational barrier models, 
educational approaches and motivational models provide evidence that the means exist by 
which advisors may optimise their activity. It is argued that it is possible for CPs to have a 
valued impact on patients' use of medicines. However, there is little evidence that CPs' 
normal activity has such an impact. 
The problem identified in this chapter is simply that patients want PMA and advisors are not 
meeting demand. When advice is provided by GPs much of the understanding is lost. Due to 
their education and position in the medication process, there may be a role for CPs as 
advisors on prescription medication. However, little is known about their normal activity or 
whether it is of any use. The problem has been noted, but the evidence that CPs are able to 
do anything about it is lacking. 
"_ ý, 
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2.2 Community pharmacists' proposed role as advisors on medicines 
Authors have suggested that community pharmacists develop their advisory role on 
prescription medication. 97 98 Mr John Tapster PhC writes in The Practitioner, a journal 
directed at GPs: 98 
'There has been a distinct shift of emphasis from the pharmacist's former role of compounder 
of medicines, to dispenser of pre-packed preparations. The time saved should increasingly be 
used to advise and counsel patients about their prescribed medicines and to treat minor 
ailments. the continues] The pharmacist will devote as much time as is necessary to advising 
patients about the dosage and time of doses of their dispensed medicines, reinforcing the 
importance of compliance and warning of any possible side-effects' 
From the history presented In chapter one of this thesis, this perception of the future is 
unlikely to be shared by all GPs. Commenting on the future of pharmacy, Dr Malvin Salkind, 
a professor of general medical practice, states that pharmacy has "lost control of the drug" 
and that patients are bombarded with information and asked the CP for products rather than 
advice 99 Dr David Roberts, general practitioner and chairman of the Dispensing Doctors 
Association, writes in the Journal of the Royal College of General Practitioners that: 10° 
"the main role of the chemist is to supply medicines according to prescriptions written by the 
doctor. It is assumed that the doctor is aware of the effects of the medications he prescribes 
and it is, of course, the doctor who takes sole responsibility for inappropriate prescribing. In 
effect, the chemist acts rather like the chef in a kitchen, preparing the order as written on the 
piece of paper presented to him. Unlike the chef, however, he is not allowed to embellish it in 
any way. He is simply a supplier of goods, a storekeeper reaching for goods from a shelf. the 
continues] It has been said that by double-checking the prescription the chemist has saved 
many a patient from the mistakes of doctors. That may be so but this role is rapidly being 
supplanted by computer technology in doctors' surgeries and dispensaries". 
Five months later and In the same journal, a medical sociologist, Dr Geoffrey Harding, and 
an academic pharmacist, Dr Kevin Taylor, 101 responded to the above statements. They cited 
the Migril case, 102103 where an overdose of tables for relief of acute migraine attacks 104 
caused ischaemia, and made the point that pharmacists shared legal responsibility with GPs 
for medicines dispensed. This is one of two such cases, the other being where Daonil, TM 
used for the treatment of diabetes, was misread and the antibiotic AmoxilTM dispensed In 
error. The mistake reinforced the joint responsibility for dispensing. 105 106 An appeal by the 
GP involved was later lost in the High court. 107 Harding and Taylor noted that computers rely 
on the capabilities of the operator and cannot make clinical, pharmacological or professional 
judgements. They state that CPs have the required knowledge and "are skilled at making 
such judgements" for the ultimate benefit of the patient. Dr Roberts made no mention of the 
shared responsibility nor of a possible role for CPs as advisors on prescription medication. 10° 
On this latter point, Harding and Taylor 101 noted that: 
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"At the point of handing over a dispensed medicine, pharmacists reiterate prescribers' 
instructions and give additional advice where appropriate. [they continued] ... by reinforcing 
the prescriber's instructions, the pharmacist enhances the compliance of patients with their 
drug regimen". 
Thus, concurrent with the loss of a compounding function, an advisory role on prescription 
medication is acknowledged and even used in defending the existence of CPs. 
Community pharmacists continue to dispense and be paid accordingly. However, they 
supplement their income by the sale of OTC, non-prescription goods. A question might be 
asked, what incentives are there to provide a dispensing service with 'free' advice if an 
alternative income provides economic viability? In 1982, British community pharmacy 
accounted for only 66.5% of OTC sales and this figure is on the decline. 108 In 1988, a 
marketing company is reported to have expressed the opinion that the future of CPs lay in 
expanding their health care role, by keeping patients' medication records and giving 
advice. 109 
It has already been shown that the amount remunerated per prescription item has reflected 
changes in the general economy and the number of prescriptions dispensed per pharmacy is 
increasing (section 1.6.2, page 36). Thus, the decline in income from non-dispensing 
activities will produce even greater reliance on prescription dispensing as a source of income 
for CPs. It might be argued that as dispensing assumes even greater prominence so will the 
available resources to refine associated tasks such as the provision of advice. 
So far in this section we have noted the emerging prominence of dispensing as an activity for 
CPs. Also, that an advisory role for prescription medication is perceived to be a fundamental 
activity. In recent history it has been the general public through its representatives in 
Government and Law who have been the arbiters of the availability of advice on medicines. 
In the Rose Case, compounders were allowed to provide medicines on the basis that advice 
was perceived as a public benefit. It is reasonable to propose, therefore, that public opinion 
on legitimate sources of advice might be a major factor in ascribing an advisory role to CPs. 
It follows that the critical questions are; to what extent does the general public perceive CPs 
as legitimate sources of advice, who do they prefer, CPs or GPs as advisors and are they' 
satisfied with the advice provided? These questions are addressed in the next section. 
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2.3 A perceived need for prescription medication advice 
2.3.1 A legitimate role for community pharmacists? 
No survey has been conducted to investigate the perception of either the general public or its 
subset, 'patients', as to the leaitimacy of CPs or GPs as advisors on prescription medication. 
It must be accepted, therefore, that individuals reporting that they would seek, or have 
sought, information are indicating their perceived need for advice and by implication are 
legitimising the advisor's role. 
The only relevant British study of this kind was commissioned by the NPA and carried out by 
the market research organisation, Marplan. Surveys were conducted before and after 
newspaper and magazine advertising which promoted CPs as advisors on minor ailments 
and OTC preparations - the 'Ask your pharmacist' campaign. Individuals were asked whether 
they would consider asking their local CP for advice on prescription medicine; 30% answered 
affirmative in August 1982 and 34% in February 1986. Further, the 1,982 interviewees in the 
1982 study were given the options of 'dispenser of medicines', 'retailer of cosmetics/toiletries 
etc', 'adviser on medicines' and 'adviser on minor ailments' then asked "which of these 
aspects do you consider as the most important, 2nd most important and 3rd most important 
of the retail pharmacist's jobs? " Community pharmacists' activities as advisors on medicines 
was ranked first by 12.8% of interviewees and dispensing, by 82%. 110 
In America, researchers have asked, "What kind of health matters do you think you might 
discuss with the pharmacist? ". 11' Prescription medication as a topic was noted by 12.5% of 
the sample 112 and 37% responded 'yes' to the question "During the past year, have you 
asked a pharmacist for advice or for counsel on prescription or non-prescription drugs? "" 13 
Pharmacists were regarded as a principal source of prescription information by 25% of the 
respondents to a survey of elderly patients. 114 Other investigations have concluded that; the 
general public's perception was that the CP did not offer advice about the prescriptions they 
dispense, ' 15 and that 'the failure of the pharmacist to serve as an advisor to patients does not 
appear to stem from patient unwillingness to accept advice. Rather as other studies indicate, 
it appears pharmacists do not offer advice, but when they do, the patient willingly accepts 
it". "6 In Australia, seven of 68 respondents indicated that they had sought PMA from a 
pharmacist in the previous 12 month period. The authors suggested that "pharmacists may 
need to become more forceful in counselling about prescribed medication ". 117 
In summary, there is some, albeit limited, published evidence which legitimises a role for 
pharmacists in Britain as advisors on prescription medication. Evidence from America and 
Australia support the view that a similar perception exists in those countries. 
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2.3.2 Preferred sources 
An unnamed market research company interviewed 500 shoppers in a Newcastle shopping 
centre, asking each about their current sources of information on prescribed medicines. Most 
respondents (65%) said they would refer to their 'doctor' if they had a problem with 
prescription medication, 25% gave a pharmacist as their preferred source, 6% would 
approach nurses, 1.6% relatives and no mention was made of the remaining 2.4%. Such 
evidence confirms the dominance of the doctor as a legitimate source of information on 
prescription medication in the eyes of this subsection of the general public. 118 
Similar findings are reported from America. Joubert and Lasagna 19 asked orthopaedic 
inpatients, general medical outpatients and 'customers' at two community pharmacies to rate 
their knowledge of OTC and prescription drugs, then to assess the importance of various 
sources of information by labelling them as; 'very important', 'fairly important' or'unimportant' 
and finally to indicate the preferred main source of information. Four results are notable. 
First, evidence form the sample indicates that public knowledge of OTC drugs and 
prescription medication is similar. Second, of the 137 (66.2%) respondents, 51.5% felt that 
pharmacists were a 'very important' source of information on prescription medication, 
although, the preferred main source was clearly the doctor. Interestingly, package inserts and 
medical reference books were preferred to both pharmacist and medication labels as sources 
of advice. Third, the trend for preferences in sources of advice was reversed for OTC drugs 
where the majority of respondents preferred the pharmacist as a source over the doctor. 
Finally, the perceived differences between OTC drugs and prescription medication, means 
that published results based on respondents perceptions of generic terms like 'drugs' or 
'medicines' without qualifications such as, OTC or prescription, may be misleading. Thus 
results such as doctor 86%, pharmacist 21% as responses to the question "Where do you find 
out about drugs and their usage? " are difficult to interpret. 120 Similarly, the change between 
1979 and 1985 from 67% to 71 % in numbers who agree with the statement "Chemists are 
really just small shop-keepers and know very little about medicines" 121 must be interpreted 
cautiously. 1-., -,. I-- 
In answer to the question of the British general public's preferences for an advisor on, 
prescription medication, the limited evidence available points to the doctor as the main 
choice. Again, American literature supports this conclusion. But what about the advice itself? 
How does the general public perceive the advice it is given? Do they want more? Is there a 
perceived need which is not being met by current practice and if not, is there a reason? 
., 
4ýt-Y 
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2.3.3 Patients want more information 
This section provides evidence that information on drug treatment and specifically drug side 
effects is both perceived as required by the patient yet not generally sought. Details of major 
studies are provided in table one, page 48. 
Morrow and colleagues in 1993, asked, 'when I am collecting a prescription the pharmacist 
explains to me about how to take the medicine'. Of 254 respondents, 93 (36.6%) indicated 
that this was always their current experience while, 168 (66.4%) desired that such advice is 
always provided. 122 Clearly the public want information and may desire more than is being 
provided. Studies in the community report 79% 123 and 92% 124 of respondents who would 
like the CP and 62% 125 either the CP or the GP to give more advice concerning prescription 
medication. Notably, 93% 123 felt they should be informed on the dangers and hazards of side 
effects from prescribed medication and between 72.7% 125 and 80% 124 were uninformed 
about potential side effects. In conclusion the authors state; "The results of the survey would 
appear to suggest that there is quite a strong urgent demand by the public for the 
[community] pharmacists to play an official and expanding role in the advisory field... "123 and, 
'The survey revealed an unsatisfactory state of knowledge about prescription medicines by 
the general public". 124 The importance of these few studies may be demonstrated by the 
number of citations. 126 127 128 129 130 A figure of 72% for respondents requiring more 
prescription drug information has been published in America. 13' 
Studies in Hospitals also support an underlying perceived need for advice. In addition they 
variously identify 11%, 132 24%, 133 and 53%134 of respondents who wanted more information 
yet failed to ask for it. Studies of communication between patients and medical practitioners 
suggest that patients are satisfied with the advice provided, 135 but are reluctant to ask 
questions. 136 Summarising public opinion concerning the NHS, detailed in Royal Commission 
research papers, Klein 137 reported that "almost half of those who wanted to know more felt 
that they could not ask their doctor for the required information". Clearly, the general public 
and patients perceive that they want more advice. Yet they fail to make their wishes known. 
As patients do not provide feedback, medical practitioners assume their information needs 
are met. A communication breakdown results. 138 Ley, in 1988,139 summarises the available 
evidence and suggests that the patient's reluctance to ask questions: °. 
"probably stems mainly from over-deferential attitudes towards doctors. Its main 
consequences are: 
a. patients being less informed about their condition than they would like; 
b. absence of feedback to clinicians about the adequacy of their performance as 
communicators; and, 
c clinicians believing that patients do not want information". 
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It has been shown that patients do request some information from GPs 140 but leave the 
consultation perceiving a need for more advice 123124125 and reportedly request information 
from other sources, such as pharmacists. 136 141 142 143 
Global figures for patient initiated request for advice from CPs vary from 2.8% 141 to 2.4%. 142 
Figures of 3% and 4% were reported for specific requests on 'how much to take' and 
'possible side effects' respectively from both pharmacist and medical practitioners. 136 
Inspection of table one, page 48, reference 136 shows that respondents recall being offered 
advice far more frequently than actively seeking information and that they report making a 
similar number of requests in both medical and pharmacy settings. Much greater values for 
patient initiated advice were noted in a hospital setting. 143 From inspection of the results, it 
would appear that hospital pharmacists supplied information about how often to take the 
drugs, how much to take each time and the best way to take it, while hospital medical 
practitioners discussed the duration of treatment and possible side effects. Concluding 
remarks made by the authors are noteworthy in the light of the differing emphasis. They 
state: The pharmacist is generally the last practitioner the patient sees in hospital and may 
therefore be an influential source of information. The prescribers' instructions can be 
reinforced and supplemented, and the patient can be encouraged to ask questions". This was 
the summary of a Drug and Therapeutic Bulletin article which suggested that 'The information 
given by the different professionals should be concordant and mutually reinforcing". 144 
However, it would appear in practice, certainly from the results presented, that the two 
advisory groups are reinforcing only part of the message, and where advice on side effects is 
concerned, the hospital medical practitioner is providing the majority of the information. 
In summary, it would appear that patients perceive a need for additional advice yet are 
reluctant to request information from either pharmacists or GPs. Patients and GPs appear 
caught in a communication trap whereby patients' perceived needs for advice are not 
fulfilled. Comparable studies of patients' perceptions of pharmacists as advisors on 
prescription medication which might rationalise why so few patients seek advice have not 
been published. In the community, respondents remember receiving more information in 
medical rather than pharmacy settings. The nature of advice may depend on who is 
providing the information. As CPs are the last link in the advisory chain, it is important to 
investigate any mismatch between advice sought by patients and provided by advisors. 
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2.4 Advice on prescription medication 
2.4.1 What the patient wants to know 
Results of the four studies A, 119 8,125 C 145 and D 146 which sought to determine what patients 
want to know about prescription medication are provided in table two below. 
Table 2 
Importance of advice by category of information 
Percentage requesting advice Rating of advice* 
A119 B12 C145 D146 
Category of information (median%, ran e n=368 n=137 n=84 n=67 n=70 
1 What to do with it (69.9%, 46.8) 
Disposal of medicines 44 
Duration of use 4.63 (0.79) 59 
Explanation of medication directions 87 
Generic and brand names 3.94 (1.34) 11 
How long to take it 75.5 
Number of refills 3.88 (1.26) 33 
Storage 56 
Storage instructions 4.21 (1.16) 13 
What to do if a dose is missed 64.4 4.04 (1.18) 10 
When and how much to take 4.46 (0.95) 64 
When and how to take it 90.8 
(2) What is prescribed 81.25%, 42.4) 
All other uses 54.7 
How to tell if it is not working 58.4 
Medication purpose 4.44 (0.96) 67 
Name of medicine 82.9 
Other important uses 74.5 
Purpose of medication 91 
Purpose of treatment 79.6 
The name 97.1 
Ways to know if the medicine is working 4.46 (0.81) 31 
What you are using it for 93.4 
3 Specific problems (80.3%, 15) 
Actions to avoid, eg driving 76 
Drug interactions 72 
Effect of alcohol with this medicine 3.32 (1.72) 19 
Effects of foods with this medicine 4.55 (0.95) 24 
Effects of other drugs 4.73 (0.74) 17 
Precautions such as possible effects on driving 87.0 
Precautions to observe 4.90 (0.53) 60 
Problems with alcohol or other drugs 84.0 
Risk of using too little 80.3 
Risks of not using at all 78.8 
Risks of overdosage 86.1 
4 Side effects (76.6%, 46.1) 
All the possible risks of normal use 76.6 
Common risks of normal use. 89.1 
Common side effects 4.50 (0.91) 40 
Major side effects 43 
Minor side effects 75 
Side effects and what to do about them 88.3 
What to do about side effects 4.62 (0.72) 17 
Notes 
Figures for'Rating of advice' column one are responses on a scale of 5=hi hl g y 
important to 1=not very important described as the Mean ±SD. Column two is the 
percentage of patients claiming to have received advice in that category. 
t='` Categories taken verbatim. In study C categories have been taken from the text 
itself. The median percentage and range are boxed and given in brackets. 
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Referring to table two, the first two studies A 119 and B, 125 from Britain and America 
respectively, surveyed patients' opinions on the information content of written inserts 
enclosed with the dispensed item. In both of these studies, the perceived importance of types 
of advice is indicated in percentage terms. It is not stated whether or not respondents were 
asked to comment on the categories in the context of receiving such information through 
prescription information leaflets. For this discussion it is assumed that responses are 
independent of method of information delivery. The third study from Australia set out 
specifically to determine what patients wanted to know 145 and the fourth, 146 from America, to 
examine patients' perceived importance of types of information about medications. 
In table two, the median response and range for categories under each heading are provided 
as summary statistics. Comparing these with the median and range for all responses of 
79.2% and 54.1 respectively, it is demonstrated that there is little difference across a broad 
range of topics in the percentage of respondents who want advice. 
Categories of advice were collated under four discrete headings'What to do with it', 'What is 
prescribed', 'Specific problems' and 'Side effects'. The latter category may be considered a 
sub category of 'Specific problems'. These categories were devised from the results of open- 
ended questionning of patients 147 and pharmacists 148 in two discrete studies conducted by 
the author. The published papers are reproduced in full in appendices A4.2 (page 302) and 
A4.3 (page 303). Notable findings included the significant dependence on younger age for a 
perceived requirement for advice on side effects. The relative importance of side effects has 
been consistently noted by authors. For example, Joubert and Lasagne 119 noted the 
perceived importance of the concept of side effects. They included the dedicated question 'If 
there is a remote chance (e. g., 1/100,000) of dying from a usual dose of a medicine you 
have to take, do you want to know? ' to determine the reliability of earlier responses. Eighty 
one percent of respondents answered affirmatively. Similarly, Ridout and Waters 125 
concluded that, most patients needed to have more information about prescribed medicines, 
especially their unwanted side effects" and Larmour 145 noted that 60% of the under 35 age 
group wanted information about serious side effects which contrasted with only 26% for the 
over 65 age group. The perceived importance to patients of the same categories of advice 
was determined by Gardner and colleagues 146 (table 2, page 50) which reinforces this notion 
of a global requirement for advice by patients. The authors comment that: 
"Physicians, pharmacists, and others who provide patient education about medications 
should be sensitive to the fact that patients perceive information about adverse drug effects 
and interactions to be highly important. A heightened awareness and provision of such 
information to patients may lead to improved patient satisfaction and compliance" 
From the patients' perspective the importance of information on side effects has been 
demonstrated. Even oncology patients with likely terminal illnesses still wish to be informed 
of investigations, treatments and side effects. 149 Only one study 150 has specifically 
investigated the attitudes of staff in health care occupations towards the seriousness and 
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need for disclosure of prescription drug side effects. Patients indicated a desire to know all 
potential side effects no matter how rarely they occurred or how minor they were. In contrast, 
medical practitioners and pharmacists felt only minor, frequently occurring side effects 
should be listed. Limitation of the research method were noted. The clinical importance of 
side effects has been described in a study of randomly selected medical outpatients 
attending an American hospital. 151 Approximately 30% of subjects taking medication reported 
adverse symptoms with at least one medication. Subjects rarely reported modifying their 
medication regimens in response to adverse symptoms and one in four subjects did not 
discuss their symptoms with either the hospital medical practitioner or hospital pharmacist. 
Commenting on the results of the study the authors suggest that "providers (of advice] must 
be aggressive in seeking out such problems. The alternative approach .... may seriously delay 
the initiation of remedial measures by the provider': Thus, it would appear that advice on the 
side effects of prescribed medication has important implications for health care and is an 
issue which requires addressing in a proactive manner. 
So far we have mainly considered advice from the patient's perspective. Evidence has been 
presented (section 2.3.3 reference 13) that by failing to ask questions of their advisors, 
patients are not setting the agenda for the categories of advice they require. They do not 
appear to have much control over the advisory activities of either CPs or GPs so the next 
question must be, what do the advisors feel patients should know? 
A report on the minimum information for self-prescribed medicines argued that "what 
information is essential depends primarily on the medicine and the purpose for which it is 
used, although the cultural setting of its use and the educational attainment of the user must 
by taken into account". 152 Using this as a base, a guide has been published for the minimum 
information in package inserts or patient information leaflets needed to enable patients to 
make treatment with prescribed drug therapy both effective and safe. 153 These guidelines 
appear to have been accepted 129 and the debate has turned to problems of format 154 and 
readability Iss 156 157 for package inserts. Categories, such as side effects or unwanted 
effects, noted in table two, page 50, are contained within the guidelines. Thus, for package 
inserts at least, there is agreement on the categories of advice which should receive attention 
between patients and medical practitioners. 
In summary, we have qualified evidence that patients want to be informed across the full 
range of categories of advice. Advice on side effects appears to be of specific importance to 
patients yet limited studies have been conducted. Categories supported by patients are also 
evident in medical guides. It now remains to be determine exactly what information is 
provided by advisors? 
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2.4.2 Activities of advisors 
There is a dearth of information about what pharmacists actually do as advisors on 
prescription medication! Even fewer studies, none in Britain, have investigated the extent of 
provision of advice on medication by GPs. Details of the major relevant studies are 
summarised in table three, page 56. 
A reluctance to proactively control or interfere with the clinical freedom of GPs 158 means that 
some studies may, by default, be an accurate reflection of their prescription medication 
advisory activities. Unfortunately, few studies 140 158 159 160 have set out to investigate the 
PMA provided by GPs. Of the three available quantitative studies, two 140 160 reported similar 
percentages of patients who were provided advice and both used observational methods. 
The remaining study 158 relied on the less valid method of self-reported activity which may 
account for the higher percentages noted. Alternatively, activity may be related to severity of 
illness, type of medication and a host of other factors. In addition, the sample frames of all 
studies were very specific, females, 140 diabetics, 158 and individuals prescribed antibiotics. 16° 
Thus, it is not possible to generalise the results and accurately determine the average 
advisory activity of GPs. What little evidence is available (table 3[A]) suggests a 
considerable range in reported advisory activity. Lower levels of activity would appear to 
support the findings of Svarstad (unpublished Ph. D., thesis cited by Ley 13) where a series of 
medical consultations were observed and only one third of patients were assessed as 
receiving adequate information about the medicines prescribed for them. Inspection of table 
three [A] and the categories of information provided supports a differential between topics 
which would be collated under the heading 'What to do with it' and 'Side effects'. 
Turning to the advisory activity of pharmacists, it would appear that the results of studies are 
dependent on the methodology which is chosen. Individuals' perceptions of their own verbal 
activity 161 (table 3[B]) suggests that pharmacists favour the provision of advice on side 
effects. No correlation was made with observed activity and all the evidence so far refutes 
this finding. The reliability of self-evaluation is called into question and it is tempting to 
suggest that the results of this study indicate the perceptions of what pharmacists feel they 
should be doing, rather than their actual activity. Using the questionnaire method a similar 
magnitude of perceived activity 162 (table 3B) was reported. In contrast, much lower levels of 
advisory activity were seen with self-completed work analysis sheets. 163 The activity levels 
reported in the latter study are only slightly lower than those employing observational 
methods 164 165 (table 3[B]). Thus, pharmacists' perceive their prescription medication 
advisory activity being greater in magnitude and with a different content pattern than is 
suggested by work activity or direct observation studies. Verbal advisory activity has been 
determined by Livingstone and colleagues 166 using the pseudo-patient technique, but the 
method restricts generalisation of the findings. 
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A similar conclusion was reached by Ortiz and colleagues 167 in a comparison of three 
methods 168 169 170 of assessing patient counselling in Australian community pharmacies 
(table 3[B], page 56). Unfortunately, specific categories of advice were not provided in the 
published results of the three studies. However, it was possible to calculate, by multiplying 
the average number of patients counselled per day by the average percentage of counselling 
events involving prescription medication, an approximate figure for the number of patients 
counselled per day for each study. Comparing the questionnaire, 168 self-completed diaries 169 
and direct observation 170 methods reveals a familiar pattern. The authors concluded, 167 
"that the self-completion questionnaires greatly overestimated these values (the frequency 
and duration of counselling] while diaries underestimated frequencies but overestimated 
durations. Direct observations influence counselling behaviours but this influence did not 
appear to be great ... [and continue]... Direct observation would seem, prima facie, to be the 
most reliable survey method, at least with respect to the accuracy and consistency of 
recording counselling events". 
Only one study has observed CPs' advisory activities in Britain. The work of Hayes and 
Livingstone 164 was first presented as a poster exhibited at the 1990 British Pharmaceutical 
Conference held in Cardiff (table 3[B]). It was not possible from the data presented to 
determine what percentage of the total subjects receiving a dispensing service were advised. 
It was reported that 98 'prescriptions' were associated with advice out of 718 (13.6%) 
observed. Although figures were not provided, it was stated that CPs provided significantly 
more advice than assistants. In addition, it is reported that eight patients were involved in 
request for information on prescription medication. Here, then, is the first study with subject 
validity which indicates that British CPs are asked for advice on prescription medication even 
if only occasionally. 
Two other studies based on an observation method have been published. One 170 (table 3B) 
gave no indication of categories of advice, only that 42% of counselling episodes related to 
prescription medication. It is not possible to directly compare such results with the second 
study 165 as advice on The number of the tablets or capsules dispensed, the number of refills 
remaining, or the cost' was excluded. This study concluded that, "the individual pharmacist 
was the most important determinant of the level of patient counselling that did take place" 
From these studies it is clear that quantifying the advisory activities of CPs depends on the 
method of assessment. At best CPs advise slightly over half and at worst less that 10% of 
patients. 
In terms of both quantity and quality, studies of professional non-compliance'" 172 173 174 
provide further insight as to the advisory activities of CPs. 15 Pharmacists were tested for 
their adherence to published recommendations for; advising on prescription drug 
interactions 'M compounding, labelling and the provision of advice '172 dispensing '173 and 
advice. 174 For each study selected pharmacists were asked to complete test prescription(s) 
54 
by pseudo-patients. The following negative conclusions are characteristic and need little 
elaboration. Rowles and colleagues 172 stated, 'The results are a grim set of data that need 
little explanation... that the results turned out as they did is surprising and regrettable to the 
authors". Similarly, Puckett and colleagues 174 commented that the "assessment of quality is 
still poor and minima! " and noted that only 13% of the prescriptions carried the appropriate 
additional information in the form of auxiliary labels. 
In chapter one the Rose case was central to the expansion of apothecaries' activities. It was 
the provision of free advice which was at the heart of the decision to allow them dispensing 
rights. We now see that advice is still sought yet evidence is lacking that the public need is 
satisfied. How and by whom advice is provided is a social question. If CPs are part of the 
solution, it is first necessary to establish the extent to which the advice currently provided is 
appropriate to the task. For their advice to be of value, patients must comprehend, 
remember, and act on the information. Given the centrality of the role it is surprising that the 
pharmacy literature in this area is limited and dwarfed by that generated form the medical 
arena. The final section of this chapter provides a brief overview of this literature. 
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2.5 Patients' comprehension, memory and compliance 
2.5.1 Patients' comprehension of their treatment advice 
It has been argued (section 2.3.3, page 46) that patients may want more information, yet are 
unlikely to request advice. As communication is a monologue, it is essential that the intention 
behind the information must be comprehended, understood and translated into accurate 
prescription medication treatment. The most frequently reported situations where counselling 
is indicated is confusion over medication. 176 Advice may be given verbally or, where 
prescriptions are concerned, conveyed through the label. In both cases a failure in 
comprehension has been found. Details of studies which have reported a degree of non- 
comprehension with verbal advice and prescription labelling are listed in table four, page 62. 
A major problem in interpreting studies of patient comprehension is in distinguishing between 
actual non-comprehension or misunderstanding and feigned non-comprehension or memory 
failure. Using the patients' understanding of treatment information provided by GPs, Kincey 
and colleagues 135 associated non-comprehension with six (14.3%) patients. Ley 139 notes 
that patients may incorrectly believe that they have understood directions. This results in an 
underestimate of failures to comprehend. Remaining studies all used 'expert' opinion to 
estimate non-comprehension. This method assumes that patients can accurately interpret 
their own actions and are able to convey the information to researchers or'experts' who are, 
in turn, able to accurately assess comprehension. Differences in methods of data collection 
and interpretation, lack of reliability and validity, plus the assumption that advice from the GP 
accounts for the total of patient comprehension, all combine to make interpretation of these 
studies difficult. 
Three studies collected data using a telephone method'177 178179 but only one reported the 
number of interviewees and a measure of reliability. "' Four used questionnaire-structured 
interviews, 158 180 181 182 but in only one were the details confirmed using patients' notes 182 and 
one 181 provided the instrument used. The results of the latter study 181 were published in an 
expanded form, with additional authors, in a second journal 183 and is one of only two sources 
which clearly distinguished between understanding or comprehension and non-compliance, 
where patients understood the prescribed regimen but did not follow the instructions. Three 
further studies used multiple techniques, 135 184 185 but in only the one case was specific detail 
on the method provided. 184 Even then it was assumed by the researchers that an incorrect 
response was a misinterpretation rather than a lack of knowledge. This was a dubious 
assumption, as the tabulated data implies that respondents had some knowledge on every 
prescribed item. Three studies reported no specific method of data collection other than a 
home visit 186 167 or interview. 188 Finally, one 189 based comprehension on a communication 
score for key points as determined by each GP. The average error rate of non- 
comprehension reported in this study contrasts with the majority of investigations. Tuckett 
and colleagues 190 reaffirmed the link between patients' comprehension and their perception 
of the information's importance using a method based on interviews, rating procedures and 
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'third party' judgement. Although investigations of reliability and validity were undertaken, no 
account was made of the number of advisory statements provided in the consultation nor the 
degree of probing allowed during interview. Quantitatively, the topic of `treatment action' was 
discussed with all of the 328 randomly chosen patients attending one of 16 selected British 
GPs. Only twenty-three patients (7.0%) were reported to have a different interpretation from 
GPs on a key point. 
It has been shown that results from studies of non-comprehension (table 4 [A], page 62) are 
dependent on the method of data collection and what is considered relevant information. 
Inspection of table four ([A]) reveals similar categories of advice to those listed in tables two 
and three. With qualification, it appears non-comprehension does occur and it does so in 
categories of advice perceived as required by patients and proffered by advisors. Although 
research has begun into the way patients perceive prescription medication instructions, the 
process by which they integrate directions into their own framework of understanding or what 
leads to non-comprehension is, as yet, unknown. 
General medical practitioners may also communicate by transferring instructions to the 
medication label (table 4 [B]). Two studies 19"92 have correlated comprehension of labelling 
with compliance. Malahy 191 in 1966 reported that an understanding of drug 'purpose' was 
second only to'timing sequence' as a category of reported error in compliance, 22.4% and 
33.7% of all errors respectively. Similarly, Boyd and colleagues 192 in 1974 noted that: 
'The written prescription, and subsequently the prescription label, was deficient in providing 
information concerning timing of administration and purpose of the medication ... [and 
continued]... with respect to timing and purpose, the patient's comprehension is found to be 
greater than the label information. Although many patients were able to establish an 
acceptable timing schedule without receiving specific label directions, the approximately 25% 
of the population which could not do so emphasizes the necessity to include this information' 
As patients gain some understanding of dosage schedules from other sources, it is clear that 
patient comprehension must be studied in the context of the total information provided. 
Unfortunately, remaining studies have only investigated patients' understanding of dosage 
schedule instructions and it is these investigations which are now considered. 
Although studies have investigated the variation in dosing frequency 193194 using 
technologically sophisticated methods 195 only four have related their findings to patients' 
understanding of their regimens. Three studies 19619798 (table 4[B]) conducted with hospital 
patients were consistent in identifying that "directions did not have a clear meaning to the 
patients ". '96 In a fourth study, only 22% of 37 elderly patients at home asked to interpret the 
directions 'Take one tablet every six hours' were judged to have understood the 
instructions. 19' 
These studies support arguments that medication instructions and auxiliary labels can be 
misunderstood and that the wording of information is crucial to understanding. This latter 
60 
point is further illustrated by a 78 year old lady who had antibiotics prescribed for her, the 
label stating, "Take after food". As she did not eat an evening meal she did not take the 
scheduled tablet. 200 Similarly, a 63 year old woman's near perfect compliance with a dosage 
schedule for prescribed eye drops was due to her permanent state of anxiety and fear that 
she would lose her eyesight because, in her words, "my doctor said what may happen if I 
don't take the eye drops exactly as he said": The patient remembered the day a month earlier 
when she was one hour late instilling an evening dose . 
201 These latter two reports provide 
further evidence that misunderstanding the intention of treatment advice can lead to, at least, 
unnecessary anxiety and even total failure in treatment. 
In summary, the provision of advice is a one way process in which the intention of the 
information must be understood by the patient as a necessary step to accurate dosing of 
prescription medication. Studies of patients' non-comprehension are fraught with 
methodological uncertainties such that only tentative conclusions are possible. This review 
has provided evidence that patients may be advised by GPs both verbally and in writing yet 
misinterpret the information such that treatment with medicines is compromised. Non- 
comprehension does occur and it does so in categories of advice perceived as required by 
patients and proffered by advisors. 
Not only may patients fail to comprehend advice during consultations, the next section 
presents evidence that they may also simply forget medication advice. This has obvious 
implications for the CP as the last link in the advisory chain. 202 It has been suggested that 
patients are diagnosis-orientated when they visit their general practitioner, and prescription- 
medication orientated when having prescribed items dispensed. Smith 203 wrote of this when 
she suggested that: 
"Patients tend to remember the instructions which are most important to them personally. 
This may not be the most important information from the viewpoint of the physician or 
pharmacist. Patients tend to remember details of the diagnosis, but frequently forget 
information about the drug. One reason is that the instructions for therapy are usually given 
by the physician immediately after the diagnosis. After patients learn the diagnosis, their level 
of anxiety increases, and high levels of anxiety are associated with low levels of recall. 
Therefore, information provided after the diagnosis has a decreased chance of being 
remembered. By the time patients arrive at the pharmacy, they are more relaxed and more 
receptive to information about the medication. In addition, the primary purpose of the visit to 
the pharmacy is to obtain the medication, in contrast to the visit to the physician's office which 
has the primary purpose of diagnosing the medical complaint". 
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2.5.2 Patients' memory of their treatment advice 
In 1963, The British Ministry of Health published a document entitled 'Communications 
between doctors, nurses and patients', which noted problems of communication between 
practitioners and patients. More recently, Tuckett and colleagues, 190 in their more 
qualitatively orientated study, reported that only 11 of 328 (3.4%) patients were unable to 
recall the key points of treatment action provided during consultation with the GP. The study 
used probing interviews to assess recall and commented that, "difficulties which patients gave 
in processing information from doctors are not due to a failure of memory; instead, they 
appear to arise at the stages of active interpretation and evaluation of the doctor's views". In 
contrast, four studies 204 205 206 207 (table 5, page 66) reported much higher values for the 
percentage of total information on treatment regimens not retained. Studies that demonstrate 
that the amount of information presented is related to memory have been reviewed by Ley 
who summarised that: 208 
1. 'patients fail to recall much of what they are told; 
2. the number of statements not recalled is a linear function of the number presented; 
3. age is not consistently related to recall; 
4. intelligence is not related to recall 
5. medical knowledge is related to recall; 
6. anxiety is related to recall; 
7. content of recall can be influenced by manipulating 
7.1. serial position effects, 
7.2. perceived importance; and, 
8. amount of recall can be influence by 
8.1. shorter words and sentences, 
8.2. explicit categorization, 
8.3. repetition, 
8.4. use of concrete-specific rather than abstract-general advice statements' 
There is evidence that patients forget prescription medication information provided by their 
GP. Also that an intervention in the form of verbal advice provided by pharmacists improves 
the level of patient knowledge. 202 Community pharmacists may, therefore, be in a position to 
improve this situation. However, if patients still take their medication in the prescribed 
manner, the CP's intervention is not critical. In the next section evidence for a lack of 
compliance with prescribed medication is presented. 
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2.5.3 Patients' compliance with their treatment advice 
Keep watch also on the faults of patients which often make them lie about the taking of things 
prescribed - Hippocrates 209 
Three questions are relevant to patient compliance and the role of CPs. First, are medicines 
taken as prescribed? If not, then a role for CPs in giving advice might be possible. Second, 
can the factors which are associated with compliance be understood and manipulated? If so, 
then pharmacists would have a theoretical structure to optimise their activity as advisors. 
Third, does the provision of advice by CPs improve compliance with treatment regimens? If 
so, then they have a positive role to play as advisors on prescription medication. 
It is not possible to provide a detailed, comprehensive review of the literature on compliance 
due to the explosion of research in this area. Therefore, only reviews of the literature and the 
most relevant papers will be cited in discussing the three questions. An appreciation of the 
academic effort directed towards compliance is evidenced by the increase in publications 
from 25 in the 1950s to 744 between 1980 and 1984210 Journals such as Patient Education 
and Counselling, and The Journal of Compliance in Health Care are devoted to research In 
this area. Publications have included reference texts in 1976,211 1979 212 and 1988 213 plus 
major reviews of treatment adherence in 1970,214 1976 215 1983 216 and 1992.17 Researchers 
into sociobehavioural determinants of compliance have generated a mass of theories and 
correlations which have been reviewed in a monograph, published in 1974,218 with an update 
10 years later. 219 In addition, reviews of studies into the psychology of compliance have been 
published in 1975 220 1979 221 and 1980 222 
First the question, 'are medicines taken as prescribed? ' This is important as there are health 
risks to non-compliance 223 which can be reduced. 224 Although patients' reports of non- 
compliance have been shown to be reliable indicators of their activity 225 unfortunately, a 
continuing difficulty in obtaining objective measurements 226 and variations in the definition of 
compliance and the method of data collection 213 mean a global 'figure' for the magnitude of 
non-compliance must be replete with cautions and disclaimers. Thus, Sackett and Snow 227 
considered only 40 (7.45%) publications from their reference pool to be useful in determining 
the magnitude of non-compliance. Of these, only 18 concerned prescription medication. 
Further reviews 214 226 229 have selected studies and listed their respective rates of non- 
compliance, then averaged the values to report a summary statistic. Table six, page 68, 
provides summary statistics calculated from the original lists of rates of non-compliance 
provided by such sources. The increase in the population of elderly people (figure 10, page 
38) has prompted concern for their non-compliance with prescribed medication. 30 A list of 
available studies of non-compliance in elderly people was compiled (table 8, page 75) using 
a 'format similar to Ley 139 and the summary statistics provided in table six. Inspection of 
table 'six indicates a general consensus that nearly fifty percent of patients are non-compliant 
with treatment regimens. 
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Table 6 
The magnitude of non-compliance with prescribed medication advice 
Reference Year Treatment Years Number of Non- Median 
Source Regimen covered studies compliant 
Mean ± SD 
214 1970 General 1954-1969 33 40.6 t 20.1 40 
228 1976 General <1970 49 43.4 
227 1979 General 1964-1975 18 41.4 ± 16.0 60 
229 1979 General 1970-1979 48.2 
231 1985 Hypertension 1975-1983 14 37.2 ± 18.5 65.5 
table 8 1994 Elderly 1962-1986 14 53.1 ± 18.2 57 
Studies of elderly non-compliance rates do not appear to support the view that this group 
presents an unduly greater problem than might have been thought, although their sheer 
numbers make this a logical area for concentrating effort. In summary, a sizeable proportion 
of patients using treatment regimens are non-compliant. It is prudent 227 to note variation in 
definitions of compliance and measurement techniques, possible selective publication of 'bad 
news' and the specific nature of sample frames as limitations in determining overall 
compliance patterns. 
Second, the question 'can the factors which are related to compliance be understood and 
manipulated? ' Although non-compliance affects individuals the collective cost is a 
considerable burden for society. 232 The involvement of pharmacy in reducing total health 
care expenditure by improving compliance has been noted 233 In order to provide some 
direction for focusing pharmacy involvement, variables associated with treatment regimen 
non-compliance are required. In determining these variables, relationships between 
compliance and structural variables, situational barrier models, educational approaches and 
motivational models have been investigated. 
If the 1970's was an era for determining the magnitude of non-compliance, it was also a 
period for attempting to understand why patients failed to adhere to treatment regimens. 
Table seven (A), page 71, lists the number of studies showing stated associations of 
structural variables with compliance in relation to treatment regimens. Scrutiny of the results 
indicates a consensus that increasing the duration of therapy or complexity of regimens, as 
assessed by the number of medications involved, has a detrimental effect on compliance. 
Parenteral medication is positively associated with compliance; however, this is not due to 
the administration technique of injection alone as, for example, insulin dependent diabetics 
are notoriously non-compliant234 Studies appear to be based on a biomedical model of 
compliance 235 in that the dependent variable was dichotomously defined as to whether 
treatment were adhered to or not. While insight into these relationships might be helpful In 
directing pharmacy services, they do not suggest how the independent variables, such as 
complexity or duration, are related to one another. Further, if structural demographic factors 
such as gender, age, ethnic origin or education are related to compliance, there is not a great 
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deal that can be done to alter them. 222 Such correlations fail to inform how compliant and 
non-compliant behaviours are generated. 
As early as 1968, research suggested that provision of information without regard to patients' 
views was not sufficient to ensure compliance. 36 However, studies which have sought to 
improve compliance by influencing patients' perceptions and attitudes have stumbled, due to 
a lack of methodological direction. 37 Attention was refocused from the patient to the 
treatment setting. The situational barrier models developed 238 239 were specific and did not 
provide a broad framework for examining non-compliance. Although useful for optimising 
treatment facilities and as an aid to management of services, they were unable to answer 
why patients were non-compliant. 
Based on the idea that knowledge is necessary for compliance, educational approaches were 
employed as early as the 1950's. Such studies are a marked change from the structural or 
situational theories as they sought to investigate the more social psychological steps needed 
for education, such as attention, comprehension, retention and belief change, then relate 
these to compliance. Although knowledge was found to be necessary for accurate 
compliance, it was not found to be sufficient, motivation was also a requirement. 40 
The search for predictive motivational models has occupied the efforts of a great many 
researchers. Emotional drive models have been used to understand patients' behaviour and 
have generally studied fear arousal as the motivating force for activity. Reviewing the 
literature, both Sutton 241 and Rogers 242 agree that studies conducted by psychologists 
consistently find stronger threat messages superior to changing attitudes. However, where 
medication is concerned, high fear messages may not be superior to low fear messages in 
motivating compliance. 222 Fear can lead individuals to resign themselves to inevitable 
dangers, making them less willing to take adequate protective action. 243 An obvious 
application of this model would be in respect of patients' perceptions of medication side 
effects, although the author knows of no such work. Ethical dilemmas may account for the 
lack of studies in this area. 22 
The major theoretical work which has formed the basis of investigations into compliance is 
the Health Belief Model (HBM) which emphasises the directive aspects of motivation. It 
treats patients' health and illness actions as the end products of a sequence of rational 
decisions. Behaviour is seen as being dependent on the value placed by an individual on a 
particular outcome and the individual's estimate of the likelihood that a given action would 
achieve the desired outcome. 244 245 The dimensions of the model (figure 12) were first 
reported in 1966 246 with the aim of increasing, "professional health worker's knowledge of 
selected research findings and theory so that they may better understand why, and under 
what conditions people take action to prevent, detect and diagnose disease". 247 
69 
Figure 12 
Health Belief Model* 
Individual Perceptions -º Modifying Factors -10- Ukei6ooc#'0. A #ro 
Demographic Variables 
(age, sex, race, ethnicity etc) 
Sociopsychological variablE 
(personality, social class, p 
reference group, pressure, 
Note 
*= Figure adapted with permission of Medical Care. 220 
Taking each dimension in turn, 'perceived susceptibility' includes the degree to which 
patients believe themselves to be vulnerable to a particular illness. Under the HBM, patients 
may perceive themselves to be susceptible. However, appropriate action will not take place 
unless patients believe that their illness has, or could have, serious undesirable 
consequences. The dimension 'perceived susceptibility' is modified by the dimension of 
'perceived seriousness'. Similarly the 'perceived benefits' which patients understand they will 
gain from adhering to treatment regimens is modified by the 'perceived barriers' to 
implementing the preventive action. Acting on all dimensions are modifying factors, and the 
process of rationalisation may be initiated by a cue-to-action. Following this model, advisors 
may provide information on prescription medication; however, compliance with their advice 
depends on whether patients believe their condition does in fact exist, is serious and that 
they are personally susceptible to it; plus whether the overall benefits of adhering to the 
advice outweighs barriers to implementing the advice. Table seven, page 71, sections [B] 
and [C ] provide an indication of the extent to which compliance has been significantly 
correlated with the dimensions of the HBM. Clearly, this model provides a useful theoretical 
framework for directing the nature and provision of advice in optimising compliance. 
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Table 7 
Correlates of compliance* 
Number of studiest 
Correlate Positive Negative No association 
(A) 
Side effects 22 
Complexity 1 11 
Frequency of dosing 23 
Dosage 1 
Duration 12 3 
Change of treatment 
for the same condition 7 12 
for a different condition 31 
Use of parenteral administration 6 
(B) 
Health Belief Model up to 1979 
perceived susceptibility 15 1 3 
perceived severity 10 2 7 
perceived benefits 8 0 8 
perceived barriers 
(C) 
Health Belief Model up to 1984 
perceived susceptibility 9 1 2 
perceived severity 10 4 
perceived benefits 9 1 2 
perceived barriers 10 2 
Notes 
*= Adapted from summary references; (A) Haynes, 248, (B) Ley, 139 who cites the 
collective works of compliance studies referenced by Haynes and colleagues, 212 and 
(C), calculated from the 14 studies concerning treatment regimens included in 
review of the HBM by Janz and Becker. 219 
Number of studies showing a significant correlation in the direction shown. 
The HBM has at least seven practical and theoretical limitations. First, perceived severity 
often fails to correlate with the degree of compliance by patients. Second, as most studies 
have related individual dimensions to outcome, the model does not account for a large 
proportion of the explained variance in behaviour. Third, cues to action appear to influence 
attitudes in a predictable manner, but this may not be translated into appropriate activity. 
Fourth, it may be incorrect to assume the underlying rationale of the model which is that 
people think in terms of probability, or levels of perception. Fifth, problems are only defined 
from a health perspective. Sixth, the model is not historical. Failure to encompass factors 
which may have led to patients' perception lessens the understanding of the processes 
involved in a patient choosing to be compliant with treatment regimens. Seventh, it is not 
clear whether educational interventions change patients' beliefs and, as a consequence, 
behaviour, or if a change in behaviour precedes a change in attitudes. Although the HBM 
incorporates at least five other'value expectancy' behavioural models, 249 additional 
dimensions have been suggested 250 251 252 253 254 to account for its shortcomings. As yet, no 
single model has found universal acceptance. 255 
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Based on discussion in the earlier sections of this chapter and the dimensions of the HBM 
plus additional specific correlates known to predict compliance with treatment regimens, the 
known sociobehavioural factors likely to influence medication compliance which advisors 
should take account of when providing advice can be modelled (figure 13). 
Figure 13 
Hypothesised medication compliance model* 
Motivating factors Modifying factors 
General perceptions 1. Comprehension of 
instructions 
1. Concern for health 2. Cost 
2. Ability to control health 3. Demographic variables - 
3. Belief in modern medicine very young/old 
4. Belief in diagnosis 4. Duration of treatment 
5. Intention to comply 5. Method of medication 
6, Susceptibility to illness administration 
7. Advisor seen as a 6. Quality of communication 
legitimate source 7. Quality of relationship 
with advisor 
8. Recall and reinforcement 
of medication instructions 
9. Satisfaction with 
consultation 
Perception of drug therapy 
illness 
Prior experience with illness 
and treatment regimen 
Perceived safety of Cues to action 
)i brut enecL , 1. Advice initiated by others 
Perceived efficacy of 2. Ineffective self 
medication medication 
3. Symptoms 
Notes 
= Adapted from the original HBM 219 and subsequent modifications for application to 
treatment regimens by Becker 220 256 and Smith . 
257 
222 Fear motivation may be motivating or inhibiting. t= 
In summary, non-compliance with prescription medication treatment has been shown to be 
widespread and prevalent. The results of investigations into why patients are non-compliant 
have provided advisors with key areas for concentrating their efforts. It is known that patients 
fail to comprehend or forget much of the advice provided by GPs during the consultation. It 
has been proposed that CPs, the last link in the advisory chain, may have a positive role in 
improving patient compliance by advising on prescription medication. 203 In 1984, Eraker and 
colleagues, 258 stated "recent studies provide strong empirical support for the value of 
involving pharmacists in attempts to increase patient co-operation with prescribed therapies" 
Further, it has been shown that pharmacists do provide patients with advice (section 2.4.2, 
page 53). The third question in this sections now remains, 'does the provision of advice by 
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Lireft ood of campkiance 
CPs improve compliance with treatment regimens? ' In this discussion, evidence for'can' CPs 
be effective is distinguished from 'are they normally' a positive force for patient compliance. 
In this way their potential role is differentiated from their actual role. 
There are many ways by which CPs may initiate information giving to patients concerning 
prescription medication. The act of dispensing the prescription 90 is not one of them. During 
this process they are only acting as a remote processing system, an activity which, it has 
been argued, does not require as skilled a workforce. They may, however, make a unique 
contribution by reinforcing appropriate administration instruction but the value of that activity 
must be realised as an increase in compliance if the intervention is to be effective. What 
options are there for reinforcing the directions given to patients? First, written material 
including auxiliary labels and concise patient information leaflets may be provided with the 
dispensed medication. These written information sources have been shown to positively 
affect patients' compliance with antibiotic regimens when added to the usual prescription 
label 259 However, CPs often fail to attach the appropriate auxiliary labelling information 172 
and, as with prescribers' directions, such instructions are often misinterpreted. Even the 
presentation of the prescriber's instructions on the label has been criticised. 260 Commenting 
on the use of additonal written drug information, Morris and Halperin 261 state, "numerous 
studies have demonstrated that written information for the patient can be an effective aspect 
of a program to improve patients' knowledge about their therapy. There is no evidence that 
written information can or should replace verbal consultation' Verbal Instruction plus written 
reinforcement has been shown to significantly improve compliance compared with verbal 
instruction alone, 262 or no advice. 63 Studies have found Improvements in patient compliance 
when varying degrees of educational input were compared with normal dispensing activity. 
For example, private medication counselling plus written reinforcement was successful at an 
American military hospital pharmacy department. 264 Similarly, planned instruction given with 
or without written reinforcement was found to be effective at an American outpatient clinic. 191 
More intensive monitoring and multiple educational techniques have also been employed In 
American community 265 and hospital settings. 66 267 Such evidence indicates that 
pharmacists can be a force for improving patient compliance. Unfortunately, there Is no 
evidence to support the view that the provision of information leaflets is a normal activity for 
pharmacists. Similarly audio-visual aids and compliance aids have not been shown to be 
normal activities used in patient prescription medication education. Written advice appears to 
be the most researched activity which pharmacists may undertake In the area of patient 
education concerning prescription medication. However, 72 of 84 (85.7%) outpatients of an 
Australian hospital, when Interviewed about their preferences for a method of information 
delivery, indicated a preference for verbal counselling OTC. 145 Joubert and Lasagna, 119 
commenting on the results of a similar study, judge "by the importance accorded to the 
doctor and the pharmacist as preferred sources of information on drugs ,... 
[that] the patient 
package insert may not be able to replace them, but could be an important source of 
complementary information" The evidence supports the view that verbal advice assisted by 
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written information is a useful mechanism whereby information is conveyed to patients by 
advisors. Also, that verbal advice is the communication mechanism preferred by patients. 
There is growing body of evidence that verbal advice from British pharmacists' may improve 
patient compliance. Five studies have investigated the effect of the provision or absence of 
hospital pharmacists' verbal advice on patient compliance (table 9, page 76). 
Methodologically, only one study reported attempts at validity or reliability 274 but failed to 
provided evidence of how representative the data was. One provided the form used for data 
recording268 one standardised the verbal information provided? BZ three 274278282 were further 
limited to geriatric populations and one to hypertensive patients 269 Of the studies, one 278 
failed to show a positive effect on compliance when patients were counselled by the hospital 
pharmacist. In this study it was suggested that the single verbal hospital counselling session 
may not be sufficient to improve drug compliance in elderly patients. 
Only one study has considered the effect of CP's advice on recall of information. Wilson and 
colleagues 270 271 used tape recordings of 44 customers' conversations and interviews the 
following day to determine the quantity of information recalled. Both advice and OTC advice 
were combined in the analysis. Results presented can not be generalised as only two of 11 
CPs participated. As with the method used in this thesis, information provided was 
categorised by'phrases' such that a single sentence may contain one or more categories of 
advice. That a mean of three of a possible 11 items of information were recalled is strikingly 
similar to more advanced studies of medical effectiveness reviewed in section 2.5.1, page 59 
and section 2.5.2, page 65. The authors concluded that "customers recall of information, 
including instructions considered to be essential, was low". Assuming that recall of advice 
relates to subsequent compliance there is some evidence that CPs may have a positive role 
in the advisory process. However, if this study is any indication of results in the future then 
CPs and GPs might share a lack of influence over patients' compliance with prescribed 
medication. 
In answer to the third question, multiple methods of patient education have been employed 
by pharmacists and have been found to be superior to verbal advice alone in promoting 
patient compliance. There is a suggestion that that verbal advice provided by British 
pharmacists can affect patient compliance. The level of influence in community settings may 
be comparable with GPs. 
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2.6 Conclusion 
f, 
S 
From the discussion presented in this chapter it can be concluded that there are many 
positive indicators for CPs to act as advisors on prescription medication. Patients clearly wish 
to be informed, It is argued that; the lack of feedback from patients to GPs, the medicine- 
orientation of patients when engaging with CPs, patients' non-comprehension and 
misunderstanding of medical instructions, plus the availability of proven models of patient 
compliance which may be used to optimise advisory activity, all act to encourage a role for 
CPs as advisors on prescription medication. Much of the literature predicts that CPs' advisory 
service would be readily accepted by patients and especially welcomed if advice on side 
effects is offered. It is concluded that there is an opportunity to develop the role of the CPs 
as advisors on prescription medication. 
However, evidence shows a shortfall in the activities of advisors. Further, there is little proof 
that CPs are actively seeking to capitalise on the opportunity to develop their role. In the 
dialogue espoused by Wildavsky 86 the development of an advisory role on prescription 
medication is a problem which is small enough to tackle and worth doing something about. 
However, for change to take place either a policy needs to be developed or an existing policy 
amended. The current policies which have a bearing on CPs' advisory role are the substance 
of the next chapter. 
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CHAPTER 3 THE RELATIONSHIP OF POLICY, PRACTICE AND THE ADVISORY ROLE 
3.1 Summary 
This chapter considers those policies of the The Society and Government which impact upon 
the advisory role of community pharmacists. The influence of an independent assessment of 
pharmacy, the Nuffield Report is considered. The final section brings together conclusions 
from the preceding chapters to present an overview of the direction of the thesis and the 
research conducted. 
In section 3.2 American definitions of Pharmacy which legitimise advisory activity are 
presented. In Britain it is The Society's Code of Ethics which sanctions pharmacists' 
prescription medication advisory role. Sanctioned in this context being to give the role 
professional backing. Although guidance is given for the use of auxiliary labels for specific 
named medicines, little direction is provided for verbal advice. Following this, the results of 
relevant American legislation are reviewed. Notably, that legal directives for both verbal and 
written advice only encouraged the use of auxiliary labels. Although the bulk of recent legal 
cases in America have failed to find pharmacists responsible for their failure to advise, the 
general principle exists in both America and Britain that pharmacists are responsible for the 
accuracy of advice volunteered. 
Section 3.3 considers the effect on Pharmacy and Government policy of a report to the 
Nuffield Foundation, the Nuffield Report. While it sanctioned CPs' advisory role, noting the 
perennial conflict with GPs, it sought to release their time for additional roles by proposing 
changes in supervision laws. In the debate which followed, arguments for a change were 
based on professional ideals, while those against noted practical difficulties and the risk of 
occupational 'suicide'. The proposed changes included the potential for pharmacy assistants 
to be the'gate keepers' of CPs' advisory activity. A special general meeting overturned the 
proposals and currently there is an expectation that, if a pharmacist considers it necessary, 
they will personally advise patients. The advisory role is, therefore, discretionary. 
Government policy also took into account the Nuffield Report's recommendations. The green 
paper, 'Primary Health Care', specifically noted the pharmacists' advisory role and the 
following white paper, 'Promoting Better Health', while not mentioning the role, outlined 
payment for CPs' advice to residential homes. 
Section 3.4 brings together the conclusions from preceding chapters. It considers the issues 
which might be addressed in this thesis and argues the major, thrust of the research 
presented in this thesis. This choice is in line with the literature on implementation of social 
policy. A summary model is presented which outlines the author's thoughts on the 
motivating, initiating and modifying factors which influence CPs' decisions to provide advice. 
it provides a theoretical basis for testing CPs' advisory policies. 
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3.2 Sanctions by The Society and legal rulings 
Chapter one described the changing function of pharmacists and the environment in which 
they currently practise. Chapter two argued that many patients, following consultation with 
their GPs, are not aware of aspects of their medication. It was noted that CPs provide PMA 
to patients. This section of chapter three addresses the question, 'is such activity an officially 
sanctioned role? ' If the answer is affirmative, CPs acting to advise patients would then be 
seen to be acting in accordance with the accepted activities of their occupation. If negative 
they might be viewed as businessmen seeking an elusive customer. 
In Britain, no functional definition for the activities of CPs exists. However, it is reasonable to 
suppose that there are parallels with conceptual definitions of pharmacy in the American 
literature. Initial attempts 286 defined the generic pharmacist as "an individual who has 
acquired the formal knowledge of the professions". The oversimplification of this definition 
was noted . 
287 The more elaborate alternative proposed considered pharmacy "as a system 
which renders a health service by concerning itself with knowledge about drugs and their 
effects upon men and animals". Within this definition they declare that, "Pharmacy knowledge 
is disseminated to physicians, pharmacists and other health care professionals and to the 
general public to the end that drug knowledge and products may contribute to the health of 
individuals and the welfare of society". Such definitions sanction advice as a legitimate action 
for pharmacists and have been quoted in Britain in the development of clinical pharmacy 
activity. Pharmacy is seen as a knowledge system and the use of information for the 
benefit of patients is specifically acknowledged. 
In Britain, an expectation that advice is a sanctioned function of pharmacy activity was 
clearly described in 1963 when The Society's Council, commenting on a report of the 
Committee on the General Practice of Pharmacy, 15 noted that, "the right medicine should be 
supplied in the right form with the right safeguard at the right time, at the right place" and that' 
"the general practice of pharmacy is an activity involving... the supply of medicines and... the 
giving of information and advice relevant to such supply". Similarly a charter 289 published in 
1983 by the Pharmaceutical Services Negotiating Committee commented that "it is essential 
to increase the advisory and counselling role of the pharmacist" 
The Society published its first collated medicines and ethics guide 290 in November, 1988. 
This included principles in the Code of Ethics, guidance notes, appendices and 
supplementary Council statements which applied during the main data collection period for 
this thesis. By law, the Statutory Committee of The Society is the arbiter of what constitutes 
misconduct. It has the power of deregistration and may look to the nine points of the Code of 
Ethics to provide an indication of the 'normal' or'expected' actions of pharmacists. With 
reference to the guide, and its subsequent editions, it can be shown that pharmacists are 
ethically sanctioned to use their judgement and may refuse to dispense prescribed 
medication, yet are directed to be tactful when interacting with medical practitioners. Further, 
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that pharmacists are expected to use their judgement and if necessary provide advice, 
however; where verbal advice is concerned, guidance for specific medicines is limited. 
The following guidance notes, which expand on a principle of the Code of Ethics, are a 
testament to the forceful expectation that CPs must not enter into conflict with prescribers 
unless absolutely necessary. It is stated that: "A pharmacist should not deviate from the 
prescriber's instructions when dispensing a prescription, except when necessary to protect 
the patient. If a pharmacist is uncertain about the content of a prescription or believes that the 
prescribed medicinal product could harm the patient, he should make every effort to contact 
the prescriber. Even if the prescriber confirms that the product which the pharmacist believes 
could harm the patient should be dispensed, the pharmacist may refuse to dispense the 
prescription. However, before refusing to dispense, the pharmacist must carefully weigh up 
the consequences for the patient of refusing to dispense the prescription against the harm 
which may arise if the prescription is dispensed. If it is impossible to contact the prescriber, 
the pharmacist should use his professional judgement and decide, in all the circumstances, 
what course of action would be in the best interest of the patient". 290 As further evidence of 
the restraining nature of the Code of Ethics, principle nine states, 'A pharmacist shall at all 
times endeavour to co-operate with professional colleagues and members of other health 
professions so that patients and the public may benefit': It is noted that freedom to judge the 
appropriateness of a prescription is not included in the contract between pharmacists and the 
employing agent. 
That pharmacists are personally responsible for providing advice and are expected to use 
judgement in the provision of advice is described in the 1988 Medicines and Ethics Guide. It 
states that: "The pharmacist has a general responsibility for the provision of information and 
advice, and should fake reasonable precautions to see that it is both accurate and 
appropriate ... land] ... in appropriate situations in which information has not been requested, 
provide it to the patient". 290 The advisory element of this statement has been progressively 
elaborated with the inclusion of possible categories of advice plus the additional expectation 
to specifically account for the wishes of the prescriber and ensure that patients understand 
directions. The April 1995 edition states: 291 "(a) A patient (or his agent(s)) should be provided 
with the information and advice required for safe and effective use of their medicines. Care 
should be taken to assess the wishes of the prescriber and the information and counselling 
needs of the individual patients. Written information should be used to supplement oral 
communication, as appropriate. (b) The pharmacist should ensure that the patient Is given 
and understands sufficient written and oral information to enable him to obtain maximum 
benefit from the medicine. Such information may include possible side effects, interactions, 
dosage, duration of treatment and any special precautions to be taken.... The pharmacists is 
responsible for ensuring the provision of advice when the medicines are delivered to the 
patient. " :... _ý 
Although more specific definition and expectation for advice is laid down in the latter edition, 
the only officially 292 293 identified reference linking medicines with advice has been the list of 
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auxiliary or cautionary labels included in a joint publication between the Pharmaceutical and 
Medical societies, the British National Formulary (BNF). 29i4 Co-authorship by both bodies 
strengthens the CPs' claim that by following the BNF their actions are legitimate and 
sanctioned. Figure 14 provides a breakdown of the number of preparation which have 
recommendations for written and verbal advice in the BNF of 1988.294 These 
recommendations were operational for the period of data collection for this thesis. It can be 
seen by the numbers of preparations in heavily shaded boxes that guidance for the provision 
of written advice far outweighs that for verbal advice. 
Figure 14 
British National Formulary written and verbal counselling recommendations* 
BNF 
Recommendations 
(1319) 
Written Verbal advice 
advice (1150) 169 
Label only (1089) Label + Patient Patient information BNF only (8) 
information leaflet leaflet (40) 
Note 
*= Figures in brackets are the number of specific prescribable items listed in the 15th edition of 
the BNF 294 for which labels and/or verbal advice are recommended. Directions for both brand 
names and generic substances are included. 
Further evidence that pharmacists are associated with an advisory role for prescription 
medication can be seen in American policies and legal requirements. In 1984, The American 
Society of Hospital Pharmacists 295 published summary categories of advice about which 
pharmacists should inform, educate and counsel patients. Subsequently, Kalman and 
Schlegel, 296 in consultation with the American Pharmaceutical Association and the American 
Association of Colleges of Pharmacy, published an account of the responsibilities of 
pharmacists. Responsibility five details how a pharmacist "Confirms and further clarifies 
patient's understanding of medication dosage, dosage frequency, and method of 
administration" and responsibility six that a pharmacist "Advises patients of potential drug- 
related or health related conditions which may develop from the use of the medication for 
which the patient should seek other medical care". The latter responsibility includes 
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explaining pertinent side effects, what to do if signs and/or symptoms occur and how to 
minimise side effects. 
Such standards imply an active role for pharmacists in America as advisors on medication. 
Notably, they are more prescriptive than even recent British directives. Legislation has 
partially reflected this activity. By 1986 eight states in America had legal requirements for 
pharmacists to keep patient medication records, 35 required pharmacists to be involved in 
continuing education, 10 encouraged patient counselling by including an advisory function in 
definitions of the practice of pharmacy, 13 legislated that the pharmacist should provide 
some sort of patient counselling, and four allowed limited pharmacist prescribing. 
297 Such 
policy decisions have had a mixed effect on pharmacists' advisory activities. Mandatory 
counselling did not translate into verbal practice, 
298 299 rather an increase in the use of 
auxiliary labelling was shown. 299 Although no study critically investigated CPs' rationale for 
failing to adhere to legislation, one sought to determine their attitudes to the implementation 
of such policies. Robinson and McKenzie 
300 suggested that if mandatory regulations were to 
be used as a method of stimulating patient-pharmacist interaction the "interrelated issues of 
reimbursement, facility changes, technician support, patient profiles, continuing education 
programs and pharmacist's attitudes towards regulated practice will need to be addressed". 
The momentum in America which developed in the 1970s and early 1980s towards the 
recognition of the pharmacist's counselling role has not continued in recent court rulings 
which reflect a limited view of pharmacists' legal responsibilities. 301 Pharmacists may perform 
an expected service according to their governing bodies, but such activity may not be seen 
as legitimate in law. Brushwood and Simonsmeier 297 have reviewed the American judicial 
denial of the pharmacist's duty to counsel. Although it is accepted that pharmacists who 
voluntarily undertake to provide information to patients must do so accurately and are liable 
for providing misinformation, legal rulings necessitating the provision of unsolicited advise 
are less clear. Notably, all cases cited concerned a failure to provide adequate information 
on possible side effects of medication. The authors describe two types of advisory activity, 
risk assessment and risk management. They suggest that the former is rightfully provided by 
the prescriber before dispensing and the latter by both prescriber and pharmacist. Thus, 
American courts failed to recognise the pharmacist's role as a provider of information for 
which assessment or judgement is necessary. Also, that cases generally fail to suggest why 
the fact that the prescriber does have a responsibility in law to warn means, necessarily, that 
a pharmacist does not have a similar duty. 
In summary, there is sufficient evidence from definitions of practice and occupational 
expectations, that British CPs' prescription medication advisory role is sanctioned, or 
professionally underwritten, by The Society. There is an expectation that CPs will counsel 
patients when necessary and, as a matter of professional conduct293 provide verbal and 
written advice. Although preparation-specific direction is provided for the use of auxiliary 
labels, there is little similar instruction for verbal advice. 
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No specific rulings have indicated a legal requirement for the British pharmacist to provide 
PMA. Yet, they are required by law to directly supervise the dispensing of a prescri ption 302 In 
contrast, several states in America have introduced legislation which requires pharmacists to 
provide advice; however, the form this should take was not specified and the law only served 
to encourage the use of auxiliary labels. The bulk of recent legal cases have failed to find the 
pharmacist responsible for any failure to advise. It is notable that legal cases all concern the 
failure to manage or provide advice on side effects. That pharmacists appear to be ethically 
and 'professionally' bound to give advice but are not legally responsible if they don't, is 
incongruous. 
For the future, there are moves by the European Commission to introduce strict liability, 
regardless of any professional concept of fault or good faith 303 This section has outlined the 
policies of The Society and the legal system in Britain and America relating to pharmacists 
advisory role. Independent assessments and Government policies regarding this role are now 
considered. 
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3.3 Independent and Governmental sanctions for an advisory role 
In October 1983, a committee chaired by Sir Kenneth Clucas was appointed by the Nuffield 
Foundation with the following terms of reference; "To consider the present and future 
structure of the practice of pharmacy in its several branches and its potential contribution to 
health care and to review the education and training of pharmacists accordingly". By March 
1986, the results of the committee's deliberations had been reported. In September of that 
year, the then president of The Society Dr TG Booth, speaking at the opening session of the 
yearly British Pharmaceutical Conference, is reported to have said, '? doubt if any single 
document has ever been analysed so closely by so many pharmaceutical bodies throughout 
the world. Clearly the developing role of the pharmacist, particularly in community practice, is 
a topic which keenly interests the profession in every country with a developed 
pharmaceutical service" 3oa 
The impact of the Nuffield Foundation's independent assessment on policy has been 
considerable and reaction to the changes it sought to implement provides a unique Insight 
into community pharmacy in Britain. Critical to this chapter, the report of the committee, the 
Nuffield Report " specifically advocated support for the pharmacist's advisory role. It is 
stated that, "The dispensing process now consists of handing it.... [the prescription] over with 
any necessary instructions to the patient or his agent.... and [making sure] that the patient is 
informed of the way in which the medicine is to be used". The provision of PMA was seen as 
one of many 'extended roles', those in addition to its dispensing role 
305 
Four suggestions were proffered by the Nuffield Report 
11 which have a direct bearing on this 
thesis. First, closer liaison between pharmacists and GPs was advised and agreed by Council 
of The Society (The Council) 307 From the discussion presented so far in this thesjs, it is clear 
that this must entail a degree of conflict. Second, a note of warning that 'professionalism' 
must not be compromised by the contradictory setting of community pharmacy as a 
business. Third, it proposed targeting pharmacists' advisory involvement towards, as a 
generalisation, the elderly, chronically sick, mentally handicapped and psychiatrically 
disturbed or those individuals taking continuous medication. This view was only partially 
supported by The Council which, since 1953, has been responsible for managing and 
directing the affairs of The Society. Six months after publication of the Nuffield Report and 
one month after circulation of a consultative document 
306 The Council published its 
deliberations. 07 Although concentrating on *minor medical and OTC product advice, the final 
wording of its response commented that community pharmacy involvement would benefit 
patients when "medicines form an important part of NHS treatment". There was little support 
for the concept of targeted advice, however, investigations to determine the effect of such a 
policy were suggested. It was stated that "... additional advice might be unnecessary with 
certain categories of medicinal products. There is a need for research to be commissioned on 
this subject". Fourth, that the Medicines Act 1968, which directs that pharmacists are in a 
position to intervene when a prescription is given to the patient, be altered to allow for 
development of an 'expanded role' encompasing more health, rather than drug, related 
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endeavours. The following summary of events initiated by this latter suggestion provides a 
useful insight into The Council's perceived role for CPs as advisors on prescription 
medication. 
Six months after the publication of the Nuffield Report, the Government indicated its 
noncommittal stance on the suggested changes to supervision. 308 3W The PSNC 310 gave 
general support to changes in supervision one month later, but emphasised the need for an 
additional CP to implement any additional activities. The Council 307 proposed to 
operationalise the fourth suggestion above through a set of rules whereby CPs could assess 
prescriptions and allow dispensed items to be given out in their absence. An editorial, 
commenting on their complexity, suggested that "Pharmacies could become as unpopular as 
main post offices" when patients failed to appreciate why an individual prescription could not 
be dispensed 31 Notably, the rules included a condition 'That the person presenting the 
prescription did not raise a query related to the prescribed medicine that could only be 
properly dealt with by the pharmacist". The council's recommendations found favour with the 
NPA 312 but by early 1988, individuals began highlighting the dangers of implementing the 
proposals. Plumb 313 suggested that, 'The public now had an expectation of being able to 
enter any pharmacy and have access to a pharmacist. It is similarly expected that a 
pharmacist will be available to counsel and assist with problems and uncertainties relating to 
dispensed medicines, appliances and dressings" and voiced the fear that The Council was 
about to "sell us [pharmacists] down the river". Such thoughts found favour with individuals 
who were describe by a Privy Council nominee, Lord Peston 314 as 'luddites'. 
The action which subsequently focused debate was a motion proposed at the Annual General 
Meeting of The Society on the 11th May 1988 by Mr John Davies 315 Whereas The Council's 
proposals allowed CPs to define when they should see the prescription, Davies's motion 
sought to restrict this to the final stage of the dispensing process. The motion was rejected by 
19 votes to three at the following monthly meeting of The Council 316 in June 1988. At that 
time, Mr John Ferguson, 17 secretary and registrar of The Society, reiterated The Council's 
view that, in accordance with the philosophy of the Nuffield Report, CPs would be directly 
Involved with each prescription but the extent should be a matter of professional discretion 
rather than the legal requirement implied by Davies' motion. That the Issues were not clear 
cut was suggested one month later when the PSNC altered its original allegiance to a hybrid 
of the two proposals 318 In August 1988, following an unofficial referendum, The Council was 
again asked at its monthly meeting to adopt Davies' motion and voted 16 to three against 
such action 3'9 Debate continued between the 'final checkers' or'luddites' and those In favour 
of The Councils' proposals. Model supervision procedures were outlined, first, unofficially 320 
then, in January 1989, by The Counci1.321 Notably a 'suitably qualified assistant' was 
empowered to provide advice on prescribed medication directly to patients. 
Although earlier calls fora special general meeting had been made 322 the lack of a final 
check in The Councils' model procedure prompted an official request for a special general 
meeting 323 This was arranged for the 9th April 1989 at the National Theatre, London 32° 
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Although The Council was not required by law to act on the result, 25 authors called for it to 
take notice of the response 326 and the 'final checkers' indicated they would abide by any 
decisions 327 In March 1989, The Council sent a leaflet to each member of The Society 
setting out in simple and clear terms its case for a new approach to supervision. 28 Support 
was forthcoming from pharmacy students at their annual conference 329 The arguments for, 
against and concerning the supervision changes are now summarised. 
Arguments for changes in supervision noted: 
1. that critics had not provided an alternative for developing CPs' roles; 216 
2. that the proposals were in keeping with the intentions of the Nuffield Report 33° 
3. that CPs should be, and act as, professionals 331 332 
4. that technicians would not be allowed to dispense in the absence of a CP 333 and, 
5. that CPs were already delegating responsibility 334 
Arguments against the changes in supervision and for the motion of Davies contended that: 
A. only a final check could account for all dispensing errors; 335 336 
B. it was impossible to define professional activity 337 
C. They were ill prepared and would require mandatory further education 338 
D. there was a lack of remuneration 338 
E. the proposals would make little time available for additional activity-, 339 
F. patients would lose faith in the dispensing activities of CPs 340 
G. there was no monopoly over dispensing; 4' 342 
H. Government would take advantage of the delegation of responsibility ity; 34344 
I. technicians would undermine the authority of the CP 345 346 
J. a lack of published evidence to support any change; 347 
K. there was a failure to indicate what objections there are to a final check; 347 and, 
L. The Council could be manipulated to the detriment of the rest 348 
Further, note was made that whether or not The Councils' proposals were implemented: 
1. no court had considered supervision 342 and only the law determined change 336 349 350 
11. patients had not been consulted 
35' 
Ill. only professional ethics could guarantee CPs' actions 352 and, 
IV. there was a dilemma in that the CP, could not be in two places at once 
353 
With these arguments well aired for a period of 21 months, over. 700 pharmacist met to 
debate and provide a mandate for, or an indication of the level of disagreement with, The 
Council's supervision proposals. On the day, the then president of The Society, Mr Bernard 
Silverman stated that "no issue which had so far ever faced the profession had been the 
subject of so much anguish and acrimony": A vote of 371 to 306 In effect defeated the 
proposed changes in supervison 354 Subsequent discussion noted dissatisfaction with the 
result, implying that those present at the meeting were not representative 355 and suggested a 
referendum 356 Others, called for the resignation of specific members of The Council 357 and 
complained that they had not been allowed to speak, that nothing new had been ventured 
during the meeting 358 Asa consequence of the decision, The Council Indicated In May 1989 
that it would look again at the supervision issue 359 In May, a motion 'that a dispensed 
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medicine should not be supplied to a patient unless a pharmacist has checked the final 
product' was withdrawn 3w One month later a working party was set up by The Council 361 In 
October 1989, three years and five months after the Nuffield Report first proposed changes 
the following policy statement was published : 362 
"A pharmacist responsible for supervising the dispensing, sale or supply of any medicine in a 
pharmacy bears the associated legal and professional liability. Every prescription for a 
medicine must be seen by a pharmacist and a judgement made by him as to what action is 
necessary. The pharmacist will exercise judgement to ensure that he fulfils his professional 
duties to his patients in the best possible way. He will thus be able to delegate to suitably 
trained staff to those tasks that he is confident can be undertaken by them. He will be 
available in the pharmacy to intervene, to advise and to check the dispensing of any 
prescription under his supervision. The pharmacist's prime responsibility in dispensing is to 
the patient. In exercising professional responsibility, the pharmacist will determine whether his 
advice needs to be given and if so, he will personally hand out the dispensed item". 
This description of the events linked to the Nuffield Report's proposed supervision changes 
was necessary as a prelude to the author's following three observations. First, it would have 
been possible under The Council's proposals for CPs to totally devolve the advisory role on 
prescription medication to assistants, yet remain responsible in absentia. Although The 
Council's response to Nuffield included a condition that prescriptions could not be given out if 
the patient raised a query, in the official model procedure, assistants could be responsible for 
deciding whether an appropriate query had been asked and whether the CP needed to be 
involved. At the very least, the assistant would have become the de facto gate-keeper of 
CPs' advisory activity. If the CP were absent then there would be considerable patient 
pressure on the assistant to attempt an answer to any query. Certainly, as Mutton 353 notes, 
CPs could not be in two places at once. Visiting residential homes in person, would leave the 
assistant 'holding the fort'. Even though the CP was still supposedly contactable, patients 
may not have sought advice if they knew there would be an unaccustomed delay. 
Alternatively, history demonstrates that it Is the perception of the public which counts. 
Assistants may have become the recognised 'experts' on prescription medication 346 and in a 
similar manner to the Rose Case may have sought due recognition. It does not make sense 
that The Council would agree with the prescription medication advisory role for CPs and then 
propose policy changes to delegate such activity, especially as it recognised the lack of 
research to support targeting of advice. The answer for this seeming Inconsistency may lie in 
the Nuffield Report's strong recommendation that CPs develop so called 'extended' roles in 
the community. 
Second, the basis of The Council's approach was a move to professional Ideals and' 
devolving responsibility: However, It was argued that some CPs could not be trusted to 
exercise restraint and that their individual failure would be cited by Government in 
withdrawing its protection of the dispensing role. 63 There are ideological grounds which 
support this reasoning which were never explored during the de'ate. Politically, Britain has 
been guided by Conservative government since 1979. Its fundamental values are freedom, 
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individualism and inequality. These are historically linked to the 'Laissez-faire' ideology, from 
the French 'allow to do'. Government policy is currently against collective state decisions, an 
'anti-collectivist' stance, and seeks to promote the philosophy of the 'free market'. Freedom is 
stressed because of its inter-relationship with a market economy. Government views society 
as individuals pursuing their own interests in a free market economy and its role to make 
rules and enforce law and order but otherwise not to interfere. As such, it sees the Welfare 
state as an embryo socialist state incompatible with the prime social values of anti- 
collectivism. Ideally, it would be dismantled to allow free market mechanisms to determine 
policy. 59 However, Government needs professions to service the Welfare state. The 
historical trade off has been collusion in the development of legal restrictions preventing 
encroachment on professional areas of activity 364 a process known as 'social closure'. The 
consequence of legislation is to reduce market freedom, to restrict patients to professions for 
specific services. Social closure is, therefore, incompatible with individual freedom and 
choice. The conflict between ideology and practicality has been partially resolved with the 
active promotion of professional accountability through the notion of patient's and citizen's 
charters. It is clear that current Government is ideologically less disposed to professions than 
in the recent past. If the proposed change in supervision rules had lead to a decrease in 
'professionalism' as perceived by the public and patients, then this literature predicts a 
danger of Government review of 'social closure' benefiting pharmacists. 
Third, that several points were not made by 'luddites' was noted by the author. A strong 
argument might have been made that the advisor-patient relationship would be threatened by 
devolution of the advisory role and concurrent absence of the CP. It has been suggested in 
chapter two that pharmacists are experts on drugs and their possible advisory activities 
potentially essential in the promotion of patient compliance. In order to realise this potential, 
personal interaction with patients would be essential, if only to monitor the requirement for 
information. However, patients may present at any time. It follows that maintenance of 
relationships and fulfilment of an advisory role would require CPs to be present at all times. A 
further argument arises from the ample evidence 139 that patients benefit from constant 
advisory input. Finally, no mention was made of legislation in America requiring pharmacists 
to be directly involved with patients. It was, however, noted at the special general meeting 
that direct involvement is legislated in France. 54 
It was stated at the beginning of this section that the Nuffield Report was instrumental in 
directing change. Government policy was also influenced by the Nuffield Report and Its 
"... general thrust... that pharmacists should be developing their roles as advisors on the safe 
use of medicines': 353 In April 1986, the green paper Primary Health Care 309 was published: It 
noted "the important task of dispensing accurately and promptly medicines prescribed by 
, ,, doctors, and counselling on their use". The changing role was thereby acknowledged and the 
advisory activity of the CP recognised. The green paper also specifically recognised the 
benefit of patient medication records and non-pharmacy based community activity. However, 
it indicated that role boundaries must be maintained and stated that; "Neither the profession 
nor the Government would wish to see an extension of the pharmacist's role result in ;_. 
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confusion over responsibilities to the patient". No statement on responsibility for advice to 
patients was made. In November 1987, the white paper Promoting Better Health 30 was 
published. No mention was made of the prescription medication advisory activities of CPs, 
however, advising on 'medicines' was noted under 'the extended role'. As the term 'medicine' 
was not defined as either prescribed or OTC, its meaning is unclear (section 2.3.2, page 45). 
It is, therefore, an anomaly that the Government's new patients' charter launched in 1995, 
indicates that 'you [the patient] can expect your pharmacist to explain these [prescription] 
instructions to you if you are not sure . 
366 Three and a half years after the Nuffield Report's 
recommendations, the white paper announced payment for both pharmacists' advisory 
activities to residential homes and the keeping of medication records, the latter presumably 
to assist their advisory role. 367 Critically, the governing statutory instruments 368 specify 
payment for advice and thereby endorse the advisory role of the CP. In keeping with 
Government ideology contracts for some defined, limited community pharmacy services are 
now locally negotiated. Notably Annex E of FHSL(94)59 includes advice to general managers 
in monitoring and ensuring that advice on prescribed medicines is provided 369 
In a global sense the World Health Organisation has recognised the advisory role of 
pharmacists. In the 1988 report 370 of a WHO consultative group on 'The role of the 
pharmacists in the health care scheme', one of the functions of pharmacists was to inform 
health care professionals and the public. Specifically, a motion to 'provide appropriate advice 
on medicines to the public, to other health professionals and to regulatory bodies and policy 
makers"was put to the 1994 World Health Assembly 371 and accepted 372 Pharmacists are 
currently expected to 'provide informed and objective advice on medicines and their use to 
the public". 
In summary, an independent assessment of Pharmacy confirmed The Society's policy 
guidelines that pharmacists have a role as advisors on prescription medication. The report 
sought to target CPs' advisory resource both at the pharmacy and in the community. In 
response, The Council of The Society noted the lack of research to support targeting, yet 
produced guidelines for devolving the advisory role. The subsequent debate split the 
profession. Arguments for change centred on developing 'professionalism' and against on the 
risk of losing Government backing for'social closure'. The point was also made that only 
decisions in law could determine the advisory role of pharmacists. A special general meeting 
defeated the proposal. The Council then reversed its proposal and announced the current 
policy that CPs should be in a position to give out prescription medication personally if 
advice was perceived to be required. The Council's initial proposals would have placed 
assistants in a key position with regard to the provision of advice to patients. Although CPs 
were deemed to be responsible, their rapport with patients may have been compromised as 
assistants became the 'gate-keepers' of CPs' advisory activities and advisors in their own 
right. The rise of pharmacy assistants as a qualifying occupation of dispensers was alluded to 
in the debate. Arguments for the role pharmacists play in patient compliance and the 
practical requirement to be available for such advisory input were notably absent from the 
debate. it is concluded by the author that both The Council and many pharmacists do not 
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consider advice should accompany each dispensed item. Although such a role is proposed to 
fill the void caused by the changing nature of dispensing, it is seen as discretionary rather 
than critical to the future of pharmacists. 
Following the Nuffield Report, the Government introduced allowances for CPs undertaking 
advisory activities in residential homes and for maintaining a dispensary record of patients' 
prescriptions. This action confirms the Government's stance that CPs provide valued advice 
in the community but only in specific areas. Government support for the idea that 
pharmacists hold responsibility for advising patients of their prescribed medication is not 
addressed. The general policy that pharmacists must avoid compromising the GP-patient 
relationship is clear. It should be noted that the value of an advisory service has been 
acknowledged by the World Health Organisation. 
In this and the previous section evidence has been presented to demonstrate the kind of 
official support which exists for the advisory role of pharmacists. That it has proved 
necessary to cover diverse literature and make substantial inferences may either 
demonstrate that the role is implicitly understood and further definition unnecessary or testify 
to a lack of general attention paid to such activity. That The Council proposed devolution of 
advisory activity to assistants must place a question mark over extension of the advisory 
role. In this discussion, the lack of research to underpin a role has been noted. Indeed the 
Nuffield Report stated, "There is a notable absence of information on what pharmacists 
actually do - as distinct from what they say they do" 1t Clearly, a rational decision as to the 
future must be made on the basis of evidence. The next section considers how this thesis 
might contribute to such evidence. 
I 
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3.4 The issues 
From chapter one it can be said that pharmacists are historically orientated towards the 
manufacture, preparation and supply of medicines. Only the latter activity remains for 
practising CPs. Chapter two presents evidence for their proposed and actual advisory activity 
plus theoretical models which may be used to support their intervention. In chapter three so 
far, we reveal that the provision of advice is expected by The Society yet not in Law or 
explicitly as the pharmacist's responsibility by Government. A constant theme throughout has 
been a lack of concrete evidence to indicate the current nature of CPs' advisory activity. The 
growing concern over this lack of research 373 is evidenced by the initiation of specific forums 
for publications 374 375 However, no individual's efforts can hope to encompass the whole of 
the problem. It must select the issues which can be appropriately and usefully addressed. As 
The Society has responsibility for 'managing' the activities of pharmacists, the research must 
provide evidence which can be readily incorporated into its current policy. Where prescription 
medication advisory activity is concerned, The Society's policy appears to be one of allowing 
pharmacists discretion as to the nature of their service while providing guidance of an ethical 
nature and recommendations for specific preparations through the BNF. 376 
In determining an appropriate policy-sensitive direction for research, Jung 377 reminds us to 
avoid large solutions which often become large problems. Gunn 378 provides practice-related 
preconditions necessary for the implementation of a successful top-down 379 approach to 
policy implementation. Using these preconditions, four key requirements can be derived 
which The Society should consider when making and implementing policy for an advisory 
role. First, CPs must have sufficient resources at the point in time when advice is 
appropriately proffered. Second, their advice must be accepted by patients such that 
subsequent behaviour leads to improved use of drug therapy. Third, they must only be 
minimally dependent on other individuals in order to provide such a service. Fourth, they 
must have control over the advisory process and clearly defined roles for each person 
Involved. 
Using these four requirements the main issues, related questions and associated research 
topics have been compiled (table 10). This enables an overall appreciation of the extent of, 
the research area and also serves to locate the research specifically undertaken In this 
thesis. Those topics which have been the subject of literature evaluation In this thesis are 
highlighted. Issues are also presented which have not been alluded to In the text and are not 
the subject of future In-depth research or discussion. For example, the feasibility of assessing 
pharmacists' competence to give advice has been raised by The Council 380 but Is not a 
central focus in this thesis because more fundamental issues are yet to be resolved. 
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Table 10 
Issues concerning the prescription medication advisory role of the community 
pharmacist 
1*. Are the necessary resources available for CPs' advisory role? 
Issues: Do CPs have the appropriate knowledge of or access to information which 
will allow them to advise? Are proven educational tools freely available? Do 
CPs have time which can be allocated to an advisory role? Are CPs able to 
delegate tasks in order to release sufficient time to fulfil an advisory role? Is 
it necessary to have a clearly defined area set aside for patient counselling? 
Is remuneration necessary to fund CPs advisory activities? 
Research 1.1 Community pharmacists' knowledge base on medication. 
topics 1.2 Availability and effectiveness of continuing education programmes. 
1.3 Availability of educational aids to complement verbal advice. 
1.4 An assessment of time which can be allocated to an advisory role. t 
1.5 The level of dispensing assistance available. 
1.6 Information on the use of dedicated counselling areas. 
1.7 The effect of remuneration on the advisory role. 
2*: Is the advice provided by Cps appropriate? 
Issues: What exactly do Cps advise and is the advice correct? What should they 
advise? What advice do patients ask for? Is the advice provided perceived 
as necessary by patients? Are Cps seen as legitimate sources of PMA? 
What is the socialising role of Cps in giving PMA? Does the advice affect 
compliance? Do all medicines dispensed require advice? What Is the best 
method of providing advice? What effect would patient registration with 
individual CP have on their activities? What effect would assessment of 
competence have on advisory activity? Would legal rulings or "professional" 
discretion best serve the advisory role? 
Research 2.1 The categories of advice provided. tt 
topics: 2.2 The standard of advice; 
2.2.1 which is provided, * and 
2.2.2 which should be provided. 
2.3 The categories of advice sought. tt 
2.4 The categories of advice perceived as needed; 
2.4.1 by patients, t? 
2.4.2 by Cps for patients, t$ andtt, 
2.4.3 by general medical practitioners for Cps 
to advise patients. t 
2.5 The effect of advice provided; 
2.5.1 on patients behaviour In the dispensary; t 
2.5.2 on patients compliance with prescribed medication; t and, 
2.5.3 , on patients' perceptions of CPs. t$ 
2.6 An assessment as to whether individual medicines require 
PMA by the CP. 
2.7 A determination of how information is best conveyed; 
2.7.1 verbally, * and. 
2.7.2 in writing. $ 
2.8 The effect of patient registration on; 
2.8.1 community pharmacists' advisory activity, and, 
2.8.2 therapeutic outcome. 
2.9 The effect of mandatory assessment of Cps' competence on; 
2.9.1 quality and quantity of PMA; and 
2.9.2 patients' use of prescribed medication. 
2.10 The effect on the advisory activities of Cps of; 
2.10.1 legislation; $ and, 
2.10.2 delegation of the role to professional discretion. tt 
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3*. What is the involvement of others in the advisory process? 
Issues: What restrictions arise from community pharmacy's position in the 
dispensing process and their dependence on general medical practitioners 
for additional prescription Information and ultimately, their income? Can the 
advisory role be delegated to dispensary assistants? 
Research 3.1 The relationships between CPs and 
topics: general medical practitioners. t$ 
3.2 Use of assistants for conveying advice; 
3.2.1 extent of reliance on assistants, and, 
3.2.2 quality and quantity of advisory activity provided by 
assistants. 
4'. Do CPs have control over the advisory process? 
Issues: Do CPs have a policy to provide advice or do they mainly respond to 
requests for information - who is in control, CPs or patients? Is confidentiality 
maintained between patient, CP and others involved? Are there intervening 
variables beyond the CP's control which affect their advisory activities? 
Does the environment in which CPs work affect their capacity to render an 
advisory service? What level of responsibility Is, or should be accepted? 
Research 4.1 Are CPs proactive or passive In giving advice. t 
topics: 4.2 Do CPs have definite policies for themselves and Involved others 
concerning advisory activities. t 
4.3 Control over confidentiality of information between; 
4.3.1 general medical practitioners and CPs, and, 
4.3.2 patients and CPs. 
4.4 The influence of situational variables such as; 
4.4.1 the dynamics of when prescriptions are presented and 
whether CPs are able to respond appropriately, t 
4.4.2 the ability to contact relevant others In the event that 
additional Information is required. 
4.5 The effect of community pharmacy setting on prescription 
medication advice; 
4.5.1 offered by the CP, and, 
4.5.2 perceived by the patient. 
4.6 An assessment as to whether CPs have access to sufficient 
information to become Involved in an advisory role. 
4.7 The level of responsibility accepted for, 
4.7.1 the advice or lack of advice provided by Cps, and, $ 
4.7.3 the actions of patients in response to the advice provided. 
Notes 
*= Issues related to the four key requirements derived from Gunn's preconditions for 
successful policy implementation. 
t= Topics which are the subject of original data collection in this thesis. 
$= Previously discussed in this thesis using literature sources. 
_, r ., 4 
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It can be appreciated from table 10 that the issues surrounding the CP's advisory role are 
many and varied. The implicit request by the Nuffield Report for evidence as to what 
pharmacists actually do, was considered crucial in deciding research topics which might 
benefit community pharmacy and provide direction for future policy. The need to remedy this 
shortfall is emphasised by Haywood and Alaszewski who made the point in 1980 that "the 
threat to the NHS posed by current economic conditions and the growth of private medicine 
strengthens the case for almost total preoccupation with what the service actually does for 
the welfare of the patients ,. 3111 If it is assumed that their advisory activities are less than 
optimal, then the main concerns of this thesis must be; to determine exactly what CPs do, to 
rationalise this activity using available literature and theory, and to consider changes in policy 
which may improve the advisory service. In this regard it might be helpful to consider what 
likely pressures and modifying factors are involved in CPs' decision to provide advice. Using 
a similar format to the hypothesised medication compliance model (figure 13 page 72) an 
advisory action model specific to CPs and the provision of advice can be devised (figure 15). 
Figure 15 
Hypothesised advisory action model for community pharmacists 
Motivating factors Modifying factors Likelihood of compliance 
Financial 
Litigation 
Peer pressure 
Routine/Policy 
Reward/feedback 
'Professionalism'/ethics 
Perceived value of advice 
1 Lack of knowledge 
2 Auxiliary labelling 
3 Demographic variables 
4. Prescription directions, 
5 Practical language 
problems 
6 Relationship with 
prescriber 
7. Resources 
Perceived benefits of 
following policy MINUS 
Perceived barriers of 
following policy 
Four requirements 
1 sufficient resources 
2. acceptance of advice by 
8 Previous experience with 3 
patient 
9. Potential for 4 
misunderstanding the 
advice provided 
Cues to action 1Per1. 
Study methodology 
2. Type of medication 
3. Initial dispensing 
4. Customer requests advice 
5. Type of customer/patient 
6. Prescription irregularities 
7. Uncommon administration 
requirements 
8. Advertising a service 
patents 
minimally dependent on other 
individuals 
control over the advi; oly 
process and clearly defined 
Web 
1 
Compliant behaviour 
Likelihood of giving advice 
Following The Society's policy 
for personal intervention 
The model is presented as the author's rationalisation of the process whereby the CP decides 
to provide advice. For example, it includes the paradox of a professional calling within a 
business setting and notes relationships with prescribers as a factor effecting CPs' advisory 
role. It also proposes that cues to action might prompt CPs to provide advice. Introducing an 
patient 
9. Potential for 4 
misunderstanding the 
advice provided 
U2s to action 
1PerStudy 
methodology 
Type of medication 2 
Initial dispensing 
Customer requests advice 
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appropriate cue, such as an advertisement in the form of a visual display promoting the CP 
as-a source of advice, may prompt a response and provide some insight as to CPs' advisory 
policies. 
In summary, the general policy of The Society, Government and the recommendations of 
independent assessors, has been to place the responsibility of a prescription medication 
advisory role with The Society which in turn uses the Code of Ethics and practice guidelines 
to direct individual CPs. There is little evidence describing CPs' advisory activity. However, 
any policy to affect their actions must consider the following four requirements to be 
successfully implemented. 
1. Are the necessary resources available for CPs' advisory role? 
2. Is the advice provided by CPs appropriate? 
3. What is the involvement of others in the advisory process? 
4. Do CPs have control over the advisory process? 
Under these main elements the broad spectrum of associated issues provides an overview of 
relevant questions which may be asked of the advisory role. Given the limitations of time and 
resources, this thesis can only hope to investigate specific questions and corresponding 
research topics. These have been chosen on the basis of the Nuffield Reports' observation 
that CP activities are largely unknown. What little evidence is available, points to a 
discrepancy between the quantity and pattern of Information they provide and patients' 
perceived needs. The possible reasons why this may be the case forms the basis of the 
theoretical approach in this thesis. In this regard a hypothesised Advisory Action Model Is 
presented which outlines the author's thoughts on the motivating, initiating and modifying 
factors which influence CPs' decision to provide advice. Under this model a cue-to-action, 
such as a suitable advertisement, may be used to provide further Insight as to CPs' advisory 
policies. 
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3.5 Conclusion 
From the reviews presented in this chapter it is possible to conclude that America is ahead of 
Britain in clearly defining the activities and legal responsibilities of an advisory role for 
pharmacists. Also that legislation may not be a reliable method of encouraging specific 
pharmacists' activities. Britain has clearly defined in a Code of Ethics the expectation that 
pharmacists should advise patients. Both Medicine and Pharmacy have collaborated to 
provide joint recommendations for the provision of advice for specific preparations. 
Recommendations are predominantly for written advice, not verbal. It is concluded that 
pharmacists have an ethically, pharmaceutically, medically supported advisory role, yet 
guidance on how to verbally carry out this role is lacking. The role Is discretionary and 
independent of general medical practitioners. 
The Council of The Society entered into debate over a potential extended role which it 
sought to implement by advocating devolution of the advisory role on prescription medication 
to certified assistants. It is concluded that The Society does not hold the prescription 
medication advisory role as sacrosanct. It, in common with the Nuffield Committee, 
considers that not all medication requires counselling by the CP. That pharmacists during the 
debate failed to cite the literature on compliance and the effect of advice on patients, leads 
to several possible conclusions. Either they were more mindful of practicalities, including the 
loss of Government protection for the dispensing role, than their role in patient's well-being, 
or they simply failed to appreciate the potential of the available literature. Alternatively, a 
lack of concrete evidence for their advisory activity may have limited their use of this 
argument. 
Government policy, by Initiating payment for both an advisory role outside the pharmacy 
premises and storage of patient medication data, has provided legislative support for 
pharmacists' advisory role. However, no Indication of how this relates to responsibility for 
patient welfare is evident in Government policy, rather pharmacy is advised not to let an 
"extension of the pharmacist's role result in confusion over responsibilities to the patient". 309 
While providing some Incentive for the 'extended role, ' the Government clearly seeks to limit 
expansion of CPs prescription medication advisory role. No official body has produced a 
comprehensive programme with specific aims and objectives to direct the advisory activities 
of pharmacists. It Is concluded that there Is little scope for macro-sociological policy analysis. 
As table 10 indicates, the research agenda associated with CPs' advisory role is large. Only a 
handful of issues can be considered by a single researcher. Without information on what CPs 
actually do In their prescription medication advisory role and possibly why, the outcomes of 
policy decisions are largely guesswork. This thesis seeks to address these most fundamental 
of questions. In doing so, the advisory action model (page 95) predicts that advertising a 
service will 'cue' Interaction between CP and customer. The effect of an advertisement which 
prompts advisory activity Is considered in this thesis. 
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CHAPTER 4 AIMS OBJECTIVES METHOD AND RESULTS 
4.1 Foreward 
Chapter four provides the reader with an overall understanding of the research conducted. 
The research is essentially epidemiological. Although qualitative and quantitative data 
reduction techniques are used and results presented in summary form in tables, the results 
are nonetheless extensive. For ease of reading, this thesis has been arranged with the bulk 
of analysis and results in the appendices (pages 159 to 293). In chapter four and the 
discussion chapters (five and six), key results are all fully cross-referenced. In this way the 
reader may elect the depth with which they access the data and analysis presented. 
In addressing the issues selected as research topics for this thesis, section 4.2 considers the 
methodological problem of taking a specific epistemological stance. It is decided that neither 
a structuralist nor interactionalist stance Is appropriate. The design of studies is driven more 
by the research problem, available techniques and a gradualist approach rather than a 
particular philosophical stance. 
Section 4.3 sets out the overall aim of the research. The specific aims for the study of CPs' 
attitudes to the provision of advice and an observational study incorporating an intervention 
designed to test CPs' advisory policies are set out in detail. Objectives and hypotheses are 
listed. In each case aims, objectives and hypotheses are cross-referenced to the relevant 
section in the appendices. 
Section advice 4.4 discusses three methods of data collection, schedule-structured interview, 
activity analysis and direct observation and concludes that the latter is most appropriate to 
the research undertaken. 
Section 4.5 provides an overview of the research conducted and specifically sets out the 
method used for the observational study. This section contains extensive cross-referencing 
to the appendices and may be used to help readers to structure their access to the material. 
Section 4.6 sets out the statistical statements governing data analysis. The statistical range 
for significance is defined. Criteria for sample size in contingency tables analysed with the 
chi-square statistic are discussed and arguments for no limit on the sample size for Fisher's 
exact test provided. 
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4.2 Quantitative or qualitative research methods 
This thesis concerns itself with a 'role' yet is directed to first determine 'activity'. The former 
might be considered discursive and open to qualitative research methods while the latter is 
distinctly quantifiable and the use of quantitative methods would be expected. Bryman 382 
notes that qualitative and quantitative research methods have been aligned to divergent 
interactionalist and structuralist epistemological stances respectively, and that entering into 
debate as to the 'correct' philosophy would result in the exclusion of research methods which 
might be technically appropriate to the task. Gerrett and Stevenson 383 summarise both 
stances and agree with Bryman that the point of exactly how we can gain'knowledge' and get 
to the 'truth' is lost in the general debate. They describe the dilemma which 'socially' 
orientated pharmacy practice research has in gaining recognition from the 'natural' or 
'scientific' community. Although no definitive solution is provided they suggest that 
researchers in 'social' pharmacy practice should state their epistemological stance, if any. 
A statement as to the stance taken is warranted as this thesis is written from a 'social' 
perspective of policy and relies on literature from the social sciences to understand observed 
behaviour yet is informed by essentially numerical findings. The author does not hold to any 
one specific epistemological stance. Rather he considers that the expectation of a limited 
range of research methods associated with any one specific stance would be too restrictive to 
enable research of the topic area. The approach is therefore eclectic, a stance which enables 
a combination of methods. The strength of combining methods has been noted 4 
A second consideration is whether to use theory for generating hypotheses, a constructivist 
approach, or to allow theory to grow from an accumulation of data, the gradualists 
conception . 
222 3"5 As the prescription medication advisory activities of British CPs are largely 
unknown, no data was available to generate theories or concepts as to CPs' advisory 
activities and none had been proposed in the literature. As such, the constructive view would 
have relied heavily on supposition. Therefore, a gradualist approach of allowing theory to 
develop from the data collected was considered appropriate. Support for this approach is 
provided by Glaser and Strauss m and their concept of grounded theory. Precise methods 
for extraction and reduction of data, such as fieldnotes and observations, without 
compromising the context of the original observation are available. 7 388 
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4.3 Aims, objectives and hypotheses of research conducted 
This section states the general aims and objectives of the research undertaken for this thesis. 
The prime purpose, which is the title of this thesis, is to determine the following: 
THE ROLE OF COMMUNITY PHARMACISTS AS ADVISORS ON 
PRESCRIPTION MEDICATION. 
In so doing, the personal, motivating objective for the author is to increase the quality and 
quantity of interactions between CPs and patients concerning prescription medication. The 
overall aim of the thesis is to: 
To investigate and rationalise interactions between community pharmacists 
and patients which concern prescription medication advice. 
The research question is 'what do community pharmacists do and why? ' Research studies 
were conducted with the following aims, objectives and hypotheses. 
1. To differentiate CPs by their attitudes to the provision of advice and relate CPs' 
attitudes to direct observations of their activity. 
(The bulk of research concerning the first aim is found in sections A2.2.1 page 187 to 
A2.2.3 page 196); 
Objectives for the first aim are as follows: 
a) to develop a set of statements which differentiate and determine CP's 
attitudes towards patient counselling; 
b) to examine associations and differences between CP's attitudinal responses 
and epidemiological variables; 
C) to compare the attitudes of CPs' participating in the observational study with 
those of the remaining sample frame; and, 
d) to compare responses with observed activity. 
2. To determine whether a particular visual display or poster is likely to prompt 
individuals into requesting prescription medication from pharmacists. 
(The bulk of research concerning the second aim is found in sections A2.3.1 page 
210 to A2.3.3 page 220); 
Objectives for the second aim are as follows: 
a) to develop a series of visual displays promoting interactions between 
pharmacists and individuals who present prescriptions at a dispensary 
(customers) which include topics or themes for discussion developed In - 
previous studies; 
b) to determine which of the visual displays is most likely to prompt discussion 
concerning prescription medication between pharmacists and customers; - 
and, 
C) to relate choice of visual display by customers with their residence, gender, 
whether they are the patient or collecting on behalf of the patient, age and 
occupation. 
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3. To determine the extent and nature of interactions between CPs and customers 
concerning advice on prescription medication. 
(The bulk of research concerning the third aim is found in sections A3.1.1 page 222 
to A3.5 page 289). 
In testing the nature of advisory policy, baseline data was collected then a visual 
display introduced. Research for the third aim is specified by the following 
hypotheses: 
a) from section A3.1.1 Presentation and collection of prescriptions, page 222: 
i) that the provision of advice is not correlated with CPs' policies of 
giving out dispensed prescriptions; and, 
ii) that the poster would not prompt CPs to give out dispensed 
prescription medication items personally. 
b) from section A3.1.2 Prescription orientated individuals, page 227: 
i) that CPs advise similar proportions of prescription orientated 
individuals (POIs); 
ii) that advice provided by CPs is independent of customer's gender, 
age, age controlled for gender, ethnic association and ownership of 
the medication. 
iii) that customer's requests for advice are independent of their gender, 
age, age controlled for gender, ethnic association and ownership of 
the medication; and, 
iv) that the preceding two hypotheses hold for all CPs. 
v) that CPs can not be distinguished on the basis of soclo-economic 
status of patients for whom they dispense; 
vi) that advice provided by CPs is not dependent on the soclo-economic 
status of the patient; 
vii) that the category of advice provided by CPs is not dependent on the 
socio-economic status of the patient; 
viii) that, for customers receiving advice, display of the poster was not 
associated with changes in the socio-economic status of patients; 
and, 
ix) that the above three hypotheses hold for customer-Initiated requests 
for advice; - 
C) from section A3.1.3.1 Advice, page 249: 
i) for preparation events, advice does not depend on the CP Involved; 
ii) that dispensing by observational study CPs may be generalised to a 
wider sample frame in terms of therapeutic class. 
iii) for preparation events grouped by therapeutic class, advice does not 
depend on the category of medication involved; 
Iv) that the category of advice discussed did not depend on the 
therapeutic class of the medicine involved. 
v) that the above hypotheses Hi. Hiii and Hiv do not hold for customer 
Initiated requests for advice; 
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vi) that hypothesis Hiii holds for both proactive and reactive CPs; 
vii) that display of the poster was not associated with changes in the 
frequency of CPs' advisory activity; 
viii) that display of the poster was not associated with changes in the 
therapeutic classification of medicines for which advice was 
provided; 
ix) that the category of advice discussed did not depend on display of 
the poster; 
x) that the above hypotheses Hviii and Hix hold for customer initiated 
requests for advice; 
xi) that the category of advice discussed did not depend on the type of 
CP; and 
xii) that the category of advice sought did not depend on the type of CP. 
d) from section A3.1.3.3 What to do with it, page 264: 
i) that the frequency of advice identified as discrete roles for the 
advisory category 'What to do with it' is not dependent on type of 
CP; and, 
ii) that unique pharmacy advice which includes judgement is not 
dependent on the type of CP. 
e) from section A3.1.5 Effect of the poster, page 274: 
I) that display of the poster had no effect on the numbers of POls 
initiating discussion on a prescription medication; 
ii) that customer initiated requests for advice are independent of age. 
f) from section A3.2 Labelling, page 277: 
I) that CPs' verbal advisory activity is not related to their use of written 
additional labelling; and, 
ii) that the use of non-verbal additional labelling was not related to the 
use of automatic printing systems. 
g) from section A3.3 Time based analyses, page 280: 
I) that the presence of the researcher had no demonstrable effect on 
the prescription medication activities of CPs; and, 
ii) that the advice seeking behaviour of POls Is not related to the 
number of individuals who concurrently ask for pharmacy services. 
h) from section 3.4 Supply, page 289: 
I) that prescription medication advice is not dependent on whether 
advice on supply aspects of medication is provided. 
I) from section A3.1.3.3 What to do with it, page 264: 
I) to determine the nature of the advisory role for topics under the 
heading 'What to do with It'. 
j) from section A3.1.4.1 Side effects page 268: 
I) to determine the nature of the advisory role for topics under the 
heading 'Side effects"; and, 
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ii) to use data reduction and contingency table presentations in 
determining any differences in approach between CPs in their 
discussion on side effects. 
k) from section A3.1.4.2 What is prescribed, page 272: 
i) to determine the nature of the advisory role for topics under the 
heading 'What is prescribed'. 
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4.4 Determination of method 
In chapter two, section 2.4.2, page 53, arguments made in the literature were cited which 
concluded that direct observation is the most appropriate method for determining 
quantitatively the exact advisory activity of CPs. 165 167 Alternatives Include the use of market 
research techniques, such as the schedule-structured interview, and activity analysis 389 
Initially, the author spent six months developing a schedule-structured interview method for 
determining the advisory activities of CPs. Unfortunately when individuals were approached 
for details of their observed interaction with the CP, they failed to answer the questions 
accurately. For whatever reason, the research instrument was found to lack subject validity 
and the method of schedule-structured interview was considered to be unsuitable. Section 
A1.1, page 159, provides a full account of this failed method. The final versions of the 
schedules and their flow diagrams are given on pages 162 to 167. 
Activity analysis has also been used to determine what CPs do 61 Studies report values of 
3.6% 390 and 1.6% 391 for the percentage of observations where CPs were noted to be 
communicating with patients. Using work sampling theory 392 to verify the frequency of 
prescription medication counselling by CPs in England at a 95% confidence level with 5% 
accuracy if the activity occurred 3.6% of the time, then the number of observations required 
would be 42,844. At one minute intervals this would require 89, eight hour days of 
observation. However, even with the most detailed observations, only limited information as 
to why events occurred could be determined. Further, a considerable proportion of research 
time would have been wasted waiting for such an infrequent activity. For these reasons, the 
use of direct observation was considered more appropriate. 
Two methods of direct observation may be employed. Either pseudo-patients present a 
fabricated scenario and directly observe CPs' responses 171 or researchers observe activity 
as it occurs in the normal course of events. 164 As the first would have limited discussion to 
CPs' policies for specific drugs only, the latter option was chosen. 
Direct observation has the advantage of subject validity because the activity is actually 
observed as it occurs. In qualitative 393 and quantitative 394 research, validity and reliability 
are highlighted as major issues. The disadvantages of direct observations are the possible 
reactions to the presence of the observer, customer reactivity, and difficulties in recording 
which may affect reliability. Reactions to the presence of the observer can often be identified 
statistically. Section A3.4, page 289, presents a time-based analysis to determine any affect 
on advisory activity associated with the researcher. This section also includes a discussion of 
customer reaction to the chosen method. In order to minimise variation in recording and 
improve use of time, a form with predetermined categories can be used. Section A1.2.3, 
page 173, provides the protocol for the observational study and includes the form used to 
record observed activity (page 175). However exhaustive published 147148 categories of 
advice may be, they can never include all cases. For this reason, a form may also allow for 
open reporting as in fieldwork notes: Even with these measures, there is always the, . 
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possibility of misinterpreting actions. Time to record fieldwork notes may be compromised by 
the necessity to note quantitative data. Such problems might be solved by a second data 
collection mechanism. 
Ideally, a second observer would provided additional data and a measure of reliability, 
however, limited resources precluded this possibility. A second option used in both 
community pharmacy 395 396 and medical settings 133 205 190 is the use of tape recordings and 
subsequent transcripts of discussions. Using this technique it would be possible to test for 
reliability of data transfer and categorisation by comparing independently entered results of 
observed activity from a devised recording form and the results determined by field notes 
plus transcripts. In addition, the combination of transcripts, field notes and information from 
such a form would provide a suitable source of data for abstraction, extraction and reduction 
to determine CP advisory'role'. The decision was taken to employ both direct observation 
and tape recording with transcription as the study method. This precluded collection of the 
following data; whether the prescription Is a repeat of earlier medication, the knowledge the 
CPs has of the patient, previous advice given to the patient, and, whether the prescription Is 
prescribed for the first time. The limitations imposed by a lack of such information are 
acknowledged. 
An advertisement, such as a poster, acting as a cue-to-action, is included in the hypothesised 
advisory action model (page 95). Section A2.3, starting on page 210, provides details of the 
development of a suitable poster. This intervention is included as part of the research 
undertaken for this thesis for the following reasons: 
1. to test this aspect of the hypothesised advisory action model; 
2. if CPs are failing to provide any advice, to engineer the potential for observing some 
activity; 
3. if CPs are providing PMA, to determine how advertising specific categories of advice 
affects the nature of discussion; and, 
4. if proved successful, advertising is an inexpensive method of increasing community 
pharmacist-patient interaction. 
To investigate the effect of an intervention, requires a minimum 'before and after study 
design if it can be demonstrated that there is a pre-existing baseline activity. Literary 
evidence presented (section 2.3, page 210, and section 2.4, page 221) suggests a low level 
of background activity. A small pilot investigation was conducted by the author to verify 
personally the likely existence of background activity in local community pharmacies. On 
Wednesday Ist April and Monday 7th September, 1987, the author, a registered pharmacist, 
spent a day dispensing at Buchans Chemist, Castle Bromwich, Birmingham. It was possible 
to be continuously available for consultation during the period from 9.00am to 1 pm and from 
2pm to 6.45pm and each dispensed item was given by the author to the person presenting 
the prescription. Prescriptions were not handed out during the interval. Considering the 
combined results of the two days, of 125 prescriptions and 215 individual items, 28 patients 
had been prescribed one or more new items and two had initiated discussion on prescription 
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medication. This exercise served to verify that a very small number of individuals, possibly 
fewer than 2%, initiate discussion on prescription medication with the CP. Based on the 
premise that information should be provided for all newly prescribed medication then CPs 
should be actively advising at least 20% of their patients. As there is clearly a baseline 
advice activity, data collection before and after an intervention was the minimum study 
design. 
The following section presents an overview of the research conducted. Cross-referencing 
allow the reader to access as much detail in the appendices as is required. 
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4.5 An overview of research conducted 
Relating to the first aim on page 100, a study was first carried out to determine attitudes of 
CPs to PMA (appendices A2.2.1, page 187 to A2.2.3, page 196). Data collection was by 
questionnaire (form 3, page 194) developed after extensive pre-piloting (appendix A2.2.2, 
page 189). Analysis of results (appendix A2.2.3, page 196) included a comparison of 
attitudes between the observational study sample of CPs and CPs practising within the 
borders of Southern Derbyshire. Results of this comparison showed no significant differences 
in attitude between the two groups. Also that observational study CPs showed an ability to 
estimate their own frequency of verbal advice when compared with observed activity 
(appendix A2.4, page 221). 
Relating to the second aim on page 100, a series of four advertisements in the form of 
posters were developed (figures 27, page 211 to 30 page 214) and their likely ability to act as 
cues for promoting customer-community pharmacist interactions assessed (appendix A2.3.1, 
page 210 to A2.3.3, page 220). The posters were designed around advertising the CPs' 
services in providing information on the previously researched 147148 categories of non-supply 
orientated advice 'What to do with it', 'What is prescribed', 'Specific problems' and its sub- 
category'Side effects'. Analysis of the results (appendix A2.3.2, page 189) showed that 
poster C (figure 29, page 213) was the most likely to have an effect. In summary, (appendix 
A2.3.3, page 220) note was made of age and ownership of the prescription as important 
variables for further study. 
Relating to the third and major aim on page 100, a piloting exercise was conducted at a non- 
sample frame pharmacy using a radio microphone and transmitter (section A1.2.2, page 170) 
attached to the CP. Appropriate discussion was recorded on tape by equipment connected to 
the receiver, all of which was contained in a box situated with the researcher. The researcher 
was discreetly positioned to observe any Interaction including the CP without becoming 
involved and was able to record details of discussion on a pre-piloted form (page 175). 
Experience was gained in collecting the required information with minimal disruption to the 
normal activities of the pharmacy. In order to further anticipate occupational difficulties and 
the possibility of alternative research designs, the researcher used the methodology 
developed and undertook a three week period in two community pharmacies as the sole CP 
In charge. It was found that a single CP could not simultaneously operate the recording 
system, take field notes and also attend to normal dispensing activities. This exercise 
excluded the possibility of CPs collecting the data themselves and indicated the requirement 
for a full-time observer. 
Twenty-seven pharmacies were randomly chosen from the 105 listed with the Derbyshire 
Family Practitioner Committee on the 11th April 1988. The sampling procedure is outlined in 
full in appendix A1.2.1, page 168. Three branches of a large multiple were chosen but were 
eliminated as permission was not granted for the study by the superintendent in charge of the 
areas outlets (section A1.2.4, page 180). The twenty-four remaining pharmacies were visited 
-107- 
individually by the researcher. The CP in charge of the dispensary was asked who was 
normally in charge on the randomly assigned day(s) for observation. The CP identified as 
being in charge of the dispensary on the predetermined day was given a protocol (section 
A1.2.3, page 173) and a verbal summary of the study objectives and methodology. On the 
same day one week later each CP was contacted to determine their willingness to participate. 
Community pharmacists were contacted a total of three times over six months before being 
designated non-participants. Twenty pharmacies of twenty four (83.3°%) agreed to 
participate and are henceforth designated as the observational study pharmacies. The 
experimental design ideally required data collection for two periods, each of up to three days, 
on the same days of the week and not more than two weeks apart. With a before and after 
research design it was considered essential that the same CP was present on both 
occasions. In four cases this meant that the time scale was relaxed, although the days 
observed were consistent. Table 63, page 284, details the time spend at each of the study 
pharmacies. The protocol required the CP to carry the radio microphone and transmitter until 
74 possible pharmacy-patient interactions occurred. This figure was determined to be the 
mean number of prescriptions dispensed per day by pharmacies in Derbyshire (section 
A1.2.1, page 168). Pharmacies were randomly chosen to display the poster on the first or 
second visit. Patients were notified about the study by the display in the dispensary area of a 
self explanatory poster. A copy of the notice is provided with the study protocol (section 
A1.2.3, page 173). Ethical approval for the study was granted by the Local Medical 
Committee and Southern Derbyshire Health Authority ethics committee. No attempt was 
made by the CP to conceal the microphone, although it was by nature inconspicuous. Details 
of interactions were recorded on a dedicated form. The names of patients and prescription 
details were noted and tape recordings taken of every discussion concerning advice which 
included the CP. Specific details on the pharmacy premises and labelling practices and non- 
pharmacy staff were also recorded. Notes were taken of all interactions which included 
verbal information on the supply of prescription medication to customers. Customers were 
considered cases as they entered the community pharmacy and presented one or more 
prescriptions to be dispensed or collected one or more prescription items. If a customer 
presented a prescription and left the community pharmacy then returned later that day or on 
an alternative day during the observation period, then they were considered a new case. 
At the end of the second observational period, the dispensing CP was asked to complete an 
attitudinal questionnaire (section A2.2.1, page 187) and type four labels (section A3.2, page 
277). The attitudinal section was identical to that piloted and used previously and a stamped 
self-addressed envelope was provided for its return. The four CPs who did not take part were 
visited specifically and asked to furnish the same details. Data for the observational study 
was collected from June 1988 to February 1989. Categorisation of observed topics of 
discussion used the heading and associated descriptions developed from previous studies. "' 
148 Two sets of results were entered into the Data Entry II spreadsheet of the SPSS suite of 
programmes for personal computers or SPSS/PC+. Analysis used versions two, three, four 
and Windows 6.1 of the SPSS/PC+ package. Concerning data entry, information was taken 
from the field notes and observations recorded using the devised forms. A second set of data 
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was entered independently using verbatim transcriptions made of all discussion recorded on 
tape concerning advice. A two percent error rate for data entry was detected. In cases of 
inconsistency, the verbatim transcripts were relied upon as the accurate indication of activity. 
It should be noted that the use of the poster resulted in no statistically significant effect on the 
quantity of advice observed. Where analysis concerns quantity, the data is aggregated. In 
most cases, the data is still split into before and after intervention groups and analysis 
presented to reaffirm overall statistical interpretation. 
The analysis of observational data was performed at four'levels'. This was possible as the 
data collected allowed the type of advice, the prescription item, the prescription or the 
customer to be analysed as cases. For the analysis presented in this thesis, if discussion 
included one or more categories of advice for one or more prescriptions with a number of 
prescribed medicines, then, irrespective of ownership of the medication, the interaction was 
said to have included a single episode of advice and be at level one. In this instance, the POI 
was a case for analysis. For levels two three and four, customers who are directly involved 
with prescription dispensing or POls may be counted many times over depending on the 
number of prescriptions involved, (level 2), medicines on prescription, (level 3) or categories 
of advice per medicine per prescription (level 4). In other words, cases for analysis may be at 
the level of first, customers or POIs; second, prescriptions and details pertaining to the form 
or patients; third, individual drugs and their classification; and, fourth, the category of advice. 
As supply-orientated advice was never specifically cited as being required by customers 
(section 2.4.1, page 50) it was excluded from 'PMA'. The relationship of supply-orientated 
advice to PMA was considered separately in section A3.4, page 289. 
Whether the hypotheses tested for the observational study (section A4.3, page 100) were 
confirmed or rejected and the level of analysis, are now presented with cross-referencing. 
The statistical value below which the decison is taken to reject the null hypothesis is p<0.05. 
1. from section A3.1.1 Presentation and collection of prescriptions, page 222: 
a) that the provision of advice is not correlated with CPs' policies of giving out 
dispensed prescriptions; 
i) a gamma value of 0.3499 (table 36, page 226) provides an 
indication of the strength of ordinal association between CPs' 
policies of giving out dispensed medication and their subsequent 
advisory activity; 
b) that the poster would not prompt CPs to give out dispensed prescription 
medication items personally; ' 
i) confirmed (analysis, level one, table 36, page 226)., 
2. from section A3.1.2 Prescription orientated individuals, page 227: 
a) that CPs advise similar proportions of POls; 
i) , rejected (analysis, level one, table 40[B], page 244); 
b) that advice provided by CPs is independent of customers' gender, age, age 
controlled for gender, ethnic association and ownership of the medication; 
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i) gender, confirmed; age, rejected; age controlled for gender, rejected; 
ethnic association, confirmed; and, ownership of the prescription, 
rejected (analysis, level one, stage one, table 38, page 238); 
C) that customers' requests for advice are independent of their gender, age, age 
controlled for gender, ethnic association and ownership of the medication; 
i) gender, confirmed; age, confirmed; age controlled for gender, 
confirmed; ethnic association, confirmed; and, ownership of the 
prescription, rejected (analysis, level one, stage two, table 38, page 
238); 
d) that the preceding two hypotheses hold for all CPs; 
i) gender, confirmed; age, rejected; age controlled for gender, rejected; 
ethnic association, confirmed; and, ownership of the prescription, 
confirmed (analysis, level one, stage one, table 38, page 238); 
e) that CPs cannot be distinguished on the basis of socio-economic status of 
patients for whom they dispense; 
i) rejected (analysis, level two, table 41, page 245); 
f) that advice provided by CPs is not dependent on the socio-economic status 
of the patient; 
i) rejected (analysis Kolmogorov-Smimov, level two, table 42, page 
246); 
g) that the category of advice provided by CPs is not dependent on the socio- 
economic status of the patient; 
i) confirmed (analysis, level four, table 43, page 247); 
h) that, for customers receiving advice, display of the poster was not associated 
with changes in the socio-economic status of patients; 
i) confirmed (analysis, level four, table 45, page 248); 
i) that the above three hypotheses hold for customer-initiated requests for 
advice; 
i) confirmed (analysis: level two, table 42, page 246; level four, table 
. 43, page 247; and, level four, table 46, page 248). 
3. from section A3.1.3.1 Advice, page 249: 
a) for preparation events, advice does not depend on the CP involved; 
i) rejected (analysis, level three, table 47, page 256); 
b) that dispensing by observational study CPs may be generalised to a wider 
sample frame in terms of therapeutic class; 
i) confirmed (analysis, level three, table 48, page 257); 
C) for preparation events grouped by therapeutic class, advice does not depend 
on the category of medication involved; 
i) rejected (analysis, level three, table 48, page 257); 
d) that the category of advice discussed did not depend on the therapeutic 
class of the medicine Involved;. - 
i) -- ' ý, rejected (analysis, level four, table 49, page 259); 
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e) that the above hypotheses Ha He and Hd do not hold for customer initiated 
requests for advice; 
i) rejected (analysis: level three, table 47, page 256; level three; and, 
table 48, page 257) 
f) that hypothesis He holds (rejected) for both proactive and reactive CPs; 
i) confirmed (analysis, level three, table 48, page 257); 
g) that display of the poster was not associated with changes In the frequency 
of CPs' advisory activity; 
I) confirmed (analysis, level three, table 47, page 256); 
h) that display of the poster was not associated with changes In the therapeutic 
classification of medicines for which advice was provided; 
i) confirmed (analysis, level three, table 48, page 257); 
i) that the category of advice discussed did not depend on display of the 
poster; 
i) rejected (analysis, level four, table 50, page 260); 
j) that the above hypotheses Hh and Hi hold for customer initiated requests for 
advice; 
i) confirmed Hh (analysis, level three, table 48, page 257) 
ii) rejected Hi (analysis, level four, table 50, page 260) 
k) that the category of advice discussed did not depend on the type of CP; 
i) rejected (analysis, level four, table 51, page 260); 
I) that the category of advice sought did not depend on the type of CP. 
i) confirmed (analysis, level four, table 52, page 261). 
4. from section A3.1.3.3 What to do with it, page 264: 
a) that the frequency of advice identified as discrete roles for the advisory 
category 'What to do with it' is not dependent on type of CP; 
i) rejected for the specific role of reiteration of prescribers' instructions 
(analysis, level four; table 55, page 267); 
b) that unique pharmacy advice which includes judgement is not dependent on 
the type of CP. 
i) confirmed (analysis, level four; table 55, page 267). 
5. from section A3.1.5 Effect of the poster, page 274: 
a) that display of the poster had no effect on the numbers of POls initiating 
discussion on a prescription medication; 
i) confirmed (analysis, level one, table 59[A], page 276); 
ii) rejected if scanning the poster is taken into account (analysis, level 
one, table 59[B], page 276); 
b) that customer initiated requests for advice are independent of age; 
i) confirmed (analysis, level one, table 60[A], page 276); 
ii) rejected if scanning the poster is taken into account (analysis, level 
one, table 60[B], page 276). 
6. from section A3.2 Labelling, page 277: 
-111- 
a) that CPs' verbal advisory activity is not related to their use of written 
additional labelling; 
i) confirmed (analysis, table 61, page 279); 
b) that the use of non-verbal additional labelling was not related to the use of 
automatic printing systems; 
I) rejected (analysis, table 62, page 279). 
7. from section A3.3 Time based analyses, page 280: 
a) that the presence of the researcher had no demonstrable effect on the 
prescription medication activities of CPs; 
I) confirmed (analysis, table 64, page 286); 
b) that the advice seeking behaviour of POls is not related to the number of 
Individuals who concurrently ask for pharmacy services; 
I) rejected (analysis, tables 66, page 288, table 67 page 288; 
8. from section 3.4 Supply, page 289: 
a) that prescription medication advice is not dependent on whether advice on 
supply aspects of medication is provided; 
i) rejected (analysis, table 69, page 292). 
9. from section A3.1.3.3 What to do with it, page 264: 
a) to determine the nature of the advisory role for topics under the heading 
'What to do with it'; 
i) three roles were determined; reiteration of prescribers' labelling 
instructions, reiteration of additional labelling instructions and unique 
pharmacy advice. (analysis, table 54, page 264). 
10. from section A3.1.4.1 Side effects page 268: 
a) to determine the nature of the advisory role for topics under the heading 
'Side effects' 
i) four roles were determined; educational/informative, confirmatory, 
compliance and socialising (analysis, table 56, page 270). 
11. from section A3.1.4.2 What is prescribed, page 272: 
a) to determine the nature of the advisory role for topics under the heading 
'What is prescribed'; 
I) three roles were determined; educational/informative, confirmatory, 
and intent (analysis, table 58, page 272). 
4 
f 
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4.6 Statistical parameters 
In the analysis, the following statistical range has been followed for the probability of a 
correct decision to reject the null hypothesis; 'statistical trend' less than 95% (p=0.05) but not 
less that 90% (p=0.1); 'statistical significance' greater than or equal to 95% (p=0.05) but not 
greater than 99% (p=0.01); and, 'very significant' greater than or equal to 99% (p=0.01). Data 
and analysis were presented with the x axis as the independent variable, the y axis as the 
dependent variable and the z axis as categories of the independent variable. For reasons of 
presentation this pattern may be altered. In such cases, this is acknowledged in the 
corresponding footnote. 
As much of the data was described as frequencies In discrete categories at the nominal or 
ordinal level of measurement, the test of choice was often Pearson's chi-square. One of the 
assumptions made when deriving the chi-square distribution, as an approximation to the 
distribution of the chi-square statistic, is that the expected frequencies are not small. For 
small expected frequencies in contingency tables with more that four cells, the common 
recommendation is that fewer than 20% of cells have expected frequencies less that five and 
all cells have a minimum of unity 402 397 A review of such recommendations notes selected 
authors who consider this 'rule' unduly restrictive 400 It has been suggested by Lewontin and 
Felsenstein 398 that for 2xn tables with fixed marginals, "a very conservative rule of 
operation would be that if expectations are I or greater the test is certainly conservative at 
the 5%, 2% and I% level of significance and that for most cases even fractional expectations 
do not affect the test. For those cases of fractional expectations in which the [chi-square] test 
is non-conservative, the deviations of the true [unknown] values form those given by the [chi- 
square] distribution are quite small". Similar conclusions were reached by Slakter 399 when 
the expected frequencies are taken to be equal and very small. As deleting or combining 
categories to realise a minimum expected frequency is not a preferred method of analytical 
manipulation, 400 the author used his judgement as to appropriate analysis in 2xn and kxn 
tables. For 2x3 tables the more stringent criterion was used, that no cell had an expected 
frequency less than unity and only one less than five. In the case of a 2x2 contingency table, 
the suggestion by Everitt 400 to use Fisher's exact test when one or more cells has an 
expected frequency less that five is accepted in the analyses presented in this thesis. It 
should be noted that there Is some confusion over the size of the sample appropriate for 
Fisher's exact test. Cohen and Holiday 401 suggest limiting the test "to N's as large as 30 
where neither row or margin totals exceeds N=15". Similarly, Norusis 402 limits the total to 
less that 30 with no statement concerning row or column totals. Everitt 400 uses a numerical 
example to demonstrate the procedure for calculating the exact probability of the observed 
frequencies then advocates ways in which the probability calculations involved may be made 
easier by reference to a table applicable for total samples sizes up to 50. It would appear that 
the limit for Fisher' exact test is based on available tables rather than mathematical 
inaccuracy. A literature search failed to determine otherwise. Version 4.01 of the statistics 
package employed calculates both one and two tailed probabilities for Fisher's exact test 
when the expected frequency of one or more cells of a 2x2 table is less that five. It does this 
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Irrespective of the sample size. Examination of the algorithm used by version 4.01 
programme to calculate the probability for a sample size greater than 30 indicates no 
reference to a stored table. 403 As an exact probability is calculated, no limit has been set for 
the analysis presented in this thesis, on the sample size for Fisher's exact test. 
For the Mann-Whitney'U' test, the two-tailed probabilities are based on Z values where the 
number of cases exceeds 20 and an exact probability calculated, based on 'U' values, where 
the number of cases is less that 20. Values of Z are calculated with a correction for ties. 
For analyses of responses to attitudinal questions, although it has been argued that the 
numbers assigned can be manipulated at interval level regardless of their relationship to the 
underlying property being Investigated '404 it was not considered statistically valid for the 
studies conducted. In the attitudinal study, the scale used was not constructed between 
absolutes and customers were asked to choose discrete categories rather than a relative 
position on a continuous scale. This stance was taken in agreement with published literature 
that responses to vague quantifiers could not be assumed to be at the interval level of 
measurement. 405 4m Analysis was, therefore, limited to ordinal associations. 407 408 
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4.7 Conclusions 
This chapter has justified the methods and provided an outline of the research conducted for 
this thesis. It is clear that the researcher is taking an eclectic approach to qualitative and 
quantitative methods. It is also clear from the appendices that quantitative analysis has 
dominated the results. This is because the research question 'what do community 
pharmacists do' is primarily a question of epidemiology. 
Examination of possible options for data collection including schedule-structured interview, 
activity analysis and direct observation concluded that the latter was the method of choice in 
this instance. 
Statistical canons used in the analysis were described and it was concluded that use of 
Pearsons chi-square and Fishers exact test could be extended and maintain their statistical 
validity. 
The following chapter integrates the results of the research conducted, usually shown 
graphically, in a discussion which draws upon relevant literature and models to provide an 
understanding of the role of CPs as advisors on prescription medication. 
._- ý_ ýz 
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CHAPTER 5 DISCUSSION OF OBSERVED ACTIVITY 
5.1 Summary 
Before summarising the discussion in chapter five, it is useful to recall the substance of 
previous chapters. Chapter one outlines the historical development of community pharmacy. 
It focuses on CPs primary activity, that of dispensing and argues that the nature of 
dispensing is changing. 
Chapter two presents arguments that CPs may adopt a 'new', more proactive role as 
advisors on prescribed medication to replace the lost activity of compounding. Evidence that 
such advice is perceived by the general public as valuable is presented. A disparity is noted 
between the perceived needs of the public for advice and the recorded activity of advisors. 
The gulf is at its greatest for advice on the side effects of prescribed medication. That advice 
may be a positive force in the effective use of medicines is demonstrated. 
In chapter three, the ethical expectation that CPs should provide PMA is explored. The 
provision of advice is clearly within CPs' professional remit. The Code of Ethics is the major 
determinant of ethical expectations. The BNF' is the main reference source for CPs. It 
provides a list of medications each with the corresponding suggested written additional 
labelling advice. Community pharmacists have the final responsibility as to whether, how, 
when and where such advice is afforded. A full account of the issues involved is presented 
and those considered by this thesis identified. Principal among these is the most basic; to 
determine the prescription medication advisory behaviour of CPs. As such, this thesis 
concentrates on the epidemiological findings of the research conducted. A model for advisory 
action is presented. It proposes a cue-to-action for promoting community pharmacist-patient 
interactions. 
Chapter four defines the research aims and objectives for this thesis. Arguments for the 
method of direct observation with remote recording and an intervention in the form of a 
poster are presented. Research hypotheses and results of analysis are listed. 
Given this background, the content of chapter five is summarised in the next paragraphs. 
Section 5.2 Is primarily concerned with the results from level one and two analyses, where 
POls and prescriptions respectively were used as cases for analysis. Full definitions for 
levels of analysis are given on page 109. The principal finding that the study CPs counselled 
approximately one in every 7.44 POIs, is discussed and compared with published literature. 
Note Is made that this thesis presents the first evidence with subject validity of the full extent 
of CPs' advisory activity. The seeking of advice by POls, but not the provision of advice by 
CPs, is found to be related to concurrent dispensing activity. This finding is discussed in the 
context of the Health Belief Model (HBM). The identification of two distinct types of CPs, 
proactive and reactive, is discussed in the context of CPs' physical environment. Four key 
activities are then considered; the use of additional labelling, CPs' apparent selectivity in not 
advising elderly POIs; whether CPs' are aware of the extent of their advisory activity, and, 
-116- 
.... ....... . _.... ý... sra... w. ýýýrn.,.... e ý.. uawnvsaw. 
3ýrourv. xnvýuu. +e, wt, týcýW.. wx.. ýayc'. vnm'mr.: asuua. , F.. > ... nt. . 
their observed activity in relation to both the Government's and The Society's apparent 
policy. Finally, the relationship of CPs' advisory activity and patients' socio-economic status 
is discussed. Community pharmacies serve patients in narrow bands of socio-economic 
status. They tend to advise patients with higher socio-economic status, yet advice is sought 
across the range of status. The limitations of the evidence are presented. 
In Section 5.3, the main results of level three, where a case for analysis is the item 
prescribed, and level four, where a case is the category of advice, are discussed. Prescribed 
medication for the elderly was found to be linked to therapeutic categories, which are 
associated with relatively high compliance. This finding is discussed in the context of the 
level one finding that CPs may be ignoring the needs of the elderly. It is argued that in 
adopting this strategy, CPs may be seen as appropriately marshalling their resources rather 
than avoiding any one single group. Community pharmacists' advice is very significantly 
associated with verbal reiteration of labelling instructions for antibiotics. This finding is 
discussed in the context of qualitative analysis which points to a further element of 
judgement in the advice afforded. The low relative position for the frequency of advice on 
side effects compared to other categories is described. Five rationales for this observation 
are presented: 
1. CPs may be receiving mixed messages from peers on the problems of prescription 
medication side effects; 
2. CPs' personal experiences may have alerted them to possible problems; 
3. CPs believe that advice on side effects may psychologically induce problems in 
patients; 
4. role boundaries between CPs and GPs may act as barriers to the provision of advice; 
and, 
5. CPs may be influenced by the absence of legal obligations to provide advice on 
'Side effects'. 
The provision of advice for medication in therapeutic classification nine, steroids, is the sole 
exception to the low levels of information provided on 'Side effects'. In discussing the 
anomaly of therapeutic class nine, three theoretical models are examined; the sick role, the 
HBM, and, the Fear Drive Model. The Fear Drive Model was found to provide a useful 
understanding of the findings. A level four analysis revealed a significant change in the 
relative quantity of advice categorised under the headings of 'Side effects' and 'Specific 
problems' when the poster was displayed. The implication for future policy is discussed. 
Attention is then turned to a discussion of the results from qualitative and quantitative 
analysis of advice categorised under headings of 'specific problems' and 'what is prescribed'. 
The diversity of advice is noted and discussed. Finally in this section, the finding that when 
CPs have problems supplying medication they are more likely to provide advice is 
considered. ,--- 
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5.2 The extent of prescription medication advice 
This section considers the results of levels one and two analyses where POI or prescriptions 
were cases for analysis. For each discussion point a common structure has been adopted. 
First the key results are presented, then discussed and the impact of the findings on the role 
of CPs as advisors on prescription medication made. Conclusions are collated at the end of 
the chapter. 
Global findings from this study of observed activity are summarised in figure 16. That CPs do 
not advise all POI who enter their community pharmacies can be predicted by retrospective 
studies of patients' recall of information presented (section 2.4.2, page 53). Visual inspection 
of figure 16 confirms this prediction. Simple comparison of axes indicates that approximately 
one in six POls are involved in verbal PMA of a non-supply nature. As the intervention did 
not produce significant change in any of the before or after measures, observed activity for 
both periods was combined. From the total data, the more accurate figure of one in 7.44 
(473: 3519,13.4%, table 37, page 236) is derived as an indicator of advisory practice. 
Figure 16* 
Frequency of prescription orientated individuals, prescription medication 
advice and customer initiated advice by time 
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Note *=A graphical representation of data in table 65, page 287. 
Considering only customers, who by definition present or collect one or more prescriptions, 
rather than POI which includes the total of all those involved with prescriptions, then 12.2% 
(424/3488, table 39, page 243) were involved in advice. This figure may be directly 
compared with the value 13.1% (50/381) in the observational study conducted in America by 
Berardo and colleagues. 165 Categories of advice were not provided in the Australian study by 
Ortiz and colleagues. The author suspects that information on supply was included in their 
figure of 41% for 'giving advice about prescribed medication'. 170 In the English study by 
Haynes and Livingstone 164 comparable data on either the numbers of POIs or customers 
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involved were not published. This thesis is therefore the first to describe the total of advice, 
POIs receive from CPs within a defined area of Britain. The use of the observational method 
with subject validity, indicators of reliability (section A3.3, page 280) and data entry (section 
4.5, page 107) provide strong support for the accuracy of the results presented. From this 
evidence it can be stated that CPs act as advisors, possibly at a level comparable to their 
American counterparts. 
Figure 16 compares PMA given by CPs with the coincident number of individuals receiving a 
dispensing service. A fundamental finding is that the provision of advice is not associated 
with the variation in dispensing activity. Section A3.3, page 280, provides a full account of 
the analysis and statistical results for this finding. Berardo and colleagues165 plus Dickson 
and Rodowskas 409 both reported similar findings. The latter study 409 used work sampling 
methods and path analysis. It was found that the time of the day in two hour segments was 
only weakly correlated (0.023) with 'patient communication'. It can be demonstrated that the 
CP's role as an advisor appears independent of the coincident number of individuals present. 
Figure 16, page 118, also illustrates that POI are more likely to initiate discussion during 
periods when fewer individuals are present in the pharmacy (section A3.3, page 280). This is 
an original finding not reported elsewhere in the literature. Two explanations are possible. 
First, CPs may be consciously conserving their resources by limiting their availability during 
times of intense dispensing. This would be predicted by the hypothesised advisory action 
model (page 95) which includes 'resources' as a modifying factor. Second, it can be argued 
using the HBM (page 70) that seeking advice depends on the balance of perceived benefits 
from receiving advice and perceived barriers of Interfering with the activities of the CPs. 
The potential for barriers is demonstrated in the following transcript. The customer (C) is a 
male Caucasian over 65 years of age who received prescribed items dispensed on the basis 
of a prescription left prior to the observation period. He accepts the items from the CP (P), 
notes the A3 size poster advertising CPs' advisory services and states: 
C-P That's a good idea (looking at poster) 
P-C Yes well ... we might get one of these things full-time C-P Well it's surprising how many people haven't the faintest idea 
P-C Umm.. that we're here for advice if they want it 
C-P And almost afraid to ask 
P-C Umm yes... (Nods in agreement) It's getting better but you're quite right.. there's an 
awful lot of people who feel... you know... as though they don't want to be any 
trouble.. you know 
C-P I know, 
P-C It's quite the opposite really 
C-P I know we used to find the same in our field but. -.. er.. 
P-C Umm.... 
Assuming that POls who would like to request advice visit community pharmacies throughout 
the day, the finding that they do not approach the CPs at certain times, points to a problem 
which requires addressing If Individuals are relied upon to make their advisory needs known. 
Just as a lack of feedback from patients has been identified as a major problem for GPs 
(section 2.3.3, page 46) the same may apply to community pharmacy. There are two options 
CPs might consider. First, they might educate POIs to be more proactive In seeking advice 
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and/or second, CPs might be proactive in providing advice irrespective of dispensing activity. 
It would appear that the latter option has already been taken by a proportion of CPs. 
Figure 17 demonstrates a further original finding of this thesis, that there are two distinct 
types of CPs; proactive CPs who provide advice and personally hand out dispensed 
medicines and reactive CPs who only provide advice when it is specifically requested and 
devolve the prescription handling activity to assistants (section A3.1.1, page 222). 
Figure 17 
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It may be proposed that CPs' environments affect their activities as advisors. Evidence 
suggests that for proactive CPs, the availablility of dispensing technician support has no 
significant effect on their advisory activities. 41J In the research presented in this thesis, there 
was a clear ordinal association for reactive rather than proactive CPs to be physically located 
closer to surgeries (table 12, page 185). The same ordinal association was found for 
managers more than manager proprietors to be reactive. Clearly, there are complex 
relationships which policy makers should consider. For example, advocating the location of 
community pharmacies adjacent to surgeries may increase CPs' interactions with prescribers 
but may reduce the advice provided to patients. Similarly, the expansion of multiples 411 with 
managers rather than proprietor managers may have a bearing on the advisory service. The 
cost implication of dispensing from surgeries has been noted. 412 
In the present study, the dispensary area of two community pharmacies could be likened to a 
consulting room; the CP in one setting was proactive, in the other reactive. In neither case 
% customer initiated of PMA 
100 
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were adjusted chi-square residuals for the frequency of customer initiated advice, compared 
to the total distribution, statistically significant (section A3.1.3.1 table 47, 'note' page 256). 
The observation that POI were reluctant to request advice was consistent for both types of 
CPs (section A3.1.1, page 222, also table 52, page 261). These results are supported by 
those in Britain of Wilson and colleagues 270 who reported the amount of information given or 
recalled in community pharmacy settings was unaffected by the area in which discussion 
took place. 
In contrast, Ludy and colleagues 413 found significantly more advice, greater patient 
satisfaction and higher levels of compliance using a private consulting room at an American 
hospital satellite pharmacy when compared to a traditional local community pharmacy with 
an open window setting. Such data supports arguments for physically secluded, dedicated 
consultation settings and has led to a policy statement in a DofH commissioned report 414 
"that basic minimum standards for community pharmacy premises should be established" by 
enacting Regulations under sections 66 of the 1968 Medicines Act. In their assessment there 
is a need 'Yo take account of the desire on the part of some members of the public for 
confidentiality when consulting the pharmacist". A counter argument may be made that 
consulting rooms within the community pharmacy may be outside the normal experience of 
POls. The private consulting room Is associated with the GP's setting and it may transpire 
that duplicating such an environment within community pharmacy would decrease CPs' 
contact with those who desire anonymity. It may, of course, be possible to have consulting 
rooms which are removed from the dispensary area and available to CPs at their discretion. 
While the data in this thesis is not able to fully address the question of the advisory setting, 
no evidence is found to support the theory that proactive or reactive CPs are Influenced by 
physical setting. Indeed, advice seeking appears independent of type of CP. It is concluded, 
therefore, that the role of CPs may be variously influenced by policy decisions which 
mandate dedicated physical areas for counselling. 
Four key questions are now discussed. First, do CPs use other than verbal advice to inform 
POIs? It has been proposed that CPs may rely on additional labelling as a means of 
educating patients. 164 From evidence in this study, this appears to be the case. However, 
results of the investigations into the labelling activities of CPs (section A3.2, page 277) show 
no statistical evidence (tables 61 and 62, page 279) that this method of patient education was 
used as an alternative to verbal advice, rather, that unless the mechanism for producing 
additional labelling information is automatic then customers were significantly less likely to 
receive such written advice. Community pharmacists In the observational study provided at 
least one correct additional label for 40.7% of sampled dispensed items for which labelling 
was advised. This may be compared to the 40% found by Ross and colleagues 299 in America 
who investigated the use of auxiliary labels with mandatory regulations in operation. In the 
present study, ' just over 22% (110/500) of prescribed items were dispensed with an additional 
label. Labels were therefore the major method by which CPs provided patients with 
information during the period studied. Aside from additional labels and two steroid cards to 
advise in emergencies that the patient was on such medication, POls were not provided with 
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any other written information or package inserts other than those included by manufacturers. 
No audio-visual methods of education were employed, or dedicated information leaflets 
supplied. Such baseline results may enable more current studies to determine the effect of a 
European directive 415 on the provision of patient information leaflets for medicines. The 
directive requires all side effects mentioned in a products licence to be Included in the 
leaflet. The first propriatory medication to include the new, specifically designed patient 
information leaflets is due for introduction in December, 1995.416 Irrespective of the use of 
written information, it is argued that verbal advice should still be provided. 19144 417 
Second, are CPs selective in the POls they advise? Evidence suggests that CPs have a 
positive attitude towards the elderly, although are concerned about non-compliance. 418 Even 
so, section A3.1.2, page 227 and table 38, page 238, presents the finding that elderly 
customers, especially females, are very significantly less likely than expected to receive 
advice. Also, that these same individuals are very significantly more likely to request advice 
from the CP. Care should be taken in the interpretation of the data presented as significant 
associations were for proactive not reactive CPs (table 38 page 238, columns 21,22) who 
were responsible for 75.9% (359/473, table 38 page 238) of the numbers of POls involved in 
discussion. Section 1.6.2, page 36, and figure 10, page 38, detail the growing number of 
individuals in the elderly population and consequent changes in prescribing patterns. The 
report to the Nuffield Foundation " notes these events and advises the need for specific CPs' 
involvement with the elderly. From the results of this level one analysis, it would appear that 
CPs are not concentrating their advisory activity as recommended 11 and, in ignoring the 
elderly, appear to be doing the opposite. From the evidence presented so far, it would appear 
that CPs are discriminatory in their advisory role. 
Third, do CPs know the level of their advisory activity? A moderately positive correlation was 
found between the estimates of advisory activity made by CPs and the subsequent results of 
the observational study (r = 0.56628, p=0.043, section A2.2.3, page 196). Such a 
relationship suggests that CPs are able to estimate the extent of their activity and by 
implication are aware of their actions. In addition, the analysis shows that the CPs in the 
main study and their contemporaries within Southern Derbyshire had similar attitudes to 
prescription medication counselling (section A2.2.3, page 196, table 23, page 205). If CPs 
attitudes also correlate with their advisory activity, it becomes possible to generalise the 
results of the observational study to the sample frame. Mason and Svarstad 419 report a 
significant correlation between positive attitudes towards counselling and observations of 
increasing counselling activity fora random selection of American CPs (r = 0.54, p<0.001). 
Assuming that both studies tap similar entrenched attitudes then there is literary evidence 
that the results of the observational study may be generalised to the sample frame. 
As CPs are aware of their advisory activity, and only one in 7.44 POis are given advice, the 
fourth question asked must be, are CPs failing to adhere to the expectations of The Society 
as described in the Code of Ethics? The Society's expectation Is that "a patient or his 
agent(s)) should be provided with the information and advice required for safe and effective 
-122- 
use of theirmedicinesn291 Section 3.2, page 80, describes that advisory activity is 
sanctioned, in the sense that it is given professional backing, but that during the data 
collection period and up to the submission of this thesis in July 1995, CPs are responsible for 
when, how and to whom advice is provided. The Society, in regulating the profession, 
assesses CPs in comparison with the 'normal' behaviour of their peers. Unlike in America, 
there are no legal rulings which direct CPs to provide advice (section 3.3, page 85) yet, if 
they advise incorrectly, they will be held accountable in law. The critical point in this 
discussion is implied in the action required by the Code of Ethics "to be provided with the 
information". In order to determine who should be provided with advice, CPs must somehow 
communicate with patients. At a practical level the BNF directs that CPs consider supplying 
written advice for just over half (section A3.2, page 277,54% table 61, page 279) of 
dispensed items and verbal advice for a very small number of prescribed medications. It can 
be argued that for the drugs specified in the BNF there are yardsticks with which to assess 
CPs' advisory activity and their adherence to the Code of Ethics. This thesis has identified 
that the vast majority of verbal advice is reiteration of BNF written labelling instructions. The 
implication is that CPs provide no advice to the remaining proportion of patients for which 
there are no BNF labelling instructions. Also that there are no yardsticks with which to assess 
this lack of activity. Perhaps these patients are receiving repeat medication? Even so, 
evidence suggests that the majority always want to receive advice. 122 It is a limitation of this 
study that repeat prescriptions could not be identified (section 4.4, page 104). Little evidence 
was found in the research for this thesis to support the view that CPs are actively seeking to 
determine either the extent of patients' knowledge of their medication or how patients take 
their medication. The conclusion must be that CPs are failing to meet the expectation of the 
Code of Ethics for a large proportion of patients. They are not determining who should be 
"provided with information , 
291 rather they are relying on the BNF to direct their role. 
A further dimention relevant to this discussion is how CPs are remunerated for their advisory 
activity; An evaluation of prescription related activities in Australia by Berbatis and 
Sunderland 420 proposed the "linking of a professional fee to the standards of pharmacist 
performance and the adoption of a scale of fees for specified professional services". Based 
on the finding that there are two types of CPs, proactive and reactive, the author presented a 
report (section A4.1, page 293) and a verbal submission to The Society's joint working party 
on the future of community pharmacy, suggesting that such a scheme was viable in Britain 
and might help to improve the overall frequency of advice provided by CPs. Studies 421 422 423 
have shown how the use of 'standardised (simulated) patients' may be used to assess GPs' 
competence. The corresponding method for CPs, using 'standard' prescriptions and direct 
observation to verify CPs' advisory service, might be used to delineate proactive and 
reactive types and, thus, determine correct payment. The presumed response from the DofH 
working party 414 was as follows: 
"5.4 lt was suggested in evidence to us that pharmacists should be specifically 
remunerated for this function [the provision of prescription medication advice], on the 
basis that it is an effective use of pharmaceutical knowledge and expertise and 
makes a substantial demand on their time. This Is in part based on a 
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misapprehension. Pharmacists are remunerated within the NHS for the provision of 
pharmaceutical services, and pharmaceutical services are currently defined in terms 
of dispensing. But as we have seen the dispensing process consists not just of the 
manipulative skills required to supply the medicine but also the cognitive and 
communication skills required to verify the appropriateness of the medication and 
counsel the patient on its effective use". 414 
The DofH response is, however, in conflict with the fact that the'on-cost' (section 1.5.2, page 
30) carried with it an element of indirect payment for advice. With the demise of the 'on-cost' 
payment in 1989, it would appear that the official monetary recognition of CPs' advisory role 
ceased. Inspection of the 1994 contract between CPs and the FHSA has revealed no specific 
responsibility or payment for CPs to advise those Individuals who enter their premises. No 
definition of the composition of the professional fee could be found. Indeed Mr Graham Hart, 
permanent secretary of the Department of Health, is reported as saying "that while advice- 
giving was important, it was not specifically mandated in the contract and related to wider 
issues than NHS dispensing". 424 Clearly the issue of payment for advice appears to be 
variously perceived by Government, The Society and practising CPs. 
No associations between patients' socio-economic status and CPs' advisory activity have 
been reported in the literature. Visual inspection of figure 18, page 125, indicates that 
community pharmacies appear to provide dispensing services to patients from narrow bands 
of socio-economic status. It is proposed by the author that the higher the socio-economic 
status of patients receiving community pharmacy services, the greater the advisory activity 
by CPs. This proposition is based on the presumed greater expectation of service held by 
individuals living in these areas and such patients' higher levels of education. Visual 
inspection of figure 18 reveals clustering along the top left to bottom right diagonal. As the 
data is arranged in order of CPs' advisory activity, this diagonal corresponds to higher levels 
of advice being given in pharmacies serving patients with higher socio-economic status. 
Analysis (section A3.1.2, page 227, table 41, page 245) indicates a low ordinal association 
(gamma -0.29812) between order of advisory activity and order of socio-economic status. 
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Figure 18 
Percentage of patients in bands of socio-economic status receiving items by 
dispensing community pharmacists in order of advisory activity 
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*=A graphical representation of data in table 41, page 245. 
While no significant difference in the distribution of socio-economic status was found (table 
42, page 246) for customer initiation of advice compared to the population, the distribution of 
customers receiving advice compared to the population was significantly different. Similarly 
the distribution of those initiating advice was significantly different to those provided advice. 
Visual inspection of figure 19, page 126, confirms the patterns implied by these results. It 
shows that those receiving advice were more likely to be of a higher socio-economic status 
than those seeking advice. Limitations imposed by the method of data collection restrict 
further discussion. However, the results point to potentially important future areas of social 
investigation based on the advisory expectations felt by CPs, their observed activity and the 
social profile of patients using their service. 
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Figure 19 
Numbers of patients receiving and requesting advice in socio-economic 
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From the evidence discussed so far, PMA may appear a loosely conducted, defined and 
regulated activity, which is clearly seen by some POls as useful but is probably outside the 
experience of most of them. Raynor 
425 published a review of the pharmacist's role in patient 
compliance citing literature from studies in hospital settings. He concludes that effective 
verbal counselling requires considerable resources and is more likely to increase knowledge 
than compliance. He suggests that interventions which simplify the dosage regimen are the 
most fruitful areas for pharmacists' attention. This stance was also taken by the Committee 
which reported to the Nuffield Foundation. 
" In response, the author would suggest that the 
effect of CPs' advice on compliance is still unknown. This thesis presents evidence from a 
small but representative sample which suggests that pharmacists in Britain vary greatly in 
the quantity of advice they provide. Also that the nature of advice varies enormously. As 
evidenced by the reviews in chapters one to three, the results in chapter four and the 
appendices plus the discussion so far, the author feels that Government, The Society and 
published literature underestimate the range and potential for CPs role as advisors on 
prescription medication and that they do so with little or no evidence. Given the lack of 
'official' direction and reassurance it is not surprising that a considerable range of advisory 
activity was observed. The following section considers the thesis findings in greater depth. 
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5.3 The prescription medication advisory activities of community pharmacists 
This section discusses the main results of level two, three and four analyses, where the 
cases for analysis of the observed activities of CPs were the number of prescriptions 
involved, (level 2), medicines on prescription, (level 3) or categories of advice per medicine 
per prescription (level 4). 
In the previous discussion the possibility that CPs were neglecting a section of the 
population, the elderly, was raised. It was noted that such neglect was associated with 
proactive CPs. What is not clear is whether the cause is the nature of the prescribed item or 
the elderly status of the patient. Figure 20 shows the distribution of advice in therapeutic 
classes of prescribed medicines. The very significant association between the provision of 
advice and therapeutic classification was due in large measure to greater than expected 
levels of advice for classification eight, antibiotics, and less than expected for classification 
four, preparations acting on the cardiovascular system (table 48, page 257, column 14). The 
same relationships between category of advice and classification was shown by Ortiz and 
colleagues 170 who suggested "that pharmacists are selective in the type of advice given to 
patients, with a preference given to advising about the use of acute or short-term medication 
over chronic or long-term medication". 
Figure 20 
Frequency of prescription medication advice, customer initiated advice and 
preparation events by therapeutic class 
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*=A graphical representation of data in table 48, page 272. 
Nearly one third (table 48, page 257, column 20,130/421,30.9%) of the total number of 
prescribed items for which proactive CPs provided advice were antibiotics. It has been 
shown that the clinical implication, in terms of compliance, of a failure to provide advice for 
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drugs in classification four is less than that for classification eight.... "" Section 1.6.2, page 
36, provided evidence that the elderly consume a greater quantity of medication than other 
groups. It is consistent that with such consumption they should be highlighted by the report to 
the Nuffield Foundation " for advice unless, as is suggested, their medication is for chronic 
conditions and of a nature where compliance is in any case likely. When it is considered that 
the elderly are more likely to be taking drugs in classification four, then the classification of 
drug, rather than the age of the patient can be seen to account for the finding that fewer than 
expected numbers of elderly individuals received advice. Community pharmacists may be 
perceived as 'directing' their resources and as a consequence seeming to 'neglect' the 
elderly. In terms of the role of CPs as advisors, suggestions by the report to the Nuffield 
Foundation " that CPs should direct their activities towards the elderly must, therefore, be 
qualified to take into account the medication consumed by this group, the likely improvement 
in compliance that may be induced and the consequence for other groups of altering the 
present pattern of advice provided. 
Figure 21 provides a graphical representation of the observed frequency of advice for each 
of the four categories by the therapeutic class of the item prescribed. 
Figure 21 
Prescription events compared to prescription medication advice in categories 
by therapeutic class 
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Two major elements are striking. First, there is the dramatic frequency of advice on 'What to 
do with it' for classification eight. Section A3.1.3.3, page 264, provides a quantitative 
assessment of this category of advice. Commuity pharmacists' most prominent proactive 
advisory role is found to be a reiteration of prescribers' directions or a verbal account of 
sanctioned additional labelling information. The evidence shows that this activity mainly 
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concerns antibiotics. However, both reactive and proactive CPs also provide advice not 
sanctioned by official sources or the prescribers' written intentions. Such activity goes 
beyond that of a verbal extension of prescribers' intentions. 
Second, the low overall observed advisory activity related to side effects together with the 
relatively greater frequency of such advice for drugs in classification nine, preparations with 
hormone or anti-hormone activity, are notable (table 48, page 257, column 14). Chapter two 
emphasised an apparent difference between patients' perceived need and CPs"activity' with 
regard to provision of information on side effects. Figure 21 confirms this relative lack in 
practice. Other research conducted to support this thesis 147 148 shows that both CPs and 
patients, when asked open questions, agree on the areas or topics of information concerning 
prescription medication about which information should be provided. This consistency allows 
a comparison of what is expected by both parties with the activity observed. The number of 
respondents who indicated that side effects of medication was a necessary element of 
advice was 67.9% (55/81) for CPs and 47.1% (40/85) for patients; the second and highest 
rankings respectively. 147 148 In contrast, the frequency of advice on side effects is ranked last 
in the observational study. It would appear that there is indeed an inconsistency between 
perceived need and observed activity as proposed in section 2.4.1, page 50. The results 
presented in this thesis confirm the limited role of CPs as advisors on the side effects of 
prescribed medication and reveal therapeutic classification nine as a category of advice 
about which Pols are seeking to be informed about (section A3.1.3.1). 
Studies in hospital settings link patients' experiences 277 and perceptions of side effects 428 to 
compliance. Such studies show that advice by pharmacists on how to manage side effects 
positively affects patients' knowledge about their medication 429 and compliance. 67 2613 
Patients' general Ignorance of side effects of prescribed medication has been already 
highlighted. 125 177 Similarly, a study by Bailie and Kay 430 showed that few patients, 6% (3/50) 
are aware of how to avoid side effects for the commonly used anti-anginal drug glyceryl 
trinitrate. It seems likely that a reduction of side effects would be an important factor in the 
economics of health care by reducing hospital admissions223 If side effects due to 
concomitant therapy with interacting drugs are included then nearly a quarter of patients 
admitted to hospitals may be involved 43' Advice on side effects is desired by patients, has 
been shown to affect compliance positively, and to be of obvious economic advantage, yet 
CPs do not appear to provide such information. The question is why are CPs so 
circumspect? The following six reasons are proposed by the author. 
First, they may be receiving mixed messages in the literature. The Pharmaceutical Journal 
presents clinical cases where advice on side effects is perceived as alarmist. 432 433 Although 
there appears no problem with the provision of written information, 434 the tone of written 
Information 154 435 is reported to alter the effect in individual cases. Community pharmacists 
may have personally experienced such cases. In addition, standard texts state that "efforts 
were made to exclude information such as rare or very uncommon side effects that could be 
suggestive to, or frighten some patients". 438 Studies of the effect of written information on 
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compliance propose that informed patients may be better able to identify clinically irrelevant 
side effects from potentially dangerous reactions, tolerating the former and seeking 
assistance for the latter. Reviews in 1979 261 and 1984 437 have considered the impact of 
providing advice on side effects on the reported incidence of such effects. They conclude 
that no evidence supports a detrimental outcome from providing this advice. The bulk of 
evidence supports the inclusion of side effects as a category of advice. Indeed as Balon 
. 
438 'The most common claim made by clinicians and drug companies is that side 
effects cause non-compliance. However, the bulk of evidence available refutes that claim". 
That this is the case has been demonstrated for both verbal plus written advice 439 440 and 
verbal advice 441 442 Even so, specific cases have been published where such information 
has had a detrimental effect on patient compliance. This may have been due to the way in 
which the information was presented and received. However, the existence of such cases 
may act to deter CPs from giving advice on the side effects of prescribed medication. 
Second, CPs personal experiences seem likely to influence their activities. This point is 
clearly demonstrated by the following case. The customer (C), a female Caucasian under 60 
years of age, notices the poster and hands a prescription to the CP (P) for Sandomigran 
tablets which are used in the treatment of migraine. She asks: 
C-P Your advice on this 
P-C Yes, of course 
C-P Umm... Could you tell me what they're for? 
P-C Basically, they are for migraine 
C-P Are there any side effects? 
P-C Yes, there can be with that particular one... um, let me tell you for sure what they're 
likely to be (CP goes to dispensary to get data sheet information) (CP asks from the 
dispensary) You've obviously not had these before 
C-P No, no 
P-C Dizziness is, I think, one of them, that you can get with that one. Having said that ... C-P Dr. C.. (GP) said take it night - it may cause drowsiness is what he said 
P-C Drowsiness is quite likely... yes. They are a fairly specific tablet In that they are not 
just an analgesic - they are specific for migraine 
C-P I did sort of debate the Issue of whether or not to try some herbal remedy like 
Feverfew or something 
C-P Yes 
P-C I've known success with that, but it's the same with a lot of these things, particularly 
things like migraines. What one person finds effective might be totally useless for 
another. I've known people use Syndol tablets to good effect for migraine and I'd 
recommend them to someone else on that basis. 
C-P No, it didn't do anything at all 
P-C So it's very specific for each person, and it's a case of finding something that suits 
them and staying with it. But this is fairly strong and Is only available on prescription. 
I'll just tell you for sure what they are (Referring to side effects) 
P-P (P to himself while in the dispensary) Of course, I'm not going to find it now. (P 
leafing through Data Sheet Compendium) I think dizziness and drowsiness are going 
to be the main possibilities, and again it doesn't always affect everyone In that way. 
Yes ... drowsiness, dizziness C-P Umm... 
P-C Umm... possibility of an increased appetite with a possibility of a gain In weight 
C-P ° Umm... Sure? 
P-C Yes, as I say, quite often they are-probably been reported in one in so many 
hundred or thousand people ... so it's not necessarily going to happen with yourself C-P Umm... but it is a possibility? 
P-C I didn't realise there was a possibility of a gain in weight to be honest... drowsiness is 
the most likely. 
C-P Probably the most common thing anyway. I may try the Feverfew method before 
resorting to those I think 
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P-C Yes, I think you'll probably find that these are more likely to be helpful. Is it the gain 
in weight, the drowsiness that is possibly putting you off? 
C-P Yes 
P-C Umm.. My advice would be to have this for the first month and see if it has any 
effect. If it doesn't in the first month, the chances are that it won't in the future 
anyway 
C-P Umm... 
P-C I mean, obviously you could try the Feverfew 
C-P I'll think about it 
P-C It's a herbal... 
C-P Yes, I'll think it through 
P-C By all means .. have a think about it. It's the sort of preparation where it probably is a 
choice of yourself. You know, it's not like a blood pressure, where the doctor said 
'you need it', then you really do need it. It you'd rather take an alternative, then by all 
means .... C-P Yes 
P-C I have heard of people using Feverfew to good effect 
C-P Yes... I think I'll think it through first (Customer takes the prescription back) 
P-C OK. 
C-P Thanks very much 
P-C OK. 
It may be that such local experiences, where the provision of advice on possible side effects 
has apparently resulted in the potential for non-compliance with prescribed medication, may 
outweigh literature reports to the contrary and have contributed to the observed low level of 
CPs' advisory activities concerning the side effects. Additional points may also be noted 
from this interaction. The customer used the CP to confirm the use of the medication or 
'What was prescribed'. Additional advice was provided by the CPs and resulted in non- 
compliance and loss of business. The CP did not insist that the medication should be taken 
just because it was prescribed, rather that the customer should decide, given the likely 
effects. Such reactions imply a caring relationship between professional and patient where 
the latter's well-being is of concern. 
Third, CPs may avoid disclosure of side effects as they believe psychologically Induced 
reactions might occur because people are highly suggestible 443 That patients do attribute 
untoward effects to medication has been shown in studies which Included placebo 
'treatment'. As early as 1933 444 and 1948 aas reports warned of the existence of pre- 
treatment conditions and placebo reactions. Pogge, 446 in 1963, found that 23% of 549 
patients In 67 published studied who were given placebos reported at least one side effect. In 
1964 Green 447 reported an investigation which described variety of signs and symptoms 
which may be attributed to side effects of medication. The problem of distinguishing true 
reactions to drug treatment has already been highlighted. 448 449 Such studies suggest that 
advisors have grounds for non-disclosure of information. If mentioning a side effect 
coincides with a similar underlying pre-existing unrelated symptom, then the medication may 
be erroneously identified as the cause which could lead to discontinuation of drug treatment. 
The following exemplary transcript demonstrates this potential for unnecessarily alarming 
customers. The customer (C), a female Caucasian under 60 years of age, scans the poster 
and is approached by the CP (P) who is unable to supply the strength of medication ordered. 
He arranges to dispense the required amount in multiples of lower strength tables and in 
defence states: 
P-C So, you know, I'll let you do it that way. I think they're only made by the hospital 
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C-P Yes 
P-C Er, because it's such a high dosage 
C-P Is it really a high dosage that I'm on at the moment? 
P-C Well it is... it is a high dosage to start with, and that's the reason why they don't 
actually... 
C-P Yes 
P-C You know, make them. But obviously if he's (Physician) trying to cut them down, he'll 
probably start from that and cut it down slowly to.... 
C-P I'm hoping so... 
P-C You know, that's right. How long have you had these.. er.. 25mg for? 
C-P I've been on... um., two weeks, I've been on them for two weeks 
P-C Two weeks, yes, er, that's all right... anyway, you wouldn't ... 
C-P 'Cause they say they're quite dangerous aren't they, if they're used... 
P-C If they're used correctly, then they're Ok 
C-P Oh, all right 
P-C The... the Consultant knows exactly what he's treating 
C-P Yes 
P-C Yes? Um, he would.. he would reduce the dosage gradually, but it's the sort of thing 
you can't just cut it down 
C-P No, it has to be.... 
P-C So, it's when... 
C-P Why is that... what exactly ....? 
P-C You get... because it, er... acts on the adrenal cortex 
C-P Yes 
P-C And if you stop abruptly, you would, er... you get a rebound effect 
C-P Oh 
P-C You know, and er... that has quite nasty symptoms, so what if you start on it, which 
he's put on it. He (Consultant) knows exactly your condition, right, so... 
C-P Yes 
P-C Just take.... 
C-P I've been on it before 
P-C Yes, that's right. What he (Consultant) will actually do is review the situation 
C-P Yes 
P-C And then... then see you and bring the dosage down 
C-P Yeah 
P-C To, you know, nil, but it's the sort of thing you can't just stop 
C-P No 
P-C You know, Ok 
C-P Right 
P-C Right... er, don't get worried about it 
C-P all right, thanks 
(The CP returns to the dispensary then brings out the dispensed items and advises 
on the dosage schedule) 
This transcript exemplifies the customer's anxiety over the medication and its Implied side 
effects. It shows the 'hole' which the CP dug for himself, and his use of both pharmacological 
knowledge and the 'expertise' of medical practitioners as a strategy to alleviate that situation. 
Given such experiences, CPs might try to avoid such uneasy interactions and potentially 
alarmist statements by simply refraining from all such interactions. In their eyes, information 
on side effects may equate with anxiety and if dialogue is not able to reassure the patient, 
then this may be a contributing reason for avoiding such advice. That customers are anxious 
over their medication and, as predicted by the theoretical models (figures 12,13, and 15, 
pages 70,72 and 95, respectively) may initiate discussion if prompted in some way, Is 
demonstrated by the two cases which follow. In the first, the poster was used as a cue and in 
the second the CPs' activities prompted action. The customer (C), a female Caucasian under 
60 years of age, presented three prescriptions, one for herself and two for her children. A 
second adult drew her attention to the poster. The CP (P) took the dispensed items to the 
front counter and asked: 
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P-C It's for the C... family 
C-P Pardon 
P-C Sony 
C-P Umm I'm just looking at that (the poster), are there any side effects with... with 
the little ones (antibiotics for children) 
P-C Umm well, there can be yes umm well they... have they had any antibiotic syrups 
before? 
C-P Umm yeah, my daughter has, he (son) hasn't 
P-C Yeah.. ok.. umm.. I mean there's a er slight chance of er things like umm diarrhoea 
or or stomach upsets or umm there are some... a risk of skin reactions, so so getting 
a rash. But if they have had antibiotics mixtures before and not had any any trouble 
then then it's unlikely that there'll be any 
C-P (Nods understanding) 
The customer (C) a male Caucasian over 65 years of age who was also the patient, is called 
by name to receive the dispensed items and initiates discussion with the CPs (P) asking: 
C-P Any side-effects with these (Oxtetracycline)? 
P-C Not really you must take them on an empty stomach half.. well the label says an hour 
before food so.. there's no side-effects with those at all umm but you may find that 
the way they're absorbed into the body is affected by umm food and other things like 
milk, indigestion mixtures so you must avoid taking those at the same time of day as 
your tablets but apart from that... 
C-P Milk... but I take tea 
P-C I should avoid, I should avoid milk in tea as well 
C-P You would 
P-C An hour or half an hour at least before you take 
C-P What after as well 
P-C Either way 
C-P Either way 
P-C It does affect the absorption... it won't... it won't affect how you feel but it will affect 
how well the drug works 
C-P I saw you looking in the book you see 
P-C Oh, no, I was just checking that gentleman's umm 
C-P Oh I see 
P-C Medication 
P-C That's just er 
C-P So it's an hour before food 
P-C Yes 
C-P But if possible If I... on an empty stomach 
P-C Yes 
C-P So that's er... what would you call... 
P-C Umm let's see, what time do you have breakfast? 
C-P Oh, about, eight 
P-C About eight, right well leave, leave about a hour to two hours and say take one at ten 
C-P Umm take one at ten for dinner 
P-C Well take one at ten o'clock then you've got to take them at regular Intervals 
throughout the day so, just try and space it In between in between your meals as 
much as you can 
C-P Umm 
P-C So that your taking it on an empty stomach last one you take at night, take it just 
before you go to bed 
C-P. Just before you go to bed 
P-C Well then you've got enough... sort of like from the day to space them out as equally 
as possible 
C-P Umm you see, when you take them an hour before ah say dinnertime is one o'clock 
so before twelve 
P-C Umm take them about twelve o'clock 
C-P And then don't have your dinner before one give a good hour 
P-C Oh, it's not.. yes give a good hour but it's not it's not critical, I mean, don't worry if 
you, you know 
C-P Umm, all right, when you first get up it's all right on an empty stomach P-C Yes you can take them when you first get up and then perhaps... say if you got up at 
seven take them at seven then you'll be all right for eating your breakfast at eight C-P Umm but don't take them with tea 
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P-C Well umm try any avoid it as much as possible but that's again, not too critical but try 
to avoid it if you can, take them with a glass of water, something like that ok (laughs) 
Critically, after this interaction the CP volunteered the following explanation: 
P-Res Yes er... it is a bit difficult really. They say, are there any side effects. There are side 
effects with everything more-or-less but, I mean, you could go through the whole list 
and, you'd worry'em half to death I mean he's worried now because he's not going to 
take them at the right time of day. 
These transcripts demonstrate that patients are anxious over their treatment and given the 
opportunity, ask for advice. The second case also indicates that CPs are aware of the 
anxiety induced by information on side effects and the potential for such information to 
influence compliance. Avoiding discussion on side effects might be seen as one way of 
reducing such anxiety. It might be said that CPs follow the adage 'what you don't know can't 
harm you' and this has resulted in the lower than expected frequency observed for this 
category of advice. 
Fourth, the lack of advice concerning side effects may be due to a perceived division of 
labour between GPs and pharmacists. Woods and colleagues 450 investigating the incidence 
of adverse reactions or side effects in children stated: 
"The role of pharmacists in advising about treating children with drugs could be more widely 
recognised in their training. Doctors might consider whether their present apparent reluctance 
to give parents specific prospective advice on the likely occurrence of common adverse 
reaction to drugs is appropriate". 
Woods and colleagues imply that advising on side effects is a medical role while conveying 
details of administration is within the pharmacists' domain. This was the finding of McMahon 
and colleagues 143 in a sample of hospital outpatients who were interviewed about who 
provided them with information. Hence, a further plausible reason why CPs are reluctant to 
give advice may be because they perceive such activity to be within the role of GPs. 
Fifth, there is no legal obligation to provide advice on prescribed medication in Britain or 
America 301 and as discussed in the chapter three, the direction offered by official bodies is 
minimal. 
Sixth, customers may require a cue-to-action inviting them to ask for advice on side effects. 
Without prompting, inhibitions towards disturbing CPs may be too great. When the 
frequencies of advice in each category with and without the poster were compared, 
statistically significant increases in the proportion of individuals given and seeking advice on 
side effects and Information categorised under the heading of 'specific problems', were noted 
(table 50, page 260). The poster may have reminded POls and CPs of the other options for 
discussion. Unfortunately, relatively few individuals scanned the poster and the overall effect 
was such that no statistically significant changes in the quantity or nature of advice was 
observed (A3.1.5, page 274, table 50, page 260). Even so, the results Imply that in the 
absence of other Influences, CPs and POls normal advisory policies default to the more 
reiterative topic of 'What to do with it'. For policy makers, it indicates that a reminder of other 
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topics for discussion can affect behaviour. Judicious use of cues or prompts may be one 
method of affecting the advisory policies of CPs and POls. 
Inconsistent messages, personal experiences, suggestive effects, role definitions, legal or 
official incentives and prompting have been presented so far to account for the discrepancy 
between patients' perceived need for advice on side effects and the observed activities of 
CPs. These points suggest that to produce change in CPs' present role as advisors where 
such advice is concerned, sufficient acceptable evidence must be presented as to the overall 
benefits of such activity. Further, CPs may need specific, official sanction that such advice is 
within their role. Also, a cue to motivate advisory activity may prove useful. 
Analysis of levels of advice on side effects when compared to advice in the four categories 
(table 66 section A3.1.3.1) indicates two further findings which inform the role of CPs as 
advisors. First, inspection of adjusted residuals reveals that CPs also initiated advice in 
therapeutic classification two, preparations acting on the nervous system. Warnings of 
sedation and interactions with alcohol are recommended as additional labelling for anti- 
depressants and sedative/tranquilliser combinations, a prominent sub-class of therapeutic 
classification two. The translation of these recommendations to verbal advice accounts for 
the observed significance. Second, POls were very significantly likely to Initiate discussion 
for prescribed medication in classification nine, medication with hormone or anti-hormone 
activity. Application of the Sick Role, Health Belief and Fear Drive models to this observation 
is instructive. Before such discussion, the reader should be aware that steroids are the most 
prescribed medication in therapeutic classification nine. Conditions which require steroid 
therapy are of a serious, generally emotive, nature and the dose-dependent, inevitable side 
effects are extensive, physically noticeable, dose dependent and potentially life 
threatening. 104 Items In therapeutic classification nine accounted for over 5% of the total 
prescribed items in 1988 Eason Bookmark not defied. which testifies to a body of experience In the 
community. Only therapeutic classifications nine and two Include medications where patients 
are advised to carry information cards notifying that they are on specific therapy. This Is the 
case for steroids in the former and monoamine oxidase inhibitors In the latter. 
In a variety of settings it has been shown that individuals making use of health services may 
assume a 'sick-role' behaviour. This has been described as "the activity undertaken, for the 
purpose of getting well, by those who consider themselves ill. It includes receiving treatment 
from appropriate therapists, generally involves a whole range of dependent behaviours, and 
leads to some degree of neglect of one's usual duties". 451 Perhaps patients rely on CPs to act 
on their behalf where advice on side effects Is concerned. That patients were motivated to 
ask for advice in the case of therapeutic classification nine implies that any application of the 
'sick-role' model should consider the nature of the medication. There is an implication that 
with the advent of increasing potent drug medication, CPs may find a role as advisors forced 
upon them. 
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Theoretical elements described by the Health Belief Model and Health Action Model (figure 
12, page 70, figure 13, page 72) include side effects as a modifying factor in determining 
compliance. It would be predicted that knowledge of the potential negative aspects of a drug 
such as its side effects would be perceived by the patient as a barrier to compliance. 
Whether medication is correctly administered will be determined by the balance between the 
magnitude of this barrier, the patient's perceived susceptibility to the underlying clinical 
problem and their understanding of its seriousness. As a corollary to this, CPs' and GPs' 
perceptions of the potential negative and positive aspects of providing advice on side effects 
would be balanced by thoughts of patients' subsequent compliance with therapeutic 
directions. Clearly, a predictive theoretical framework is available for future research. What 
has been shown by the results of research conducted for this thesis is that such studies 
should control for specific therapeutic classifications of medication. 
In section 2.5.3, page 67, the Fear Drive Model was introduced and its application to 
patients' perceptions of medication side effects alluded to. Before discussing the Fear Drive 
Model, it is acknowledged that the approach taken appears to provide an explanation for 
observed activities by excluding complexities even though authors have noted that an 
individual's response to fear is in fact very complex. 22 241 Levanthal and colleagues 222 have 
simplified the complexity and described the causal linkages of the model as follows: 
1. the message is received; 
2. the message gives rise to an emotional fear response; 
3. the fear response produces discomfort; 
4. awareness of the subjective discomfort motivates the individual to eliminate it; 
5. the stronger the discomfort, the stronger the motivation will be to act to eliminate it. To 
eliminate fear, the individual searches for various coping responses and tries them out, 
either symbolically or actually, to identify which ones will reduce fear; and, 
6. when coping response effectively lowers fear it becomes a permanent part of the 
individual's coping repertoire. 
An application of this model leads to the view that patients' limited understanding of the 
potential side effects of medication included in therapeutic classification nine, say, recalled 
from a consultation with GPs (the first link), would lead to perceived implications and 
induced fear (the second link), resulting in anxiety (the third link), and motivation to seek 
more information and reassurance from others (the fourth link). The more serious the 
perceived side effects, the stronger the motivation to ask for advice. As steroid medication 
can cause demonstrable side effects and this potential is likely to be known by patients, 
there will be a motivation to consult and gain as much information as possible (the fifth link). 
Once information has been obtained and fear is lowered, the coping response becomes 
permanent (the sixth link). The lesson from this model for the role of CPs is that patients 
perceptions of medication may prompt them to become proactive in seeking advice. When 
they do so, they may be looking for coping mechanisms. Once satisfied they will no longer 
be frightened, however, they may remain wary. Concerning this latter state, a female 
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Caucasian customer (C) over 60 years of age was observed noticing the poster and while 
purchasing Potters catarrh pastilles asks the assistant (Al): 
C-Al I'm on steroids. Can I have something, you can't be too careful 
Al-P (explains the request to the CP and that she had recommended Potters Catarrh 
Pastilles for runny nose. The CP takes the dispensed item, Cordarone tablets, to the 
front counter) 
P-C Yes, that will be OK. 
It is interesting to note that in this case, half an hour later, the CP involved provided a steroid 
card with a dispensed item; however, one day later steroids were dispensed to a different 
customer without any additional information. The provision of a steroid card appears to be a 
'cued' action with a residual effect rather than a specific policy on the part of the CP. 
Qualitative analysis of discussions concerning advice on side effects is presented in section 
A3.1.4.1, page 268, table 56, page 270. The two roles, 'compliance' and 'socialising' are 
identified. It is demonstrated that CPs' attempt to socialise patients and engender an attitude 
towards maintaining their well-being. In doing so they use the fear of potential side effects as 
a method of motivating patient compliance. If they are tapping elements of the Fear Drive 
Model then it follows from this discussion that patients will develop a coping response which 
will nullify their efforts. Community pharmacists should be advised that their role in promoting 
compliance using fear as a method of motivation may induce coping responses in patients. 
This discussion has dwelt on 'What to do with it' as the most frequent category of advice. 
The focus on'Side effects' was also taken as there was literary evidence and observed 
confirmation of a discrepancy between perceived need and activity. Attention is now turned 
to the remaining categories of advice, 'Specific problems' and 'What was prescribed'. 
Advice listed under the category 'specific problems' (section A3.1.3.2, table 53, page 262) 
included whether the prescribed medication was appropriate to the medical condition. In 
contrast to 'what is prescribed' as therapy, is the question, is 'what is prescribed' correct for 
the problem? Responses in such cases imply more that just knowledge, rather an 
assessment of many factors such as medical condition, options for medication both 
therapeutically and pharmaceutically, plus an implied understanding between CPs and 
prescriber. On two occasions CPs provided advice on clinically important Interactions 
between concurrently prescribed medication. Community pharmacists also referred POls 
back to their GPs when problems with prescribed medication became apparent. A sub- 
category of 'concern' was identified (table 53, page 262) which included cases where CPs 
asked POIs whether they had received the medication before and even if the answer was 
'yes', on 35.7% (table 53, page 262, concern, 10/28) occasions reinforcing information was 
provided. The content of the category 'Specific problems' serves to indicate that CPs provide 
a wider range of advice than may be documented in the literature. The appropriateness of 
medication, advice on referral, concern that patients are not anxious and clearly understand 
their medication, and specific pharmaceutical advice have been identified. If the poster was 
noticed, then significant increase in requests for advice on topics listed under 'specific 
problems' were demonstrated (table 50, page 260). Again, it is the more problematic, less 
repetitive or defined elements of drug therapy which were associated with prompting. In 
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terms of the advisory role, CPs and those in positions of influence should be made aware of 
the many facets of advice which may be provided. 
Section A3.1.4.2, page 272 provided a qualitative evaluation of the role of CPs as advisors 
on prescription medication concerning 'What is prescribed'. Similar roles to those listed 
underside effects are identified, 'educational/informative' and 'confirmatory' (table 58, page 
272). In addition a unique role of 'intent' was noted whereby the CP not only infers from the 
prescribed item the prescriber's intentions but also describes the medication's mode of 
action. It is noteworthy that the largest proportion of POls were observed requesting advice 
in this category. In contrast, CPs were strongly orientated to advise on 'What to do with it'. 
Perhaps CPs rely on the prescription label to convey information on 'What is prescribed' but 
they assume that patients are able to link brand names with therapeutic action. The extent to 
which patients are able to do this has not been researched. When considering their role as 
advisors, CPs should take note of the relative importance patients place on 'What is 
prescribed'. 
Finally in this section, field notes taken during the observational study suggested a 
relationship between problems of supplying medication and the provision of advice. The 
following transcript is exemplary of the process noted by the author. The customer (C), also 
the patient, is a female Caucasian under 60 years of age who presents a prescription at 
9.50am and subsequently receives the dispensed item from the dispensing technician. At 
10.22am she returns and ask the following of the CP (P): 
C-P Hello 
P-C Hello 
C-P You've just given me these (Vibramycin capsules) and on the box if said there should 
be ten and there's only eight in it 
P-C Let me have a look 
(CP checks Prescription) 
It's my mistake. Sorry, only I do these in me sleep. Only Dr. C.... (General 
Practitioner name) normally gives eight and Dr. W........ s (General Practitioner) given 
you ten. I'm sorry 
(P adds extra capsules and returns to C in the "Front Shop") 
The saying's very true, you know. Familiarity breeds contempt 
C-P (Laughs) 
P-C Have you taken any? 
C-P Yes 
P-C When you do, make sure you have them after food, 'cause they're Ok if you take 
them after food, but if you take them on an empty stomach, they do tend to make 
you a bit sickly 
C-P So 'me first two.... 
P-C Two straight away, yeah. If you take them, well, you know, you want to take them 
after a meal anyway 
C-P Yeah 
P-C OK 
In the first instance no verbal advice was provided, but when a dispensing error was made 
advice was provided. In addition, Vibramycin capsules have British National Formulary 
labelling notes six, nine and 27 which do not include taking the medication after food. 
However, it is noted in the official manufacturing information available 'if gastric irritation 
occurs, it is recommended that Vibramycin be given with food or milk', 104 In this case the 
CPs has gone further than normally sanctioned and provided a slightly enhanced advisory 
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service. Advice as defined in this thesis does not include discussion between CPs and 
patients concerning the supply of medication; however, it appeared to the author that 
whenever there was a problem with supply, medication was more likely to be associated with 
advice. Section A3.4 details an analysis of such an association and, after accounting for 
duplication, it was shown that such a relationship exists. Perhaps CPs offer advice in order to 
entice those individuals they have inconvenienced back to their premises? Alternatively, the 
fact that supply problems were dealt with by both proactive and reactive CPs means that 
they were driven into contact with POls. It has been shown that coming into contact is 
correlated with advice (section A3.1.1). 
In the previous section it was concluded that policy directives defining CPs' advisory role are, 
at the least, difficult to define. Following on, discussion in this section has relied on the 
results of level two, three and four analyses to inform future policies for directing CPs' 
advisory role. If neither directives nor remuneration are maintaining CPs' level of verbal 
activity, the question must be asked, what is? It is this question which is addressed in the 
following chapter. 
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5.4 Conclusion 
From the discussion presented in chapter five; which is based on the results, summaries and 
conclusions from previous chapters and appendices, further conclusions may be drawn. 
These are now presented with paragraphs numbered according to the chapter section. 
Numbers for conclusions correspond to those used for recommendations in chapter seven. 
The following major conclusions are drawn from section 5.2: 
5.2.1. that CPs are providing a demonstrable level of verbal and written advisory service; 
5.2.2. that CPs may be divided into proactive and reactive types; 
5.2.3. that the location of pharmacies near surgeries and ownership of pharmacies may 
affect the advisory service provided by CPs and that, if current trends continue, it is 
likely that there will be a decrease in PMA provided to patients 
5.2.4. that POls request a demonstrable level of advisory service; 
5.2.5. that the results of this study can be generalised to the sample frame of Southern 
Derbyshire CPs; 
5.2.6. that POls are not making their needs for PMA known during busy dispensing periods. 
5.2.7. that written additional labelling is quantitatively the major form of advice provided by 
CPs; 
5.2.8. that The Society's Code of Ethics is the mechanism whereby CPs are given 
guidance on The Society's expectations of their advisory activity. The labelling 
instructions in the British National Formulary (BNF) provide the main source of 
instruction for the advisory role; and, 
5.2.9. that there may be general associations between the socio-economic status of 
patients and CPs advisory activity. 
The following major conclusions are drawn from section 5.3: 
5.3.1. that CPs may be taking into account the nature of prescribed medication in seeming 
to focus their advisory activity away from the elderly; 
5.3.2. that, while CPs' advisory role is fundamentally reiterative in nature, advice requiring 
value judgement is also provided; 
5.3.3. that there is a disparity between customers' perceived need for advice on side 
effects and CPs' activity. Also, that there are arguments and theoretical models 
which provide a basis for understanding this finding; 
5.3.4. that an external 'cue', in the form of a poster advertising advisory services, can alter 
the content of discussion between POls and CPs bringing it more in line with POIs' 
expectations; and, 
5.3.5. that the overall effect of the external 'cue' in this study was negated as POls failed to 
notice the poster's message. 
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CHAPTER 6 EXPLANATIONS FOR OBSERVED ACTIVITY 
6.1 Summary 
This chapter is divided into three sections, all of which draw on the literature of the 
professions. The first section begins with a brief history of the professional literature. Two 
descriptions of professional activity are proffered, one using trait theory, the second, focusing 
on professional control through the use of social and political closure. 
It is argued that CPs are constrained in their advisory role by the expectations of The 
Society's Code of Ethics and a lack of information on diagnosis. Specific examples of the 
consequences are provided. Indications that there is a willingness to share information on 
diagnosis are considered. However, concerns over cultivation of medical backing are noted. 
Given the current anti-collectivist political climate, the potential for lobbying Government to 
facilitate access to information is discussed. The importance of highlighting any improvement 
in patients' well-being due to a change in policy is stressed. The potential for direct conflict 
with GPs over the diagnosis aspects of the 'expanded role' and the lack of positive evidence 
for CPs' advisory role for OTC medicines are described. It is argued that CPs' prescription 
medication advisory role should not be linked to either of these roles. The observation that 
conflict arises when financial interests overlap, or there is an element of judgement by a 
professional other than a medical practitioner, is used to structure a discussion which predicts 
conflict between the professions of Pharmacy and Medicine if the provision of advice were to 
become a tendered service. 
This thesis has already presented evidence that CPs provide advice to Pols. Section two of 
this chapter focuses on professional motivation to help account for this finding. Two 
motivational drives are proposed, one based on specific educational objectives, the second 
on adherence to the traits of a professional as espoused in the literature. Published 
observations are cited to support the first option and the response of individuals to criticism 
of the professional nature of pharmacy practice provide evidence for the second motivation. 
A problem is described where, due to professional or ethical directives, CPs are unable to 
off-load the blame for inappropriate drug therapy instigated by GPs. The resulting decrease 
in credibility and perceived expertise attacks the core of motivation. 
The final section argues the case for the use of the British National Formulary (BNF) to 
provide medication-specific information on the provision of verbal advice to patients, 
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6.2 Constraints on advisory activity 
"What the pharmacist can say and do in interaction with this customers who bring a 
prescription to be dispensed, appears to be determined by the pharmacist's relationship with 
the prescribing doctor". 452 
It is a central contention of the author that CPs' advisory activities are inevitably constrained 
both by a lack of information on diagnosis and by their relationship with prescribers. 
Sociologists have observed and debated the activities of professions from an academic 
perspective. Their understandings provide the basis for further discussion of the role of CPs 
as advisors on prescription medication. It is not, however, a central concern of this thesis to 
argue pharmacy's place as a 'profession' or pharmacists' actions as professional. 
To place this discussion in context it is useful to first provide a brief chronological overview 
of the relevant literature of the professions. Only principal authors widely acknowledged as 
having presented original thoughts and perspectives are included. It should be noted that no 
single theory of the professions exists. The literature is a massive collection of observations 
and postulations based on selected elements of society who have existed within a recent 
narrow period of history and only within a limited number of nations, principally America and 
Britain 453 454 The size and importance of those groups describing themselves as 
professionals lead sociologists to first define and characterise what constitutes a 
profession 455 The earlier trait approach has its origins in the work by Flexner 45r' who 
identified 'professional spirit' in his 1915 paper'Is social work a profession? ' Millerson 457 in 
1964 and Greenwood 458 in 1965 distinguished 23 and 5'traits' of professions respectively. 
The latter identified systematic theory, community sanction, authority, an ethical code and a 
professional culture as the elements which underpin a profession. If traits are the criteria, 
Harding argues that Pharmacy is a profession, but notes the limitations imposed by its 
dependence on the prescriber. 305 Limitations of this approach are identified by Wilding ass 
who notes firstly, the assumption that professional work is in some way unique, secondly, the 
requirement for an archetype against which aspiring occupations may be measured and 
finally, and perhaps most telling, that the status of traits and their direct influence on 
occupations has not been researched, rather their mere existence is taken as an indication of 
behaviour. 
Freidson 453 also observes a lack of theory to link the various elements in the trait model and 
notes the 1960s as a watershed in sociological writings on the professions. Subsequently, 
authors became far more critical of the privileged positions professions held in society and 
began to locate such occupations in given social structures. In 1970, Freidson 459 used the 
political and socialising activities of the medical profession to demonstrate its functional 
autonomy. Two years later Johnson 364 argued that trait model did not produce definitions of 
particular type of occupation, rather they specified the characteristics of an institutional form 
of occupational control. Using this approach he considered the relation of professions to the 
state. Five years after this, in 1977, Larson 460 considered the relationship of professions to 
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market and class systems. Turner 461 succinctly describes the two mirror-image models of 
professionalism noting: 
"in the first model, a profession is defined in terms of a group of attributes which takes a 
particular notice of the prominence of knowledge (which is exact and systematic) and ethics 
(which underline the importance of a service rather than a business orientation to the client). 
in the second model, pro fessionalization involves occupational control which, through 
credentialism and social closure, excludes competitors and allows the exercise of 
occupational dominance and autonomy". 
In the literature of the 1970s, the profession of medicine came under the sociological 
microscope. By the 1 980s authors, such as Larkin'462 began to consider non-medical 
participants in the health division of labour. He charted the development of ophthalmic 
opticians, radiographers, physiotherapists and chiropodists under medical domination which 
he describes as a form of 'occupational imperialism'. The 1990s would appear to be the 
decade in which sociologists may chart the decline in medical domination in America 463 and 
arguably in Britain. 64 
No sociologist has specifically charted the historical development of community pharmacy 
from the perspective of domination by the medical profession. Although, an attempt to apply 
the first model, as outlined by Turner, 461 to perceptions of pharmacists in varying branches of 
practice failed "r5 Unlike the occupations considered by Larkin, pharmacy does not have a 
predominance of medical representation on its controlling board. This renders The Society a 
degree of autonomy in determining its expectations of its members. It also means that The 
Society has the potential to implement policy and bring about change. 
Throughout this thesis, the tension between CPs and GPs has been noted. The following 
transcripts exemplify how CPs were observed by the author managing the day-to-day 
consequences of this tension. 
First, CPs' advisory activities are inevitably constrained by a lack of diagnostic information 
from prescribers. They are thereby constrained in the extent to which they are able to inform 
patients. Consider the following case. The customer (C) a Caucasian female under 60 years 
of age approaches the CP (P) and asks: 
C-P What is it for... is, it a tranquillizer (Stemetil tablets)? 
P-C No, they're not tranquillizers, but the indications for them vary 
C-P Oh 
P-C They also cause drowsiness but they're not tranquillizers 
C-P Are there directions? 
P-C He put twice a day when needed, so yes 
C-P Morning and evening 
C-P Right, thank you very much 
Stemetil tablets have Data Sheet 104 Indications which include; the prevention or treatment of 
nausea and vomiting, vertigo and Meniere's syndrome, the short term management of 
anxiety, and schizophrenia and other psychotic disorders. This example demonstrates that 
CPs are practically limited due to a lack of prescribing knowledge. The CP is unable to verify 
that the correct medication has been prescribed and Is limited to a reiterations of directions. 
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Savage 466 identifies the problem in stating, "I know that 1 am not in the full possession of that 
patient's health records or all the relevant details and therefore in no position to challenge a 
colleague's decision". 
Second, there is an expectation defined in The Society's Code of Ethics that CPs regard 
patients well-being as paramount, yet avoid implying any inadequacy on the part of the GP. 
What has not been appreciated is nature of the dilemma this produces for CPs and the 
confusion it might generate in patients. For example, CPs may verbalise the limitations 
imposed by the Code of Ethics yet advise patients to seek confirmation. Alternatively, CPs 
may provide both prescribers' instructions and 'normal' dosing which must cause the patient 
some conflict. Two cases are now presented which show the pattern of activity observed. In 
the first case a Caucasian female customer (C) under 60 years of age presents a prescription 
for herself. She is approached by the CP (P) with the dispensed item and asked: 
P-C Did the doctor tell you how to take them (Vibramycin capsules)? 
C-P Yes, two immediately then one twice a day 
P-C But er.... well ... I've never .... I've never ever come across..... C-P Twice a day? 
P-C No, I've never ever come across that-never come across anything other than... 
C-P (Murmur) 
P-C Pardon? 
C-P You do it your way (Unpleasant tone of voice) 
P-C Well, I can't obviously tell you, you know. I can't go over the doctor's head, 
but I should probably advise you to phone you know, and say the chemist 
said just one a day. That's the normal dose anyway 
C-P Yeah 
P-C I've never known any different to that 
C-P What's that.... fourteen day course is it? 
P-C Well it'll be thirteen 'cause you're taking two today 
C-P Right 
P-C All right? 
C-P Yes 
P-C Thanks, cheerio 
In a further case, a female Caucasian under 60 years of age, is approached by the CP who 
uses printed information to correct the inaccurate prescription advice from the GP. The CP 
states: 
P-C The doctor says use (Cerumol ear drops) twice a day, but if you follow the 
instructions on the back, there's some comprehensive.... 
C-P OK 
P-C .... instructions there C-P Thanks very much 
P-C Thank you 
Third, they act to encourage patients to accept the GP's role while offering corrections to 
inaccurate prescribing. Commuity pharmacists may strongly emphasise the general 
practitioners right to diagnose, to define the problem yet provide the customer with the 
'normal' administration pattern thus demonstrating a degree of both autonomy and 
judgement. The following case is exemplary of this activity. A female Caucasian customer 
(C) under 60 years of age presents a prescription for her son to the assistant (Al) and asks: 
C-Al 
_- 
What's it for? He got a temperature this morning... he's got a runny nose and a 
measles jab about a fortnight ago 
P-C Oh 
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C-P Is that what it's for? 
P-C That's an antibiotic to clear up an infection basically 
C-P Oh, he hasn't got an infection 
P-C Oh... um.. well, well let's leave the diagnosis to the doctor shall we? She's the 
expert 
C-P But she told me to give one of them in the morning and one at night, and two spoons 
of that four times a day (inconsistency with directions on the prescription) and you've 
put one to be taken four times a day (Erythroped-PI) and she told me two 
P-C Oh dear 
C-P No, I'm not being funny ... it's just that she said give him two teaspoonfuls 
P-C (Laughs) Oh dear.... oh dear. For a one year eight.... 
C-P Well he's twenty months 
P-C Yeah, twenty months that's what she's (general practitioner's) put, one year eight 
months 
C-P Oh course she has, yeah! 
P-C Lactulose syrup, one 5ml spoonful at night, Calpol syrup one 5ml spoonful four times 
a day, Erythroped "PI" 5ml four times a day 
C-P But she said didn't she.... told me to take two teaspoonfuls of Calpol (Inconsistent with 
directions) 
P-C I rather think for the Lactulose what she means Is... um.. initially you can give it twice 
daily, morning and night 
C-P Yeah 
P-C That's how they normally use it anyway 
C-P But if it goes you can knock it off completely? 
P-C Yeah 
Finally, CPs act as a safeguard against incorrect supply. It is argued that they have a role in 
safeguarding patients 467 They are aware of inter-professional issues, perceiving and 
accepting both the dominance of the medical profession and the relative impotence of the 
pharmacy 'profession'. The following case confirms this role. A male Caucasian customer (C) 
under 60 years of age presents a single prescription to one of the two assistants present. At 
11.18 in the morning, he is the only POI in the dispensary. Within minutes the CP (P) offers 
the customer a dispensed item saying: 
P-C I can't pronounce it I'm afraid Briz... 
C-P Yeah, that's not her name though 
P-C Is it not 
C-P No it's K... (incorrect name on the prescription) 
P-C & C2 Is the address right 
C-P No 
P-C & C2, That was another lady a polish lady 
P-C You've just seen? 
C2-P Dr D... (GP) 
C2-C Yes just, just 
P-C & C2 And did she give you that prescription (Stemetil tablets) 
C2-P Yes but another person 
C-P Yes I was in there 
C2-C Another polish lady 
P-C & C2 I should go back to the surgery and just check that you've got the right 
prescription. I don't want to give you another ladies prescription 
C-P The reception, just go to reception 
At this point the CP turned to the researcher (Res) and offered the following unsolicited 
opinion: 
P-Res Other professions tend to look after their own don't they yet ours wants to get rid of 
you at the slightest error. I mean like doctors they seem to carry on whatever they've 
done don't they they're protected by their own association 
Res-P Yes they're a very strong association 
P-Res . Umm yet we're the ones who get done for dispensing their mistakes (laughs) 
'rýz.. 
f. 
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Figure 22 below lists the observed content of discussion and direction of communication 
between CPs, POI and GPs. 
Figure 22 
Inter-professional relationships concerning prescription medication noted in 
qualitative analysis of verbal interactions involving the community pharmacist 
and the patient or general medical practitioner* 
Inter-professional Content of discussion Direction of communication 
relationship CP (P) POI GMP 
(At) Mechanical 
(B) Advisory clinical 
(Ct) Advisory 
Verification of prescriber's intent 
Notification of a drug interaction, incompatibility, 
side-effect, dosage change 
Information for prescribing 
P=GMP 
P=>GMP 
P. GMP 
(D) Reassurance Appropriateness of prescriber's intent P=ýPOI=GMP 
(E) Blame, mechanical Prescribers responsibility for dispensing P=POI=GMP 
irregularities 
(F) Professionalism Professional ethical constraints influence advice P=>POI=>GMP 
(G) Advisory clinical Appropriate item to be prescribed P=POI=GMP 
(H) Advisory personal Advising on interacting with the general P=ýPOI=>GMP 
practitioner 
(I) Referral Referred to general practitioner P=POI=GMP 
(J$) Confidant Relationship of POI with the general practitioner PGPOIGGMP 
(Kt) Dependence diagnosis Information on diagnosis required for discussion PGPOIGGMP 
(Lt) Dependence directions Information on prescribers directions required P=POIGGMP 
(M) Referral Referred to CP PGPOIGGMP 
Notes 
*= Arrows indicate the direction of initiation of discussion in the interaction. The 
relationship of CP to general practitioner can be direct as in groups A to C or indirect 
where the inter-professional relationship is implied through discussion between the 
CP and customer. Evidence of implied inter-professional relationships includes the 
data on clinical judgements made by the CP where advice is in addition to or not 
exactly in accordance with the prescribers directions. 
t= Supply function. 
$= Confidant in this context is where the CP is given confidential information concerning 
the relationship between the POI and GP and acts in a sense as a counsellor on 
behalf of the latter 
Inspection of figure 22 shows evidence of the verification process Cps undertake on the 
patients behalf to ensure appropriate supply of medication (A and B). Also, that Cps are 
dependent on customers for critical information (K and Q. Only on rare occasions did cps 
contact prescribers directly to confirm their intent. The lack of information necessitates that 
CPs make judgements. This has been demonstrated in this thesis and more recently by 
Greene. 468 
The prescription form used to convey information for dispensing activity (section 1.6.1) 
contains no reference to diagnosis. At no time were either CPs, prescribers or patients 
observed in discussion as to what constitutes appropriate PMA. However, the current Code 
of Ethics, 291 which details what is expected of CPs' for continued registration, directs CPs to 
"assess the wishes of the prescriber and the information and counselling needs of the 
individual patients". Practical difficulties for CPs in continuously liaising with prescribers have 
prompted studies to improve access to information between patients, prescribers and Us 
using a notification card 469 and patient held computer cards. 470 Although these studies were 
well received, information has tended to be conveyed in one direction, from CPs to 
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prescribers, and the level of pharmacy access to diagnostic information has remained 
minimal or non-existent. Other than the patient and the implication from what is prescribed, 
there are currently no communication mechanisms which would provide a basis for CPs' 
advisory role. Thus, if a prescribed item has more than one therapeutic indication, then there 
is highly likely to be an element of guesswork in providing advice. The dangers involved 
have been highlighted by the NPA director Mr Tim Astill 471 advised, "giving advice by 
guesswork is always going to be dangerous, so don't do it". As CPs have little information 
upon which to base even the most basic clinical interpretation it is no wonder that most 
discussions between POls and CPs includes reiteration of prescribers' directions and verbal 
advice based on 'professionally' sanctioned written information available in the BNF 376 
Literature 472 cites restricted access to information as one mechanism used by the medical 
profession to maintain domination over related occupations. It may be argued, therefore, that 
the power currently rests with the prescriber to enable greater development of CPs' 
prescription medication advisory role. Historical requests for a team approach 473 have been 
taken up by the World Health Organisation. 70 which states that, "At all levels of health care, 
the provision of care is multiprofessional. The health care team, which Is inevitably concerned 
with the use of drugs, must therefore include a pharmacist. This has been adequately 
demonstrated in the team approach to clinical care in hospitals and health centres". Although 
'demonstration' in community settings is not acknowledged, the multiprofessional approach is 
advocated at all levels. So far only isolated accounts of Integration 474 475 476 °n and calls for 
better relations 11 pre-empt the sharing of Information. Recently, it has been argued that all 
CPs should be located in surgeries. 478 Parallels can be made with the Rose case of 1703, 
where apothecaries eventually dominated medical practice. Then it was the provision of free 
advice and a unique knowledge of compounding which forced events. Similarly, the 
provision of free advice and an In-depth understanding of drug action, which enables CPs to 
make sure patients understand their medication, might be crucial to future events. Currently, 
however, examples of the underlying tension between Pharmacy and Medicine dominate. 479. 
As the much referenced General Report of the Pharmaceutical Survey 480 notes, 
"Nevertheless, when one digs beneath the surface of things as they appear to be, one finds 
that medicine, as a profession, maintains an attitude of condescending superiority towards 
pharmacy as a profession" 
It has been suggested that interactions between CPs and GPs should take place at a higher 
level than clarification of prescription ambiguities. 81 However, there has been a failure to 
identify, and place on the agenda for discussion, the specific need for information on 
diagnosis for CPs from GPs. Therefore, there is no policy to specifically address this 
problem 482 Lukes 483 would describe this lack of policy as an example of latent conflict 
whereby power is operating at its most advanced level of control. Preferences are influenced 
neither overtly nor covertly yet power is demonstrated by decisions taken to avoid conflict. In 
contrast, the advantages of the CPS' knowledge for GPs has been espoused. i' Yet American 
studies have reported that the infrequent discussions'which do occur between CPs and GPs 
concern mainly practical supply problems 484 with even fewer requests for information on 
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side effects or drug contraindications. 485 General medical practitioners still see the CP's role 
as that of a compounder and dispenser. 486 In Britain only 4% of GPs indicated that they 
would make use of CPs for information concerning adverse drug effects and 
contraindications. 87 In a report to the Nuffield foundation li it was suggested that community 
pharmacies be located near surgeries. Subsequently, it has been argued that the CP's place 
is in the general practitioner's surgery. 88489 Harding, 90 using a semi-structured interview 
method, reported the influence of a health centre environment on the CP's role as a drug 
information source. It was noted that CPs practising in such an environment were consulted 
more frequently by GPs than those less accessible. Such results confirm earlier 
questionnaire based results from America. 491 That there is little contact between CPs and 
GPs is verified by the present study as, during the observation period, only one GP 
contacted a CP for advice on a supply issue. Notably on two occasions CPs contacted 
prescribers to notify them of clinically significant drug interactions and on one occasion the 
problem identified was one of side effects. 
There are, nonetheless, indications that GPs are not entirely against sharing information. 
Marsland 492 reported in 1987 that 47% of 403 British GPs, representing a 35% response 
rate, were prepared to share patients' details with CPs. Similarly, 90% of 493 CPs 
representing a 60% response rate were willing to exchange information. Sutters and Nathan 
reported 80% of GPs who would welcome CPs input in a variety of extended roles including 
compliance. 493 Such research points to the potential, however small, for policy makers to 
rectify the information chasm confronting CPs. It may have been considered that 
confidentiality as a concept would have precluded exchange of information between CPs and 
GPs, although, In hospital settings it Is normal practice. From the rural dispensing example of 
inter-professional conflict presented later in this section, it may be surmised that greater 
resistance is likely in rural settings. This Is confirmed by Marsland 492 who reported only 23% 
of GPs in rural areas who also dispensed were in favour of information dissemination. 
Clearly, any policy bringing about a sharing of information may need to contend with varying 
entrenched attitudes on the part of GPs. In a separate study Gerrett and Willcocks 494 
Investigated the extent of GPs' perceived mandate for a drug counselling role by CPS and the 
magnitude of that role in terms of surgery consultations. Of 194 (74% response rate) 
responses to a questionnaire, 46.6% felt CPs had a role in advising patients on medication 
side effects. In a prospective study 16 (66.7%) general practitioners provided details on 1590 
patients and felt 62 (3.9%) would have benefited from the CP's intervention concerning side 
effects of prescribed medication. This was the most frequently identified area of advice. The 
authors concluded that such an invitation to provide advice implied "a mandate to advise" but 
only for specific Individuals. The problem arises, how can CPs be made aware which 
individuals require such additional service?, 
Clearly, access to information on patient diagnosis is a key topic for Pharmacy. Although 
research has been conducted, it appears to have missed the point that CPs cannot be 
expected to provide an advice service at the level desired by patients without the additional 
information on diagnosis being made available by GPs. 
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Community pharmacists are the last health care professionals to interact with patients before 
they take over responsibility for their own medication. General medical practitioners as 
members of the dominant profession may order the service but do not interpret, evaluate or 
consume the dispensing and advisory service. That CPs have access to patients and are not 
overseen by the medical profession is critical to expansion of their advisory role. For policy 
makers this thesis identifies what Wildavsky 96 would describe as a problem "for which 
solutions might be attempted" At Issue is to what extent the medical profession can be 
persuaded to provide the necessary information to enable the full potential of CPs' advisory 
role to be realised. 
Consistently authors364 459 have noted collusion between the medical profession and the 
state in sanctioning the former's dominant position. As described in sections 1.5.1, page 28 
and section 3.3, page 85, the current Government ideology is one of anti-collectivism which 
emphasises the social values of freedom, inequality and individualism. Individual choice is 
incompatible with the principle of social closure and Government backing for all professions 
has come under pressure. As Medicine is also losing Government backing, then its ability to 
successfully resist calls for access to diagnostic information must be In question. Larkin's 
thesis, 462 although published in 1983, provides several observations of inter-professional 
relationships which are still useful in discussing this point. He notes that the paramedical 
occupations he considered tried to improve their status by cultivating the medical profession 
and all ended up subservient. The price of medically assisted 'closure' was the containment 
of further growth. It follows from these arguments that it may be an opportune time for 
Pharmacy to make proposals for such access. Also, that calls for access might be better 
served by lobbying Government rather than directing all efforts towards Medicine. The 
necessity to involve Government and change policy in order to surmount inter-professional 
495 dilemmas has been recently noted by Jepson and Strickland-Hodge. 
If information on diagnosis were made available, and CPs role as advisors on prescription 
medication became central to their existence, it may be asked, what would be the effect of 
devolving the act of dispensing to assistants while CPs retained direct access to patients for 
the provision of advice? Larkin is 462 thesis is instructive on this point. He noted that radiology 
as a medical discipline only attained high status when the physical activity of developing X- 
ray plates was devolved to radiographers. The important additional point to note is that 
radiologists report their judgements direct to their colleagues. Similarly, if CPs gave out all 
dispensed medicines to patients, providing an advisory service involving judgement as to the 
optimum use of medication, and assistants only prepared the dispensed item, then it follows 
that community pharmacy as an activity would increase in status. 
It would seem, therefore, that the supervision debate (section 3.2.2) missed the point. The 
'Luddites' fought to maintain the need for the CP's presence when a prescription was given to 
the POI, and The Society, suggested that an assistant could interact directly with POls 
without direct supervision; however, neither party suggested elevating CPs' advisory role in 
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the manner which has lead to radiologists' increase in status. To have delegated the 
dispensing role plus the advisory role to assistants would have further distanced CPs from 
POls and weakened their claim for promoting patient well-being. The intention of The Society 
to revise the Code of Ethics and require CPs to personally determine that a patient 
understands their prescribed medication, must provide a more solid basis for the future. 496 
Of all the prerogatives the medical profession covet, the exclusive right to diagnosis is the 
most fundamental. 497 Recently, CPs have expanded into areas which involve some degree of 
diagnosis or at the very least judgement. As early as 1947, pharmacists' non-prescription 
advisory role was placed under the umbrella term of 'health education'. 498 Calls have been 
mounting since the early 1960s in Britain 15 and America 499 to recognise and develop the 
role further. However, this has proved controversial. Recent involvement in the simple 
provision of leaflets (section A3.3) has been less contentious than, for example, the provision 
of advice on coronary heart disease 500 Taking such advice as an exemplar, initial research 
was conducted 501 502 case studies presented, 503 and training provided 504 which 
demonstrated a positive advisory role for pharmacists. Conflict with the medical profession 
did not become apparent until community pharmacies began diagnosis in the form of blood 
pressure screening 505 506 507 508 However, it was not possible to continue suggesting that CPs 
lacked suitable training to provide such a service, as the medical knowledge base was shown 
to be insecure; 09 rather inaccuracies in the measuring instrument 510 and warnings against 
mass screenings 511 were voiced. That CPs' expansion into areas of high independent 
judgement or autonomous action are likely to meet medical resistance has been shown, 512 
although, Norwood and colleagues 513 in America determined that the lowest resistance was 
for advice on prescription medication. 
The health education example demonstrates that a proposal implying any right for CPs to 
diagnose would be contested by the medical profession. The inclusion of 'advice and 
counselling' under the heading of health promotion has been noted. 14 As access to 
information on diagnosis is less contentious than the act of diagnosis, the case presented for 
advancing CPs' advisory role should avoid confusing the provision of PMA with 'health 
education' or its synonym 'health promotion'. 
Evidence has recently been published that many CPs already perceive their advisory role to 
be under the umbrella of the extended role 515 It is argued that this may dilute the case for 
the advisory role 516 Community pharmacists have not been educated for the majority of 
extended roles. However, they are educated to provided PMA (section 1.2.2, page 21). 
Further, this thesis provides evidence that POls accept CPs' role as advisors on prescribed 
medication. Evidence is also available to show that the public are unaware of the extended 
roles 517 Even linking PMA to over-the-counter (OTC) drugs may not help the case for 
developing CPs' prescription medication advisory role. While the quality of OTC advice 
appears to be satisfactory, 396 independent pseudo-patient studies published in 1975,518 
1985,519 1987 520 1988 8,521 1991,522 and 1994 523 have consistently demonstrated the lack of 
appropriate supervision. If an independent proposal were made to Government to facilitate 
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CPs access to information on diagnosis, The Society's moves to tighten up practice by 
accepting profession audit 524 525 and considering assessment of competence 380 would 
enhance the case. Also, the recent availability of patient compliance training packs freely 
available for CPs 526 must register the importance placed on the advisory role. The medical 
profession may counter the argument for enabling CPs' advisory role on the basis of a lack 
evidence that it exists. This thesis provides one more response to this criticism. 
It may also be proposed that advice on prescription medication is a service which should be 
fully remunerated. In section 5.2 the issue of payment for CPs' PMA was discussed and left 
unresolved. Consider, for this debate, and in keeping with the current government's market- 
forces philosophy 59 that PMA was 'put out to tender'. 
Larkin makes the point that when areas of financial interest overlap there will be conflict. The 
occupations he considered initially practised in areas which were neglected by medical 
practitioners, but were still of economic importance. As financial incentives for this work 
increased, so did conflict. The Rose case, described in section 1.2, page 15, is a clear 
historical example of financial conflict between CPs and GPs. Then it was the patients' well- 
being which decided the outcome. More recently, the rural dispensing dispute provides a 
useful example of financial conflict. Once again, it is the patients' well-being which is a key 
factor, one which is consistently ignored by both parties. 
In early 1990, Sir George Young, the then member for Ealing South, noted the fact that GPs 
in rural areas could dispense under the National Health Service and wondered why the same 
was not true of all doctors. 27 The Society found itself defending its members Government 
sanctioned dispensing role and responded by comparing community pharmacy dispensing 
costs with those of dispensing general medical practices. 528 Sir George's proposed 
amendment to the National Health Service and Community Care Bill, which would have 
allowed medical practitioners and dentists freedom to dispense on the National Health 
Service, failed to reach debate and was lost. 529 Sources close to the then Secretary of State 
for Health, Mr Kenneth Clarke, noted that, "the argument about who should dispense should 
be fully determined by what provides the best service for patients and not by inter- 
professional quarrelling". 530 In parting Sir George 531 warned the Issue of dispensing GPs "will 
not go away" The Government's response to the sole use of financial arguments by both 
professions is exemplary of its fundamental anti-collectivist ideology. 
The rural dispensing example demonstrates that the patient's well-being would be a major 
factor in defending and advancing with the current Government an advisory role for CPs. In 
this respect, public opinion polls in Australia 532 and Britain, 533 which place pharmacists high 
on the list for ethics, honesty and quality of advice, would provide some evidence of patient's 
general attitudes towards community pharmacy practice 
In summary, a major stumbling block for the role of Cps as advisors is a lack of information 
on diagnosis. Attempts to convey information between cps and GPs have so far failed, but 
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reportedly on technological grounds. Community pharmacists are currently adhering to their 
Code of Ethics and attempting to provide PMA to patients while avoiding the implication of 
any inadequacy on the part of GPs. They do so while ensuring correct supply and advising 
patients with only limited knowledge available to them about diagnosis. Inevitably their 
advice comes into conflict with that of the prescriber. This may cause confusion in patients. 
As the last link in the professional advisory chain logic dictates that CPs should be the ones 
who are fully informed. 
With respect to conflict with the medical profession, CPs' role as advisors is less contentious 
than activities under the banner of 'health education' which require diagnostic skills. The 
subservience of professions who have courted the favour of the medical profession indicates 
that the alternative of lobbying Government to enable access to information on GPs' 
diagnosis should be considered. In doing so, the patients' well-being must be central to any 
arguments. The potential for success is supported by indicators such as the decrease in the 
power of the medical profession and calls for multidisciplinary teams. It may be predicted 
that that CPs and GPs will come into direct conflict if advice is 'put out to tender. Critically, 
to advance CPs' role as advisors on prescription medication the topic must first become part 
of the policy agenda and be openly and fully discussed. It may truly be said that their 
advisory activities are currently 'a well kept secret'. 
This thesis presents evidence for two types of CPs, proactive and reactive. Although 
proactive CPs provide very significantly greater amounts of advice than their reactive peers 
(table 40, page 244), both do provide advice. The next section considers pharmacy 
education and adherence to the Ideal of being professional to account for the advisory 
actions of CPs. 
i 
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6.3 Explaining the advisory practice of community pharmacists 
Community pharmacists offer advice on prescribed medication. At no time during the study 
was a request for advice ignored and in only 4.4% (22/495, section A3.1.2 table 57) of the 
total observed cases of advice was information provided through a third party. The question 
may be asked, why do CPs provide 'free' advice on prescribed medication? Two reasons are 
proposed. First, the professional education of CPs may train them to behave in a particular 
manner. Second, the concept of being a professional and being part of the professional 
culture may be promoting adherence to a particular pattern of activity. 
Professional education is generally seen as having a long term influence on subsequent 
actions. This may account, in part, for CPs' advisory activity. The influence of undergraduate 
education on professional judgement has been published for hospital 534 not community 
pharmacy settings. This discussion must, therefore, rely on the general observations in the 
literature. There is a body of opinion that the education of professional groups shape their 
future activity. Ham and Hill 379 cite Lukes in maintaining ' .. that people's expressed 
preferences are shaped by socialisation, education and the mass media': Freidson 472 notes 
"... the indubitable fact that doctors are not wholly born but are in some way made by medical 
school". Also, that educational processes are to prepare practitioners "... to resist all 
temptations to ethical or technical lapses by virtue of his inner resources alone": In 1956 
McCormack 535 writes of "The young pharmacist who develops a professional identification 
through his education". Clearly there is an opinion that education prepares practitioners for 
the future. It has been argued in this thesis that CPs confront the dilemma of a lack of 
information from GPs at the same time as being expected to be mindful of their wishes. That 
CPs are able to remain faithful to their Code of Ethics yet, with limited knowledge, provide 
judgmental advice may be due to their educational preparation. Recent graduates who have 
had the benefit of an increasing emphasis on behavioural sciences and effective preparation 
for communication with patients and health professionals 536 may be better equipped to deal 
with this ethical dilemma. No research has addressed this supposition. 
A second potential explanation why CPs provide advice may be based on the Ideal of being 
professional. Consequently, a value is placed on adherence to the Code of Ethics. The 
etymology of the term professional can be traced to the word profiteor, to 'acknowledge 
openly', 'confess', 'avow', 'declare ones self to be'. Dingwall 537 argues that it is the perception 
of members of an occupation and the individuals with whom they interact which defines 
whether organisations are professional. Indeed, Moline 538 speculates "that to be a 
professional x in the honorific sense is to be a self-declared x". Pharmacists perceive 
themselves to be professional 539 They may be adhering to the ideals proffered by the trait 
theories which act as a driving force for their advisory activities. Their activities may be 
sustained by the constant literature espousing their professional role. Brown and colleagues, 
in 1991,540 Identified a collective professional consciousness in nine occupations, including 
medicine and pharmacy, using content analysis of documents such as Codes of Ethics. 
Although Wilding's 455 criticism is valid, that existence of words does not necessarily equate 
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with activity, for the purposes of this discussion, the use of professional concepts particularly 
in connection with pharmacy was shown 540 That pharmacists perceive advice as a 
professional activity has been shown by Kirking 541 Freidson 472 identifies professional 
orientation where the practitioner "put his client's interests before his own". In the same 
manner Moles 542 advocates "Let us serve because that is the calling of a profession - 
because we care - and not tell our patients that we will not care unless we get paid to do so" 
Such literature testifies to patterns of reinforcement, of what is expected of a professional. It 
is this calling which may be a factor in sustaining the advisory activity. The detrimental 
543 impact of a recent preoccupation on the negative aspects of CPs' activities Is noted. 
Just as there is literature reinforcing CPs' self-identity as professional, sociological debate is 
querying this supposition and challenging the idea of a vocational calling. Arguments centre 
on the dilemma for professionalism which is created by Pharmacy's professional business 
orientation 544 Evidence for a relationship between the act of supply and the provision of 
PMA is provided in this thesis (section A3.4, page, 289). In 1939 Talcott Parsons 545 argued 
that professional practice was the antithesis of business. However, McCormack, 535 In 1965, 
noted that "pro fessionalization by means of formal training has been the major counteracting 
force" against the non-professional ideals of business. In 1988, a marketing report notes the 
conflict of a profession in business and reportedly states, "the roles of pharmacist and retailer 
have never fitted comfortably together. The chemist often finds it difficult to take a 
commercial view which does not compromise his professional role". 109 Even in law the 
actions of pharmacists may not be judged by the implication of being a professional. 97 
Recent perspectives on professionalism provide an alternative. Turner 461 In 1985 presented 
a perspective of professionalism which emphasised the interpretative nature of practice 
rather than the validity of knowledge where the "range and necessity for professional 
judgement" was the key issue. Similarly, Harding and Taylor 546 published a short balanced 
account of pharmacy's professional dilemma and concluded that judgement is the essence 
of professionalism. This thesis provides evidence that CPs use judgement in their actions. 
However, pharmacy has been poor at educating the public as to its 'professionalism'. 547 548 
This may be a consequence of being ignorant of the diagnosis and ethically unable to refute 
prescribers' actions. The patient who is the judge of status, is left unaware of the level of 
CPs' expertise and the actions they undertake on their behalf. If Dingwall's 537 proposition is 
correct, this must undermine pharmacy as a profession. 
Both education as a professional, reinforcement of that role as a vocation and the debate as 
to the professional nature of pharmacy may all be factors influencing the advisory activities 
of CPs. The lack of a diagnosis is clearly a major stumbling block to the development of CPs 
advisory role. Even with the diagnosis, however, the only professionally backed literature 
which provides direction for advice is the list of additional labelling instructions in the British 
National Formulary (BNF). This text currently controls the role of CPs as advisors on 
prescribed medication. The final section of this chapter considers how the BNF may be used 
to advance the advisory activities of CPs. 
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6.4 Developing the role using the British National Formulary 
It Is proposed by the author that the additional labelling instructions in the BNF be expanded 
to provide a list of medication-specific indications of the verbal advice which The Society and 
the British Medical Association would expect to be provided and customers to understand. 
Professional accountability by individuals is dominating current policy making 464 549 
Accountability is the cornerstone of the currently operational Government paper'Working for 
Patients'. Community pharmacists must be made accountable for the provision of advice as 
directed in their Code of Ethics. However, it has been argued that for a large proportion of 
medication there is no yardstick with which to assess CPs additional labelling activity. A 
measure for their verbal activity is virtually non-existent. Until the expectations for both 
verbal and written advice are made more explicit, then there is little The Society can do to 
advance CPs' advisory role. Adherence to enhanced directives on advice would be a matter 
of good professional conduct, thereby invoking penalties for professional non-compliance. 
The actions of proactive CPs might be used as the basis for the 'average' CPs' advisory 
activity. This has the added advantage of acting as a peer reference for reactive CPs. The 
Society's inspectorate are in a position to act as the monitors for CPs advisory activities. The 
pseudo-patient technique recently reported by Fisher 550 is a possible second option for mass 
measurement of advisory activity. 
This thesis has argued that the BNF 376 is the reference source which is dictating the advisory 
role of CPs. It Is through this source that the expectations of The Society are communicated. 
It Is proposed that the number of medications listed in this reference Is expanded and each 
entry includes specific reference for both written and verbal advice. 
Gunn 378 (section 3.3, page 85) sets out the preconditions for the success of this policy. First, 
CPs must have sufficient resources at the point in time when advice is appropriately 
proffered. Available time is an issue for implementing this policy, 390 551 however, locating 
advisory information in a single text and detailing the expectations explicitly would expedite 
the process. Second, CPs' advice must be accepted by patients such that subsequent 
behaviour leads to improved use of drug therapy. Only by having a set of expectations which 
can predictably alter CP's advisory activity can the delivery of advice be refined and 
optimised to improve the use of drug therapy. Third, they must only be minimally dependent 
on other individuals in order to provide such a service. The issue of diagnosis would need to 
be resolved, and CPs to be informed, before the full benefit of this policy could be realised. 
In this respect a pilot scheme with GPs providing the suspected diagnosis along with the 
prescription for an antibiotic may prove Instructive and a basis for further development. 
Fourth, they must have control over the advisory process and clearly defined roles for each 
person involved. It is implicit in this policy that the CP must, either hand out dispensed 
medication and advise personally, or produce a written protocol for the involvement of other 
individuals. The CP would remain personally responsible. 
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6.5 Conclusion 
From the discussion presented in chapter six; which is based on the literature of the 
professions plus results, summaries and conclusions from previous chapters and appendices, 
further conclusions have been drawn. These are now presented with paragraphs numbered 
according to the chapter section. Numbers for conclusions correspond to those used for 
recommendations in chapter seven. 
The following major conclusions are drawn from section 6.2, that: 
6.2.1. the lack of information on diagnosis is a major limitation to the expansion of CPs 
advisory role; 
6.2.2. community pharmacists are remaining true to their ethical obligations; 
6.2.3. Government assistance in enabling CPs' access to information on diagnosis should 
be sought on the basis that it would be of ultimate benefit to patients; 
6.2.4. that cultivating only the medical profession to advance the advisory role of CPs may 
bring about short term gains at the expense of long term restrictions; 
6.2.5. the advisory role for CPs on prescription medication may be disadvantaged if placed 
under the umbrella of the extended role or linked to their activities as advisors on 
OTC medicines. 
6.2.6. the provision of PMA by CPs is not a priority agenda item; and, 
6.2.7. if financial incentives are available for the provision of advice, then there will be 
conflict between Pharmacy and Medicine. 
The following major conclusions are drawn from section 6.3, that: 
6.3.1. that a complicated educational preparation may partially account for the professional 
actions of CPs in providing PMA; 
6.3.2. that the idea of acting professionally is a factor underpinning the advisory role; and, 
6.3.3. evidence of judgement in CPs' advisory activities presented in this thesis supports 
arguments for the professionalism of Pharmacy. 
The following major conclusion is drawn from section 6.4, that: 
6.4.1. that the advisory role of CP may be developed by expanding the medication-specific 
guidelines for both written and more importantly verbal advice in the BNF 376 
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CHAPTER 7 RECOMMENDATIONS 
The following recommendations arise from the results, analysis and discussion presented in 
this thesis. Each has as its intention the optimisation of CPs' prescription medication advisory 
role. The paragraph numbers correlate with conclusions drawn and presented in the final 
section of chapters five and six. 
The following recommendations arise from the conclusions of section 5.2, page 140, that: 
5.2.1. the general public, patients and policy makers are made aware of the growing 
evidence for CPs advisory role. Further studies should consider collating data under 
comparable categories of advice and using observation as the study method; 
5.2.2. investigations are conducted to determine why CPs fall into reactive or proactive 
groups in providing PMA. This understanding may reveal ways of increasing the 
overall level of CPs advisory activity; 
5.2.3. trends to locate community pharmacies near surgeries and for multiple ownership 
should be considered in the context of what is best for the patient. Further research 
in this area is a priority; 
5.2.4. the general public, patients and policy makers are made aware of the fact that POls 
independently request PMA from CPs and thereby legitimise the advisory role. The 
extent of customer initiated requests for advice should be considered for use as a 
baseline indicator for monitoring the developing role of CPs as advisors; 
5.2.5. studies are conducted in areas other than Southern Derbyshire in order to develop a 
clear understanding of the overall advisory activities of CPs; 
5.2.6. research should be conducted to determine why POIs are reluctant to Initiate advice 
during busy periods. Community pharmacists should be made aware of such 
reluctance and advised to be more proactive during times of high dispensing activity; 
5.2.7. investigations should be conducted to determine why CPs apply additional labels in 
only the minority of recommended cases. Such information may clarify their use of 
discretionary power and their use of professional judgement; 
5.2.8. the importance of the BNF to CPs advisory role is made clear to policy makers; 
5.2.9. Further research is conducted to clarify the relationship between socio-economic 
status and advisory activity. 
The following recommendations arise from the conclusions of section 5.3, page 140, that: 
5.3.1. the full impact of directing CPs to focus their PMA on the elderly should be assessed 
and must take account of the nature of prescribed medication, as well as, for 
example, the complexity of prescribed regimens; 
5.3.2. policy makers should be made aware of the fundamentally reiterative nature of CPs' 
advice and be prepared to recognise the extent of independent judgement provided; 
5.3.3. advisors are given a clear message that they are failing to meet the expectations of 
Pols with regard to advice on side effects. Also, that the literature both supports and 
explains the effect of providing such advice; 
5.3.4. community pharmacists consider advertising their availability to provide PMA; and, 
5.3.5. the use of any 'cue' in advertising is supported by an effective marketing strategy. 
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The following recommendations arise from the conclusions of section 6.2, page 156, that: 
6.2.1. that all efforts are made to securing access to information on diagnosis; 
6.2.2. the actions of CPs in adhering to their Code of Ethics are acknowledged publicly; 
6.2.3. research is conducted to determine the direct effect on patients of providing CPs with 
access to information on diagnosis; 
6.2.4. in advancing CPs advisory role, a broad range of support should be sought. The 
major effort should be directed towards securing Government backing; 
6.2.5. community pharmacists' role as advisors on prescription medication is not linked to 
their extended role or activities as advisors on OTC medicines; 
6.2.6. the provision of PMA is made a major agenda item in discussions of the future of 
community pharmacy practice; and, 
6.2.7. the issue of remuneration for CPs advisory services is made clear. If the role is 
clearly being financed, then policy makers must consider the implications carefully. 
This thesis argues that the provision of free advice to the public has been key factor 
in advancing the cause of Pharmacy. 
The following recommendations arise from the conclusions of section 6.2, page 156, that: 
6.3.1. from an educational perspective, the preparation of CPs for a professional role 
should be fully researched. Educationalists should re-examine the role they foresee 
CPs playing as advisors on prescription medication and structure student preparation 
accordingly; 
6.3.2. those who publish on the 'professionalism' or otherwise of Pharmacy should be 
mindful of their potential to adversely affect CPs' concept of acting professionally; 
and, 
6.3.3. any decisions affecting the role of CPs as advisors on prescription medication take 
into account the judgmental nature of this activity. 
The following recommendation arises from the conclusion of section 6.4, page 156, that: 
6.4.1. It is recommended that guidance for verbal advice on specific antibiotics is provided 
in the BNF 376 This should take account of CPs' judgement in educating patients as 
to the use of their medication. Provision of such advice should be made a matter of 
professional conduct. The Society's inspectorate should monitor CPs advisory 
activities, possibly using a pseudo-patient technique. The activities of proactive CPs 
should be the expectation of The Society in matters of de-registration. If such policy 
was shown to be successful then it could be widened to include other prescribed 
medication. Accountability to The Society would be seen as the initial motivation. In 
the long term, policy makers should consider the fundamental tasks of making such 
activity accountable to patients. 
-158- 
APPENDIX 1 DETAILS OF METHOD 
A1.1 Schedule-structured interview method 
The present section expands on the note made in section 4.5 (page 107) of the use of the 
schedule-structured interview method to collect data on the advisory activities of CPs. 
A schedule-structured interview method is one in which an interviewer asks interviewees the 
same questions in a predetermined fixed sequence. With respect to the task of determining 
the advice CPs provide and patients seek, unlike direct observation, there is no issue of 
subject reactivity as the technique is essentially retrospective. Community pharmacists and 
prospective interviewees need not know that details of their communication may be queried 
at a later time; however, the retrospective nature of the interview method has its own 
problems of instrument validity, and the question must be addressed as to whether 
interviewees accurately recount their experiences. The method is labour intensive and a 
request was made to the College of Pharmacy Practice for support (letter 1, page 161) but to 
no avail. For six months, from late 1987 to early 1988, two schedule-structured interview 
forms were piloted. The first form (form 1, page 162) and corresponding flow diagram (figure 
23, page 164) defined the questions for determining the nature of baseline advisory activity 
and pinpointing when recalled communication takes place. The second form (form 2, page 
165) and its flow diagram (figure 24, page 167) included additional questions which were 
designed to determine the effect of a poster advertising the CPs prescription medication 
advisory service. 
The objective of the study was; to evaluate the potential for a schedule-structured interview 
method in investigating the following: 
1. the frequency of requests for information on prescription medication, minor medical 
matters and OTC products made by interviewees from specific pharmacy staff; 
2. the frequency of provision of information on prescription medication, minor medical 
matters and OTC products made by CPs to interviewees; 
3. the chronological sequence of events surrounding requests for information with and 
without observation of the poster; and, 
4. relationships between advice, observation of the visual display and the epidemiological 
variables gender, residential address, age, and occupation, of interviewees. 
Two pharmacies were chosen to pilot the development of schedule-structured interview 
forms. The CP in charge of each dispensary were aware of the exercise and an aspect of 
negotiation for determining the validity and reliability of the method was that the specific 
location of the pharmacy would remain anonymous. One was situated in an East Midlands 
city and one in a suburb of the same city. The former was a dispensing only establishment 
with chairs in the dispensary waiting area and the latter a more typical retail outlet with 
merchandise and advertising. The former was chosen to provide the poster with an 
environment in which the poster would be a unique element with little else to distract 
potential enquirers. The building construction of the latter enabled the researcher visual 
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access to the activities of the pharmacy while positioned outside the premises. Over a period 
of four months two formats (forms 1 and 2) of schedule-structured interviews with the general 
public were piloted with 125 interviewees and revised a total of 13 times. Customers were 
chosen randomly and were approached by the researcher for information as they left a 
pharmacy. Interviews lasted approximately 10 minutes and details were recorded 
immediately after completion. Unfortunately, on three separate occasions at the suburban 
pharmacy, customers were observed, and later confirmed by enquiry, to have discussed 
prescription medication with the CP; however, found to have responded inappropriately 
during interview. It could not be determined whether the fault lay with the interviewer, the 
research instrument, the CP or interviewee or a combination. In any case, it was clear that 
information on the actual events taking place in the dispensary was required in order to place 
the results of interviews in perspective. Either two researchers were required or an 
alternative method. 
In summary, due to lack of subject or instrument validity and potential problems of reliability, 
the schedule-structured method was passed over in favour of observation and a radio 
microphone was used to tape interactions between CPs and the general public. 
t 
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Letter 1 
Letter requesting support for schedule-structured interview method* 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
Medicines Research Unit 
Your ref: Derby Royal Infirmary 
Our ref: CPP London Rd 
Derby DEI 2QY 
0332 47141 ext 323 
Dear Miss Mitchell 26th June, 1987 
re: Funding for research on patient counselling 
We read with interest one of the recent conclusions made by the Pharmaceutical Society 
Council's working party on information to patients (I). The recommendation made was that 
"Studies on a larger scale than those previously carried out should be undertaken in an 
attempt to assess the value of counselling and other methods of providing information to 
patients" and it was agreed that this should be referred to the College of Pharmacy Practice. 
The College has indicated a willingness to assist in the funding of appropriate practice 
research (2). 
The appointment by Southern Derbyshire Health Authority (SDHA) of a Staff Pharmacist 
Health Education, has provided the opportunity of exploring effective methods of educating 
the public to seek counselling from pharmacists. Unique research in this aspect of patient 
counselling is currently being undertaken under the guidance of Professor Willcocks of 
Nottingham University. A brief summary of the research being undertaken is attached 
(appendix one). 
By August, 1987 the investigation will have advanced to a stage which necessitates 
extensive interviewing of the public. To limit study variables and produce a valid analysis of 
the intervention, interviews must be conducted in a short period of time. For a three month 
period the support of a temporary assistant trained in market research will be required at an 
estimated cost of £3,000. The College has shown an interest in this type of research (3) and 
we hope that it could consider assisting us in our investigation by the provision of these 
additional funds to allow for the appointment of a research assistant. Please do not hesitate 
to request further information if you feel this investigation merits assistance. 
Your sincerely 
Mr D. Gerrett (Staff Pharmacist HE) Mr A. M. S. Cullen (DPhO) 
4RAoe&f 
Professor A. J. Willcocks, Dept Social Science, Nottingham University 
(1) Anon. Report to the working party on information to patients. Pharmaceut J 
1986; 237: 306-8. 
(2) Anon. Getting started in practice research. Pharmaceut J 1986; 237: 547. 
(3) Anon, Post Hereford - The researchers' toolbox, College of Pharmacy Practice, 
1987; Newsletter no 22 (Feb): 5-8. 
Note 
*= Signatures have been scanned into this presentation from the original letter. The text 
of the original letter is accurately presented. 
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Form 1 
Schedule-structured interview form for baseline advisory activity 
CONFIDENTIAL 
Southern Derbyshire Health Authority 
Baseline Interview guide for the general public 
1. 
4. 
5. 
Q6 
Questionnaire No Pharmacy Case 
code notes 
Date? 
----88 
12. Time? ..... 13. Selection method? ABCDEF1.12.13. I- -88/ 1 
Subject gender? Male.. (1) Female.. (2) 412 
Subject accompanied? Yes 51 
if Yes, state numbers and details No 52 
Say-Excuse me, I'm doing some research for the Southern Derbyshire Health Authority. Yes 61 
We are trying to determine who people talk to when they visit a chemist shop? rve only No 62 
got a few questions, I wonder if you could help? Other 63 
Cite political polls If required. Details 
07 Ask-Could you tell me whether you (o7=Yes, or any member of the party") have just 
taken a prescription Into the chemist shop to be made up? 
Details(eg prescription left yesterday) 
08 Ask-May I ask whether the prescription was for you or whether you were collecting it for 
somebody else? 
Details 
09 Ask-Did you speak to the pharmacist or assistant about anything at all? 
Prompted details recorded In 013, A-D 
010 Ask-Did the pharmacist or assistant speak to you about anything at all? 
all Ask-politely-It's unusual that nobody said anything. it is Important, are you sure? 
Details 
Q12 Ask-I know this may sound like I am prying but I assure you, anything you say will be kept 
In the strictest confidence. Would you tell me just generally what sort of things you talked 
about? (Interviewer pause) 
013 Prompt-For example, did-1 you or-2 the pharmacist or assistant; talk about... ABC. 
Qualify-1 Did you speak to.. or-2 Who spoke to you; the Pharmacist the Assistant or Both? 
Yes No 0 P A B 
A Anything to do with the prescription or 6 78 9 10 11 
something you would get on a prescription? 
B Anything to do with a minor medical matter 12 13 14 15 16 17 
for example a cough, a cold or an injury? 
CA product which you would normally buy 18 19 20 21 22 23 
over the counter of a chemist shop? 
D Other 24 25 26 27 28 29 
Specify 
NOTEQ13i689or10 
Q14 Ask-When you talked about (mention topic) did you ask the pharmacist the assistant or 
both (Q13=11) for information..... or did they start the discussion? 
Details 
NOTE Q13  7 and/or 09   No, Q10   No, Qt 1  Yes 
Q15 Ask-Although you didn't talk to the pharmacist or assistant about a prescription or 
something you would get on a prescription, was there anything at all you would like to 
have asked? 
Details (of other sentence) 
Q16 Interviewer explanation of poster 
Ask-Would you please suggest any improvements which might be made to the poster? 
Pause Can you think of different sentences? 
Details Subjective evaluation of understanding? 
Yes 7 
No 7 
Other 7 
1gotoQ8 
2 go to 09 
3 
Yes 8 1 
No S 2 
Other 8 3 
Yes 9 1 
No 9 2 
Other 9 3 
Yes 10 1 go to 012 
No10 2goto011 
Other 10 3 
Yes 11 1 Ask 013 A 
No11 2gotoQ12 
Other 11 3 
Yes 12 
No 12 
Other 12 
N/A 12 
c PROMPTING 
1 Ask 013 A 
2 go to 012 
3 
4 volunteered 
SUBJECTIVE EVAL 
RELATED SENTENCES 
1234(5) 
Yes 14 1 subject 
No 14 2 pharm/assist 
Both 14 3 
Other 14 4 
SENTENCES 
Yes 15 1234 
No 15 5 
Other 15 6 
SENTENCES 
A-2-3-4 
a18 017 018 019 
Yes 16 "1.2""-""3-4 
No 16 -1-2-3-4 
Alter 16 "1.2"""--3.4 
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co de notes 
Note Q20 " Q23 only If 013 =6 or 8 Sentences 
020 Ask-Did one or more of the sentences apply to the discussion you have just had with the Yes 20 1234 
pharmacist/assistant about the prescription? No 20 5 
Details Other 20 6 
Note 07 a Yes, Q13=7 
021 Ask-Did one or more of the sentences apply to the prescription you have just had made Yes 21 1234 
up at the chemist shop? No 21 5 
Details Other 21 6 
Q22 Ask-When did you first talk about the prescription with the pharmacist /assistant? Was it Before B-1 
Before, As or After you gave the prescription into be made up? 22 As-25 
Details relative to prescription) As 22 A=3 
After 22 4 
Other 22 
023 Before-State-In summary then, you first talked with the pharmacisVassistant Before you Yes 23 1234 
had given the prescription Into be made up and it was because..... Other 23 5 
(1) &/or (2) &/or (3) &/or (4) &/or Other 
Details 
024 As-State-In summary then, you first talked with the pharmacist/assistant Yes 24 1234 
Details 
025 After-State-In summary then, you first talked with the pharmacist/assistant After you had Yes 25 1234 
given the prescription In to be made up and it was because........ Other 25 5 
(1) &/or (2) &/or (3) Vor (4) &/or Other 
Details 
State-It would be very helpful if we knew certain personal Information In order to make sure people make the best use of the 
services available. Of course, any details you give will be kept In the strictest confidence. 
026 Ask-May I ask, where do you live? 26 12345 
Derby city (DE1).. (1) Derby Suburb.. (2) Country Town. (3) 
Country Village.. (4) Other.. (5) Specific Location 
Q27 Ask-And what Is your age? 27 
less than 20 (1) 21 - 30 (2) 31 - 40 (3) 41 - 50 (4) 51 - 60 (5) over 61 (6) 
028 Ask-Could you tell, me what Is your occupation? (Social class) 28 
029 Ask-And finally, so that we are aware of any duplication, may I have the Initials of your Yes 29 
name, not your full name just your initials. Could you start with the initial of your first name No 29 
then middle name(s), If any, then surname? N/A 29 
NOTES Including PRESCRIPTION Item(s) 
123456 
IIIIIIaIIIbIV V 
//II 
zz 
00 
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Figure 23 
Flow diagram for baseline advisory activity schedule-structured interview 
questions 
General Information (Q1-Q6) 
Interviewee has taken a prescription to the pharmacy? (Q7) 
Prescription for interviewee pr collecting on behalf of? (Q8) 
Interviewee spoke to pharmacicist/assistant about anything at all? (Q9) 
Possible open question interviewer confidentiality 
statement Wth a request as to what the itn'ee 
or pharmacistlassistant spoke about (Q12). With or 
without prompting, related to sentences and with 
Pharmacy/assistant spoke to 
interviewee about anything 
at all? (Q10) 
E jnterviewer attempt to determine 
if conversation took place? (Q11) 
Discussion? --No-q, 
Instigator of corn nication? (Q14) Interviewee wanted to ask? Q15 
Yes No 
(Q16-Q19) meaning of sentences and application to discussion? 
(Q20-Q21) (Q22) Initial communication is Before As After the prescription is given? 
Before the prescription As the prescription After the prescription is 
is given to the is given to the given to the pharmacists, 
pharmacists 
(Q23) Related to Notice? 
pharmacists 
(Q24) RelaYd to Notice? 
upon its completion 
(Q25) Related t4 Notice? 
Personal details (026-Q29) 
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Form 2 
Schedule-structured interview form for'cued' advisory activity 
r 
i 
CONFIDENTIAL Questionnaire No Pharmac Case 
Southern Derbyshire Health Authority 
Interview guide place for the general public with poster In place 
1. 
4. 
5. 
06 
Date? 
_-_-88 
12. Time? ..... J3. Selection method? 
ABC DEF 
Subject gender? Male.. (1) Female.. (2) 
Subject accompanied? 
If Yes, state numbers and details 
Say-Excuse me, I'm doing some research for the Southern Derbyshire Health Authority. 
We are trying to determine who people talk to when they visit a chemist shop? rve only 
got a few questions, I wonder if you could help? 
Cite political polls If required. Details 
1. /2.13. 
4 
Yes 5 
No S 
Yes 6 
No 6 
Other 6 
- -881 
12 
1 
2 
1 
2 
3 
07 Ask-Could you tell me whether you (Q7=Yes, 'or any member of the party) have just Yes 71 go to as 
taken a prescription Into the chemist shop to be made up? No 72 go to 09 
Details(eg prescription left yesterday) Other 73 
as Ask-May I ask whether the prescription was for you or whether you were collecting lt for Yes 81 
somebody else? No 82 
Details Other 83 
09 Ask-Did you speak to the pharmacist or assistant about anything at all? Yes 91 
No 92 
Prompted details recorded in 013, A-D Other 93 
Q10 Ask-Did the pharmacist or assistant speak to you about anything at all? Yes 10 1 go to Q12 
No 10 2 go to Q11 
Other 10 3 
all Ask-politely-It's unusual that nobody said anything, it is Important, are you sure? Yes 11 1 Ask 013 A 
Noll 2gotoQ12 
Details Other 11 3 
c PROMPTING 
Q12 Ask-I know this may sound like I am prying but I assure you, anything you say will be kept Yes 12 1 Ask 013 A 
In the strictest confidence. Would you tell me just generally what sort of things you talked No 12 2 go to Q12 
about? (Interviewer pause) Other 12 3 
N/A 12 4 volunteered 
Q13 Prompt-For example, did-1 you or-2 the pharmacist or assistant; talk about ... ABC. SUBJECTIVE EVAL 
Qualify-1 Did you speak to.. or-2 Who spoke to you ; the Pharmacist the Assistant or Both? RELATED SENTENCES 
Yes No 0PAB 1234 (5) 
A Anything to do with the prescription or 6789 10 11 
something you would get on a prescription? 
B Anything to do with a minor medical matter 12 13 14 15 16 17 
for example a cough, a cold or an Injury? 
CA product which you would normally buy 18 19 20 21 22 23 
over the counter of a chemist shop? 
D Other 24 25 26 27 28 29 
Specify 
NOTE Q13 =689 or 10 
014 Ask-When you talked about (mention topic) did you ask the pharmacist the assistant or Yes 14 1 subject 
both (013=11) for information..... or did they start the discussion? No 14 2 pharm/assist 
Both 14 3 
Details Other 14 4 
NOTE Q13 =7 and/or Q9 = No, Q10 = No, Q11 = Yes 
015 Ask-Although you didn't talk to the pharmacist or assistant about a prescription or SENTENCES 
something you would get on a prescription, was there anything at all you would like to Yes 15 1234 
have asked? -, No 15 5 
Details (of other sentence) Other 15 6 
Q16 Interviewer explanation of poster Yes 16 1 go to 018 
Ask-When you were In the pharmacy, did you see (a stand about three foot high) with an No 16 2 go to 017 
official-looking, black and white poster or notice (attached)? Other 16 3 
Details 
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017 Say-As you did not see the poster. It has failed to attract your attention. Could you help us Yes 17 1 gp tp 028 
by telling me whether you were close to (the dispensary counter) at any time? No 17 2 Show poster 
Other 17 3 (ask 020 and 
Details (positional problems) ....................................... 
go to 028 
Q18 Ask-Did you read what was on the poster? Yes 18 1234 
No 18 5 
Details Parts 18 6 
019 Ask-Can you tell me all you remember about the poster? 
Sentences 19 1 234 
Format of notice 19 5 
Position In pharmacy 19 6 
Other 19 7 
020 Say-Overall, what do you feel the poster was asking you to do? "prompt the general public Yes 20 1 
for advice" No 20 2 
Other 20 3 
Details 
NOTE Q21 to Q26 If Q13a 6or8 
Q21 Ask-Do you remember whether you saw (Q18=Yes, read saw) the poster Before or After before 21 13-1 
your discussion with the pharmacist/assistant about the prescription? After 21 A3 
Other 21 3 
Details 
022 Ask-When you saw (read) the poster was it Before or After you gave the prescription In to Bator* 22 
be made up? After 22 A-2 
Other 22 3 
Details 
023 State-So that I am clear about this, Ask-You saw (read) the poster After your discussion AA (2.21 
with the pharmacist/assistant and that was also After you gave the prescription into be Yes 23 1 
made up? No 23 2 
Details Other 23 3 
024 State-So that 1 am clear about this, Ask-You saw (read) the poster Before your discussion BA (1.21 
with the pharmacist/assistant and that was also After you gave the prescription Into be Yes 24 1 
made up? No 24 2 
Details Other 24 3 
025 State-So that I am clear about this, Ask-You saw (read) the poster After your discussion AB (2.11 
with the pharmacist/assistant and that was also Before you gave the prescription in to be Yes 25 1 
made up? No 25 2 
Details Other 25 3 
026 State-So that I am clear about this, Ask-You saw (read) the poster Before your discussion 1313M. 11 
with the pharmacistlassistant and that was also Before you gave the prescription In to be Yes 26 1 
made up? No 26 2 
Details Other 26 3 
027 Ask-Please tell me, had the notice not been there, would you have done the same thing? Yes 27 1 
Details No27 2 Other 27 3 
State-It would be very helpful If we knew certain personal Information In order to make sure people make the best use of the 
services available. Of course, any details you give will be kept in the strictest confidence. 
028 AsK-May I ask, where do you live? 28 12345 
Derby city (DEI).. (1) Derby Suburb.. (2) Country Town. (3) 
Country Village.. (4) Other.. (5) Specific Location 
029 Ask-And what Is your age? 29 123456 
less than 20 (1) 21.30 (2) 31 -40 (3) 41 -50 (4) 51 - 60 (5) over 61 (6) 
Q30 Ask-Could you tell, me what is your occupation? (Social class) 30 III Ilia Illb IV V 
031 Ask-And finally, so that we are aware of any duplication, may I have the Initials of your Yes 31 
name, not your full name just your Initials. Could you start with the initial of your first name No 31 ZZ then middle name(s), if any, then surname? N/A 31 00 
Q32 Enquire delicately-I know this may sound terribly Impolite but, could you tell mewhether Yes 32 1 
you are able to read English? No 32 2 
Details (Notes of lanauaae abilitvl..... .. _ 
NOTES Including PRESCRIPTION item(s) 
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Figure 24 
Flow diagram for 'cued' advisory activity schedule-structured interview 
questions 
General Information (Q1-Q6) 
Interviewee has tak na prescription to the pharmacy? (Q7) 
Prescription for interviewee or collecting on behalf of? (Q8) 
Interviewee spoke to pharmacist/assistant about anything at all? (Q9) 
Possible open question interviewer confidentiality Pharmacy/assistant spoke to 
statement with a request as to what the itn'ee interviewee about anything 
or pharmacist/assistant spoke about (Q12). With or at all? (Q10) 
without prompting, related to sentences and with 
pharmacy/assistant (Q13) Interviewer attempt to determine 
if converstation took place? (Q11) 
Discussion? --p 
Instigator of communication? (Q14) 
\Iý/Interviewee 
wanted to ask? (Q15) 
Interviewee obse es Poster? (Q16 
F -'Yes No 
Interviewee reads Poster? (Q18) Interviewee clos to Poster? (Q17) 
Interviewee's recall of Poster (Q19) WO Yee 
Undrrstood intent of Poster? (Q20) 
(Q21) Poster seen Beforeand (Q22) Poster seen After or Before 
or after communication prescription given for dispensing 
(Q23) AA communication due 
to poster unlikely 
(Q24) BA Int'ee hands prescription In and 
sees poster then communicates. 
Communication due to poster likely 
(Q25) AB Int'ee communicates then 
observes the poster and gives 
prescription in. Communication due 
to poster unlikely -, 
Qs18 to Q26 
AA, Bq, AB, BB 
Would int'ee have c`oVmmunicz 
if the poster had not been thet 
(Q27) 
1 
General information (Q28-Q3 
AN Bq, AB, BB 
Would int'ee have communicated 
if the poster had not been there? 
Understands English 
(Q26) BB Int'ee observes poster then communicates 
1 and gives prescription In. Communciation due to 
poster likely 
Possible permutations with time; - 
1 Communicates, hand prescription In, see the poster AA 
2 Hand prescription in, 'communicate, see the poster AA 
3 Communicate,, see the poster, =., hand prescription in AB 
4 Hand prescription in see the poster, communicate BA 
5 See the poster, hand prescription in, communicate BB 
6 See the poster, communicate, hand prescription in BB 
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A1.2 Observational study 
A1.2.1 Sampling 
A list of the community pharmacies holding current contracts with the Family Practitioner 
Committee on the 11th April, 1988 was obtained. An operational decision was made to 
restrict, as far as possible, the full time data collection to the calendar year 1988. As the 
method for the observational study called for two visits to each pharmacy and up to three 
consecutive days in any week, the worst scenario would be for each pharmacy to require two 
weeks of research time. With 40 weeks left to the end of the year the least number of 
pharmacies expected in the study was 20. As not all pharmacies were expected to 
participate, a 75% response rate was assumed giving a figure of 27 pharmacies to be 
randomly chosen. It was accepted that all those who agreed to participate would be included 
irLthe study, even if data collection extended into 1989. 
The method for random selection of observational study pharmacies was to first list the 
registered pharmacies in alphabetical order of their trading title and assign to each its rank 
order number between I and 105. Each pharmacy was then assigned a second unique 
number between 1 and 105 which was randomly chosen from standard mathematical 
tables 552 Finally, the first 27 values between 1 and 105 in the random number tables were 
matched with the second unique figure to determine the observational study pharmacies. 
Pharmacies were also randomly allocated to start observation on a particular day of the 
week. Saturdays were excluded as a starting day to ensure, as far as possible, that 
consecutive days were observed. First, observational pharmacies were listed in alphabetical 
order. Then, the days Monday to Friday were allocated numbers one to five. Using random 
number tables, 552 the values one to five were randomly selected 27 times and assigned 
sequentially to the 27 alphabetically sorted pharmacies. A bias towards the beginning of the 
week was noted with Monday to Wednesday chosen as a starting day for seven, six and six 
pharmacies respectively compared with Thursday, three and Friday, five. 
Display of the poster was randomly allocated to the first or second visit by whether the last 
digit of the assigned unique random number was even or odd respectively. 
As communication concerning prescription medication is most likely when a prescription is 
dispensed, it was felt necessary to provided guidance on the period of observation in terms 
of the number of customers who presented or collected prescriptions rather than the number 
of items dispensed or time spent observing activity. In this way all study CPs were given a 
minimum opportunity to demonstrate their advisory activity to customers. Unfortunately, 
figures for the number of individuals who present or collect prescriptions are not known and a 
decision based on the number of prescriptions dispensed was necessary. Either the mean 
value or the median for dispensing activity could be used. The most common pharmacy or 
median would have been the preferable figure, however, available details for Derbyshire 
dispensing only permitted calculation of the mean. Information from the PPA revealed that, 
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during the period January to December 1987, an average of 3,577,392 prescriptions and 
6,009,061 items were dispensed each month by an average of 2044 Derbyshire FPC 
accounts. Assuming a 5.5 day working week for 52 weeks a year then the average number of 
whole prescriptions and prescription items dispensed was 74 and 124 respectively. As stated, 
in order to correlate numbers of prescriptions with numbers of customers, figures for the 
proportion of prescriptions per patient would be required. Such detail was not available at the 
time of this study. Further, it is known that the number of prescriptions dispensed by CPs is 
skewed. For the year 1989, just over 7% (700) of all pharmacies in England dispensed on 
average more than 6,000 prescription items per month which accounted for nearly 19% of 
the total. The median level of prescription dispensing was 2,500 per month 553 Use of the 
mean value is in this case an overestimate of the median; however, it is unlikely that all 
customers present single prescriptions which, in part, compensates for the overestimation. 
For want of an alternative, the figure of 74 prescriptions was used as the minimum number of 
customers to be observed at each pharmacy for both visits. As it was likely that 74 was still 
an overestimate, it was anticipated that the majority of pharmacies would be observed for 
two or more days before and after any study intervention. 
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A1.2.2 Equipment and piloting 
The study method required the taking of field notes and recording of conversations. The 
technique of recording required the use of radio microphone equipment. A Cygnus series two 
kit from EDC Elkom Design Ltd of Dorsett, England was available until December 1988 from 
the Derbyshire College of Higher Education's Media Services Department. The system 
included a remote "CRX" receiver (figure 25) requiring mains power and pocket transmitter 
using a six volt rechargeable battery. By balancing the audio gain and squelch controls on 
the receiver the quality and intensity of signal from the transmitter could be maximised. The 
status display also gave an indication of battery charge in the transmitter. A small 
microphone attached by a crocodile clip to the pocket or lapel was connected by a cable, 
which also served as the aerial, to a single input "CTXP/1" transmitter (figure 26) usually 
placed unobtrusively in the trouser or coat pocket. If the transmitter was left on continuously, 
a single battery enabled conversations to be recorded for a four hour period. The receiver 
was in turn connected to a Philips D6920 Mkt AV Audio Visual portable stereo cassette 
recorder, which was also mains powered, and subsequently to a set of inconspicuous 
earphones. By listening to conversations between CPs and individuals the researcher was 
able to make field note observations and interpretations could be readily verified while a 
permanent record was being automatically kept. 
Figure 25 
CRX receiver 
Figure 26 
CTXP/1 transmitter 
It was possible by using the transmitters on/off switch for the CP to cut transmission at any 
time. For two pharmacies observed in late 1988 and early 1989, a standby radio microphone 
was used. In these cases the "Audio RM5" manufactured by Audio was used. Here the 
receiver was powered by a nine volt PP9 batters and the signal was less clear, however, the 
transmitter was of a similar size and design. For both sets of equipment the receiver and 
Philips recorder were concealed in a brown paper box resting on the researcher's knee. 
Two piloting exercised were carried out prior to the main data collection. First, a non-sample 
frame CP, who requested to remain anonymous, agreed to wear the radio microphone for 
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one day and, for ethical reasons, to display the notice (section A1.2.3, page 173) to those 
individuals presenting at the dispensary. No comment concerning the notice was recorded or 
noted in field notes. Only minor format changes to the form for noting observed interactions 
(section A1.2.3) were required in order to further facilitate data collection. It was considered 
that the method could cope with considerable increases in PMA associated with advertising 
the advisory services of the CP. Experience of the use of the radio microphone system was 
gained. Specifically, the signal was effected when the microphone contacted clothing. 
Positioning the microphone through a button hole then clipped to one side of a garment was 
found to be the most effective method of reducing interference. Problems were found with 
the adjustments necessary to receive a clear signal. Battery power critically effected quality 
and below 5.5 volts the signal was indistinguishable from background noise. The receiver 
was not capable of simultaneously operating and recharging batteries for the necessary 14 
hours, thus it was necessary to charge the batteries overnight using the receivers attachable 
battery charger. No problems were found from the CPs' perspective and the system was 
soon forgotten as the activities of the pharmacy intensified (section A3.3, page 280). 
Second, the author undertook two periods of one and two weeks as a locum CP while 
simultaneously using the developed recording system. A letter of introduction outlined the 
study (Letter 2, page 172). During this time it was found that conversations could be recorded 
and details of the prescription taken but time did not allow extensive field notes to be made. 
It was concluded that the presence of the researcher was required to manage the recording 
system and take down additional notes. This excluded study designs where the CP was 
responsible for data collection. 
For this and all research conducted using the radio microphone, a £12.50 five year "wireless 
telegraphy licence" from the Department of Trade and Industry was sought by completion of 
form BR9. The following letter was sent to CPs to introduce the second piloting exercise. 
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Letter 2 
Letter introducing the author's piloting of the observational method 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
District Pharmacy 
your ref: Derbyshire Royal Infirmary 
our ref: RTI. Itr London Rd 
Derby 
DE1 2QY 
Mr A. M. S. Cullen 5th April, 1988 
District Pharmaceutical officer 
Dear Pharmacy manager 
re: Two week Pharmacy locum 
A fully qualified pharmacist with three years relevant experience wishes to spend two 
consecutive weeks in a series of community pharmacy outlets for the purpose of 
investigating a health education initiative. The effectiveness of a poster which directs the 
general public to consult the pharmacist for necessary advice on prescription medication, is 
being assessed. 
The researcher will act as a pharmacy "locum" and will conduct the research in addition to 
the work requirements of the pharmacy. A fee of £6.00 per hour will be charged by the 
Southern Derbyshire Health Authority for a 39 hour week. Any time in excess of 39 hours, 
which is required to fulfil the opening obligations of the Pharmacy, will be undertaken at the 
same rate but paid directly to the researcher. 
The research entails recording patient-pharmacist interactions concerning prescription 
medication. Patients will ultimately be anonymous and if requested, pharmacies shall not be 
identified by name. A radio-microphone will be used to tape conversations and a list of 
details (appendix 1*) kept for each interaction. A similar technique has been used 
successfully in London to evaluate the Pharmacist's "response to patient's symptoms". 
Patients will be advised about the recordings by a prominently displayed note (appendix 2*) 
and the tie microphone will not be concealed from view. The names of patients, initially kept 
for the purpose of identifying duplication and for earmarking conversations, will be 
subsequently erased. If the patient requests anonymity the transmitter shall be switched off. 
A suitable area in the pharmacy may be identified where the researcher can give out each 
prescription. Patients will be given the opportunity to initiate a request for information from 
the researcher but if a request is not forthcoming the necessary information shall be 
imparted. 
A baseline for pharmacist-patient interactions will be recorded during one week and similar 
data collected during a second week when the poster will be on display. The poster shall be 
randomly selected to appear on the first or second week. Data will be held on a personal 
computer, accessible only by the researcher and analysed using the SPSS suite of 
programmes. The results will be forwarded to all participants. 
For further details, please contact Mr David Gerrett on Derby 47141 x 2788 or after office 
hours on Derby 517525. 
Yours faithfully, 
Mr A. M. S. Cullen 
Notes 
Appendices were taken from the observational study protocol. The signature has 
been scanned into the presentation from the original letter. The text of the original letter is accurately presented. 
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A1.2.3 Protocol 
The 27 community pharmacies randomly chosen by the process described in section A1.2.1 
were visited by the author, advised of the study and provided with a full protocol. The 
protocol is now presented. First the wording of the letter of introduction (letter 3, page 174), 
then the protocol itself (protocol 1, page 175) with the form used to record observations, the 
first section of the attitudinal questionnaire which CPs were asked to complete at the end of 
the observation period, the poster used to advise the general public and patients of the 
research and finally the form used for field notes. 
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Letter 3 
Letter of introduction for the observational study* 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
Department of Community Pharmacy 
your ref: Derbyshire Royal Infirmary 
my ref: Poster2. Itr London Rd 
Derby DE1 2QY 
19th May, 1988 
To whom it may concern 
re: Response of the general public to a Health Education Initiative 
This is to acknowledge that Mr D. Gerrett is conducting research for the Southern Derbyshire 
Health Authority to determine the response to a health education initiative. 
The initiative is a visual display in the form of a poster which directs members of the public 
to identify themselves to the Pharmacist for information about prescription medication. 
The work is under the supervision of the Department of Social Administration, Nottingham 
University. 
If you have any questions concerning the study please do not hesitate to contact Mr D. 
Gerrett or Professor Willcocks at the University. The numbers are 0332-47141 x 2788 and 
0602-484848 x 3073 respectively. 
Yours sincerely 
MrA. M. S. Cullen - District Pharmaceutical Officer, SDHA 
ý% 
Professor A. J Willcocks Department of Social Administration 
Nottingham University 
Note 
*= Signatures have been scanned in. The content and format of the letter is original. 
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Protocol 1 
Protocol for the observational study 
PROTOCOL 
Researching the effect of a poster to promote pharmacist-patient interactions concerning 
prescription medication 
INTRODUCTION 
The Nuffield report 
1 states that community pharmacists should have greater involvement 
with members of the public (para 3.38) and that personal advice on the taking of medicines 
should be concentrated on those most likely to benefit from it (para 3.52). The District 
Pharmacy of the Southern Derbyshire Health Authority recognises the constraints and 
pressures of community pharmacy and that it is difficult to ascertain the prescription 
information needs of each and every individual. However, if patients were prompted to 
identify themselves to the pharmacist as having a problem then valuable time may be 
saved. With the guidance of Professor Willcocks of Nottingham University, the Department 
has produced a visual display in the form of a poster. It is hoped that the display will act as a 
filter by prompting those patients who do require prescription information to ask relevant 
questions of the pharmacist. A study of the general response to the poster is being 
conducted in randomly selected community pharmacies in Southern Derbyshire. 
METHODOLOGY 
The research entails recording patient-pharmacist interactions concerning prescription 
medication. A radio microphone will be used to tape conversations. A suitable area in the 
pharmacy will be identified where the researcher will be seated and able to note details of 
the interaction which are not recorded on tape (appendix 1). Details of the type of pharmacy 
and information from the pharmacist(s) present (appendix 2) will also be requested. Patients 
will be advised about the recordings and no attempt will be made to conceal the microphone. 
A note (appendix 3) will provide this information. The names of patients will be kept initially 
for the purpose of identifying duplication and for earmarking conversations after which such 
information will be erased. If the patient requests anonymity the transmitter will be switched 
off. 
Patients will ultimately be anonymous and pharmacies will not be identified by name. Only 
conversations concerning prescription medication will be recorded. 
Pharmacies will be randomly allocated a day in the week. The researcher will document a 
minimum of 74 patient-pharmacist interactions on this day, continuing into the next day if 
required to reach the minimum level. Similar data will be collected on the same day(s) a 
week later. Pharmacies will also be randomly chosen to display the poster on the first or 
second visit. 
ANALYSIS 
The data collected will be held on a computer accessible only by the researcher and will be 
analysed using thd'SPSS suite of programmes. 
RESULTS 
If requested, the information related to a particular premises will be available, in confidence, 
to that pharmacy only. 
(1) Pharmacy: A report to the Nuffield Foundation. The Nuffield Foundation: London 
1986 
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Appendix 1 
Confidential Questionnaire for Radio microphone 
1. Date I 18 2. Tape number side 4. case number 
5. Time 3. to............ side 6. Mic on 11 ]/off [2] 
7. Identification-gender M [1 ]! F(2] 8. Initial tape count "C" 
Name Final tape count 
INTERACTION 
9.1 Subject presents prescription(s)? Y [1] N [2] NS [3] 
2 .......... To 
P [1) A [2] DT [3] 0 [4] NS [5] 
3 Subject collects prescription(s)? Y [1] N [2) NS (3] 
4 .......... From 
P [1] A (2] DT [3] 0 [4] NS (5] 
5 ........ Prescription for subject? 
Y ill N (2] NS (3] 
6 R for person accompanying subject? Y [1j N [2] NS [3] 
7 
.............. 
Relevant discussion? Y [1] N [2] NS [3] 
8 Other ............................. 
Y [11 N [2) 
10. page <15 16-19 20-29 30-49 50-59 >60 >65 NS ? 
11. approx ethnic group Caucasian (1] Oriental [4] 
Afro/Caribbean [2] Other (Mixed) [5] 
Asian [3] NS (6] 
12. Notice seen? Y [1] N (2] NS [3] Not Applicable [4] ? [5] 
Discussion When R Notice Who 
With given? Seen Started 
13. INTERACTION PA DT 0 Ba A BaASPA DT 0 
1. Prescription 
rh, on 
123 
2. What is prescribed 
3. Specific problems 
4. What to do with it 
5. Side effects 
6. Supply 
6+ Path 
7. Minor medical 
8. Product 
9. Type Specific 
problem 
Where 
Notes on Prescription 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
P=Pharmacist B=Before 
A=Assistant a=as 
DT Disp Tech A=After 
O=Other 
B=Before S=Subject 
a=as P=Pharmacist 
A=After A=Assitant 
DT=Disp Tech 
O=Other 
Name ............................................................. 
14 Duplication Y [1] N (2] 0 131 NS [41 
Address ............................................................ 
................................................................... 
15 Within ward? Y Ill N- [21 NS [31 
Prescription item 
General Notes M=Male, F=Female, Y=Yes, N=No, NS=Not sure, NA=Not applicable, and, ? =don't know. 
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Research notes 
1. 
2. 
3. 
4. 
Appendix I (continued) 
Date 
Tape number 
to number 
Case number 
Is the premises a............ Single Independent 
Branch of a small multiple 
Company (7 to 20 outlets) 
Company (21 to 500 outlets) 
Company (over 1000 outlets) 
Other (specify) .............. 
5. Number of staff 
in dispensary 
Front shop 
special area 
a .............. 
b .............. 
c .............. 
P 
Label 
V] 
121 
[31 
[41 
151 
(101 
Qualifications 
A 
DT 
0 
6. Opening hours 
M F 
T S 
W S 
T 
7. Photo of the position of the poster. Y [1J/N [2]. 
8. Labels 
Propranolol tab Metronidazole tab Pondocillin tab Diazepam tab 
90 x 100mg 30 x 200mg 30 30 x 2mg 
I tds I tds 1 tds 1 tds 
g, Customers tend to come from? 
10. Position of nearest surgeries? 
Diagram of premises Indicating poster position, shelving, till(s), special areas, drawn to scale. 
General Notes 
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F 
Appendix 2 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
All information suaolied will be keat in the strictest Confidence 
Please complete the following questions which will help us determine whether the public's response to 
the display is related to a particular aspect of the premises and/or the experience of the pharmacist. 
Please circle the number in the box adjacent to your answer or write as appropriate. For example, if 
the premises has a "front shop" area of approximately 30 sq meters you would circle [2] in answer to 
Q1. 
ABOUT the PREMISES 
Q1 To enable us to categorise pharmacies by size, would you please indicate the approximate 
"front shop" floor area of the pharmacy as... 
"SmaII".... with a front shop floor area up to 25 sq meters [1] 
"Medium"... with a front shop floor area 25 to 50 sq meters [2] 
"Large".... with a front shop floor area over 50 sq meters [3] 
Not sure ................................................... [4] Don't know 
................................................. [5] 
Q2 What percentage of the overall income of the pharmacy comes from the activities of the 
dispensary? 
0 to 30% [1] 
30 to 50% [2] 
50 to 70% [3] 
70 to 90% (4] 
over 90% [5] 
Not sure [g] 
Don't know (7] 
ABOUT the PHARMACIST 
Q3 Please Indicate your Gender Male (1] Female [2] 
Q4 Your date of birth .... 
1.... / 19 
.... 
Q5 Please indicate where applicable, what total time (in years or fractions of a year) you have 
spent as a registered pharmacist in: 
(a) Community Pharmacy.... (years) (d) Academia 
... (years) 
(b) Hospital Pharmacy .... 
'(years) (e) A related field ... (years) 
(c) Industry .... (years) 
Q6 Is your relationship with this pharmacy as... 
Manager Ill 
Proprietor (2) 
Locum 13] 
Other 4 
If other (please specify) ................... 
Q7 In the capacity mentioned in Q6 above, how long have you been involved with this particular 
pharmacy? .............. (years) 
Please turn to the second page and complete Q8 to Q23. 
Questions 8 to 23 relate to pharmacists thoughts on patients counselling. As initial responses are 
required, this section of the study can't be given to participants until after the two data collection visits. We hope you will understand and bear with us in this matter. 
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Appendix 3* 
Dear Customer 
In order to make your visit to the 
Chemist more worth-while, the 
Southern Derbyshire Health 
Authority is looking into the sort 
of information you require. Many 
discussions take place so the 
Pharmacist is wearing a recording 
device. Any information collected 
will be kept in the strictest 
confidence and no customer will 
be ultimately identifiable. If you 
have any doubts or worries please 
do not hesitate to talk to the 
pharmacists concerning the 
recording device as it may be 
switched off. 
Thank You 
Note 
The size of the notice has been reduced to 71 %of the original A4 to enable printing 
within the margins dictated for thesis submission. 
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A1.2.4 Exclusions 
It was noted In section 4.5 page 107, that the three randomly chosen pharmacies owned and 
managed by Boots the Chemist Ltd did not participate in the main observational study. 
Similar exclusions applied to the radio microphone research conducted by Smith. 396 Prior to 
randomisation, a meeting was arranged between the author and Mr Donald Crosslands, then 
superintendent pharmacist in charge of the study pharmacies. The protocol (section A1.2.3, 
page 173) was discussed and, unfortunately, no agreement was reached which would have 
enabled the study to take place, although, as a fall back position use of the schedule- 
structured interview method (section A1.1, page 159) was permitted. The result of this 
conversation was conveyed In Letter 4 (page 181). 
Of the 24 remaining CPs, four were approached but did not participate the in the 
observational study. One male was under pressure from the Department of Inland Revenue 
for tax evasion and, before the end of 1988, suffered a stroke. Another pharmacy was 
entirely staffed by locum CPs and there was no guarantee that the same CP would be 
available for two consecutive weeks. This was the case on three separate visits to negotiate 
participation in the observational study. One male CP in charge of the dispensary was 
restricted by his proprietor superintendent from participating and one female CP dispenser 
simply refused. 
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Letter 4 
Letter confirming non-participation of Boots the Chemist Ltd outlets in the 
observational study 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
your ref: 
our ref: Boots2. Itr 
Mr D. M. Crosslands 
Superintendant Pharmacist 
The Pharmacy Superintendents Office 
The Boots Company PLC 
Nottingham, NG2 3AA 
Dear Mr Crosslands 
re: Health Education Initiative Study 
Drug Information Centre 
Derbyshire Royal Infirmary 
London Rd 
Derby, DE1 2QY 
31st May, 1988. 
96-47141 x 2788 
Thank you for our discussions of the 12th April, 1988. We were considering my request for 
permission to approach Boots managers concerning the effect of a health education 
initiative. The initiative, as you recall, is in the form of a poster which directs members of the 
general public to consult the Pharmacist if they have a question about prescription 
medication. A copy of the particular poster which will be on display is attached (appendix 1*). 
I would ask you not to present this final format to widely until all the data has been collected 
as it may introduce a further variable which would be difficult to analyse. Data collection will 
be complete by December this year. 
Please find attached (appendix 2) the addresses of the three establishments of the "large 
community pharmacy company" which were selected in the random sample of Pharmacies 
in Southern Derbyshire. I understand that you might be able to inform these branches about 
the research but that the final decision as to whether they participate in the study will be left 
to each manager. Also, that the technique of assessment will be by questionnaire not by 
radio microphone. Would you please confirm that I have your permission to approach each 
of the pharmacies concerned. 
The results of the study will be forwarded to you in due course. 
Yours sincerely 
Mr D. Gerrett - Staff Pharmacist Health Education, SDHA 
cc Mr A. M. S. Cullen - District Pharmaceutical Officer, SDHA 
Professor A. J. Willcocks - Nottingham University, Department of Social Administration 
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Appendix 2 
Boots the Chemist Ltd 
507 Nottingham Rd 
Chaddesden Rd 
Derby 
DE26NA 
Boots the Chemist Ltd 
122-124 Bath St 
Ilkeston 
Derbyshire 
DE7 8FF] 
Boots the Chemist Ltd 
5 Shardlow Rd 
Alvaston 
Derby 
DE2 0JG 
Notes 
*= Appendix I was poster C, page 213 
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A1.2.5 Sample 
In table 11 immediately following this section, Community pharmacies who participated in the 
observational study have been arranged in alphabetical order from one to 20. Non- 
participants are similarly arranged from 21 to 27. Details of the CP in charge of the 
dispensary during the observational study or to whom advances to participate in the research 
were made, have been listed. Inspection indicates a spread in each category as would be 
expected from a random sample. Section A2.2.1.1-4 analyses the details in relation to 
responses to an attitudinal survey and the findings of the observational study. Of the 20 
pharmacies participating in the observational study 11 (55.0%) were located outside the 
Derby city boundary. This figure can be compared to 57 (54.3%) in the sample frame of 105 
pharmacies who were similarly located and 301,403 (58.4%) for the population resident in 
this area as of the 1981 Census. This figure was not calculated on mid-year estimates as the 
Southern Derbyshire boundary cuts a West Derbyshire ward, and a multiplication factor of 
0.353 for the population in this ward to account for the population resident within the borders 
of the Southern Derbyshire Health Authority was only known for Census data. 
Clearly, the balance of participants in the observational study were representative of 
community pharmacy in Southern Derbyshire and at a general level, the population they 
serve. The prescription medication advisory activity of the study CPs, when divided into 
proactive and reactive groups according to section A3.1.2 and by their advisory activity as a 
percentage of preparation events (section A3.1.3.1, page 249), was not found to be 
statistically related to CPs' age, whether they were managers or proprietor/managers, or 
whether the pharmacy was an independent or part of a multiple chain, proximity to the 
surgery, or whether located within the boundary of Derby city (table 12, page 185). However, 
if proactive and reactive types are considered ordinal in the sense of decreasing advisory 
activity, similarly, that there is an order to managers and proprietor/managers and proximity 
to the surgery, then the common Gamma values of -0.71429 and Somers' D of -0.41667 
(table 12, page 185) provides evidence of ordinal associations. These figures imply that as 
CPs have greater personal involvement in their pharmacies or the pharmacy is located 
further from the surgery, advisory activity increases. 
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APPENDIX 2 SUPPORTING STUDIES 
A2.1 Foreward 
This section considers two separate studies which support the main observational study in 
appendix three. Each section is presented as an individual study with an aim, specific 
objectives, method, results and summary. In each case responders and non-responders are 
compared for relationships with the available epidemiological variables. Analysis is 
presented which tests for links between responses and epidemiological variables. 
Section A2.2 combines the results of four separate episodes of data collection into an 
analysis of the attitudes of specifically CPs towards advice. The studies include two piloting 
exercises and two attitudinal studies, 1987 and 1988. 
Section, A2.3 details the development of four posters advocating the CP as a source of 
advice. Quantitative analysis of customers' opinions of each poster leads to the selection of 
a single display which is most likely to effect their advise seeking behaviour. 
186 
A2.2 Attitudes of community pharmacists 
A2.2.1 Aims, objectives, method 
This section concerns the aims, objectives and method used in studies of CPs' attitudes to 
the provision of advice. 
Aim To differentiate CPs by their attitudes to the provision of advice and relate CPs' 
attitudes to direct observations of their activity. 
Specific objectives of research conducted 
1. To develop a set of statements which differentiate and determine CP's attitudes towards 
patient counselling. 
2. To examine associations and differences between CP's attitudinal responses and 
epidemiological variables. 
3. To compare the attitudes of CPs' participating in the observational study with those of the 
remaining sample frame. 
4. To compare responses with observed activity. 
Method 
Commencing in January 1987, an attitudinal questionnaire was developed which would fulfil 
the aim and objectives of the study. Sixteen statements concerning CPs' positive or negative 
attitudes towards the provision of advice were designed and responses investigated. Positive 
attitudes were; to consider the provision of such advice as a worthwhile professionally- 
orientated activity all CPs should undertake proactively whatever the circumstances. Details 
of the piloting process are given in section A2.2.2. The final version was given to CPs on two 
occasions, the 1987 and 1988 attitudinal studies. 
As the study aim was to determine absolute differences in attitudes to the provision of advice 
as a professional activity in a business setting, an operational decision was made to first 
exclude from quantitative analysis statements where over 20% of respondents were 
undecided. Following this, responses from individuals who were undecided for more than 
25% of the remaining statements were excluded. The common methodological practice of 
scoring attitudes, summing, comparing distributions for reliability then ranking respondents 
and determining correlations with demographic and activity variables was not considered 
acceptable as outlined in chapter four section 4.6 (page 113). In addition, a short readily 
completed questionnaire was thought essential to achieve a usable response. Thus, 
respondents were not asked to report the difficult task of quantifying the interval between, for 
example, agree and strongly agree which would have enabled individuals' responses to be 
weighted and arguably produced interval level responses. Having indicated the statistical 
stance taken, analysis of was limited to ordinal associations such as Gamma 407 and Somer's 
d`408 
The 1987 attitudinal study's sample frame consisted of the CPs associated with the 95 
pharmacies situated within the borders of the Southern Derbyshire Health Authority, having 
187 
contracts with the Derbyshire Family Practitioner Committee on the 18th May 1987. Over the 
next four months, each pharmacy was visited by the author who introduced himself to the CP 
in charge of the dispensary at the time of the visit as a colleague based at the Derbyshire 
Royal Infirmary with an interest in health education who was seeking their thoughts on patient 
counselling. Attitudinal questionnaires and a stamped self-addressed envelope were left with 
the CP seen on the day of the visit who was asked to distribute additional copies to all other 
CPs associated with the dispensary with the exception of 'one-off locums. Details of the 
pharmacy, the CP seen and CPs associated with the pharmacy were noted. 
Analysis of 1987 results was in four parts. First, personal and workplace details of 
respondents and non-respondents seen during the data collection visit were compared. 
Second, statements were altered to agree with the attitude of the majority of respondents to 
provide an overall picture of the attitude of CPs. Third, opposites of attitude were 
investigated for association with demographic variables. Fourth, internal correlations were 
tested using association measures for variables with ordered categories. 
The 1988 attitudinal study's sample included the 20 pharmacies participating in the 
observational study having contracts with the Derbyshire Family Practitioner Committee on 
the 17th May 1988. Fourteen of these were included in the 1987 attitudinal study. The 
random sampling procedure and details of the pharmacies and CPs involved in this study are 
provided in sections A1.2.1 to A1.2.5. 
Analysis of the 1988 attitudinal study was in five parts. First, personal and workplace details 
of CPs participating in the two attitudinal studies were compared. Second, absolute attitude 
responses were similarly compared and reliability tested by investigating changes in attitude 
with time using responses from the 14 CPs common to both attitudinal studies. To determine 
any divergence in attitude between the 1987 and 1988 attitudinal study groups, the 
distributions of responses for both studies were also compared. Third, the attitude responses 
of the 20 respondents were investigated for dependence and association with demographic 
variables. Fourth, a valid basis for interpretation of the direction and strength of absolute 
attitudes was provided by correlation with observed activity. Fifth, CPs' estimated activity 
was validated by correlation with observed activity. The former estimate was then used to 
interpret responses for those CPs' common to both attitudinal studies and the results of the 
1987 study. 
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A2.2.2 Pilot 
This section deals with the piloting process used in the development of the attitudinal 
questionnaire. Initially the available literature is described and Inspected for themes which 
may divided CPs by their attitude to counselling. The development and piloting of statements 
tapping these themes is then reported and finally summarised. 
Only one study is available which reported the frequency of pharmacists responses to 
attitudinal statements on generic patient counselling. 554 The sample frame consisted of 
pharmacists in New South Wales, Australia from which a total of 1364 replies, representing 
68% of all pharmacies surveyed, were received. Inspection of the raw data revealed five out 
of 29 statements where responses were divided by a minority of greater that 20%. These 
could be grouped under three themes, professionalism, remuneration and the practical 
aspects of counselling. Table 13 shows the specific statements and frequency of responses 
reported by the study under these three headings. 
Table 13 
Pharmacist's attitudes to couns elling 
Statement Frequency of response* 
1 2 3 4 5 
Professionalism 
I am worried about contradicting doctors 21 257 186 659 241 
Remuneration 
I am not paid for counselling 99 215 120 525 405 
Practical aspects of counselling 
There is a lack of feedback from people 31 419 218 560 136 
counselling may not be necessary 25 377 176 532 254 
should not counsel without adequate medical history 115 436 195 510 108 
Note 
*= Category of response 1=Strongly agree, 2=Agree, 3=Uncertain 4=Disagree, 
5=Strongly disagree. n=1364. 
Acknowledgement: selected results from Oritz M, Thomas RE, Walker WL, Beed TW. 554 
The study assumed interval level responses, summed scores and reported a small but 
statistically significant positive correlation between attitudes and stated behaviours. No 
correlation with observed activity was reported. 
An assumption was made that CPs in the attitudinal studies would be divided by statements 
which tapped these same three themes. Sixteen statements (Q8 to Q23, first pilot table 15, 
page 193) were composed and positioned after seven questions asking for epidemiological 
and factual information plus one requesting a subjective estimate of counselling activity 
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(form 3, page 194). As the objective of the statements was to divide respondents by their 
absolute attitudes, an operational decision was taken to use the term 'undecided' as the 
middle option rather than 'uncertain' as used by Ortiz. It was felt the former term was more 
definitive and that the latter was more likely to lead respondents with no immediate response 
to waver and possibly record an unintentional absolute attitude. The statements were 
randomly assigned a sequence and the total questionnaire piloted with seven hospital 
pharmacists and one CP on the 26th March 1987. The CP practised outside the sample- 
frame area for the attitudinal studies. 
Four statements (table 15; Q8, Q15, Q20, Q23) appeared likely to divided CPs and were 
incorporated in a second pilot. Three statements produced absolute responses (QA, QB, QC) 
and were discarded. Two further statements (Q11, Q12) were associated with absolute 
attitudes, however, an exaggerated response may have been produced by the bias of 
hospital pharmacists who are salaried and have a captive audience to advise, thus these 
questions were passed through, after improving their clarity, and re-piloted with a more 
homogeneous sample. Notice was taken of the implication of this result and responses in the 
full study from CPs with hospital experience were compared with their colleagues. Two 
statements concerned CPs and postgraduate education (Q14a, Q14b). Five respondents 
were undecided with the second statement which was discarded and the first was 
incorporated in the second pilot. Statement Q19 was altered for the second pilot to include a 
measure of how much information CPs felt GPs should provide patients. Two statements 
(Q21 a, Q21 b) concerned the availability of CPs for advice. As two respondents were 
undecided with the second statement and the separation was not as even, the first statement 
was used in the second pilot, although, 'continuously' was altered to 'always' as it was felt to 
be less suggestive that 'availability' was synonymous with 'burden'. Three respondents were 
uncertain for statement Q18 and only the CP disagreed. The context was altered to examine 
whether successful communicators could be 'made' by the currently popular postgraduate 
educational programmes in communication skills or whether it was a matter of genetics. A 
second related question (Q13) was added in the second pilot to determine whether 
respondents felt such programmes were in any way effective. Discussion with respondents 
after completion of the first pilot indicated that all questions were clearly understood and 
answered within a framework of issues recognised by the researcher and related to current 
literature and debate; however, concern was noted as to whether a mechanism for 
remuneration of counselling activity could be devised. Statement Q10 was reformulated to 
include "a payment based on individual activity and re-piloted. 
Twenty-one CP who indicated they would attend a one day seminar on patient counselling, 
held in northern Wales on Sunday 12th April 1987, were mailed the second pilot 
questionnaire with a reply self-address envelope prior to the event. All practised outside the 
sample-frame area for the main attitude study. Fourteen responses were received (66.6%) 
and all respondents attended the seminar. Non-responders included four males and three 
females who failed to attend on the day. One respondent defaulted on two statements, 
190 
commenting that for Q19 'Both should be regarded as equal' and for Q21 that 'If this 
condition arises, then ample remuneration for a second pharmacist should be made 
available'. As both statements divided the remaining respondents with few undecided, they 
were not altered In light of these isolated comments. Six respondents were undecided for the 
revised version of Q10 and were specifically approached during the seminar to discuss this 
result. The revised statement was perceived to have two dimensions. First, whether there 
should be a payment for the advice service CPs provide and second, the mechanism of 
assessment. Discussion lead to the additional statement 'Pharmacists should be paid for the 
counselling service they provide' which would precede a revised Q10, 'If pharmacists 
received a payment for counselling, the amount involved should be calculated on a sliding 
scale which depended on the number of patients counselled'. Although statements Q13 and 
Q14 showed consistently absolute responses, they were included in the final version as 
markers to indicate whether respondents had read the statements and were discriminating in 
their responses. No other difficulties were expressed for either completion of the 
questionnaire or interpretation of the statements and the pattern of responses was consistent 
with the first pilot; thus, the second pilot with these revisions was used in both 1987 and 1988 
attitudinal studies (table 20). 
To determine whether the statements reliably tapped diverse but entrenched attitudes, a 
follow-up using the second pilot questionnaire was conducted after seven months. As in the 
second pilot, nineteen CP practising outside the sample-frame area for the main attitudinal 
study were mailed the second pilot questionnaire with a reply self-addressed envelope prior 
to a one day seminar on patient counselling held in northern Wales on Sunday 15th 
November 1987. Thirteen responses were received (68.4%) and all respondents attended the 
seminar. Table 19 indicates the epidemiological similarities of the second pilot and follow-up 
study respondents. Table 15, page 193, indicates the similarity of distributions for each 
attitudinal statement, with the sole exception of Q10 where there was a distinct shift in 
attitude with time. 
In summary, published results of CPs' attitudes to patient counselling served as a basis for 
likely themes which would divide respondents into two groups. Initial piloting of statements 
tapping these themes was followed by a more extensive second pilot of revised statements 
which resulted in slight modifications but only major revision of one statement. A measure of 
reliability was indicated by the similarity of the second pilot responses to a matched follow-up 
group. An exception was a statement concerning the mechanism of payment for individual 
CP's prescription medication advisory activity. Empirical validity was confirmed in 
discussions between the researcher and respondents concerning the attitudinal basis of their 
responses. 
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Table 14 
Comparison of piloting samples* 
Variable Second 
Pilot n=14 
Follow-up 
n=13 
Gender 
age 
Experience in community pharmacy 
relationship with pharmacy. 
Manager 
Proprietor 
Other 
Tyre of outlet 
Male 
Female 
38 ± 13 (22-65) 
14 ± 14 (<1-42) 
3 
5 
6 
95 
58 
45 i 14 (21-64) 
18 ± 16 (<1-40) 
0 
4 
9 
Single independent 7 7 
Branch 1-7 outlets 0 2 
Branch >7<1000 outlets 2 0 
multiple >1000 outlets 4 3 
other 0 1 
Notes 
*= Time variables in years at the time of the study, i one standard deviation with the 
range given in brackets. 
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Form 3 
Form used for 1987 and 1988 attitudinal studies 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
III 
QUESTIONNAIRE for PHARMACISTS 
This questionnaire is CONFIDENTIAL. 
Please complete the following questions concerning patient counselling by circling the 
number adjacent to your answer or indicating as appropriate. Confidential information has 
been requested in order to avoid future duplication. 
Q1 Please indicate your marital status? 
Q2 Please indicate your title? 
Q3 What is the initial of your surname? [] 
Q4 What is your date of birth? / .... / 19 .... 
Q5 In which type of pharmacy do you currently work? 
Single 1 
Married 2 
Other 3 
Dr 1 Mr2 
Mrs 3 Ms 4 
Miss 5 
Single independent 1 
Branch of small multiple [1 to 7 outlets] 2 
Branch of multiple [>7 but <1000 outlets] 3 
Branch of multiple [>1000 outlets] 4 
Other 5 
If other, please specify .................. 
Q6 As a registered pharmacist, What total time - if at all- have you spent in: 
(a) General practice (retail) pharmacy? .......... (years) 
(b) Hospital pharmacy? .......... (years) 
(c) Industry? .......... (years) 
(d) Any other related field? .......... (years) 
Q7, If counselling is defined as "the provision of any advice given to a patient concerning 
prescription medication", then - 
- On average, during general practice (retail) pharmacy business hours, what 
percentage of available time do you estimate you spend "counselling" patients? 
.......... % 
ANY COMMENTS: 
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Please complete 08 to Q23 by circling the number which corresponds to your INITIAL 
RESPONSE. Indicate whether you; strongly agree (1), agree (2), are undecided (3), disagree 
(4) or strongly disagree (5) with the statements below. 
Strongly Undecided Strongly 
Agree Agree Disagree Disagree 
Q8 If everyone consulted a pharmacist when collecting 
dispensed medicines, health care would improve 
overnight. 
Q9 Pharmacists should be paid for the counselling service 
they provide. 
Q10 If pharmacists received a payment for counselling, the 
amount involved should be calculated on a sliding scale 
which depended on the number of patients counselled. 
Q11 By continuing to counsel patients free of charge, 
pharmacists will do the profession a disservice. 
Q12 Patients who require counselling are expected to ask for 
advice. 
Q13 Training pharmacists in communication skills makes them 
better counsellors. 
Q14 Pharmacists repeatedly communicating incorrect 
Information should undertake post-graduate education. 
Q15 It is difficult for a pharmacist to identify those patients who 
need counselling. 
Q16 There are not enough general practice pharmacists to 
counsel adequately those patients who require advice. 
Q17 It is reasonable for pharmacists to manage a pharmacy 
and still maintain their pharmaceutical knowledge. 
Q18 Good communicators are born not made. 
Q19 General Medical Practitioners should be the patients' 
main source of drug therapy Information. 
Q20 Financial reward should be secondary to professionalism. 
Q21 Being always available to talk to patients in a pharmacy i: 
unrealistic. 
Q22 Patients expect too much from the pharmacist. 
Q23 Supervision of dispensing is the pharmacist's first priority, 
COMMENTS:,,,, 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
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A2.2.3 Results 
This section details the results of the 1987 and 1988 attitudinal studies in the order listed in 
subsection A2.2.1 (page 187) under the heading method. 
Analysis of 1987 results. 
Ninety-five addresses were listed as having pharmacy contracts with the Derbyshire FPC on 
the 18th May 1987. One was a pharmacist, not a pharmacy, who asked to be placed on the 
register in order to receive information bulletins, two pharmacies had ceased to trade and 
one could not be located. Of the 91 pharmacies remaining, 71 responses were received from 
cps in charge of the dispensary at the time of the visit. Analysis for generalisability of 
specific variables included comparison of the distributions of the CPs seen who responded 
and those seen who did not. No dependence on gender or status in relation to pharmacy 
management was demonstrated. Similarly, no association was noted between the type of 
pharmacy, independent or multiple and whether a response was received (table 16, page 
199). Excluding 'one-off locums, the 91 pharmacies were associated with 114 CPs of whom 
89 (78%) replied, representing 76 pharmacies. Exclusions included; three respondents who 
were undecided for greater than 25% of remaining statements and one pre-registration CP 
leaving 85 responses for analysis. Of the 85, comparison of the distributions of the 66 
respondents who were seen and responded and the 19 who were not seen but responded 
showed no dependence on gender, status, age or type (table 17, page 199). These results 
indicate that the results of the 85 respondents may be generalised to the sample frame for 
these variables. 
Using the frequency of responses from the 85 respondents, the revised second-pilot 
statements were reoriented to reflect the majority view. Statements were listed under the 
three sub-themes of; (1) professionalism, (2) remuneration and professionalism and (3) 
practical aspects of advice (table 18, page 200). Over 20% of the 85 respondents were 
undecided for statement Q10 and it was excluded from further quantitative analysis. 
Qualitative inspection shows a majority belief that benefits were derived from advice and 
that such 'free' counselling promoted the profession. They felt this activity should be 
remunerated but were undecided as to whether payment should be related to the number of 
patients counselled. Respondents considered it was reasonable to manage a pharmacy and 
maintain their knowledge base with mandatory post-graduate education for those who fail to 
communicate correct information. Training in communication skills was considered effective 
in promoting such counselling skills. Finally, supervision of dispensing was seen as the CP's 
first priority. 
By definition, CPs were divided if more that 20% were in a minority. Divisions occurred in the 
practicalities of whether CPs or patients should Initiate discussions on prescription 
medication and the difficulties for CPs in identifying those to counsel. Community 
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pharmacists were split as to whether it was realistic for them to be always available for 
discussion and whether good communicators were born or made. General medical 
practitioners were not necessarily seen to be the patient's main source of advice and it was 
undecided whether financial reward should be secondary to professionalism. 
Piloting indicated a strong bias for two statements Q13 and Q14 which were included in the 
1987 and 1988 attitudinal studies to act as markers enabling isolation of indiscriminate 
respondents. A similar bias was seen in these studies with no disagreements received from 
the 1988 attitudinal study providing confirmation of the reliability of the results. Only one 
respondent disagreed with the majority view for both statements in the 1987 attitudinal study. 
Six other disagreements were received. As the numbers were small and the same 
individuals were not common for both statements none of these respondents were excluded. 
Only one statement, Q10, was excluded as greater than 25% of respondents were 
undecided. The independence of absolute responses to the remaining 15 statements to the 
specific variables investigated for generalisabilty was analysed using the chi-square test. 
Due to observations during piloting, any divergence of attitude between CPs with previous 
hospital pharmacy experience and their colleagues was also investigated (table 19, page 
201). Relationships between attitudinal response and respondent's ages were tested for 
significance using the Mann-Whitney U test (table 20, page 202). The non-parametric 
equivalent of Student's t-test was used as the distribution of the population could not be 
assumed normal for independent samples (figure 6, page 27). A second ordinal variable, 
respondents' estimates of the time spent counselling patients on prescription medication was 
investigated using Gamma 407 and the non-parametric analogue of the traditional regression 
coefficient Somers V408 (table 25, page 207). 
Analysis of 1988 results. 
In comparing the 1987 and 1988 attitudinal study groups, CPs in the sample frame of the 
latter were treated as a unique group and the details of those respondents common to both 
studies were deleted from the former study. Thus, details of the 20 CPs who participated in 
the latter study were compared with those of the 1987 attitudinal study. Of the 20,13 were 
common to both studies and replied, one failed to respond and six were not able to 
participate in the second study. As the 1988 attitudinal study included managers who were 
also proprietors and managers, details of dispensers and locums were also excluded from 
the 1987 attitudinal study. The distributions of these populations were comparable in terms of 
gender, status, type, age and experience in community and hospital pharmacy (table 21, 
page 203). 
Of the fourteen, 1988 attitudinal study participants common to both studies 13 completed the 
attitudinal questionnaire on both occasions. The sum change in absolute attitude over the 15 
statements was not greater than t2 for any participant and appeared unrelated to observed 
prescription medication advisory activity (table 22, page 204). McNemar's test for changes in 
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absolute attitude over the period failed to reach significance for any statement. Each 
statement's absolute response distribution was found to be independent of study when 1987 
and 1988 attitudinal responses were compared (table 23, page 205). 
Absolute responses to the 15 statements to the specific variables previously investigated for 
generalisabilty plus hospital pharmacy experience was again analysed using the Mann- 
Whitney (table 20, page 202) and Fishers exact test (table 24, page 206). 
As a valid basis for interpretation of the direction and strength of absolute attitudes relative 
to the provision of advice, two bands of respondents' activity were chosen to reflect the 
proactive and essentially passive or reactive groupings found in the observational study. In 
this respect, results for pharmacy number nine were included in the reactive grouping as the 
analysis concerned advisory activity rather than CPs' reaction to the provision of advice. In 
other words, one respondent in the observational study was noted to be proactive in giving 
advice but the rate of advice was less than 6.2% of possible prescription events. Values 
below 6.2% were generally associated with reactive CPs who responded to requests for 
information rather than initiated such activity. The figure of 6.2% was used as a benchmark 
to divide CPs' advisory activity into high and low groupings (table 25, page 207). 
Level three observed prescription medication advisory activity of 'preparation events' (section 
A3.1.3.1, page 249) was correlated with respondents' estimates of time spent providing such 
advice for the 13 CPs common to both 1988 and 1987 attitudinal studies. A modest value 555 
of 0.56628 for Pearson's correlation coefficient provided a valid indication of respondents' 
capacity to estimate their own activity. The correlation was statistically significant with a 
probability of 0.043. Comparison of 1988 and 1987 means for the respective distributions of 
estimated time spent counselling shown no significant difference (students-t test, F= 3.44, 
p=0.022, separate variance, t=0.30, two-tailed p=0.763). Estimates of the percentage of time 
spent counselling were then used to interpret the direction and strength of absolute attitudes 
relative to activity for those CPs common to both attitudinal studies and the 1987 study (table 
25, page 207). 
1ý1 
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Table 16 
Independence of responding to the 1987 attitudinal study and selected 
variables 
Variable analysed for independence 
n=91 Gender* Statust Typet 
Response MF M/P M0 IM 
Responders 51 20 29 31 11 33 43 
Non-responders 13 7 884 87 
Chi-square§ 0.0984 0.2439 0.1774 
Significance 0.7538 0.8852 0.6736 
Notes 
Test for an association between the 71 CPs seen during the visit who responded, the 
20 seen who did not respond and the proportion of Males = M, Females = F. 
t= Test for an association between the 71 CPs seen during the visit who responded, the 
20 seen who did not respond and the proportion of Manager proprietors = M/P, 
Managers = M, Dispensers or locums = 0. 
$= Test for an association between receiving a response, whether from the CP seen or 
not, and the type of pharmacy the CP was involved with, Independent =I or Multiple = 
M. Responders include the 71 CPs seen during the visit who responded plus the 5 
CPs who were not seen represented their pharmacies as the person seen has not 
responded. No response at all was received from 15 pharmacies. 
§= Chi-square value calculated in accordance with the statistical methods described in 
section 4.6, page 113. 
Table 17 
Independence of type of responder and selected variables 
n=85 Variable analysed for independence 
Gender* Statust Age$ Type§ 
Responder MF M/P M0 Mean Cases IM 
Rank 
Responder seen 47 19 26 30 10 43.57 66 7 12 
Responder not 12 74 10 5 41.03 19 27 39 
seen 
Chi-square° 0.1512 2.609 0.3956 0.0028 
7 
Mann-Whitney U 
Significance" 0.6974 0.271 0.6924 0.9576 
2 
Notes 
= Test for an association between the 66 CPs seen during the visit who responded, and the 19 
who were not seen but respond and the proportion of Males = M, Females = F. 
t= Test for an association between the 66 CPs seen during the visit who responded, and the 19 
who were not seen but respond and the proportion of Manager proprietors = M/P, Managers = 
M, Dispensers or locums = 0. 
$_ Test for age differences between the 66 CPs seen during the visit who responded, and the 19 
who were not seen but respond. 
§= Test for an association between the 66 CP seen during the visit who responded, and the 19 
who were not seen but responded and the proportion of Independent =I and Multiple =M 
pharmacies the CPs were involved with. 
O= Chi-square value ° 
¶= Mann-Whitney U calculated as aZ value corrected for ties. 
"" = Chi-square probability. Mann-Whitney U two-tailed probability. 
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Table 18 
Frequency of response to statements for the 1987 and 1988 attitudinal 
studies* 
Strongly Undecided Strongly (Missing) 
Response ,l Agree Agree Disagree Disagree 
Statement 
ýý 
Q10t If pharmacists received a payment for counselling, the 6 24 24 24 61 
amount involved should be calculated on a sliding 13691 
scale which depended on the number of patients 
counselled. 
(1) Professionalism 1 
Q14 Pharmacists repeatedly communicating incorrect 13 11 49 20 
information should undertake post-graduate education. 0 20 3 14 30 
Q19t General Medical Practitioners should [not] be the 5 16 13 40 11 0 
patients main source of drug therapy information. 124 13 0 
Q22 Patients [do not] expect too much from the pharmacist. 29 14 47 13 1 
034 13 0 
(2) Remuneration and Professionalism 1 
Q9 Pharmacists should be paid for the counselling service 
they provide. 4 11 10 25 35 0 11378 
Q11 By continuing to counsel patients free of charge, 
pharmacists will do the profession a[ ]service. 45 14 43 19 1 121 10 6 
Q20t Financial reward should be secondary to 
professionalism. 6 22 8 39 10 2 
3 034 11 2 Q8 
Practical aspects of PMA 1 
If everyone consulted a pharmacist when collecting 
dispensed medicines, health care would improve 0 16 17 41 10 0 
overnight. 044 10 2 
0 
Q12t Patients who require counselling are [not] expected to 
ask for advice. 0 24 9 42 80 
051 11 3 
Q13 Training pharmacists in communication skills makes 1 
them better counsellors. 037 47 28 
004 11 50 
Q15t It is [not] difficult for a pharmacist to identify those 
patients who need counselling. 2 29 17 36 11 
081 10 1 
Q16t There are [] enough general practice pharmacists to 
counsel adequately those patients who require advice. 4 22 15 39 5 
16580 
Q17 It is reasonable for pharmacists to manage a pharmacy 
and still maintain their pharmaceutical knowledge. 379 55 10 
122 14 1 
Q18t Good communicators are [made not born]. 
6 19 12 35 12 
03791 
Q21t Being always available to talk to patients in a pharmacy 
is [ ]realistic. 10 20 0 44 11 
:ý 18470 
Q23 Supervision of dispensing is the pharmacist's first 
priority. 2 14 8 34 26 
Notes 03296 
"_ Statements have been altered to reflect the views of the majority of respondents for the first 
study. Alterations from the original questions (form 3) ar e given in brackets [ ]. Statements 
concerned the main theme of provision of advice but have been arranged under the three 
sub-themes of (1) professionalism; (2) remuneration an d professionalism; and, (3) practical 
aspects of PMA. Responses for each statement have be en arranged from strongly disagree 
to strongly agree with the statement indicated. Frequency of response for each statement for 
the 1987 attitudinal study (n=85) are listed above those for the 1988 attitudinal study (n=20). 
No missing values were reported in the latter study. 
t= More than 20% of respondents disagreed with the majority response to statements 
Q12, Q15, Q16, Q18, Q19, Q20 and Q21. Statement 10 was excluded as >25% of respondents 
' were undecided., 
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Table 21 
Independence of 1987 and 1988 attitudinal study responders and selected 
variables 
Variable analysed for independence 
Gender* Statust Typet Age§ Experiencell 
Mean Community Hospital 
Responder MF M/P MIM Rank Cases Mean Cases Mean Cases 
Rank Rank 
1987 Responder 28 12 21 19 17 23 31.0 40 32.15 40 7.39 9 
1988 Responder 17 38 12 7 13 29.5 20 27.20 20 10.81 8 
Test% 0.9000 0.4088 0.0781 -0.3136 -1.0364 -1.4833 
Significance** 0.3428 0.5226 0.7799 0.7538 0.3000 0.1380 
Notes 
*= Association between the 40 proprietor/managers or managers seen during the 1987 
attitudinal survey who responded only to the 1987 attitudinal study, the 20 respondents to the 
1988 attitudinal study and the proportion of Males = M, Females = F. 
t= Association between the 40 proprietor/managers or managers seen during the 1987 
attitudinal survey who responded only to the 1987 attitudinal study, the 20 respondents to the 
1988 attitudinal study and the proportion of Manager proprietors = M/P, Managers = M, 
Dispensers or locums = 0. 
$= Association between the 40 proprietor/managers or managers seen during the 1987 
attitudinal survey who responded only to the 1987 attitudinal study, the 20 respondents to the 
1988 attitudinal study and the proportion of Independent =I and Multiple =M in which they 
were employed. 
§= Differences in age (years) between the 40 proprietor/managers or managers seen during the 
1987 attitudinal survey who responded only to the 1987 attitudinal study, the 20 respondents 
to the 1988 attitudinal study. 
= Differences in years of experience both as a CPs and In hospital practice between the 40 
proprietor/managers or managers seen during the 1987 attitudinal survey who responded only 
to the 1987 attitudinal study, the 20 respondents to the 1988 attitudinal study. 
¶= Chi-square value. Time related variables tested with Mann-Whitney U calculated as aZ value 
corrected for ties. 
**= Chi-square probability. Mann-Whitney U two-tailed probability. 
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Table 22 
Change in attitude with time* 
Pharmacy PMAt Reactivet Change§ Absolute change II 
Proactive 
3 .0r -6.00 -1.00 2 1.3 r -6.00 -2.00 
10 2.6 
17 2.6 
19 3.3 r +1.00 -1.00 
9 3.7 p +5.00 +2.00 
1 4.5 
13 4.7 r +1.00 +1.00 
12 5.0 r +1.00 0.00 
Essentially 16 5.7 
Reactive 7 6.2 r 0.00 0.00 
Essentially 6 6.7 p -2.00 -1.00 
Proactive 15 7.9 
11 9.6 
18 11.8 p -4.00 -2.00 
4 13.0 p -5.00 -1.00 
5 16.0 p 0.00 0.00 
14 17.8 p +3.00 +1.00 
20 25.1 
8 38.6 p -2.00 -1.00 
Notes 
*= Pharmacies listed in order of prescription medication ad visory activity. Thirteen of a 
possible 14 returned pre and post observational study questionnaires. 
t= PMA as a percentage of preparation events. 
$= Reactive as defined in section A3.1.2. 
§= Change on the five point questionnaire scale. 
= Absolute change of attitude agree E--* disag ree, excluding undecided responses. 
Total individual -ve changes = 9, total +ve changes =4 
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A2.2.4 Summary 
This section considers the results of the piloting process plus both 1987 and 1988 attitudinal 
studies in the framework of the overall aims and objectives listed in section A2.2.1, page 
187. 
The first objective, to develop a set of statements which would reliably divide respondents 
into two camps depending on their absolute attitude, was addressed in the piloting process. 
Using published literature as a guide, 16 statements were researched and found on follow-up 
to be reliable in tapping entrenched attitudes to advice. Only one result was remarkable 
during piloting and reliability assessment. Statement Q10 showed a dramatic swing from 
disagreement that'There should be a specific payment to general practice pharmacists who 
counsel over a given number or percentage of appropriate patients entering their pharmacy' 
in April 1987, to agreement in November 1987. This was a period when payment for items of 
service was beginning to become a reality. 
The second objective was to examine associations and differences between absolute 
attitudes and selected variables. It was shown that respondents and non-respondents who 
were seen during the data collection for the 1987 attitudinal study did not differ In respect of 
the variables gender, status in relation to pharmacy management or the type of pharmacy, 
whether the respondent was associated with an independent or multiple chain pharmacy. 
Similarly respondents did not differ from those who were not seen in gender, status, type or 
age. With the assumption that hospital experience was also evenly sampled, the results of 
the analyses may be generalised to the response of CPs in Southern Derbyshire, with whom 
the general public may come into contact in having a prescription dispensed. 
Notable associations or differences at a significant level indicated that of the 85 respondents: 
1: a higher proportion of managers favoured financial reward over professionalism when 
compared to managers who were also proprietors, dispensers or locums (Q20); 
2. - previous hospital experience was a significant factor for CPs to feel that consulting a 
pharmacist when collecting dispensed medicines would positively effect health care (Q8). 
Those who disagreed had significantly more years experience in community practice; 
3. a higher proportion of CPs employed by multiple, rather than independent outlets felt that 
'Good communicators were made not born' (Q18); and, 
4. ° respondents expecting patients who required counselling to ask for advice were 
-significantly older and had more experience in community practice than those who did 
not expect such notification (Q12). = ..:. . 
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Trends were noted for: 
1. community pharmacists with no hospital experience and those working at multiple rather 
than independent pharmacies to agree with the statement that "There are enough 
general practice pharmacist to counsel adequately those patients who require advice" 
(Q16); 
2. managers who were also proprietors working at independent pharmacies to agree that "it 
was reasonable to manage a pharmacy and still maintain their pharmaceutical 
knowledge" (Q17); and, 
3. Younger and less experienced CPs to agree that repeatedly communicating incorrect 
information should warrant undertaking post-graduate education (Q14). 
Respondents to the second 1988 attitudinal study which incorporated the observational 
research and respondents to the 1987 attitudinal study did not differ significantly in gender, 
status, type, age, years of experience in community practice and years of previous hospital 
experience. As expected with smaller numbers, fewer statistically significant results were 
notable. First, CPs who felt financial reward should be secondary to professionalism were 
significantly younger and less experienced than those who disagreed (Q20). Second, 
managers who were also proprietors rather than those who were solely managers tended to 
feel that consulting a CP when collecting dispensed medicines would positively effect health 
care (Q8). 
Responses to statements from the 1987 and 1988 attitudinal studies were compared as 
directed by the third objective. The results of three comparisons are presented. First, no clear 
pattern was discernible when overall and absolute changes in attitude for those participants 
common to both studies were ranked in order of observed frequency of advice. Second, no 
significant changes in absolute attitude were noted when the 1987 and 1988 responses to 
each statement were compared. Third, the distribution of absolute attitudes for each 
statement was independent of the study from which the data was taken. In summary, both 
1987 and 1988 attitudinal study respondents had similar attitudes. Absolute responses were 
consistent with time and any, changes were unrelated to advisory activity. These results, in 
conjunction with the evidence reported in the piloting process, are also a measure of the 
reliability of the research instrument. 
_. . 
Research conducted for the fourth objective showed that observed activity was positively 
correlated with respondent's estimated time spent providing advice. Community pharmacists 
responding to this study are clearly cognisant of their advisory activity. If attitude and 
behaviour are linked, then this finding may be generalised to the larger sample frame-, 
i 
kýý",. 
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A2.3 Customers' selection of visual display 
A2.3.1 Aims, objectives, method 
This section concerns the aims, objectives and method used to determine patient's 
preferences for visual displays which prompt them to consult the pharmacist concerning 
prescription medication. 
Aim To determine whether a particular visual display or poster is likely to prompt 
individuals into requesting prescription medication advice from pharmacists. 
Specific objectives of research conducted 
1. To develop a series of visual displays promoting interactions between pharmacists and 
individuals who present prescriptions at a dispensary (customers) which include topics or 
themes for discussion developed in previous studies. 
2. To determine which of the visual displays is most likely to prompt discussion concerning 
prescription medication between pharmacists and customers. 
3. To relate choice of visual display by customers with their residence, gender, whether 
they are the patient or collecting on behalf of the patient, age and occupation. 
Method 
Four visual displays in the form of A2 size posters were developed to convey the four 
categories of information; 'Side effects', 'Specific problems', 'What is prescribed' and 'What 
to do with it, pharmacist felt patients should be aware of and which individuals who present 
prescriptions at a dispensary thought they should be informed about. 147148 Central to each 
display was; the prescription form which was shown to be readily recognisable and 
associated with prescription medication, the appropriateness of the pharmacist to provide 
such advice and a directive to consult the pharmacist. Two visual displays, figures 27 and 28 
labelled [A] [B], (pages 211 and 212) were constructed in the traditional document style of an 
important notice where the themes embodied in the four categories where conveyed using a 
sentence-like format with four sub-sections, the latter being more explicit about the meaning 
of the term 'medication'. Two further visual displays, figures 29 and 30 labelled [C] [D] (pages 
213 and 214), employed a more modern, suggestive approach using short questions related 
to the four categories, the last being more directive of what a prescription item was and what 
medication comprised. Each visual display was mounted Al size, in a randomly determined 
order, on separate display panels in the outpatient dispensary of the Derbyshire Royal 
Infirmary. Attached to each display panel was a cardboard mailing box. A questionnaire was 
designed and piloted to relate voting action with personal factors and implicit attitudes. The 
sequence of posters was then rotated during four equal study sessions for four working days 
from the 28th April 1988. Individuals were selected if they were the next person to present a 
prescription at the dispensary hatch when a clipboard with attached pencil and questionnaire 
became available. Two hundred possible respondents were given a brief verbal account of 
the objectives of the study as indicated on the questionnaire. The directions required that a 
completed questionnaire was 'mailed' in the collection box below the poster of their choice. 
When no possible respondents were in the dispensary the researcher collected the forms 
from each box and endorsed the choice accordingly. 
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Figure 27 
Poster A 
IMPORTANT NOTICE 
Your pharmacist is professionally qualified and has 
specialist knowledge of medicines 
Please 
Consult your pharmacist if: 
(1) You would like to 
know more about a 
prescription 
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(3) You are not sure 
how to take or use 
the medication 
(4) You feel the 
medication is 
having unwanted 
side-effects' 
or Isn't helping 
211 
ý.. ý_... ý. _.. _ ý.. _ . Mýdt. _ _. _. _.... W .,., ý_.. ý,. 
Figure 28 
Poster B 
IMPORTANT NOTICE 
Your pharmacist Is professionally qualified and has 
specialist knowledge of medicines 
Please 
Consult your pharmacist if: 
(2) The doctor has prescribed any 
(1) You would like new Item or changed any old ones 
to know more I 
about a (3) You are not sure how to take 
prescription or use the medication 
(4) You feel the medication Is having 
unwanted side-effects 
or Isn't helping 
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Prescription 7 Medication item Pills Tablets Capsules 
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Medicines Sprays Suppositories 
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Figure 29 
Poster C 
DO YOU UNDERSTAND 
THE PRESCRIPTION? 
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C-014 E 
PHARMAC. IST 
WHO IS PROFESSIONALLY QUALIFIED AND 
KNOWS ABOUT' PRESCRIPTION MEDICATION. 
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Figure 30 
Poster D 
DO YOU UNDERSTAND 
THE PRESCRIPTION? 
For example- 
DO YOU KNOW HOW TO TAKE OR 
USE THE MEDICATION 
Ft1Pý CJCi wA ý Capsules Creams tý 
`'Cý`"' 
` 
Dressings Drops 
tnhaters Injections 
Medicines Mixtures 
ý- 
ý 
Ointment Pills 
Powders Sprays ~ 
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Suppositories 
J . ý-. ++. ý. r. -". -. _. Tablets 
" HAS THE DOCTOR PRESCRIBED ANY, NEW MEDICATION? 
* IS THE MEDICATION HELPING? 
* ARE THERE SIDE-EFFECTS? 
For Information- 
LT -THE . NSU co 
PHARMACIST 
WHO IS PROFESSIONALLY QUALIFIED AND KNOWS 
ABOUT PRESCRIPTIONMEDICATION 
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A2.3.2 Results 
During the first day of poster display, four versions of a questionnaire were piloted, amongst 
27 randomly chosen individuals who attended the dispensary and presented a prescription, 
to ascertain its clarity of instruction and suitability for determining the preferred poster. 
Alterations to the format and changes intended to personalise the questionnaire were made. 
The final version (form 4, page 216) was given to 200 randomly chosen individuals who 
present prescriptions at the Derbyshire Royal Infirmary dispensary hatch over the remaining 
six half-day sessions. Sessions continued until a total of 50 responses for the particular 
orientation of the posters had been collected. Table 26, page 217, indicates the relative 
position of each poster as viewed by respondents. 
Of the 200 responses, five were excluded; four due to bad eyesight and one who couldn't 
read, write or understand English. Twenty-six of the respondents indicated 'No' to question 
seven, that there wasn't a poster which would prompt them into asking for advice. No 
significance was found between this group and those that selected a poster using Chi-square 
tests for independence to analyse available data on gender, whose prescription they were 
waiting for, whether they lived within the Derby city boundary or the border of the SDHA and 
whether they were over 50 years of age or not (table 27, page 217). Interestingly, only two of 
the 26 indicated that no poster displayed would prompt them, five that no poster at all would, 
but 19 that they would ask the pharmacist anyway. 
Descriptive analysis of the 169 respondents who indicated a poster preference shows a wide 
representation of occupations and previous occupations (table 28, page 217). Further 
analysis indicated that poster choice was independent of two broad bands of occupations and 
previous occupations which were defined using the criteria for inclusion in OPCS social class 
categories (table 29, page 218). Thirteen of the 169 offered a poster preference but also 
indicated positively that they would ask the pharmacist anyway. Their choice of poster was 
similar to that for the bulk of respondents (table 30, page 218). Combining these with the 19 
who did not choose a poster but also indicated they would approach the pharmacist provided 
two groups of respondents, those who would not be specifically influenced by the poster but 
would ask for advice and those who chose a poster and might be influenced. No significant 
dependence was found relating the two groups to a series of variables, although, a trend was 
seen for respondents collecting their own prescription to favour selection of poster (table 31, 
page 218). As the aim was to determine the poster which was most likely to prompt 
individuals who present prescriptions at a dispensary into discussion with the pharmacist, 
subsequent analysis was performed on the 156 who implied they may be influenced. Poster 
C was the clear choice with 81 (51.9%) 'votes' and no obvious second contender (table 29). 
Poster choice was not found to be significantly dependent on the order of display (tables 32, 
page 219 and table 43), gender or whether they lived within the Derby city boundary or the 
border of the SDHA; however, there were significant dependencies for choice of poster with 
whether or not respondents were waiting for their own prescriptions and for age (table 33, 
page 219). 
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Form 4 
Form for collecting data on respondents' preferences between visual displays 
SOUTHERN DERBYSHIRE HEALTH AUTHORITY 
PLEASE HELP 
In front of you are four posters A, B, C and D. 
We would like to know which poster YOU like? 
First, however, it would be VERY helpful if we knew certain personal details which will allow us to 
group the information, for example, into responses from males and females. 
All details will be kept in the strictest confidence and you will not 
be identified. 
BEFORE YOU VOTE 
PLEASE ANSWER THE FOLLOWING QUESTIONS 
Directions: 
In the following questions, circle the number in the box nearest your answer. 
For example, in Q1 for males your answer would be Male Female [2]. 
Otherwise write you answer in the space provided. 
Q1 Are you a male or a female? Male [1] Female [2] 
Q2 Is it YOUR prescription you are waiting for? Yes [1] No [2]? z 
Q3 Where do you live in Southern Derbyshire? 
Derby city (DEI). [1] Derby Suburb.. [2] 
Country Town.. ... [3] Country Village. [4] 
Other (please specify) .............. [5] 
Q4 What is your age in years? less than 20 [1] 21 - 30 [2] 
31 - 40 [3] 41 - 50 [4] 
51 - 60 [5] over 61 [6] 
Q5 What is your present occupation? ............................ 
Q6 If retired or unemployed, what has been your main occupation? 
Please specify ..................................... 
I HANK YOU, Please read on 
07 IF YOU HAD A QUESTION ABOUT A PRESCRIPTION WHICH YOU WERE TAKING TO A 
CHEMIST SHOP, IS THERE ONE POSTER (A, B, C OR D) WHICH IS MOST LIKELY TO 
PROMPT YOU TO CONSULT THE PHARMACIST FOR INFORMATION ? 
Answer Q7 by circling (11 if there is, [2] if not. Yes [1J No [2] 
Q8 If the answer to Q7 is YES (1J, YOU HAVE ONE VOTE Please fold this piece of paper and 
place it in the box below the POSTER of YOUR CHOICE. You have finished THANK YOU 
FOR YOUR HELP. 
Q9 If the answer to 07 is NO [2], please circle whether it is because 
You feel that NO POSTER DISPLAYED would prompt you? [1] 
You feel that NO POSTER AT ALL would prompt you? [2] 
You would ask the pharmacist anyway? [3] 
Other [4] 
(please specify) .................................................................................. 
THANK YOU FOR YOUR HELP 
Please fold this paper and place it in any box 
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Table 26 
Sequence* 
of 
poster 
display 
Note 
Sequence of poster display vs time of session 
Time of session 
29/4/88 29/4/88 3/5/88 3/5/88 4/5/88 4/5/88 
am pm am pm am pm 
A A D C C B 
B B A D D C 
C C B A A D 
D D C B B A 
*= The posters were displayed in sequence from left to right as the customer viewed them. 
Table 27 
Independence of choosing a poster or not and specific variables 
Variable analysed for independence 
Number (#) 
# of Respondents 
who chose a poster 
# of Respondents 
who did not 
Chi-Square 
Significance 
Notes 
Residence* Gender 
n=185 n=195 
City Country Male Female 
96 64 70 99 
16 9 14 12 12 14 14 12 
0.02577 0.95741 1.59140 0.0000 
0.8725 0.3278 0.2071 1.0000 
Customer's R? tAge$ 
n=192 n=194 
Yes No 550 )50 
102 64 93 75 
= Respondents were excluded if there residence was outside the boundary of the SDHA. Two 
indicated Burton-on-trent, Three Nottingham, Two gave no information and one response was 
received for Matlock, NW Lincolnshire and Amersham. 
t= Three respondents failed to indicate whether it was their prescription they were waiting for. 
$= One customer failed to indicate their age in a particular band. Age ranges were selected to 
divide the smaller group for maximum analytical capacity. 
Table 28 
Social class of current and previous occupations* 
Present Social Class of previous occupation if presently a 
occupation Housewifet Retiredt Unemployed§ 
Social Class 
i5022 
li 22 370 
iii Non-manual (iiiN) 12 641 
iii Manual (iiiM) 28 381 
iv 9201 
v3000 
Total 79 14 21 5 
n=169 
Notes 
= Classification of occupations into social class is based on Office of Population Census and 
Statistics guidelines 1980. Data excludes 7x students. 
t= 38 x Previous occupation inadequately described (housewife) 
$=1x Previous occupation forces, 3x previous occupation inadequately described 
§=1x Previous occupation inadequately described (unemployed) 
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Table 29 
Independence of specific poster selection and current or previous 
occupation* 
Social class 
Count i, ii, iiiN HiM, iv v Row 
Expected Value total 
A 
"= Non-manual and manual categories collapsed. 50 missing observations as for table 45 
Chi-Square D. F Significance 
3.53127 3 0.3167 
Note 
14 11 
13.4 11.6 
7 13 
10.8 9.2 
32 24 
30.1 25.9 
11 7 
9.7 8.3 
25 
21.0% 
20 
16.8% 
56 
47.1% 
18 
15.1% 
Column 64 55 119 
Total 53.8% 46.2% 100.0% 
Choice of B 
poster 
C 
D 
Table 30 
Respondents' choice of poster 
Number of respondents Number of respondents* 
n=156 n=13 
Poster 
A 28 (17.9%) 1 (7.7%) 
B 24 (15.4%) 2 (15.4%) 
C 81(51.9%) 8 (61.5%) 
D 23 (14.7%) 2 (15.4%) 
*= Respondents who indicated a specific poster would prompt them into discussion but also that 
Note 
they would ask the pharmacist anyway. 
Table 31 
Independence of poster selection or independently consu lting the pharmacist 
and specific variables* 
Variable analysed for independence 
Residence* Gender Customer's 91? tAge$ 
n=178 n=188 n=185 n=187 
Number (#) City Country Male Female Yes No 550>50 
Number choosing a poster Observed f 85 62 64 92 96 57 86 69 
Expected f 91 62 
Number who would consult Observed f 23 8 18 14 14 18 16 16 
irrespective of poster Expected f 19 13 
Chi-Square 2.23023 1.92182 3.21252 0.13855 
Significance 0.1353 0.1657 0.0731 0,7097 
Notes 
*= Analysis included 188 resDondents. Nineteen of the 26 resnonHAnte whn nnewArori nn to 
question 7 but indicated they would ask the pharmacist plus 13 who preferred a specific 
poster but also indicated that they would consult the pharmacists compared with the 156 who 
indicated a poster preference without caveats. Missing values are the same for the notes in 
table 27, page 217. 
t= Three respondents failed to indicate whether it was their prescription they were waiting for. 
$= one customer failed to indicate their age in a particular band. Age ranges were selected to divide the smaller group for maximum analytical capacity. 
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Table 32 
Independence of selection of poster and display order 
Order of poster display* 
Count First Second Third Fourth Row 
Expected val Total 
A85 11 4 28 
6.5 7.7 6.5 7.4 17.9% 
Choice of B4 10 55 24 
poster 5.5 6.6 5.5 6.3 15.4% 
C 19 25 15 22 81 
18.7 22.3 18.7 21.3 51.9% 
D535 10 23 
5.3 6.3 5.3 6.0 14.7% 
Column 36 43 36 41 156 
Total 23.1% 27.6% 23.1% 26.3% 100.0% 
Chi-Square D. F. Significance 
13.98792 9 0.1228 
Note 
"= The posters were displayed in sequence from left to right as the customer viewed them. 
Table 33 
Independence of choice of poster and specific variables 
Variable analysed for independence 
Residence* Gender Customer's 91? t Age$ 
Choice of n=147 n=156 n=153 n=155 
Poster A to D City Country Male Female Yes No 550 )50 
Observed fA 12 12 16 12 18 9 19 8 
Expected fA 16.9 10.1 15.0 12.0 
Adjusted residual§ +1.7 -1.7 
Observed fB 10 11 9 15 20 4 8 16 
Expected fB 15.1 8.9 13.3 10.7 
Adjusted residual -2.4 +2.4 
Observed fC 47 33 30 15 41 38 50 31 
Expected fC 49.6 29.4 44.9 36.1 
Adjusted residual +1.6 -1.6 
Observed fD 16 6 9,14 17 6 9 14 
Expected fD 14.4 8.6 12.8 10.2 
Adjusted residual -1.7 +1.7 
Chi-Square 3.53087 3.69627 9.73266 10.95921 
Significance 0.3168 0.2962 0.0210 0.011 9 
Notes 
"= Nine respondents were excluded as there residence was outside the boundary of the SD HA. 
t= Three respondents failed to indicate whether it was their prescription they were waiting for. 
$= One customer failed to indicate their age in a particular band. 
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A2.3.3 Summary 
Four posters were produced with a mixture of styles and a central theme, to prompt the 
general public into discussion with the pharmacist over prescription medication. A 
mechanism for determining whether respondents felt they would be influenced by a poster 
and which of those displayed would be most effective was developed. Although extrapolation 
to the general public is not possible, respondents were members of a sub-population involved 
with illness and likely to be interacting with a pharmacist in some way, thus were considered 
appropriate to the study. In addition, the concentration of this population at a hospital 
dispensary enabled data collection over a short period. 
The results of the study provide implicit support for the potential efficacy of a poster as the 
majority of respondents made the choice of which one would prompt them to consult the 
pharmacist for information. In addition, poster C was the overwhelming choice by 
respondents and, with no clear second contender, its potential for influencing the PMA 
activities of pharmacists was considered sufficient for its selection. The validity of this result 
is strengthened by the methodology of rotating posters and that choice of poster was shown 
to be independent of poster position. 
No clear pattern emerged to indicate whether choosing a poster depended on a series of 
demographic and personal factors. However, analysis of the results showed two areas 
dependence concerning the choice of poster. First, that respondents who are patients rather 
than acting on behalf of patients chose a poster implying that a poster would act as a cue. 
Those collecting for another individual were more inclined to consulting directly with the 
pharmacist. Being a patient was also associated with choice of poster. Those respondents 
not collecting a prescription for themselves clearly preferred poster C whereas this trend was 
not as dramatic for respondents waiting for their own. Poster C was still the choice for over 
twice a many of the latter respondents than for any other display. Second, choice of poster 
appeared dependent on age with respondents 50 and under preferring the less complicated 
styles of posters A and especially C while those over 50 were less in favour of C and divided 
amongst the rest. 
The results of this study proffered poster C for use as the instrument for influencing 
interactions concerning advice and that special attention should be made of age and 
ownership of prescriptions in subsequent studies. 
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A2.4 Conclusion 
From the studies of CPs attitudes to prescription medication counselling it can be concluded 
that: 
1. community pharmacists may be differentiated by their attitudes to prescription 
medication counselling; 
2. attitudes of CPs in the observational study were not significantly different to those of 
colleagues practising within the boundary of the Southern Derbyshire Health Authority; 
and, 
3. community pharmacists demonstrate through their estimated time spent counselling an 
understanding of the true level of their advisory activity. 
From studies of the development and subsequent opinion of customers concerning four 
visual displays, it may be concluded that poster C was the sole choice for use in the 
observational study. 
APPENDIX A3 RESULTS OF OBSERVATIONAL STUDY 
A3.1 Prescription medication advice 
A3.1.1 Presentation and collection of prescriptions 
This section deals with observed patterns of prescription handling and their relationship with 
both CPs' prescription medication advisory activities and display of the poster. Two 
hypotheses are considered: 
H, that the provision of advice is not correlated with CPs' policies of giving out 
dispensed prescriptions; and, 
H2 that the poster would not prompt CPs to give out dispensed prescription medication 
items personally. 
Tables 34 to 36, pages 224 to 226, list the data and analysis pertinent to this discussion. 
Considering the first hypothesis, tables 34 and 35 list the 20 pharmacies in order of the 
prescription medication advisory activity of the CP in charge (section A3.1.3.1 page 249). For 
each pharmacy, the relative and absolute number of customers who presented their 
prescription form(s) or collect their dispensed item(s) from either the CP or the assistant is 
listed. The data is presented to provide an indication of the CPs' actions relative to those of 
assistants in prescription handling activity, both collecting (table 34) and giving out dispensed 
medicines (table 35). By ordering CPs by their advisory activity it is possible to consider 
whether CPs involvement in an advisory service is correlated with prescription handling 
related behaviour. This may appear obvious to the reader at first, as advice occurs when CPs 
are present and CPs were listed in order of their advisory activity; however, CPs may 
physically give out medication and not provide advice. This was clearly the case in pharmacy 
number 17 (table 35) where the CP in charge gave out dispensed medication to 82.1% of 
customers but only provided advice with 2.6% of dispensed items. From the analysis in table 
36, page 226, it can be seen by the values of Somers' D and Gamma that CPs' ultimate 
involvement in providing advice is weakly correlated with whether they personally collect 
prescriptions from customers. There is, however, a stronger correlation between the amount 
of advice CPs provide and their policy for personally handing out dispensed medication 
rather than devolving the responsibility to assistants. Such results are consistent with 
rejection of the first hypothesis, that CPs who give out medication are likely to provide advice 
while those who do not advise, devolve responsibility for the advisory role and leave the 
giving out of prescriptions to assistants. 
The second hypothesis proposes that CPs would be prompted by the presence of the poster 
advertising their services to personally give out dispensed prescription medication items. To 
quantify observed change, columns 1 and 4 from both tables 34 and 35 were compared for 
all study CPs and within proactive and reactive groupings. Although the mean number of 
customers, seen by the CP personally, consistently increased when the poster was displayed, 
no level of significance or trend was found (table 36). It is not, therefore, possible to reject 
the hypothesis and it can be concluded that in this study the effect of the poster on CPs' 
prescription handling behaviour was insignificant. If individual CPs changes in prescription 
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handling behaviour are investigated (table 35, column 10), the average net percentage 
change in the number of customers given prescriptions by proactive CPs when the poster 
was displayed was +3.1% (+30.7%/10). This compares to +0.19 (+1.9%/10) for reactive CPs. 
This locates any overall positive change associated with the poster to the proactive rather 
than reactive grouping. 
It was also noted that the relationship between providing advice and collecting or giving out 
prescriptions became consistently stronger when the poster was displayed. This was 
indicated by increases in values of Somers D in table 36. By inspection of table 35 column 
10, it can be seen that display of the poster was associated with dramatically altered patterns 
of prescription delivery for selected proactive CP. If these proactive CPs are influenced to 
give out more medication personally and the first result holds, then a corresponding absolute 
increase in the quantity of advice would be expected. Table 35 lists the standardised 
residuals for advisory activity when the poster was displayed. For example. the CPs in 
charge of pharmacy number eight increased by 24.5% the number of customers to whom he 
personally gave out prescription medication when the poster was displayed. A greater than 
expected increase in advice was recorded at this time, with 37 customers receiving 
information when the expected frequency was 34.1. The standardised residual (37-34.1/4 
34.1 = 0.5) indicates that the poster was associated with a positive effect on advice over and 
above that expected under the first hypothesis. Had the standardised residual been 0.0 then 
the poster would have had no effect and the first hypothesis would still hold. Considering 
table 35, at an individual proactive CPs' level, the poster encouraged four CPs, discouraged 
four and had no discernible effect on two. In other words, in the presence of the poster some 
CPs increased the percentage of customers to whom they personally gave out dispensed 
medication and provided advice to numbers in excess of those predicted under the first 
hypothesis. Conversely, in the same situation, those who handed out less dispensed 
medication to customers provided advice to even less than expected numbers of customers. 
For whatever reason, the poster was associated with a mixed but measurable effect on 
individual CPs' prescription handling and advisory activities. 
In summary, the data and analysis supports rejection of the first hypothesis. It was 
demonstrated that the more CPs give out dispensed medicines the more they provide 
advice. Those that generally delegate such activity to'assistants are reactive to customers 
requests for information. The second hypothesis was not rejected by the data and the overall 
effect of the poster on prescription handling was insignificant. However, at an individual 
level, the poster was associated with a mixed reaction. Proactive CPs appeared either 
encouraged to interact with more customers and advise more frequently or discouraged from 
interaction and provided even less advice than would be expected under the first hypothesis 
by the numbers of customers involved. 
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Table 34 
Frequency of advisory activity compared to the degree of devolved 
responsibility for customers presenting their prescriptions to pharmacy staff* 
Pharmacy 
number$ 
8 
20 
14 
5 
4 
18 
11 
15 
6 
7 
16 
12 
13 
1 
9 
19 
10 
17 
2 
3 
Type§ 
P 
P 
P 
P 
P 
P 
P 
P 
P 
r 
r 
r 
r 
r 
p 
r 
r 
r 
r 
r 
Total 
Columnst 
123456789 
Notes 
t= 
#_ 
§_ 
26.6 73.4 79 53.6 46.4 56 37.8 62.2 135 
29.8 70.2 47 25.0 75.0 32 27.8 72.2 79 
10.5 89.5 38 15.3 84.7 59 13.4 86.6 97 
31.9 68.1 69 28.0 72.0 75 29.9 70.1 144 
44.7 55.3 47 33.3 66.7 45 39.1 60.9 92 
7.1 92.9 112 15.1 84.9 106 11.0 89.0 218 
2.3 97.7 86 14.5 85.5 76 8.0 92.0 162 
15.5 84.5 58 8.8' 91.2 68 11.9 88.1 126 
9.2 90.8 109 16.7 83.3 84 12.4 87.6 193 
3.6 96.4 110 4.5 95.5 111 4.1 95.9 221 
21.2 78.8 104 17.6 82.4 91 19.5 80.5 195 
11.9 88.1 159 12.8 87.2 149 12.3 87.7 308 
1.8 98.2 55 0.0 100.0 59 0.9 99.1 114 
13.2 86.8 68 30.4 69.6 56 21.0 79.0 124 
8.8 91.0 57 3.8 96.2 52 6.4 93.6 109 
19.0 81.0 52 54.0 46.0 50 38.0 62.0 92 
13.6 86.4 88 18.1 81.9 83 15.8 84.2 171 
29.1 70.9 79 14.8 85.2 81 21.9 78.1 160 
11.9 88.1 84 9.8 90.2 82 10.8 89.2 166 
2.2 97.8 91 1.9 98.1 105 2.0 98.0 196 
1582 1 61 20 31 1021 
Statistical analysis for this table is summarised in table 36. 
Columns represent the percentage of customers who give their prescription(s) to the CP 
(columns 1,4 and 7) or any assistant (columns 2,5 and 8). Columns three, six and nine are 
the actual number of customers for each pharmacy where, in the first instance (columns 1 to 
3) the poster was not on display and in the second, (columns 4 to 6) the poster was 
displayed. Columns seven, eight and nine list the combined data, thus column nine Is the 
sum of columns three and six. 
The data excludes three occasions (1 x pharmacy 14,2 x pharmacy 15) when prescriptions 
were handed by the customer directly to the researcher who was mistaken for pharmacy staff. 
On each occasion the prescription was handed on and no discussion took place between the 
researcher and the customer. Six further customers were excluded (2 x pharmacy 15,4 x 
pharmacy 10) as the researcher could not be sure who the prescription was given to. 
Pharmacies are listed in order of the CP's prescription medication advisory activity as 
indicated in table 37 section A3.1.3.1. The number identifies each pharmacy by alphabetical 
order. It should be noted that pharmacy number nine was proactive by definition but provided 
relatively little advice. 
Type is divided into proactive and reactive CPs as defined in section A3.1.2. 
4-Faý 
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Table 35 
Frequency of advisory activity compared to the degree of devolved 
responsibility for customers collecting their prescriptions from pharmacy staff* 
Pharmacy 
number$ 
8F 
20 F 
14 
5 
4K 
18 r 
11 { 
15 { 
6{ 
7 
16 i 
12 i 
13 i 
1i 
9 
19 
10 
17 
2 
3 
Notes 
t= 
$= 
§_ 
Type§ 
r 
Total 
Columnt 
123456789 10 11 
66.7 33.3 75 91.2 8.8 57 77.3 22.7 132 +24.5 +0.5 
95.7 4.3 46 100.0 0.0 35 97.5 2.5 81 +4.3 0.0 
90.0 10.0 40 85.2 14.8 61 87.1 12.9 101 -4.8 -0.2 
94.2 5.8 69 88.6 11.4 70 91.4 8.6 139 -5.6 -0.2 
63.3 36.7 49 55.8 44.2 52 59.4 40.6 101 -7.5 -0.4 
38.6 61.4 114 32.7 67.3 107 35.7 64.3 221 -5.9 -0.3 
35.4 64.6 82 53.2 46.8 77 44.9 56.0 159 +17.8 0.0 
41.4 58.6 58 29.0 71.0 69 34.6 65.4 127 -12.4 +0.4 
56.1 43.9 114 80.0 20.0 80 66.0 34.0 194 +23.9 +0.8 
17.4 82.6 109 20.7 79.3 111 19.1 80.9 220 +3.3 
94.7 5.3 114 93.7 6.3 95 94.3 5.7 209 -1.0 
41.4 58.6 157 32.9 67.1 149 37.3 62.7 306 -8.5 
25.8 74.2 97 28.7 71.3 108 27.3 72.7 205 -2.9 
11.9 88.1 67 11.1 88.9 54 11.6 88.4 121 -0.8 
54.5 45.5 55 50.9 49.1 53 52.8 47.2 108 -3.6 +0.3 
51.5 48.5 66 66.3 33.8 80 59.6 40.6 146 +14.8 
22.7 77.3 88 25.9 74.1 81 24.3 75.7 169 +3.2 
86.4 13.6 81 77.8 22.2 81 82.1 17.9 162 -8.6 
13.6 86.4 81 15.3 84.7 85 14.5 85.5 166 +1.7 
2.2 97.8 91 2.9 97.1 105 2.6 97.4 196 +0.7 
1653 1610 3263 
Statistical analysis for this table is summarised in table 36. 
The following customers are excluded; five (5 x pharmacy 12) when prescriptions were given 
to the customer by a vocational training student, one when the research was asked by the CP 
to give dispensed medication to a customer (1 x pharmacy 11), and, six when it was not 
absolutely clear which member of the pharmacy staff provided customers with their dispensed 
medication (1 x pharmacy 14,5 x pharmacy 10). On the occasion when the prescription was 
handed on by the researcher, no discussion took place. 
Columns represent the percentage of customers who received their dispensed prescription(s) 
from the CP (columns 1,4 and 7) or any assistant (columns 2,5 and 8). Columns three, six 
and nine are the actual number of customers receiving prescriptions for each pharmacy 
where, in the first instance (columns 1 to 3) the poster was not on display and in the second, 
(columns 4 to 6) the poster was displayed. Columns seven, eight and nine list the combined 
data, thus column nine is the sum of columns three and six. Column 10 Is the change in the 
percentage of customers given their medication by the CP (column 4 -column 1). The net 
value for proactive pharmacies was +30.7 and for reactive, +1.9. Column 11 lists the 
contingency table standardised residuals, 
400 or the difference between observed and expected 
frequencies (residuals) divided by the square root of the expected frequency, for the number 
of customers given advice when the poster was displayed. This is a relative measure of 
whether the observed frequency of advice when the poster was displayed was greater than 
expected. 
Pharmacies are listed in order of the CP's prescription medication advisory activity as 
indicated in table 37. The number identifies each pharmacy by alphabetical order. The reader 
should note that pharmacy number nine was proactive although the amount of advice 
afforded was minimal. 
Type is divided into proactive and reactive CPs as defined in section A3.1.2, 
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A3.1.2 Prescription orientated individuals 
This section concerns relationships of advisory activity to observed characteristics of Pols. 
The bulk of the data concerns customers who handed in at least one prescription form to be 
dispensed or collected one or more dispensed items, whether for themselves or on behalf of 
the patient. This is the basic activity which brings the customer into possible contact with CPs 
and therefore provides the opportunity for advisory activity. In addition, sections of the data 
and subsequent analysis include the characteristics of those individuals who proactively 
request information on prescription medication and have not already been recorded plus 
those individuals who CPs advise outwith their dispensing role while still remaining in the 
vicinity of the pharmacy. The combined data represents the characteristics of the total 
number of'POIs' who have the potential for, or are actively engaged in, discussion 
concerning prescription medication. Thus, it will be noted that the total cases of 3519 in table 
37, (page 236, column 24) is greater than the 3263 cases listed in table 35, page 225. The 
difference is accounted for by those individuals involved in discussion concerning 
prescription medication but not associated with the concurrent dispensing of prescriptions. 
The definition of 'customer initiated' is that, during discussion directly with the CP, one or 
more topics defined within a category of advice was started by an individual. Thus, for level 
one analysis, a CP may provide advice in several categories, but if dialogue included at least 
one original category of discussion started by the customer, the whole advisory episode was 
deemed customer initiated. Of the 151 POls whose discussions were deemed customer 
initiated (table 37 column 27), 64 (42.4%) received additional categories of advice initiated 
by the CP. Categories used to define advice are discussed in section A3.1.3.1, page 249. In 
addition, the aforementioned section demonstrates that display of the poster did not 
significantly effect the frequency of advice provided by CPs, therefore, the data for both 
visits is combined in this analysis. 
It was noted in an analysis of social policy indicators for Derbyshire 556 that, 
"In social status terms Derbyshire is very much a divided county. There is a sharp contrast 
between the affluent rural west of the country with high percentages of professional and 
managerial workers and the industrial urban centres of the east dominated by skilled and 
unskilled manual workers. These differences are reinforced by a similar contrast in the 
distributions of car ownership, higher education qualifications and housing tenure". 
With such a divide and the potential for CPs to provide information selectively, it was 
decided to investigate the effect of socio-economic status on advice. As customers are not 
restricted to specific outlets, analysis required individuals residential addresses, rather than 
the crude location of community pharmacies and their implied catchment area. It was 
methodologically impractical to determine the socio-economic status of customers directly, 
however, information on patients' addresses was recorded for each dispensed prescription. It 
should be noted, therefore, that there is an assumed link between customers and patients in 
this analysis. Customers entering into discussion concerning advice were allocated the socio- 
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economic status of the patients' ward whether or not the customer was known to be the 
patient. Thus, analysis on socio-economic status concerning advice is at best directive of 
possible associations and interpretation of the results limited. 
Using a list of street names, house numbers and corresponding 1981 District Electoral Ward 
names, 557 in conjunction with the census abbreviation for District Electoral Wards 558 
prescriptions were coded by the 1981 District Electoral Wards of patients. Codes were 
subsequently related to published ward loadings of socio-economic status for Derbyshire 556 
Unfortunately, no comparable analysis of socio-economic status was available for counties 
other than Derbyshire. Analysis of ward data is, therefore, restricted to those patients whose 
addresses were within the boundary of the SDHA. Of the prescriptions dispensed during the 
observational study, 3,458 (91.7%) were included in this analysis. 
To demonstrate the method of data manipulation for analysis of socio-economic data, 
consider the following case. The customer was a male Caucasian, exempt from prescription 
charge being over 65 years old, who presented a single prescription to an assistant, noticed 
the poster and upon receiving the dispensed items from a community pharmacist-initiated 
discussion which included elements of advice. In this case, the customer, who was also the 
patient, presented a prescription with a Derby address within ward "FPAT". This ward is 
allocated a relative loading of -1.1 in the published literature. 556 and in the present analysis, 
was similarly coded. Loadings for Southern Derbyshire ranged from +2.5 to -1.6 with more 
positive values related to higher socio-economic status. In this way each prescription in the 
analysis is allocated the value of the socio-economic status of the patients ward. As 
described on page 109, cases for analysis may be at four levels. Table 41, illustrated by 
figure 18, page 125, provides details of the level one analysis, where patients are cases, of 
20 community pharmacies and the socio-economic status of patients in bands. Pharmacies 
are ranked In order of the CPs' advisory activity. Table 42, page 246, details the analysis of 
CP's activities and relates advisory activity to socio-economic status. Figure 19, page 126, 
illustrates the results of this level two analysis. Although, the data Is banded to Improve 
presentation, that the socio-economic divide exist for customers was demonstrated In this 
figure. Tables 43 to 46, pages 247 to 248 detail level four analyses of type of advice, display 
of the poster and type of CP with socio-economic status. 
The following hypotheses were considered in the analysis of the data presented at the end of 
this section: 
H, that CPs advise similar proportions of Pols; 
H2 that advice provided by CPs is independent of customers' gender, age, age 
controlled for gender, ethnic association and ownership of the medication. 
H3 that customers' requests for advice are independent of their gender, age, age 
controlled for gender, ethnic association and ownership of the medication; and, 
H4 that the preceding two hypotheses hold for all CPs. 
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H5 that CPs can not be distinguished on the basis of socio-economic status of patients 
for whom they dispense; 
H6 that advice provided by CPs is not dependent on the socio-economic status of the 
patient; 
H7 that the category of advice provided by CPs is not dependent on the socio-economic 
status of the patient; 
H8 that, for customers receiving advice, display of the poster was not associated with 
changes in the socio-economic status of patients; and, 
H9 that the above three hypotheses hold for customer-initiated requests for advice; 
Considering the first hypothesis, empirical assessment of table 37 column 28 Indicates the 
potential for two distinct types of CPs, those who are proactive and those who react to 
requests for advice from POIs. Taking a figure of 50% for the proportion of customer initiated 
advice of total advice clearly divides the pharmacy sample. Using this figure, pharmacy 
number nine was included in the proactive group. Analysis indicated that the proportion of 
advice initiated by POls is very significantly dependent on the type of CPs (table 40 [A], page 
244). 
Table 37 ranks CPs by the percentage of preparation events associated with advice (section 
A3.1.3.1, page 249). With only one exception, CPs were divided into reactive and proactive 
groupings. It would appear that for those CPs associated with Infrequent advisory policies, 
what information is provided is asked for. The proportion of POls who receive advice was 
found to be very significantly dependent on type of CP (table 40 [B]), however, the proportion 
who initiated advice was not dependent on type (table 40 [C]). This points to an underlying, 
relatively constant, rate of customer initiated requests for advice directed towards pharmacy. 
A further dimension to this hypothesis is that indirect customer initiated requests for advice, 
where face-to-face discussion between CPs and the POI does not take place rather 
information is conveyed through the assistant, were very significantly dependent on type. 
Reactive CPs proportionally electing not to engage in direct conversation (table 40 [D]). 
In summary, there are two statistical findings which lead us to reject the null hypothesis and 
accept that there are difference between CPs on the basis of the numbers of POls given 
advice. First, the proportion of POls provided with advice was dependent on type. Second, 
the proportion of indirect customer Initiated advice of advice was dependent on type. On the 
basis of these results it was accepted that two types of CPs existed and value of 50% was 
Incorporated In the definition of type, 'proactive' or'reactive'. In addition, it was noted that the 
proportion of POls who initiated advice was not dependent on type which lead to the 
conclusion that such activity was consistent across types of community pharmacies and 
proactive CPs were a separate group as they provided advice in addition. 
The following three hypotheses; H2, H3 and H4 are considered by interpretation of the 
analysis presented in table 38, page 238. Data was collected by direct observation, however, 
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certain information on POls characteristics could not be validated. Whereas it was possible 
to determine gender without hesitation, the ability of any researcher to distinguish an 
individual's age or ethnic association by observation is not as clear. Figures have been 
published for the gender and age distributions of individuals observed to be involved in 
prescription 'counselling events'. 170 As an individual may be involved in several events, this 
data distorts the relative proportions of individuals directly involved with the CP and is not 
comparable with the present analysis. In other words, studies have reported 'counselling 
events' as cases, while this present analysis considers individuals as cases. Further, the age 
categories used in this thesis were based on the bandings of the Office of Population 
Censuses and Surveys and are not comparable with published figures known to the author. 
In any case, the subjective nature of assessing age without validation is so limiting that little 
use can be made of the data. Perhaps this partly explains why, although data on age was 
collected, analysis of this information was not reported by a further study using an 
observational method. 165 In order to produce partially validated data on age for this analysis, 
prescriptions were inspected to determine whether one or more were for the customer and if 
so, whether they were exempt from payment. Males aged 65 and over plus females aged 60 
and over were exempt during the period of data collection. Of the 3519 cases processed, one 
or more prescriptions could be attributed to 1861 customers. For those individuals who did 
not present or collect one or more prescriptions but were Involved In prescription medication 
discussion, or if the customer presented a previously signed prescription, a subjective 
assessment was made as to their age. It was felt that this method of determining age 
relationships with advisory activity was slightly more valid than subjective assessment by a 
single researcher of individuals' ages. 
Ethnic association is a further area of subjective assessment. Using a combination of the 
name on the prescription, dress, language, the location of the pharmacy and patients' 
residential address, an assessment was made as to individuals ethnic association. It is a 
limitation of the method chosen that the information on ethnic origin was not externally 
validated. 
It was possible to determine ownership of medication by observing customers when they 
signed for prescriptions and noting the similarities of individual signatures with identifying 
prescription names. Further clarification and confirmation of the relationship between 
customer, medication and patient was often determined from customers' discussions with 
CPs or assistants. Inevitably, as considered above, cases arose where individuals presented 
pre-signed prescriptions and it was not possible to determine ownership of medication from 
discussion within the pharmacy. In such cases customers' ownership was assigned to an 
'unknown' category in common with those for whom the relationship of customer, prescription 
medication and patient was not observable. Two further categories used in the analysis 
included, where the customer was the patient and where the customer was'related' to the 
patient as defined in a specific algorithm (table 39, page 243). Ownership was limited to 
those individuals who were customers by definition and therefore presented a prescription or 
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collected a dispensed item. The potential for this method of determining ownership of 
medicine may be assessed by noting that 76% of prescriptions dispensed in England In 1988 
required a signature in claiming exemption from prescription charge 553 
With these constraints the data in table 38 was analysed in three stages for dependence of 
advisory activity on the independent variables gender (A), age (B), age by gender (C), ethnic 
association (D) and ownership (E) (table 38). First, the analysis compares the distribution of 
those individuals who could possibly receive advice and those who were observed being 
advised when divided into the categories of the independent variable. The data was then 
divided into proactive and reactive groups and reassessed. Second, as a critical element in 
this thesis is the policy of customers in initiating advice, the data was then analysed for 
dependence of customer initiated episodes against each variable using the total sample. 
Again this analysis was repeated dividing the sample into types. Third, the dependent 
variable, customer initiated advisory activity was tested for association with the independent 
variables for the sub-section of POls who received advice. The three stages of analysis were 
given the labels'1'; 2' and T. The hypothesis H2 is tested by the first stage, hypothesis H3 by 
both stages two and three and H4 at all stages. 
From the results of first stage analyses presented in table 38, the following associations 
concerning H2 were noted. First, advisory activity appears independent of customers' gender 
(columns 1,2) but significantly dependent on age (columns 19,20) with those males and 
females aged over 65 and 60 years respectively receiving proportionally less advice. This 
significance can be traced to a trend for females over 60 years rather than males over 65 
(columns 37,38 and 39,40) to receive less advice. A positive ordinal association was found 
between decreasing advisory activity and increasing age, although the correlation was weak. 
No evidence was found for a dependence of ethnic association and advisory activity, 
(columns 73,74,75). Ownership of the prescription was very significantly associated with 
receiving advice (columns 94,95,96) with those customers who were related to the patient 
received markedly less information than expected (column 95). 
The third hypothesis H3 considered customer initiated requests for information both at stage 
two analysis, related to the total sample, and, at stage three, in comparison to the sub- 
section who received advice. At stage two, the dependent variable, customer initiated 
advisory activity appears independent of gender (columns 7,8), age (columns 25,26), age 
controlling for gender (columns 49 to 52) and ethnic association (columns 82,83). Ordinal 
comparisons showed a reversal from earlier observations with customer initiated advice 
increasing as age Increased. At this stage of analysis, only ownership of the medication was 
found to be very significantly associated with customer initiation of advice. Stage three 
analysis, where customer initiated advice was compared to otherwise initiated advice for 
each of the independent variables, revealed a trend for females to request advice 
proportionally more than males (columns 13,14). There was a very significant dependence 
for advice which was requested to be given to older POIs (columns 31,32). By controlling for 
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gender (columns 61 to 64) it was shown that the stage of significance was related more to 
females age than males. There was no dependence noted for customer initiated advice and 
ethnic association (columns 88,89). 
Having listed the relationships between advisory activity and selected characteristics of 
customers, the hypothesis H4 holds that the preceding findings are consistent for both 
proactive and reactive CPs. 
Considering stage one analyses and hypothesis H2, the lack of dependence for advisory 
activity on gender (columns 3 to 6) holds for both types, however, the significant dependence 
on age noted earlier is clearly due to the activity of proactive rather than reactive CPs 
(columns 21 to 24). This continued to be the case when age is controlled for gender (columns 
41 to 48). Advice and ethnic association remained independent for both types. Advisory 
activity was also found to be dependent on ownership of the prescription for both proactive 
and reactive CPs. 
Greater divergence was found between types for stage two and three analyses and 
hypothesis H3. Although the proportion of customer initiated advice of the total sample was 
independent of gender for both types (columns 9 to 12), comparison with the advised 
population (columns 15 to 18) showed a trend for females rather than males to request 
advice from reactive CPs. The earlier finding that advisory activity was dependent on age for 
proactive CPs was further strengthened as only for this type was the proportion of customer 
initiated requests for advice dependent on age. This was the case whether customer initiated 
advice was compared to the total sample (columns 27 to 30) or the advised population 
(columns 33 to 36). When age was controlled for gender and customer initiated advice 
compared within the advised population, both males and females in the older age group 
requested proportionally more advice from proactive CPs than expected. No such finding 
was found with reactive CPs (columns 65 to 72). Customer initiation of advice was found to 
be independent of ethnic association for both types of CP and at stage two and three analysis 
(columns 84 to 93). The dependence of advice and customer initiated requests for 
information on ownership when compared with the population of customers held for both 
types (columns 106 to 111), however, the dependence of customer initiated advice was lost 
when compared with the advised group (columns 112 to 120). 
In summary, this analysis lead to the rejection of HI, thus CPs may be divided into two 
advisory groups on the basis of the percentage of advice which Is Initiated by Pols. 
Proactive CPs are associated with very significantly more advisory activity and direct 
involvement with POls. There was no evidence to suggest that POIs have a bias for 
requesting advice from one or other types of CPs which points to a low consistent ubiquitous 
level of customer initiated requests for advice. 
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A mixed result was found for the independence of CPs' advisory activity and the variables 
gender, ethnic association, age, age controlled for gender, and ownership of the medication. 
For the first two variables the null hypotheses could not be rejected, however, for the latter 
three, dependencies were noted and H2 rejected. Specifically, a significant relative lack of 
advice was afforded males and, to an even greater extent, females over 65 and 60 years of 
age respectively. Increasing age was weekly correlated with decreasing advice. Advice was 
also dependent on ownership of the medication with customers collecting on behalf of a 
relative receiving relatively less advice. 
The null hypothesis H3 for independence of customer initiated advice on the same variables 
as above could not be rejected for all but ownership of the medication. It was noted that 
increasing age was now weekly correlated with increasing initiation of advice. When the 
proportion of customer initiated advice was considered relative to the advised population 
rather than all POls or customers, the older age group, mainly females, were found to be 
responsible for a disproportionately greater amount of requested advice. In this analysis of 
customer initiated advice compared with total advice, the hypothesis H3 was rejected for age 
and gender but not ownership of the medication. 
Community pharmacists appear involved in advising younger males and females while 
responding to requests for advice from older, mainly female, customers. When the data was 
controlled for type, it was shown that these dependencies were clearly due to the selective 
activity of proactive CPs. The hypothesis H4 was rejected for the variables gender, age and 
age controlled for gender. Only ethnic association and ownership of the medication was 
consistent for both types across all levels of examination. 
With the exception of customer ownership of the medication, no statistical differences were 
found between the characteristics of the population who ask for advice and those of 
customers. As this group was responsible for the majority of advice for reactive CPs, it is not 
surprising that little difference was found when customer initiated advice was compared with 
the total population for reactive CPs. In contrast to the characteristics of the customer 
initiated groups, proactive CPs demonstrate a policy for advising a younger, less female 
dominated group and it was this activity which lead to rejections of hypotheses as outlined. 
We now turn our attention to hypotheses H5 tö H9 and take each in turn. 
Concerning the fifth hypothesis, empirical assessment of figure 18, page 125, a three 
dimensional histogram with the x axis showing CPs in order of their prescription medication 
advisory activity, the z axis the socio-economic bands of patients addresses and the y axis 
percentage of patients, demonstrates that CPs dispense for discrete sections of socio- 
economic status. A second level analysis (table 41, page 245), where prescriptions are 
cases, of the kxn contingency table indicates that pharmacy and socio-economic status are 
very significantly dependent. Thus, the null hypothesis is rejected and community 
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pharmacies can be distinguished on the basis of the socio-economic status of the patients for 
whom they dispense. 
The sixth hypothesis contends that CPs' advisory activity is not associated with the socio- 
economic status of patients. Figure 19, page 126, shows the banded socio-economic status 
of those patients for whom advice was provided to the presenter of the prescription in 
comparison with the socio-economic status of those patients not linked to advice. Analysis of 
the unbanded data (table 42, page 246) failed to find a statistically significant difference 
between the mean ranks of both populations (Mann-Whitney). Using this result the null 
hypothesis would not be rejected, however, further analysis sensitive to variations In 
distribution were very significant (kolmogorov-Smirnov). It will be noted in figure 18 that as 
CPs' advisory activity decreases, the socio-economic status of patients for whom 
prescriptions are dispensed also decreases. Notable exceptions to this pattern were 
community pharmacies eight and 20 This is reflected in the analysis presented in table 41 
where gamma has a value of -0.2981. From this finding, it would be a reasonable postulate 
that the frequency of individuals provided with advice would be dependent on socio- 
economic status of the patient for whom prescribed items were dispensed. As expected, 
figure 19 shows that the socio-economic status of patients for whom advice Is provided Is 
skewed towards the positive, however, there also appears to be a relatively large proportion 
of patients in the lower band. This is due to pharmacies eight and 20 which, due to high rates 
of advice, pulled the distribution to the lower bands. An interpretation of these findings would 
be that socio-economic status was not a factor for individual CPs in determining their own 
advisory activity, however, those CPs who provide advice are more likely to be providing an 
overall service to patients of a higher socio-economic status. Clearly this area requires 
further clarification with a larger sample of CPs. With the conflicting results of the present 
analysis it Is not possible to make a clear statement with regard to the sixth hypothesis. 
A level four analysis (table 43, page 247) comparing the distributions of socio-economic 
status of patient for the four categories of advice provides evidence that the hypothesis H7 
can not be rejected, therefore, the category of advice provided by CPs is not dependent on 
the socio-economic status of the patient. 
Investigation of the 516 cases of advice and the socio-economic status of patients with and 
without display of the poster does not lead to rejection of hypothesis H8 (table 45, page 248). 
It can be stated that the poster was not associated with changes in the socio-economic status 
of those patient for which advice was directly or Indirectly provided. 
Hypothesis H9 contents that the previous three hypotheses hold for customer-initiated 
advice. Figure 19, page 126, shows the banded socio-economic status of those patients for 
whom advice was requested by the presenter of the prescription in comparison with the 
socio-economic status of those patients not linked to advice. Empirically, it is clear from this 
figure that the distribution appears to mimic that of the non-advised patient population. Thus, 
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not only is the frequency of customer Initiated advice constant across community 
pharmacies, the socio-economic status of patients linked to such initiation may also reflects 
the larger population. That this is the case is demonstrated in table 42, page 246, as both 
Mann-whitney and Kolmogorov-Smirnov tests failed to show statistical significance. Thus, for 
customer initiated requests for advice, it is possible to state that advice sought is not 
dependent on patients' socio-economic status. Similarly, for hypotheses H7 and H8 no 
measure of statistical significance was found in the customer initiated population for the 
dependence of category of advice on socio-economic status of patients (table 42, page 246) 
or socio-economic status of patient on display of the poster (table 46, page 248). In both 
these cases the null hypotheses are not rejected. It can be stated that for the population of 
individuals who request advice on prescription medication, category of advice is not 
dependent on the socio-economic status of patients and that the socio-economic status of 
patients for whom advice was requested was not dependent on display of the poster. 
In summary, this section considers the relationship of prescription medication advisory 
activity to the epidemiological, structural and demographic variables of those individuals 
receiving advice. Categories previously defined were used to quantify the advice provided. 
Socio-economic status was included as a social factor which may have been linked with 
patterns of advisory activity. Evidence based on analyses detailed at the end of the section 
was presented to determine the statistical justification for a series of hypotheses. Each of 
these was considered in turn and the findings summarised at the end of the discussion. In 
one case, hypothesis number six, it was not possible to make a clear statement as to 
rejection or otherwise of the hypothesis. 
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Table 39 
Algorithm for ownership of prescription medication* 
Customer is 'involved' with the 91, the Customer Categoryt 
is....... 
the patient 0 
related to the patient....... 
Spouse R 
Parent/grandparent R 
Descendant R 
Sibling/ brother, sister -in-law $ 
signs pt's surname +/- address $ 
"involved" through occupation, the Customer 
is....... 
Community nurse $ 
Collecting for home $ 
General practitioner 
Staff of surgery $ 
Customer is not the patient but the patient is in the pharmacy $ 
Not known U 
Miscellaneous....... 
Collect from surgery pharmacy staff $ 
patient is an animal $ 
$ Not applicable 
Notes 
= Based on the 3488 customers who presented a prescription or collected dispensed 
items from the pharmacy. Of these, 424 were provided with PMA. 
t= Categories OR and U relate to those used in the analyses listed In table 38, page 
238. 
$=A total of 114 customers (3.3%) fell into these categories. Eleven cases of advice 
were observed when . 13.9 were expected. As the numbers in this category were 
relatively small, the expected and observed frequencies close and the relationship of 
the customer with the medication diverse, the data in these categories was excluded 
in the analysis presented in table 38. 
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Table 40 
Advisory activity and type of community pharmacist 
Variable analysed for independence* 
Type 
Dependent Proactive Reactive 
variablet 
(A) 
PMA (customer initiated) 75 76 
Expected value 114.6 36.4 
PMA 284 38 
Expected value 244.4 77.6 
(B) 
PMA 359 114 
Expected value 205.0 268.0 
No PMA 1166 1880 
Expected value 1320.0 1726.0 
(C) 
PMA (Customer initiated ) 75 76 
No PMA 1450 1918 
(D) 
n Chi-Square Significance 
473 81.33081 0.00000 
3519 234.42346 0.00000 
3519 2.31418 0.12820 
PMA (direct) 359 114 
Expected value 348.8 124.2 
PMA (indirect) 6 16 
Expected value 16.2 5.8 495 23.21810 0.00000 
Notes 
*= Prescription orientated individuals are divided by the type of pharmacy in which they 
were observed. Pharmacy number nine being included in the former category. 
t= (A) Compares the distribution of the number of POIs given advice with those who 
requested advice from one or other type of CP. 
(B) is a contingency table which compares the distribution of POls who receive 
advice from one or other type of CPs. 
(C) is a contingency table which compares the distribution of the number of POls 
who request advice from one or other type of CP. 
(D) In the above tables (A) to (C) advice was provided directly between CP and POI. 
Advice was also given indirectly with a pharmacy assistant acting as spokesperson 
for both parties. Twenty-two such cases were observed. The last table compares the 
distribution of these cases with the direct advisory activity of the two types of CPs. 
Table 41 
Independence of socio-economic status of patient and community pharmacy 
Soc io-economic status A* 
Community -1.35 -0.85 -0.35 +0.15 +0.65 +1.15 +1.65 +2.15 +2.50 Row 
pharmacyt total 
8 34 55 2 6 31 1 18 1 0 148 
20 0 13 42 1 32 1 0 0 0 89 
14 2 1 5 89 8 0 0 0 0 105 
5 1 0 1 7 132 0 1 0 0 142 
4 0 0 48 15 28 1 4 7 0 103 
18 0 3 7 34 4 0 218 1 1 268 
11 1 60 17 96 10 1 0 0 0 185 
15 0 20 10 107 11 0 0 0 0 148 
6 0 2 111 62 18 0 0 0 0 193 
7 7 55 25 138 19 0 0 1 0 245 
16 0 1 205 0 0 2 4 0 1 213 
12 2 10 268 54 3 1 0 0 0 338 
13 2 1 6 3 25 5 20 156 0 218 
1 12 74 5 4 21 0 4 1 1 122 
9 22 5 53 8 13 4 1 0 0 106 
19 0 112 19 1 6 0 0 0 0 138 
10 1 4 114 74 17 0 0 0 0 210 
17 80 19 64 1 0 4 0 0 0 168 
2 0 0 88 35 48 0 0 0 0 171 
3 108 -19 7 12 2 0 0 0 0 148 
Total 272 454 1097 747 428 20 270 167 3 3458 
Socio-economic status B* 
8 23.0 37.2 1.4 4.1 20.9 0.7 12.2 0.7 0 
20 0 14.6 47.2 1.1 36.0 1.1 0 0 0 
14 1.9 1.0 4.8 84.8 7.6 0 0 0 0 
5 0.7 0 0.7 4.9 93.0 0 0.7 0 0 
4 0 0 46.6 14.6 27.2 1.0 3.9 6.8 0 
18 0 1.1 2.6 12.7 1.5 0 81.3 0.4 0.4 
11 0.5 32.4 9.2 51.9 5.4 0.5 0 0 0 
15 0 13.5 6.8 72.3 7.4 0 0 0 0 
6 0 1.0 57.5 32.1 9.3 0 0 0 0 
7 2.9 22.4 10.2 56.3 7.8 0 0 0.4 0 
16 0 0.5 96.2 0 0 0.9 1.9 0 0.5 
12 0.6 3.0 79.3 16.0 0.9 0.3 0 0 0 
13 0.9 0.5 2.8 1.4 11.5 2.3 9.2 71.6 0 
1 9.8 60.7 4.1 3.3 17.2 0 3.3 0.8 0.8 
9 20.8 4.7 50.0 7.5 12.3 3.8 0.9 0 0 
19 0 81.2 13.8 0.7 4.3 0 0 0 0 
10 0.5 1.9 54.3 35.2 8.1 0 0 0 0 
17 47.6 11.3 38.1 0.6 0 2.4 0 0 0 
2 0 0 51.5 20.5 28.1 0 0 0 0 
3 73.0 12.8 4.7 8.1 1.4 0 0 0 0 
Analysis§ 
Total 3458 Minimum expected frequency 4.278 
test n 3435 Chi-square 9606.90198 
DF 114 Probability 0.00000 
fcells <5 2.1% Gamma -0.29812 
Notes 
(A) = absolute frequency. (B) = percentage. Values of socio-economic status are the 
midpoints of bands of width 0.5. For example, values of -1.60 to -1.10 are in band -1.35, while 
those from -1.11 to -0.60 are denoted -0.85. 
t= Pharmacies in order of prescription medication advisory activity. Listed by alphabetical 
number from one to 20. 
$= Rows may not sum to 100% due to rounding off errors. 
§= Analysis of absolute frequency excluded socio-economic categories 1.15 and 2.5 to account 
for multiple minimum expected frequencies less than unity. 
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Table 42 
Relationship between socio-economic status of patient and advice 
Statistical relationship of group with socio-economic status* 
Group Mean Cases Mann- Kolmogorov- 2-tailed 
Rank n=3458 Whitney Z Smirnov Z probability 
Patients receiving no advice 1722.90 3054 -1.0719 0.2838 
Customers receiving advice 1779.41 404 
Patients receiving no advice 3054 1.857 0.002 
Customers receiving advice 404 
................................................................................................................................................ 
Patients receiving no advice 1730.52 3348 -0.3310 0.7407 
Customers initiating advice 1698.58 110 
Patients receiving no advice 3348 0.451 0.987 
Customers initiating advice 110 
............................................................................................................................................... 
Patients receiving advice 205.84 294 -0.9409 0.3468 
Customers initiating advice 193.59 110 
Patients receiving advice 294 1.229 0.098 
Customers initiating advice 110 
Note 
*= Analysis based on the original unbanded data. An independent Students t-test was 
considered inappropriate as the population distributions appeared to be bimodal 
rather than normal (Figure 6, page 27). 
,ýo 
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Table 43 
Independence of category of advice and socio-economic status of patient 
Socio-economic status* 
Category of advicet -1.35 -0.85 -0.35 +0.15 +0.65 +1.15 +1.65 +2.15 Row 
total 
Side effects 3 8 8 6 6 0 2 1 34 
Specific problems 3 9 25 23 9 0 11 4 84 
What is prescribed 6 14 26 17 20 2 10 1 96 
What to do with it 27 52 57 77 53 1 31 4 302 
Analysis* 
Total 516 
test n 513 
DF 18 
fcells <5 17.91% 
Chi-square 22.01419 
Probability 0.23136 
Notes 
*= Values of socio-economic status are the midpoints of bands of width 0.5. 
t= One cell (1,8) had an expected frequency less than unity, 0.663. In line with the 
robustness of homogeneity tests in 2xn tables this was judged acceptable. Analysis 
excluding socio-economic factor 2.15 resulted in a change of probability to 0.28514. 
Table 44 
Independence of category of advice requested and socio-economic status of patient 
Socio-economic status* 
Category of advicet -1.35 -0.85 -0.35 +0.15 +0.65 +1.65 +2.15 Row 
total 
Side effects 1 4 4 4 6 0 1 20 
Specific problems 3 5 14 8 5 4 3 42 
What is prescribed 4 8 19 5 5 2 1 44 
What to do with it 3 11 13 17 11 3 3 61 
Analysist 
Total 167 
test n 167 
DF 18 
fcells <5 53.6% 
Minimum expected frequency 1.0 
Chi-square 17.15417 
Probability 0.51253 
Notes 
*= Values of socio-economic status are the midpoints of bands of width 0.5. 
t= Statistical interpretation was invalid due to the large number of cells with expected 
frequency less than five. This data is presented to demonstrate the pattern of advice 
sought in relation to the residence of the patient. 
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Table 45 
Independence of socio-economic status of patient receiving advice and 
display of poster* 
Socio-economic statust 
Display of postert -1.35 -0.85 -0.35 +0.15 +0.65 +1.15 +1.65 +2.15 Row 
total 
Yes 20 39 72 67 53 1 22 5 279 
No 19 44 44 56 35 2 32 5 237 
Analysis 
Total 516 
test n 516 
DF 7 
fcells <5 18.6% 
Minimum expected frequency 1.378 
Chi-square 10.58775 
Probability 0.15764 
Notes 
*= The dependent variable, socio-economic status is given the y axis to improve display. 
t= Values of socio-economic status are the midpoints of bands of width 0.5. 
Table 46 
Independence of socio-economic status of patient for customer initiated 
advice and display of poster 
Socio-economic status* 
Display of postert -1.35 -0.85 -0.35 +0.15 +0.65 +1,65 +2.15 Row 
total 
Yes 7 16 23 14 20 55 90 
No 4 12 27 20 743 77 
Analysis$ 
Total 167 
test n 167 
DF 6 
fcells <5 28.6% 
Minimum expected frequency 3.689 
Chi-square 8.67942 
Probability 0.19243 
Notes 
"= The dependent variable, socio-economic status is given the y axis to improve display. 
t= Values of socio-economic status are the midpoints of bands of width 0.5. 
$= Contingency table judged valid. 
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A3.1.3 Quantitative 
A3.1.3.1 Advice 
In the first section of appendix three the activities of CPs in collecting prescriptions and 
presenting dispensed items to customers were explored. It was shown that CPs who give out 
prescriptions are likely to proffer advice and that the effect of the poster on prescription 
handling was insignificant. Following this, section A3.1.2, page 227, provided evidence for 
two types of CPs, proactive and reactive. Also, that the bulk of advice is provided by 
proactive CPs who advise younger customers while receiving proportionally more requests 
for advice from those who are older and mainly female. In addition, it was shown that a CP 
dispenses for patients whose addresses are banded within a limited range of socio-economic 
status, and that the category of advice is definitely not associated with such status. These 
previous sections dealt with CPs' policies or activities regarding people, but what about 
prescription medicines? 
Research has demonstrated that advice can be described by three categories, 'What Is 
prescribed', 'What to do with' and 'Specific problems'. Also, that a discrete subsection of 
'Specific problems' containing issues of 'side effect' was justified . 
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the framework used to quantify the observed topics of advice in the current analysis. As 
described on page 109, cases for analysis may be at four levels. An appreciation of the 
relative multiplication effect for level two analysis where POls may be counted many times 
over depending on the number of prescriptions involved, is gained by realising that 13.1% of 
customers in the observational study received dispensed items from more than one 
prescription. We now turn to the manipulation of data in preparation for additional analysis at 
further levels of investigation. 
Concerning analysis of advisory activity and medication, prescribed items may be classified 
by therapeutic use, pharmacological action or form of administration such as drops or 
tablets. Medications have a range of pharmacological actions and may be presented in 
combination in several products intended for varying routes of administration, however, only 
two options for therapeutic classifications are readily available, either the system used in the 
British National Formulary or, alternatively, the classifications used by the Department of 
Health. The latter was chosen as National figures are published allowing comparison with 
observed data and the former is not an exhaustive list of prescribed items. Further, the DofH 
classification has elements of route of administration and pharmacological action, for 
example "preparations acting locally onthe skin and mucous membranes" and "preparations 
acting on the nervous system" respectively. It is essentially a classification of prescribers' 
main intentions for the use of medicines. Specifically, the 1987 Drug Master Index, 559 which 
lists prescribed items with respective therapeutic classes and the accompanying explanatory 
folder which details the interpretation of the index 94 were used. Each medication was coded 
according to the schedule listed at the foot of figure 11, page 38 It was classification by this 
schedule which lead to figure 21, page 128. A total of 6,072 prescription items defined by 
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3778 forms were dispensed during the study period. The ratio of dispensed items to forms of 
1.61 is similar to published figures for England of 1.68 for the period 1988 560 An additional 
745 items were noted where the form was taken by customers for alternative dispensing, 
medication was left by customers to be collected later, items were owing from previous 
prescriptions, discussion included advice on previously prescribed medication, prescription 
medication was discussed OTC but no item dispensed, and items where CPs advised 
indirectly through the assistant. By considering the total of 6,817 discrete medications as 
cases (level 3), in other words, the total items which the CP was aware of, an appropriate 
measure of advisory activity relative to medication can be derived. Each case is defined as a 
'preparation event'. In this way a prescribed item is linked semantically to the potential for 
advice. In order to illustrate the coding scheme used it may be helpful to consider the 
following complete verbatim transcription. The customer (C), upon receiving the dispensed 
items from a CP (P), initiated the following discussion: 
C-P Can you tell me what these are for? (1) 
P-C Yes. These red ones (Erythromycin tablet. Community pharmacist shows the tablets 
on her hand) 
C-P Eh? 
P-C Red ones, that's an antibiotic (1) 
C-P Yeah 
P-C So it's important you take all of those (2) 
C-P Yeah 
P-C Alright? 
C-P (Nods) 
P-C Then there's some tiny purple ones. They're to help you breathe (1) (Ventolin 
tablets) 
C-P Yeah 
P-C When you feel a bit wheezy (2) 
C-P Yeah 
P-C That's when you have one of those 
C-P Yeah (Mumble, mumble) 
P-C Yeah, OK thenl 
C-P Thank you.... and no beer? (3) 
P-C Well, not too much. You can have a couple 
C-P Not too much. Thank you kindly 
P-C Alright 
C-P 'Bye, 'bye 
Two preparation events, or prescribed items, are noted in this example, Ventolin and 
Erythromycin tablets. Using the DofH therapeutic classification, Ventolin, whose active 
component is salbutamol a respiratory stimulant, was coded 052 and Erthyromycin, being an 
antibiotic, 088. Each prescribed items was linked to three categories of advice, 'What was 
prescribed' (1), 'What to do with it' (2) and 'Special problems' (3). These are illustrated in the 
example above In bold type with the aforementioned numbering. In addition, the customer 
was noted to have initiated discussion for both items concerning what was prescribed but the 
CP independently advised for both items what to do with them. Finally, the special problem 
of drinking concerning both items was initiated by the customer. In total the customer 
initiated two out of three categories of advice for each prescribed Item. Clearly, a preparation 
event can be linked with up to four categories of advice, "any number of which may be 
customer initiated. Table 47, page 256, illustrated by figure 17, page 120, concerns a level 
three analysis of preparation events and both CPs' advisoryactivity and customers' requests 
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for information. The effect of the poster on preparation events is also considered. Table 48, 
page 257, lists the 6817 preparation events by therapeutic class with a variety of level three 
analyses. Table 49, page 259, lists categories of advice by therapeutic class and details the 
level four analysis. This data is illustrated in figure 21, page 128, which also provides a 
comparison with the distribution of preparation events (level 3). Finally, table 50, page 260, 
details the analysis of category of advice and display of the poster (level 4). 
The following hypotheses are considered in the analyses of data presented in tables at the 
end of this section: 
H, for preparation events, advice does not depend on the CP involved; 
H2 that dispensing by observational study CPs may be generalised to a wider sample 
frame in terms of therapeutic class. 
H3 for preparation events grouped by therapeutic class, advice does not depend on the 
category of medication involved; 
H4 that the category of advice discussed did not depend on the therapeutic class of the 
medicine involved. 
H5 that the above hypotheses HI, H3 and H4 do not hold for customer initiated requests 
for advice; 
H6 that hypothesis H3 holds for both proactive and reactive CPs; 
H7 that display of the poster was not associated with changes In the frequency of CPs' 
advisory activity; 
H8 that display of the poster was not associated with changes in the therapeutic 
classification of medicines for which advice was provided; 
H9 that the category of advice discussed did not depend on display of the poster; 
H10 that the above hypotheses H8 and H9 hold for customer Initiated requests for advice; 
H11 that the category of advice discussed did not depend on the type of CP; and 
H12 that the category of advice sought did not depend on the type of CP. 
Taking each of the above hypotheses In turn. First, it is clear from table 47, page 256, that 
the frequency of advice for preparation events is dependent on individual CPs. Only five of 
the 20 observational study CPs had adjusted residuals for advice which were not significant 
(<±1.96) at the 95% confidence interval. In this case we are able to reject the null hypothesis 
and state that for the CPs in the study, the relative frequency of advice POls received for 
each prescribed item is very significantly dependent on the CP Involved. 
Second, table 48, page 257, columns three and four provide evidence that in the 
observational study, the distribution of preparation events by therapeutic class is not 
statistically different to that of dispensed prescriptions. In turn, columns four and five 
demonstrate a similar finding for prescriptions dispensed by observational study CPs when 
compared with dispensing in Great Britain for the same period. Therefore, the null 
hypothesis that the distributions by therapeutic class of preparation events, dispensed 
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medicines observed in this study and those dispensed in Great Britain are statistically similar 
can not be rejected. In this analysis, the 20 randomly chosen CPs are considered 
representative of CPs in Southern Derbyshire. Evidence to support such a stance is also 
presented in section A2.2.1, page 187. It is shown that attitudinally and in terms of structural 
variables, the 20 observed CPs are comparable with the 95 of the first survey of CPs in 
Southern Derbyshire. It is considered justifiable, therefore, to generalise the results of 
analysis based on categories of therapeutic class to the larger sample frame of Southern 
Derbyshire. 
Third, table 48, page 257, columns 12,13 and 14 reveal that advisory activity is dependent 
on therapeutic classification. Adjusted residuals locate the significance to a lack of 
information on preparations acting on the cardiovascular system (therapeutic class 4) and 
preparations used in diagnosis (therapeutic class 17) and dressings (therapeutic class 20). In 
contrast, significantly greater than expected frequencies of advice for; preparations acting 
systemically on infections (therapeutic class 8), preparations acting on the eye (therapeutic 
class 15), and, preparations for immunology (therapeutic class 16) were observed. It should 
be noted that implied confidence intervals for lack of information on preparations acting on 
the cardiovascular system (adjusted residual -6.1) and preparations acting systemically on 
infections (adjusted residual +12.8) indicate dramatic deviations from expected advisory 
activity. The null hypothesis is rejected and it is possible to state that for the CPs in the 
study, the relative frequency of advice POls received for each prescribed item is very 
significantly dependent on the therapeutic class of the medication involved. In this respect, 
seven of the 20 therapeutic classes in the analysis were significant contributors to this finding 
and two were outstanding. 
Fourth, table 49, page 259, provides a comparison of advisory activity for prescribed items in 
therapeutic classes at level three analysis, where medicine is a case (column 2), with that of 
a level four analysis where advice itself is a case (column 3). The mean of the ratios for 
observed activity of 1.43 and the standard deviation of 0.305 provide an Indication of the 
average multiplication factor between the two levels and the small variation between 
therapeutic classes. Table 49 columns four to 15 provide additional details of the relationship 
between advice in the four previously defined categories and the therapeutic class of 
prescribed medication. It is shown that category of advice is very significantly dependent on 
therapeutic class of medication. Significantly greater than expected frequencies were found 
for discussion on the side effects of preparations acting on the nervous system (column 6, 
therapeutic class 2) and to an even greater extent the side effects of preparations with 
hormone or anti-hormone activity (column 6, therapeutic class 9). Preparations acting on the 
gastro-Intestinal system (therapeutic class 3) were associated with significantly greater than 
expected frequencies of discussion concerning specific problems and preparations acting 
systemically on infections were similarly associated with discussion on what to do with it. The 
results of this analysis lead to the rejection of the null hypothesis and it is shown that 
category of advice is dependent on therapeutic class of medication. Significantly greater 
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than expected frequencies of discussion were noted for four combinations of advice and 
therapeutic class of medication. 
Fifth, table 47, page 256, indicates that, for preparation events, the frequency of requests for 
advice is dependent on individual CPs. Although the association was significant, the 
individual adjusted residuals reached significance for only three of the 20 observational 
study CPs. This is in agreement with the general finding that POI's requests for advice mirror 
the study sample population more closely than the total of advisory activity. Again, the null 
hypothesis is rejected, thus, for preparation events, customer initiated requests for advice 
are found to be very significantly dependent on CP. Table 48, page 257, columns 15,16 and 
17 follow a similar pattern to columns 12,13 and 14 and the null hypothesis Is again 
rejected. It can therefore be stated that, for preparation events, customer initiated requests 
for advice are found to be very significantly dependent on therapeutic class of medicine. In a 
further analysis, customer initiated requests for advice were tested for association with the 
therapeutic classes of medicines for which advice was provided (columns 15,18,19). In 
other words, of the preparation events which included advice the therapeutic classes of 
medications for which discussion was customer initiation were investigated. Considering the 
results of the analysis by comparing column 19 with 14, a significant reversal was noted for 
preparations acting systemically on infections. Further, POls requested significantly more 
information on preparations with hormone or anti-hormone activity than expected, however, 
requested relatively less that expected information on preparations acting on the 
cardiovascular system and preparations affecting allergic reactions (therapeutic class 13). 
These results may be interpreted as follows. Community pharmacists are significantly the 
main initiators of discussion concerning preparations acting systemically on infections and 
preparations affecting allergic reactions, but are also responsible for the lack of advice on 
preparations acting on the cardiovascular system. POIs are significantly responsible for 
initiating advice on preparations with hormone or anti-hormone activity. This interpretation is 
totally consistent with the results of the level four analysis of advice in table 48 columns 16 
to 18. The hypothesis H4 Is rejected and it can be stated that for advice, the category of 
customer initiated advice is dependent on the therapeutic class of the medicine Involved. 
Sixth, it can be seen from table 48, page 257, columns 20 to 25 that, of prescription events, 
observed advice was dependent on therapeutic class for both proactive and reactive CPs. 
From the adjusted residuals (columns 22,15) it can be seen that the overall lack of 
information on preparations acting on the cardiovascular system and the greater than 
expected frequencies of advice for preparations acting systemically on infections are due to 
both types of CPs. However, reactive CPs are responsible for the greater than expected 
proportion of advice for preparations with hormone or anti-hormone activity. This is a likely 
finding given that advice provided by reactive CPs generally is customer initiated. Such 
findings are consistent with a constant level of requests for advice on this topic irrespective 
of type of CP. The hypothesis that for preparation events grouped by therapeutic class, 
advice depends on the type of medication does not hold for both proactive and reactive CPs 
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is rejected. Evidence is provided for a constant and unexpectedly high frequency of 
customer initiated requests for information on preparations with hormone or anti-hormone 
activity. 
Seventh, table 47, page 256, shows that the quantity of advice provided by individual CPs is 
not dependent on display of the poster. A lack of statistical significance leads to rejection of 
the hypothesis and it can be said that display of the poster was not associated with 
statistically significant changes in the quantity of preparation events involving advice. 
Eighth, table 48, page 257, columns six and seven indicates that the distributions of 
prescription events in therapeutic class were the same whether or not the poster was 
displayed. This being the case, the lack of statistical significance for columns eight and nine 
leads to acceptance of the hypothesis that display of the poster was not associated with 
changes in the therapeutic classification of medicines for which prescription medication was 
provided. 
Ninth, the analysis presented in table 50, page 260, columns one and two indicates that 
display of the poster was very significantly associated with changes in the distribution of 
categories of advice. Examination of the adjusted residuals for display of the poster shows 
significantly greater frequencies of discussion for side effects and specific problems and 
significantly less for what is prescribed. The null hypothesis is rejected and category of 
advice is shown to depend very significantly on display of the poster. 
Tenth, following on from the findings for hypothesis H8, the lack of statistical significance for 
columns 10 and 11 of table 48 indicates that the null hypothesis can not be rejected. Thus, 
when the poster was displayed the therapeutic classification of medicines about which 
customers initiated advice did not alter. In contrast, for H9, it is shown in table 50 columns 
three and four that for customer initiated discussion category of advice was significantly 
dependent on display of the poster. In this case the null hypothesis is rejected. 
Eleventh, Consider the following findings; customer initiated category of advice is dependent 
on therapeutic class of medicine and reactive CP are customer lead with respect to the 
advice provided. As proactive and reactive CPs are likely to dispense similar quantities of 
therapeutic classes of medicines and significant differences have been found for therapeutic 
class between customer initiated and overall advice, then it is reasonable to suspect a 
significant difference between the categories of advice provided by the two groups. 
Specifically, it was noted that proactive CPs are responsible for the unexpectedly high 
quantity of advice concerning preparations acting systemically on infections (table 48) and 
that this was specifically advice on what to do with it (table 51, page 260). Thus, it would be 
reasonable to expect that any differences between types of CPs would include a significantly 
greater than expected quantity of advice for the category 'What to do with it'. Table 51 
confirms these suppositions and summarises the differences between types of CPs with 
254 
respect to their advisory activity. The null hypothesis is rejected and it is shown that category 
of advice is dependent on type of CP. 
Twelfth, following on from the discussion of the previous hypothesis and with hindsight that 
customer initiated advice appears quantitatively to be consistent across both types of 
community pharmacies, it might be expected that category of advice would be independent 
of type. Table 52, page 261, provides a level four analysis which confirms this suspicion. 
However, it is noted that customer initiated advice on side effects is significantly more 
associated with proactive CPs. Advice on side effects was also related to specific therapeutic 
classes of drug, namely preparations acting on the nervous system and preparations with 
hormone or anti-hormone activity. Consistent with the expected result, the null hypothesis is 
not rejected and of customer initiated requests for information, category of advice is not 
dependent on type of CP. Specific significance was noted for greater than expected requests 
for advice on side effects from proactive CPs. 
In summary, this section considers the relationship between the total possible medicines CPs 
were aware of and both the provision of and requests for, advice. Categories previously 
defined were used to qualify the types of advice and medicines were grouped by recognised 
therapeutic classification. Evidence based on analyses presented at the end of the section 
was presented to determine the statistical justification for a series of hypotheses. Each of 
these was considered in turn and the findings summarised at the end of the paragraph. 
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Table 50 
Associations of catego ry of advice, initiation of advice and display of poster 
Variable analysed for independence* 
Pres cription medication advice Customer initiated advice 
Category of advice Poster displayed Poster di splayed 
Yes No Yes No 
Columns 12 3 4 
'Side effect' 33 21 18 12 
Expectedf 25.9 28.1 14.2 15.8 
Adjusted residual +2.0 -2.0 +1.5 -1.5 
'Specific problems' 62 45 25 15 
Expectedf 51.4 55.6 18.9 21.1 
Adjusted residual +2.2 -2.2 +2.2 -2.2 
What is prescribed' 68 97 26 41 
Expectedf 79.2 85.8 31.6 35.4 
Adjusted residual -2.0 +2.0 -1.7 +1.7 
What to do with it 198 228 23 35 
Expectedf 204.5 221.5 27.4 30.6. 
Adjusted residual -1.0 +1.0 -1.4 +1.4 
Totals 361 391 92 103 
test n 752 195 
DF 3 3 
Chi-square 11.39858 8.94893 
Probability 0.00975 0.02998 
Notes 
"= Individual categories of advice are cases. 
Table 51 
Associations of category of advice and type of community pharmacist* 
Type of community pharmacistt 
Category of advice Proactive Reactive 
Columns 12 
'Side effect' 38 16 
Expectedf 40.4 13.6 
Adjusted residual -0.8 +0.8 
'Specific problems' 68 39 
Expectedf 80.1 26.9 
Adjusted residual -2.9 +2.9 
What is prescribed' 111 54 
Expectedf 123.5 41.5 
Adjusted residual -2.5 +2.5 
What to do with it' 346 80 
Expectedf 318.9 107.1 
Adjusted residual +4.6 -4.6 
Totals 563 189 
test n 752 
DF 3 
Chi-square 22.05834 
Probability 0.00006 
Notes 
"= Individual categories o f advice are cases. 
t= Proactive includes pha rmacy number nine. 
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Table 52 
Associations of category of advice sought and type of community pharmacist* 
Type of community pharm acistt 
Category of advice Proactive Reactive 
Columns 1 2 
'Side effect 20 10 
Expectedf 14.5 15.5 
Adjusted residual +2.2 -2.2 
'Specific problems' 19 21 
Expectedf 19.3 20.7 
Adjusted residual -0.1 +0.1 
What is prescribed' 31 36 
Expectedf 32.3 34.7 
Adjusted residual -0.4 +0.4 
What to do with it' 24 34 
Expectedf 28.0 30.0 
Adjusted residual -1.2 -1.2 
Totals 94 101 
test n 195 
DF 3 
Chi-square 5.28614 
Probability 0.15200 
Notes 
*= Individual categories of advice are cases. 
t Proactive includes pharmacy number nine. 
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A3.1.3.2 Specific problems 
This section deals with the coding of the special problems advisory category. Table 53 below 
lists the total discrete topics of advice categorised under this heading. This detail is provided 
to demonstrate the variety and extent of CPs' advisory role. Further quantitative analysis was 
considered unlikely to be of use as many case frequencies were unique. It should be noted 
that the observed discussion between POls and CPs may have included several areas of 
advice coded as specific problems, however, the individual was only counted once even 
when advice was a case. 
Table 53 
Algorithm for allocation of specific problems as a category of advice* 
Problem implying judgement 
Specific 
Problems 
propriate 
'scnbina 
on what to prescribe 
Direct 
iption reiatea 
fitmed interacts with 9imed 
Kmea interacts with yIc fitem 
me or item interacts with Alcohol 
he-Counter 
OTC item interacts with OTC item 
Frequency $ 
7$ 
3 3$ 
4 2t 
5 7$ 
6 22$ 
7 18$ 
81 
94 
10 1 
11 11$ 
12 2 
13 1 
Referral to GP 
relates to prescribed medication 
relates to minor medical advice +1- pro uc 
relates to sale of product 
Referral to Chiropodist 
Enquiry and advice "have you had these before" 
Answer, "yes" 
Further information given `' 
No further information given 
Enquiry and advice "have you had these beFor-F7 "No 
Check implying concern 
Check other tablets prescribed/medication, 
L; heCK how ime is being taken 
Problems concerning supply 
l Prescription altered 
Method of communication 
ro riate use of prescribed medication Code t 
Medical use I 
Pharmaceutical use 2 
14 1 
15 10$ 
16 18 
17 4 
ýe implying concern 
Change in appearance of 91med 
18 5 
19 4 
20 1 
21 2 
22 6$ 
23 1 
24 it 
25 7$ 
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Us of drug not specified on % Code t Frequency$ 
1 Judgement on form (cr/oint, tab/cap, soIfinsoI) 26 9 
tJudaemen on close 27 47 
Details of prescribed item not specified on 'R 28 5 Judgement on size, type of stockings/shoes 
Detai s of drug specified u altered 
Judgement on form, dose, content 29 7 
Method I Discussion by phone 30 14 
communication 
General practitioner advises customer 
To obtain OTC item from harm ac 31 1 
To ask pharmacy to stock specific 
ýOM 
32 1 
Research 
Opinion of poster and pharmacist's role 33 1 
iscellaneous Radio microphone noticed 34 1 
Over-the-Counter 
Pharmacist notices OTC sale 35 1 
Pharmacist tails to notice OTC sale 36 1 
Pharmaceutical opinion sought 
Stability of dispensed item 37 2$ 
preferable brand of item 38 1 
Correctly isoense v another p armacv 39 1 
)ac ing 40 1 
New code= Combination of Frequency 
previou s codes 
41 = 1 +11 3 
42 = 1 +11 +30 1 
43= 1+12 2 
44 = 1 +27 2 
45 = 1 +28 1 
46 = 1 +29 1 
47 = 1 +30 
48 = 3+12 2$ 
49 = 4+12 it 
50= 6+12 2 
51 = 8+13 1 
52 = 9+12 1 
53= 9+30 1 
54 = 11+27 
55 = 11 +30 it 
56= 12+14+18 1 
57= 12+18 1 
58 = 12+26 1 
59 = 16+27 1 
60 = 16+29 1 
61 = 17+25 it 
62 = 17+27 
63 = 19+34 1 
64 = 26+27 1 
65= 29+30 1 
Notes 
"= Specific problems used to denote all medication advice which is not categorised using the 
headings 'Side effects', 'What is prescribed' or'What to do with it'. 
t= Code used to identify specific problems as topics of discussion. This was necessary as 
discussion coded as 241 included more than one topic. For each code the matching 
frequency of observed discussion is listed. 
$= Frequency of individual topics of specific problems. Only direct or indirect conversations 
between CPs and POls are included. A total of 137 topics or combinations of topics were 
noted during discussions with CPs. This number may be reduced in analysis if, for example, 
advice did not coincide with ward data. 
§= Excludes one case of discussion concerning OTC medicine and alcohol. 
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A3.1.3.3 What to do with it 
This section deals with additional quantitative and qualitative data on the category of advice, 
'What to do with it'. Table 54 lists the various roles identified with such advice. 
Table 54 
Roles for community pharmacists identified from verbal discussion 
categorised under the label 'What to do with it' 
Role II Comment and verbatim examples 
Reiteration of Community pharmacist verbal reiteration of the prescribers' 
prescribers' dosage and frequency directions. 
labelling eg 
instructions P-S There you are one, one a night. 
2. Reiteration of Community pharmacist verbal reiteration of British National 
additional Formulary additional labelling instructions. 
labelling eg 
instruction P-S You just have to swallow them whole and umm don't 
take indigestion medicines same time as you swallow 
them. Thank you bye bye. 
3a. Unique pharmacy Advice concerning pharmaceutical aspects of administration 
advice which include, for example, details on storage or physical 
management of the dosage method. 
eg* 
P-S No, just spread it on don't be too heavy handed with it. 
3b. Unique pharmacy Advice which includes judgement by the CP. This includes 
advice information which is; provided in the absence of any officially 
sanctioned direction, neither an exact reiteration of the 
prescribers instruction nor a variation of the additional 
labelling recommendations. 
eg 
P-S Can you drink plenty of fluid. 
Notes 
*= This advice is a version of the BNF 376 recommendation that topical steroid 
preparations are "to be applied sparingly". That the wording is changed is the 
responsibility of the CP which altered the appropriate role from 2 to 3a. 
To help place the identified roles in context the following verbatim transcript is presented. 
The customer (C) was a female Caucasian who presented to the CP (P) one prescription for 
herself and one for her husband. At no stage was she observed to have noticed the poster. 
Both were of pensionable age and the customer signed each prescription appropriately. The 
CP handed the dispensed items to the customer saying: 
P-C One four times a day about an hour before food (Penicillin -V capsules) C-P Before food 
P-C Yes and that's for Mr G (p # S, person accompanying customer) one three times a day (Propranolol tablets 10mg) 
C-P Yes 
P-C It's best if you can space these (Penicillin - V) out about every six hours around the 
clock 
C-P About six hours 
P-C Yes 
C-P And I have'em before me meals? 
P-C About an hour before your meals on an empty stomach 
C-P Alright thank you 
P-C Thank you 
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In the first sentence the CP reiterates the label instructions then adds information sanctioned 
by the BNF 376 advisory label instructions. The customer provides verbal confirmation of 
understanding then the CP reiterates label instructions for the second prescription. Following 
this the CP provides a value judgement as to the appropriate administration of the antibiotic 
penicillin - V, an understanding of which the customer subsequently confirms. This case 
exemplifies three identified verbal advisory roles (table 54, page 264,1,2 and 3b) which CPs 
undertake. In this case the customer was identified with all three roles but only once for one 
of the four categories of advice. There was not considered to be a great variation in 
discussion content categorised under this heading. Between CPs, a consistent policy of 
activity was found. As further qualitative evaluation was considered unlikely to greatly 
improve the depth or understanding of the advisory process concerning this category of 
advice and sufficient data had been collected, it was decided to limit further analysis to an 
elaboration of quantitative differences between types of CPs. The following two hypotheses 
were considered in the analyses presented in table 55, page 267: 
H, that the frequency of advice identified as discrete roles for the advisory category 
'What to do with it' is not dependent on type of CP; and, 
H2 that unique pharmacy advice which includes judgement is not dependent on the type 
of CP. 
It can be seen from the analysis presented in table 55 [A], that half of the 348 POls received 
advice identified by role one (table 54). Further, that proactive CPs provided a very 
significant proportion of such advice. No similar dependencies were found for CPs' roles in 
reiteration of advisory labelling (table 55 [B]) or the total of unique pharmacy advice (table 55 
[C]). The first hypothesis is rejected only for the specific role of reiteration of prescribers' 
instructions. 
In table 54, page 264, the third role was split into two parts. It is interesting to note that 119 
POIs received advice which was neither sanctioned by the prescribers written Instruction or 
the BNF 376 additional labelling nor concerned pharmaceutical administration or storage. The 
second hypothesis contends that this most judgmental of CPs advice is not dependent on 
type of CP. Table 55 [D] details a level four analysis, where advice is a case, which 
compares the 119 with the remaining 341 cases of advice in this category and the 
distributions of each for proactive and reactive CPs. A trend was shown for advice of an 
unsanctioned, uniquely pharmacy nature to be dependent on the type of CP. Reactive CPs 
appear to be proportionally more involved in role 3b activities. The second hypothesis is not 
rejected. It should be noted that details of customer initiation of advice in specific roles was 
not coded in the original data and no statement regarding this can be made. 
In summary, three primary roles were identified for CPs in providing advice under the 
category 'What to do with it'. Of these, unique CP advice was further divided to identify a role 
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which was essentially judgmental in nature where specific guidelines were not available for 
direction. An example was presented to demonstrate the roles which exist and the coding 
structure. Analysis of the coded data lead to partial rejection of the hypothesis that the 
frequency of advice in each role was not dependent on type of CP. It was found that 
proactive CP were significantly responsible for the frequency of reiteration of prescribers' 
directions. Of the advice provided, that of a judgmental nature was found to be more 
prominent for reactive CPs than for their proactive colleagues. 
Overall, proactive CPs provide the lions share of advice concerning 'What to do with it' but it 
is mainly of a reiterative nature. Where unique and judgmental CP advice is provided there 
is less of a distinction between the two types. 
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Table 55 
Independence of advice and type of community pharmacist 
Type of community pharmacist* 
Proactive Reactive n Chi-square probability 
Dependent variable 
(A) Role 1. 
Reiteration of prescribers' labelling 
instructions 
Yes 152 22 348 6.91175 0.00856 
Expected f 142.0 32.0 
No 132 42 
Expected f 142.0 32.0 
(B) Role 2. 
Reiteration of additional labelling 
Yes 89 15 348 1.20165 0.27299 
No 195 49 
(C) Role 3. 
Unique pharmacy advice 
Yes 139 35 348 0.47865 0.48903 
No 145 29 
(D) Role 3b. 
Unique pharmacy advicet 
Yes 93 26 460 3.08887 0.07883 
Expected f 99.6 19.4 
No 292 49 
Expected f 285.4 55.6 
Notes 
Type includes pharmacy number nine as proactive. 
t= For contingency tables A, B and C POl s are cases. In the case of D, advice Is a case for 
analysis. 
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A3.1.4 Qualitative 
A3.1.4.1 Side effects 
This section details a qualitative assessment of discussion between CPs and POls 
concerning side effects of prescribed medication. 
Following published guidelines as to methods of data reduction 387 relevant transcripts of 
discussion were first ordered by case number and printed in one large single list. This was 
inspected for patterns or trends then rearranged in cells as to whether the CP was proactive 
or reactive and whether the poster was displayed or not. The qualitative matrix of poster and 
type was intentionally designed to mimic a 2x2 contingency table as follows; 
Posters 
Type 
Displayed Not displayed 
Proactive 
CP CELL A CELL B 
Reactive 
CP CELL C CELL D 
In the next stage of data reduction common themes in each cell were extracted with 
examples. These were listed in context together with postulated explanations (table 56, page 
270). Having described the common themes in the four cells, unique themes in each cell 
were collated (table 57, page 271). These provided a qualitative evaluation of any 
differences between proactive and reactive CPs' advisory activities and relationships with the 
poster. The results may be summarised as follows. More complicated interactions concerning 
side effects appear to be entered into when the poster is displayed although this could be an 
artefact of the limited numbers of interactions without the poster. Reactive CP, as expected, 
are asked for specific details on side effects rather than volunteering advice. They appear 
not to get involved in discussion on steroids. Reactive CP dispensed 17 steroid items, 
proactive 26. Overall, discussion on side effects appears to be incorporated In general 
discussion on medication, rarely is It the main topic unless as part of the additional labelling 
recommendations for the drug. Community pharmacists volunteer limited Information on 
prescription medication side effects, sedation and gastric effects are prominent areas of 
discussion but are keen to recommend the general practitioner if patient compliance Is an 
issue or they perceive anxiety over possible side effects. POls appear to react to 'cues' In 
requesting advice on side effects of prescribed medication as predicted in figure 15, page 95, 
but the cue appears based more on the medication than the type of CP (section A3.1.3.1, 
page 249). 
In summary, the following four common roles were identified for both proactive and reactive 
CPs discussing side effects with POls: 
268 
1. educational/informative: short "robot-like" monologues by the CP informing of 
possible side effect, usually drowsiness or gastric upset as part of the additional 
labelling recommendation for the drug; 
2. confirmatory: confirmation by the CP of a link between medication and side effects; 
3. 
4. 
compliance: use by the CP of side effects, usually gastric, to increase the likelihood 
of compliance with directions; and, 
socialising: CP possibly responsible for socialising customers to be wary of specific 
side effects of drugs which have implications on everyday activity. 
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Table 56 
Four common themes for discussions concerning the side effects of 
medicines between community pharmacists and prescription orientated 
individuals* 
(1) Educational/informative 
Short "robot-like" monologues by the CP informing of possible side effect, usually drowsiness or 
astric upset as part of the additional labelling recommenaanon Tor me arug. 
Examples Circumstances Rationale 
Cell A: . they, 
they will cause drowsiness, so no Monologue Community pharmacist 
alcohol and be careful driving initiates discussion to allay 
Cell B: "they might make her feel a little bit fears, prevent litigation, as a 
sleepy" 'safe bet or automatic, 
Cell C: "It um.. might make him a bit dopey" 'robot-like'. 
Cell D: No cases recorded. 
(2) Confirmatory 
ConTlrmatlon D [ne Gi- or a UnK oetween 111ruiaauv11 01W awv auc%, w 
Examples Circumstances Rationale 
Cell A: "Yeah, it does say it can make you a bit Customer states Allay fears, forms a part of 
sleepy" side effect, CP the discussion, rarely 
Cell B: "Yeah, they can have that effect" confirms link. Part central to 
Cell C: "Drowsiness is quite likely.... yes" of complicated discussion. Informative 
Cell D: "It's harmless, yes-won't do you any dialogue. rather than directive. 
harm" 
(3) Compliance 
Use by the CP of side ettects, usually gastric, to increase me uicennooa or compuance witn airecuons 
Examples Circumstances Rationale 
Cell A: "sip it otherwise you might feel sick" Dialogue with Informing of side effects to 
Cell B: "Sometimes people have trouble with discussion on promote compliance with 
them Irritating the stomach then... then they "how to takeit" medication. Discussion of 
space them out" followed by the the form 'do it or else! ' Also, 
Cell C: "after food otherwise they'll give you a consequences. to indicate why medication is 
very taken in a specific manner 
bad er... indigestion" 
Cell D: "if you take them on an empty stomach, 
they 
do tend to make you a bit sick))(' 
(4) Socialising 
Community pharmacist possibly responsible for socialising customers to be wary of specific side 
effects of drugs which have implications on everyday activity. 
Examples Circumstances Rationale 
Cell A: "He's not fit to drive Customer initiated, relates to Implication that CPs' constant 
really" dispensed medication reiteration and labelling of 
Cell B: "Be alright driving won't medicines as having a sedative 
you? " side effect has socialised 
Cell C: "Driving isn't affected is customers o consider this 
it, aspect of medication. 
Cell D: No examples of 
customer initiated discussion. 
Note 
"= The data has been arranged in a qualitative matrix of poster and type of CPs designed to 
mimic a 2x2 contingency table. Cell A includes discussion by proactive CP when the poster 
was on display, cell B with no poster. Similarly, cell C considers discussion between reactive 
community with the poster displayed and cell D without the poster. 
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Table 57 
Unique themes in discussions between community pharmacists and 
customers concerning side effects of medicines 
tr 
fC 
5 
i 
r 
E 
Poster Displayed No Poster 
CELL A CELL B 
Complicated scenarios usually involving Discussion on steroids related to 
steroids where the customer's fear of the informing CP of medication rationale or 
consequences of side effects is obvious justification of dosage change. Advice 
"they (steroids) won't hurt him will they", seeking activity "cued" from previous 
specific details of the side effects are not interactions involving side effects. Fear of 
given. drug dependence "don't want to get 
addicted" 
Proactive 
CP Relationship to GP Relationship to GP 
Customer's anxiety over side effects is Community pharmacist indicates 
referred to GP, "let him (GP) know your appropriate activity of GP, "I don't think 
little bit worried" rather than details on he intends you to" (become addicted) 
incidence of side effects provided. Side 
effects considered sufficient to warrant 
contacting GP over appropriate 
rescribin . CELL C CELL D 
Direct requests for information on side Direct requests for Information on side 
effects "any side effects with these? " leads effects 'is there any side effects? " 
to lengthy discussion. Advice seeking Discussion initiated by dosage problem 
activity "cued" from; poster, "I'm just or product palatability. Discussion on side 
Reactive looking at that (poster), are there any side effects linked to supply aspect of 
CP effects.... " and CP's activity "I saw you dispensing. Possibly as this forces an 
looking in the book you see". interaction and the CP includes 
information on side effects as 
Relationship to GP compensation for inconvenience or 
Discussion on side effects reveals a lack of justification of dosage. 
compliance, CP refers customer to GP. 
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A3.1.4.2 What is prescribed 
This section details the results of a qualitative analysis of discussion categorised under the 
heading of 'what is prescribed'. Using the analytical method described in the previous 
section, three roles were found to be consistent across both types of CPs whether or not the 
poster was on display. The results are summarised in table 58 below. 
Table 58 
Roles identified for discussions between community pharmacists and 
prescription orientated individuals concerning the category of advice 'what is 
prescribed' 
Role Description Example* 
EDUCATIONAU Identification of prescribed P-S "Then your antibiotics, two 
INFORMATIVE preparations other than three times a day for the first 
reiteration of brand or two days, then reduce it to one 
generic name, three times a day'till they're all 
gone" 
Identification of a P-S "Just antibiotics there for a 
pharamcological class or a week, OK? " 
specific example within a 
class. P-S "That's the penicillin for J.... " 
Identification of a P-S "This is the one for nausea" 
prescribed preparation by 
is therapeutic use. 
Identification of the active P-S "It's a very well balanced er 
constituents of a (laughs) and tried formula, 
prescribed preparation. you've got two Ingredients in 
one capsule which you would 
normally have separately" 
CONFIRMATORYt Confirmation of possible P-S Yes, it's a special type of 
uses for prescribed penicillin for skin infection this 
preparations one (flucloxicillin) 
INTENT Explanation of what a S-P What are Brufen (Brand name) 
preparation is prescribed for? 
for and/or "how it works". P-S Joint pain 
The main theme to 
describe what the 
preparation does not to 
mearly associate the 
preparation with a 
therapeutic action 
Notes 
*= Included as examples are excerpts from discussions where the main theme is 
identification of the prescribed item. Examples may exemplify more that one role. 
t= Implies prior knowledge which requires ratification. 
An assumption is made in the first two roles that POls are able, or have been educated, to 
link descriptive terms such as 'antibiotics' with therapeutic intent, in this case treatment of 
Infection, thus Information on what the prescribed preparation is for may be relayed by 
reiteration of the pharmacological grouping of the medication. This is not the case for the 
latter role of 'intent'. A total of 32 cases of 3519 POIs were recorded where discussion 
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included 'intent'. Of these 19 involved proactive CPs and 13 reactive. It is considered from 
empirical assessment of table 58 that, of the three roles, 'intent' is the one which implies the 
greatest unique judgmental contribution by CPs to POI drug therapy. It is this role where the 
information content provided is not clearly defined by the prescribed item. 
In summary, a qualitative evaluation of CPs 'controlling' for type and display of the poster 
identified three common roles for CPs concerning advice on 'what is prescribed'. Of the three 
roles advice including the 'intent' of prescribed medication was considered to contain the 
largest degree of judgement on the part of the CP. 
trt. a 
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A3.1.5 Effect of the poster 
This section considers two further aspects of the poster in the observational study, first, 
difficulties of observation and second, validation of a possible relationship of poster efficacy 
with POls' age. 
First, it has been shown in previous sections that overall the poster had no statistically 
significant effect on the prescription handling activities of CPs (section A3.1.2, page 227) or 
the total quantity of advice provided, but, that the pattern of advice was significantly changed 
(section A3.1.3.1, page 249). In these analyses the poster on display was the criteria for 
dividing the data. It can be argued that for the poster to have a wider use in promoting 
interactions between POls and CPs then it must succeed or fail on the basis of its presence. 
There is, however, a fundamental problem that the poster requires to be seen prior to 
discussion concerning advice in order to have had an influence. In collecting the data, an 
attempt was made to record if POls noticed the poster and exactly when such inspection 
took place relative to presentation of prescriptions and advisory activities of CPs. In this way 
it was hoped to collect data equal in content to that proposed in section A1.2, page 168, but 
directly observed and, therefore, valid. The criteria adopted for positive internalisation of the 
information presented was that individuals' eyes were observed to at least scan the content 
of the poster. It is acknowledged that "differences in eye movement characteristics between 
goal-relevant and incidental text are not simple predictors of differences in learning between 
goal-relevant and incidental information" 561 and it is an assumption In this study that 
observation of scanning eye movements implies understanding of the information. The 
following hypothesis was tested for using the available data: 
H1 that display of the poster had no effect on the numbers of Pols initiating discussion 
11 on a prescription medication. -" 
Table 59[A], page 276, presents results of a level one analysis of the data for customer 
Initiated discussion and display of the poster. On the basis of this result the null hypothesis 
would not be rejected and it was felt that data could be legitimately aggregated. If, however, 
the distribution of those individuals observed to scan the poster and the proportion who 
subsequently requested advice is compared to the remaining POls in the study and their 
information seeking activity, then customer initiation becomes very significantly dependent 
on display of the poster (table 59[B]). Of the 1724 POls who had the opportunity to scan the 
poster, 668 (38.7%) were observed doing so and of these, 51 (7.6%) initiated discussion on 
one or more of the four categories of advice. In comparison with the remaining data, which 
Included 234 individuals who glanced at the poster without clearly scanning the content, only 
28.7 of the 668 were expected to initiate discussion, In short, there is an addendum to the 
above hypothesis that, although display of the poster had no statistically significant effect on 
the overall numbers of individuals initiating discussion on a prescription medication, those 
who were observed to scan the poster were more likely to request advice than those who did 
not. Clearly, the additional 22 whole individuals (51-28.7 approximately) was not sufficient to 
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produce an overall statistical significance in the global analysis. That the category of advice 
was associated earlier with significant change, testifies to a relatively great effect of the 
poster on a few individuals. 
A major shortfall in the realisation of the potential of the poster to effect POIs' activities may 
simply have been that it was not seen. This limitation was, in part, forced by the 
observational study methodology which allowed CPs freedom to positioned the poster as 
they felt appropriate and their choice may not have been ideal from a potential readers 
perspective. Of the 1724 POls who entered community pharmacies during the observational 
period with the display in place, 1436 had the opportunity to scan an A2 size poster displayed 
on a purpose build stand, 200 may have seen an A3 size poster used as the surface upon 
which prescriptions were written and 88 may have noticed an A3 size poster on the side of 
the dispensary till. 
Second, it will be remembered from section A2.3.3, page 220, that age was related to choice 
of poster. Respondents less than or equal to 55 years of age responded more favourably 
than those older in choosing poster C, although, the difference was not statistically significant 
as measured by the adjusted residual of 1.6 (table 33, page 219). A potential validation of 
this finding would be if customer initiated requests for advice from prescription medication 
orientated individuals who scanned the poster were observed occurring significantly more 
often from younger persons. The relevant hypothesis is that: 
H2 customer initiated requests for advice are independent of age. 
Using the same age split as described in section A3.1.2, page 227, males Z65 with females 
z60 and males <65 with females <60, table 60[A], page 276, indicates that, of the 3516 POls 
for whom data was available, there was no dependence for noticing the poster on age; 
however, of those who scanned the poster, initiation was very significantly dependent on age 
(table 60[B]). Moreover, the older age group were observed asking for information more 
frequently than expected which is in direct contrast to the expected result. This result fails to 
confirm a bias for younger people to react to the poster, however, indicates that age Is 
associated with reacting to the poster's message. A practical limitation of this analysis is that 
different age groups were compared. Results of this analysis lead to rejection of the null 
hypothesis. It can be stated that, for those who scanned the poster, customer initiated 
requests for advice was dependent on age. Caveats for this statement are that the poster 
was scanned and that age groups were specifically defined. It is also noted that the effect of 
the poster in increasing customer initiated advice for the total data was not significant. In 
summary, overall the poster has been show to have had a limited effect on advisory activity. 
The current analysis points to a specific effect of promoting older POIs to seek advice and to 
a greater than realised potential for the poster. 
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table 59 
Independence of customer initiated requests for advice on display of the 
poster 
Independent vari able 
[A] Display of the poster [B] Scanning of the poster 
Customer initiated requests 
for advice Yes No Yes No 
No 1646 1722 617 2751 
Expectedf 1650.0 1718.0 639.3 2728.7 
Yes 78 73 51 100 
Expectedf 74.0 77.0 28.7 122.3 
n 3519 3519 
Chi-square value 0.34372 21.45301 
Significance 0.55769 0.00000 
table 60 
Independence of scanning the poster or customer initiated requests for 
advice and age 
Dependent variable* 
[A] Scanned the poster [B] Initiated advice 
Independent variable 
Age Yes No Yes No 
Age males <65, females <60 474 2095 28 446 
Expectedf 36.2 437.87 
Age males 465, females z60 194 753 23 171 
Expectedf 14.8 179.2 
n 3516t 474 
Chi-square value 1.73207 6.089631 
Significance 0.18815 0.00858 
Notes 
*= The dependent variables noticing the poster and initiating advice are given the y axis 
for ease of presentation. 
t= Three missing values for age. 
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A3.2 Labelling 
This section considers the non-verbal advisory activity related to labelling of prescribed 
items. 
As part of the observational study, a time was identified during the morning dispensing period 
when at least 25 items were dispensed and waiting to be collected. Details of a selection of 
25 consecutively dispensed items were recorded. It was noted whether additional labelling 
was advised 294 for each prescribed medication and whether one or more appropriate 
additional directions were included with the label. Further, the labelling machinery was noted 
as to whether such information was automatically printed when the medication was entered 
into the word processing system or whether additional labelling required the physical 
adherence of separate labels. This was confirmed by asking the CP at the end of the final 
observational period to print labels for four items. These were selected because at least one 
unique additional label is advised 294 for each and they were a legitimate combination having 
been previously prescribed and dispensed by the researcher during early piloting of the 
research method. It was observed that each CPs made a point of preparing the labels and in 
each case the BNF 294 was consulted for the appropriate advisory labelling information. The 
four items were: 
1. metronidazole tables 200mg, 1 tds x 30. 
2. propranolol tables 10mg, 1 tds x 100; 
3. pondocillin tables, 1 tds x 30; and, 
4. diazepam tables 2mg, 1 tds x 30; 
Each item was indicated for administration three times a day (1 tds) and the results are 
provided in table 61, page 279, column six. In a separate study, individual CPs' labelling 
policies were determined using the ratio of the number of items out of 25 for which the BNF 
recommended one or more advisory labels 294 and the number of dispensed items bearing at 
least one such label (table 61, column 5). The distribution of ratios was examined and found 
to be bimodal with a median of 33.33. Community pharmacists with ratios equal or less than 
this figure were designated as having 'low' rates of labelling. The remainder were considered 
to have 'high' rates. Two hypotheses central to this data were: 
Hi. that CPs' verbal advisory activity is not related to their use of written additional 
labelling; and, 
H2. that the use of non-verbal additional labelling was not related to the use of automatic 
printing systems. 
Empirical assessment of table 61 columns two and seven indicates that CPs' policies for 
labelling are unlikely to be related to verbal advisory activity. The rate of verbal advice was 
divided as in section A3.1.3.1, page 249. Analysis presented in table 62, page 279, confirms 
this expectation. It was not possible to reject the null hypothesis and, for the observational 
study CPs', verbal advisory activity was not found to be statistically related to labelling rate. 
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In contrast, no CP whose labelling policy was considered 'high' used a machine that did not 
automatically produce appropriate labelling information. In other words, if the prescription 
label was not automatically printed with the additional information, CPs did not adhere sticky 
labels to provide the recommended non-verbal advice. Analysis (table 62, page 279) 
revealed a statistical significance for 'low' and 'high' labelling policy and whether the labelling 
machine automatically printed additional information. In this case the null hypothesis is 
rejected and it is possible to state that CPs' rate of additional labelling of prescribed 
medication is significantly different and related to the capacity of the labelling system to 
automatically produce such information. Further analysis of the distribution of ratios revealed 
a mean of 40.7 and a standard error of 7.42 - 500 possible items (25 items x 20 CPs), 110 
items of 270 (40.7%). 
In summary, CPs' rates of appropriate use of advisory labels was investigated. It was found 
that their policies for including advisory labelling with dispensed medication was not related 
to their verbal advisory activity but was related to the capability of labelling devices to 
automatically include such information. 
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Table 61 
Community pharmacists' additional labelling activity* 
Pharmacy Rate Label Item with Ratio label Label 
of advised Z1 label Advise/ machine policy 
PMA by BNF present observed automatic 
Column*t 1 2 3$ 4 5 6 7 
4 13.0 15 0 0 Yes Low 
9 3.7 18 0 0 No Low 
12 5.0 9 0 0 Yes Low 
19 3.3 15 0 0 No Low 
20 25.1 13 0 0 No Low 
13 4.7 16 1 6,25 No Low 
15 7.9 13 2 15.38 Yes Low 
18 11.8 13 4 30.77 No Low 
2 1.3 15 5 33.33 Yes Low 
3 0.0 9 3 33.33 Yes Low 
17 2.6 15 5 33.33 Yes Low 
11 9.6 12 7 58.33 Yes High 
10 2.6 8 5 62.50 Yes High 
16 5.7 11 7 63.64 Yes High 
1 4.5 11 8 72.73 Yes High 
5 16.0 8 6 75.00 Yes High 
6 6.7 14 11 78.57 Yes High 
7 6.2 20 16 80.00 Yes High 
8 38.6 17 14 82.35 Yes High 
14 17.8 18 16 88.89 Yes High 
Notes 
Based on a sample of 25 consecutive dispensed items. One or more written abels were 
recommended for 54% of dispensed medication. 
t= For column 1 pharmacies are Identified by their alphabetical order but are listed In order of 
the ratio in column 5. The latter value is calculated by dividing the number of items for which 
the BNF 294 advised one or more additional labels by the number of labels observed to have 
such information. Column 7 identifies the 'low' and 'high' adherers to additional labelling 
directives based on those 11 less that or equal to the median value of 33.33 for column 5 
compared to those nine over this value. 
$= Column three sums to 270 with an average of 13.5 
Table 62 
Independence of community pharmacists' labelling policy and selected 
variables 
Independent variable* 
Labeller automatically Type of community pharmacist 
produces additional 
Information 
Policy of pharmacist 
Yes No Proactive Reactive 
'Low' labellers 6547 
'High'Iabellers 9,0 5 4, 
Fisher's exact testt 0.03793 0.65342 
Notes Type of CP includes pharmacy number nine as proactive. 
t Two-tailed test. 
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A3.3 Time based analyses 
This section contains three separate parts. First, in a study of reliability, researcher effects on 
CPs is investigated based on an analysis of their advisory activity and time. Second, 
information is presented for a consistent pattern of external influence, other than display of 
the poster, on POls to ask CPs for advice. Finally, the time when POls request Information is 
related to the number of Individuals requesting alternative services. 
First, as described in the observational study method (section 4.5, page 107) the first day of 
data collection was randomly chosen for the working days Monday to Friday. Of the 3519 
POls, the percentage of cases for each day Monday to Friday was 15.7,17.2,21.9,22.3, 
20.4. In addition, two CPs were observed on Saturday contributing 2.6 percent of cases. If 
the first day, whatever day of the week, Is designated day one of period one and subsequent 
days labelled consecutively then the first day of the second visit given the title day one of 
period two and following days again labelled consecutively, then, an analysis for study 
reliability concerning advice may be performed by comparing the two periods for any 
statistically significant variation in the quantity of advice provided. For example, CP number 
20 was seen for the first observational period, first day on Friday the 16th September, 1988 
when the poster was displayed (table 63, page 284). As 74 customers were not observed a 
second day was necessary, day two of the first observational period. The second period of 
observation commenced without the poster on Friday one week after the first day of the first 
period, however, it was not possible to complete the study on the following day as the CP 
was not available. In this case, the last day of observation was the Saturday two weeks after 
the second day of the first period. Consistency of day of the week was maintained and the 
study data was collected within two weeks. Data for analysis in this case included days one 
and two of the first observational period and days one and two for the second. If CPs reacted 
to the presence of the researcher, then it might be expected that there would be an initial 
effect on their actions but that any change would be transient. Having provided the CP with 
the study protocol it would be clear that the study concerned advice. If CPs were prompted 
by the researcher and the study implications to change their normal activities then it is 
reasonable to expect that this would be reflected In their prescription medication advisory 
activity with time. The relevant hypothesis is: 
H1 that the presence of the researcher had no demonstrable effect on the prescription 
medication activities of CPs. 
Table 64, page 286, presents an analysis of the dependence of prescription medication 
advisory activity on the period of observation. Time periods considered are; the total 
distribution [A], the first and the second observational periods [B], the first day of the first 
period and the first day of the second period [C], the first day of the first period compared 
with the second day of the first period [D] and the same analyses limited to the first 120 
minutes of opening. From the results of the analysis presented in table 64, page 286, there is 
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no statistically significant reason to reject the null hypothesis and it is possible to state that 
the frequency of advice was not associated with the presence of the researcher. 
Other factors which may influence the reliability of the results may have come from the effect 
of the recording equipment and display of the advisory notice. It was the researcher's 
experience that his presence and that of the recording equipment was soon Ignored as the 
normal activities of the pharmacy commenced. The following factors tend to verify this 
observation: 
1. one CP went to lunch with the radio microphone attached; 
2. one CP attempted to drive home while wearing the radio microphone; 
3. only two POls made verbal note of the presence of the radio microphone and neither 
asked for or were provided with relevant advice; 
4. three POls presented their prescriptions to the researcher who was mistaken for a 
member of staff; 
5. only one POI made note of the advisory notice (section A1.2.3, page 173); 
6. only 1.9% (67) cases were noted where the microphone was not operational. In only one 
case was this a conscious decision made on the part of the CP to switch the system off. 
The remainder were cases which were observed while the CP was being set up for 
recording. Two of the 67 cases included discussion on prescription medication and both 
were within hearing range of the researcher who noted relevant details verbatim; and, 
7. four cases (0.001%) occurred where epidemiological details of POls were asked of the 
CPs. 
Clearly the impact of the study method on POls and CPs was relatively minimal. 
Second, the poster was designed as an instrument to test the customer initiating activities of 
POls. Coincident with the display of the poster two major advertising campaigns promoting 
the CP as an appropriate source of advice were being conducted throughout England. Both 
these schemes are referred to in the discussion. Critical to the reliability of the present study 
is that both of their effects are considered constant. Taking the campaign currently known as 
"Pharmacy Healthcare", a list has been published of the leaflets which have been sent to 
CPs. Ten were distributed in 1986, nine in 1987, seven In 1988 and three up to march 1989. 
It is noted that not one leaflet Is specific for PMA and that leaflets have been consistently 
distributed at the rate of over the period 59 The National Pharmaceutical Association has run 
a second campaign with the slogan 'Ask you pharmacist - You'll be taking good advice' using 
poster and advertising in newspapers and magazines since 1983. An enquiry to the NPA 
indicated that it was Impossible to detail the exact nature of all advertisements as they had 
been commissioned and several advertising companies were involved, therefore, it Is 
impossible to state whether any have been specifically orientated towards advice prior to the 
observational period; However, during this period CPs' role In advising on prescription 
medication was not the subject of any advertising in any of the 14 sources published at the 
start of the campaign 563 In addition to national advertising, local initiatives were also 
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conducted. During the observational period, Express Woman of the 13th October carried an 
article on how to get rid of head lice in which the 'chemist' was noted as a source of a 
suitable product. The Belper News carried inserts on the 13th and 27th of October and 17th 
November 1988, by the NPA with the title'Ask you local pharmacist: What? Why? When? 
On medicines, minor ailments and other problems - from the National Pharmaceutical 
Association'. Each was based on a question and answer format and on the 17th November 
one such question asked 'My doctor said that I must take some tables three times a day. 
Does this mean I take them with my meals? ' The response did not directly mention the CP as 
the person who could interpret this direction. No other mention was made of the CPs' 
prescription medication advisory role in any of the other questions and answers. However, on 
January 11th 1989, the Long Eaton Trader carried an article on page 20 entitled 'Medicines 
warning'. Specific advice on interactions was mention yet the CPs as a source of advice was 
not. Finally, during Central Television's 'Getting on' programme transmitted on the 20th July 
1988 at 11.30am the "Ask your pharmacist" campaign was discussed for seven minutes. 
Mention was made of the CPs use of patient medication records to verify the general 0 
practitioners' prescribing, monitoring of possible prescription drug Interactions and a specific 
example shown of advice on 'what to do with it'. As prescription medication roles for CPs' 
were described, special attention was made during observations made on that day at 
pharmacy number five as to whether any POls mentioned viewing the programme. No such 
discussion was noted. With this one exception and as far as is known by the author, 
advertising of CPs advisory role on medicines was consistent for the observational period 
and specific acknowledgement of the CPs prescription medication advisory activities was 
local and Insignificant. It Is the considered assessment of the researcher that any effect on 
POls ascribed to the poster was unlikely to be erratically influenced by external advertising. 
As part of the observational study, data collection Included the exact time when customers 
presented prescriptions at community pharmacies or POis initiated discussion with CPs. This 
is a direct measure of the 'business' of community pharmacies. The hypothesis under 
consideration was whether customer initiated discussion was related to the 'business' of 
community pharmacies. The hypothesis is that: 
H, The advice seeking behaviour of POls Is not related to the number of individuals who 
concurrently ask for pharmacy services. 
The earliest recorded time of possible interaction between the CP and a patient orientated 
individual was 8.30am and the latest 7.18pm. For analysis, the number of minutes after 
8.30am when a possible interaction may have commenced was Identified for each POI. For 
display purposes, table 65, page 287 and figure 16, page 118, list and display respectively 
numbers of customers and POis observed in the pharmacy for time bands of 12 minutes. 
Inspection of figure 16 identifies three periods, first a morning peak of activity which ceases 
at lunch time (0 to 312 minutes) followed by an much smaller, more constant period of 
activity during early afternoon (313 to 468 minutes) which slowly builds to a second peak 
during late afternoon (469 to 648 minutes). Figure 16 also displays the corresponding 
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numbers of Pols who are provided with advice by CPs and those who seek advice. From 
observation the distribution of the former appears to follow that of the overall distribution. In 
contrast, the relative numbers of POIs who initiate discussion seem to progressively increase 
as time increases. Table 66, page 288, an analysis of the unbanded data, confirms these 
observations. Group A of table 66 compares the ranking and distribution of those POls given 
advice with those who were not. No statistical significance was found. This was not the case 
for group B. Results of a Mann-Whitney test indicated a mean rank of 1919.57 for those who 
initiated advice compared with 1752.84 for those who did not. The difference was significant 
and may be interpreted as showing that advice seeking activity is more likely to occur later in 
the day which is the time when comparatively less individuals are seeking alternative 
pharmacy services. That there is a statistical trend for a change in advice seeking behaviour 
is demonstrated by the results of the Kolmogorov-Smirnov test. Given such findings 
differences in timing between those who received advice and those who initiated advice 
would be expected. This was confirmed by analysis of group C (table 66). In order add clarity 
to this explanation the data was banded into the three periods referred to previously and 
shown in figure 16. Table 67, page 288, details a chi-square analysis and the readers 
attention is drawn to the adjusted residuals for the three periods, morning, mid and late 
afternoon, -1.3, +0.4 and +1.1 respectively. Such results provides clear evidence of a 
changing pattern of advice seeking behaviour where more than expected number of POIs 
seek advice during the latter periods of the day. These periods also correspond to lower 
levels of pharmacy activity. The weight of evidence point to rejection of the null hypothesis 
and it is shown that the advice seeking behaviour of POls Is related to the number of 
individuals who concurrently ask for pharmacy services. 
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Table 63 
Observatio nal study data collection* 
Pharmacy Date Time Total Num ber Case No Poster Cell 
1 2 3 4 5 67 8 
Proactive 5 880608 494 31 180-232 1 A 
11 5 880609 518 233-277 1 A 
5 880610 72 278-286 1 A 
5 880720 517 287-335 0 B 
5 880721 533 2134 336-377 0 B 
14 880708 525 65 378-421 1 A 
14 880715 510 422-459 0 B 
14 880726 185 460-473 0 B 
14 880729 455 1675 474-508 1 A 
15 880711 475 67 509-548 0 B 
15 880712 493 549-572 0 B 
15 880713 165 573-595 0 B 
15 880719 455 596-628 1 A 
15 880725 485 629-655 1 A 
15 880727 153 2226 656-678 1 A 
6 880817 515 34 1030-1085 1 A 
6 880818 561 1086-1126 1 A 
6 880824 560 1127-1197 0 B 
6 880825 550 2186 1198-1251 0 B 
11 880823 515 50 1252-1298 1 A 
11 880921 501 1299-1338 1 A 
11 881004 530 1339-1396 0 B 
11 881012 430 1976 1397-1430 0 B 
18 880906 575 91 1431-1495 0 B 
18 880907 505 1496-1552 0 B 
18 880913 531 1553-1617 1 A 
18 880914 529 2140 1618-1674 1 A 
9 880926 448 45 2358-2406 0 B 
9 880928 146 2407-2435 0 B 
9 881003 414 2436-2479 1 A 
9 881005 177 1185 2480-2496 1 A 
4 881115 453 29 3230-3271 1 A 
4 881116 180 3272-3297 1 A 
4 881122 451 3298-3338 0 B 
4 881123 170 1254 3339-3363 0 B 
20 880916 515 97 3590-3622 1 A 
20 880917 399 3623-3637 '1 A 
20 880923 522 3638-3674 0 B 
20 881001 376 1812 3675-3699 0 B 
8 890206 562 41 3700-3781 0 B 
8 890213 563 1125 3782-3840 1 A 
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Table 63 continued 
Pharmacy Date Time Total Number Case No Poster Cell 
Reactive 2 880607 590 04 1-90 0 D 
2 880705 555 1145 91-179 1 C 
12 880812 520 61 679-844 1 C 
12 880819 515 1035 845-1029 0 D 
17 880908 543 78 1675-1769 1 C 
17 880915 551 1094 1770-1855 0 D 
3 880810 220 05 1856-1961 1 $ 
3 880831 245 465 1962-2054 0 $ 
19 880902 495 93 2055-2115 1 C 
19 880903 425 2116-2150 1 C 
19 880909 515 2151-2197 0 D 
19 880910 232 1667 2198-2225 0 D 
1 880919 541 03 2226-2299 0 D 
1 881017 552 1093 2300-2357 1 C 
7 880929 558 39 2497-2549 0 D 
7 880930 540 2550-2616 0 D 
7 881006 586 2617-2678 1 C 
7 881007 586 2270 2679-2741 1 C 
10 881010 544 49 2742-2804 0 D 
10 881011 550 2805-2853 0 D 
10 881024 556 2854-2912 1 C 
10 881025 574 2224 2913-2960 1 C 
16 881026 545 69 2961-3020 1 C 
16 881027 535 3021-3084 1 C 
16 881109 572 3085-3143 0 D 
16 881110 570 2131 3144-3229 0 D 
13 881117 570 63 3364-3482 1 C 
13 881124 562 1132 3483-3589 0 D 
Notes 
*= Data is arranged in chronological order of case number for proactive and reactive 
CPs. 
t= Column I is the ord er from one to 20 of community pharmacy based on the 
alphabe tical order from one to 105 provided in column 5. Column 2 lists the precise 
days spent at each community pharmacy and columns 3 and 4 the time period in 
minutes spent recording activity. Column 6 lists the case number. Readers will note 
that the maximum of 3840 Is greater than the 3519 for POls. The difference was 
made up of OTC advice which was recorded in case advice on prescription 
medication was me ntioned. Column 7 indicates whether the poster was displayed (1) 
or not (0) and column 8 whic h cell the data was assigned for qualitative evaluation, 
table 57 page 271. 
3 
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Table 64 Dependence of advice on observational study period 
Period* 
First observational period Second observational period 
PMAt One Two Three One Two Three DF Chi Significance 
u -square 
[A] 
No 1097 418 72 1037 405 17 
Expectedf 1101.0 414.6 73.6 1034.4 403.4 19.0 
Yes 175 61 13 158 61 5 
Expectedf 171.0 64.4 11.4 160.6 62.6 3.0 5 2.29524 0.80697 
[B] 
No 1587 1459 
Expectedf 1589.2 1456.8 
Yes 249 224 
Expectedf 246.8 226.2 1 0.02887 0.86508 
[C] 
No 1097 1037 
Expectedf 1100.3 1033.7 
Yes 175 158 
Expectedf 171.7 161.3 1 0.10923 0.74103 
[D] 
No 1097 418 
Expectedf 1100.0 414.4 
Yes 175 61 
Expectedf 171.4 64.6 1 0.23071 0.63100 
[E] 
No 298 113 25 276 104 7 
Expectedf 299.6 113.6 25.8 275.5 100.7 7.7 
Yes 50 19 5 44 13 2 
Expectedf 48.4 18.4 4.2 44.5 16.3 1.3 5 1.56839 0.90505 
[F] 
No 436 387 
Expectedf 439.0 384.0 
Yes 74 59 
Expectedf 71.0 62.0 1 0.22785 0.63312 
[G] 
No 298 276 
Expectedf 299.0 275.0 
Yes 50 44 
Expectedf 49,0 45.0 1 0.01393 0.90604 
[H] 
No 298 113 
Expectedf 298.0 113.0 
Yes 50 19 
Expectedf 50.0 19.0 1 0.00000 1.00000 
Notes 
*= Periods are the day of observati on. 
t= The following associations of advice and period are presented: A= the total data n=3519; B= 
first observational period (days 1,2 and 3) compared with the second (days 4,5 and 6); C= 
the first day of the first period compared with the first day of the second period; D= the first 
day of the first period compared with the second day of the first period; E, F, G and H are the 
same as A, B, C and D respectively only limited to the first 120 minutes of opening. 
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Table 65 
The number in specific time bands of prescription orientated individuals 
requesting services from community pharmacists* 
Number of prescription orientated individuals 
Time band* Total Prescription Customer initiated 
medication advice advice 
6 4 0 0 
18 7 0 0 
30 33 1 0 
42 73 9 2 
54 77 17 2 
66 142 23 6 
78 138 17 3 
90 157 23 7 
102 151 24 7 
114 138 16 4 
126 155 17 6 
138 116 14 2 
150 147 19 4 
163 102 18 6 
174 94 11 7 
186 113 13 6 
198 84 13 3 
210 90 9 2 
222 52 3 2 
234 44 2 2 
246 59 3 2 
258 38 5 2 
270 23 2 2 
282 15 2 1 
294 24 3 0 
306 19 3 0 
318 20 4 2 
330 27 2 1 
342 49 3 2 
354 36 6 3 
366 49 4 3 
378 37 3 0 
390 48 10 3 
402 40 3 1 
414 36 7 4 
426 45 8 2 
438 38 7 3 
450 46 5 2 
462 41 5 2 
474 51 9 4 
486 72 11 2 
498 77 4 2 
510 92 14 5 
522 93 16 7 
534 104 15 5 
546 127 28 10 
558 92 12 4 
570 75 6 1 
582 50 12 2 
594 37 10 3 
606 22 1 0 
618 12 1 0 
630 6 0 0 
642 2 0 0 
654 0 0 0 
Total 3519 473 151 
Note 
"= Time bands are measured in 12 minute intervals after 8.30am. The midpoint of the band is 
given in this table. 
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Table 66 
Relationship of time of possible discussion with observed time of advice and 
customer initiated advice 
Statistical relationship of group with time* 
Group Mean Cases Mann- Kolmogorov- 2-tailed 
Rank n=3458 Whitney Z Smirnov Z probability 
[A] 
Receiving no advice 1754.78 3046 -0.7734 0.4393 
Receiving advice 1793.62 473 
Receiving no advice 3046 1.082 0.192 
Receiving advice 473 
............................................. [B] 
......................................................................................... ....................... 
Receiving no advice 1752.84 3368 -1.9750 0.0483 
Customers initiating advice 1919.75 151 
Receiving no advice 3368 1.278 0.078 
Customers initiating advice 151 
............................................ 
[C] 
........................................................................................ ........................ 
Receiving advice 229.55 322 -1.7318 0.0833 
Customers initiating advice 252.89 151 
Receiving advice 322 1.458 0.028 
Customers initiating advice 151 
Note 
Analysis based on the original unbanded data. Students t-test was considered inappropriate 
as the population distributions appeared to be bimodal rather than normal. 
Table 67 
Independence of customer initiated advice and time in bands 
Time* 
Customer initiated 0 to 306 318 to 462 472 to 654 
No 2157 326 885 
Yes 89 16 46 
Expectedf 96.4 14.7 39.9 
Adjusted residuals -1.3 +0.4 +1.1 
Chi-square value 1.67231 
Significance 0.43337 
IMUM 
*= Time is banded from 0 to 312 minutes, 313 to 468 and 469 to 660 minutes. The labels in the 
table relate to the midpoint values in table 83. This is done to enable more direct comparison. 
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i 
3.4 Supply 
Table 68, page 290, lists the advisory activities of CPs which include aspects of supply for 
prescription medication. Data has been grouped in a similar manner to that of advice on 
specific problems (section A3.1.3.2, page 262, table 53, page 262). A central question 
addressed in this thesis is whether advice is associated with information on the supply 
aspects of prescription medication. The hypothesis is that: 
H, Prescription medication advice is not dependent on whether advice on supply 
aspects of medication is provided. 
Table 69[A], page 292, shows that advice is very significantly associated with concurrent 
advice on the supply aspects of prescribed medicines. Of the 473 POls provided with advice 
114 were given information on supply aspects of medicines when only 61 were expected. 
This relationship held when the data was controlled for type of CP, proactive (table 69[B]) 
and reactive (table 69[C]). These results lead to rejection of the null hypothesis and it is 
stated that advice shows dependence on concurrent information concerning supply. 
There is, however, a separate issue of duplication of cases which should be addressed. It will 
be remembered from the definition of case (section 4.6, page 113) that an individual may 
leave the pharmacy and upon return any time afterwards be counted a second, third... time. 
This was considered appropriate as CPs had more than one opportunity to initiated or 
respond to requests for, advice. Such cases occurred when, for example, customers dropped 
off their prescriptions, went shopping and returned or were asked to return as prescribed 
items were not readily available for dispensing. In the most extreme example, one 
prescription was linked to five separate customer enquiries before the item was dispensed. 
On occasions a prescription would be presented and a second customer would subsequently 
collect the dispensed item. Although the latter case is not strictly duplication of an individual 
rather of a prescription, it was included. In each case the function of supply was involved, 
either dispensing was not quick enough to satisfy the customer, the prescribed item was not 
readily available or for whatever reason supply was to a customer other than the one who 
originally presented. Table 87[D] considers whether duplication is associated with advice. 
The negative result indicates that there is no reason to doubt the above statement 
concerning the hypothesis. However, in the case where supply was the reason for 
duplication, it was the researchers impression from field notes that such customers where 
more likely to receive advice. Table 87[E] is a contingency table of the 102 customers who 
were recorded on two or more occasions where supply of prescribed medication was at 
Issue. The impression was confirmed by a trend for such customers to receive advice. 
In summary, advice does appear to be associated with concurrent discussion on supply. This 
relationship is not altered due to the duplication of cases, however, a trend was noted for 
duplication of cases linked to supply to be associated with advice. 
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Table 68 
Algorithm for allocation of supply as a category of advice* 
Inability to supply Code t Frequency$ 
sil kept 1 148 
i IR even ac 26 
Pure Supply Location of 91 not at pharmacy 37 
Abilit to supply 
Whether all items have been dispensed 44 
u specific items on 91 51 
Supply specific items on 91 66 
elp signing the 92 form 
etails of item on 91 incomplete 
Sent to surer 
Patients' personal detail 
Dispensing 
act Form disc 
rp 
Incorre 
FI 
Information Name 
on supply 
in a sinale container 
to two containers 
screw ca re uire 
. 
container overfilled 
ona customer 
How Ion 91 forms are valid/le al require 
Availability o quantities/strengths 
How Iona the auantitv of item will last 
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74 
8 10 
91 
10 5 
11 17 
12 1 
13 1 
14 1 
15 1 
16 1 
17 31 
18 3 
19 19 
20 8 
21 2 
22 6 
23 4 
24 1 
25 2 
' 26 11 
27 30 
28 3 
29 1 
30 2 
L 
Prescription 
Info 
fors 
rrectly prescribed 
Pharmaceutical form of iti 
ose a ere d ue o su 
empteed dose alteration 
inappropriately prescribed 
Item does not exist, wronc 
Dose altered an item dis 
em 
e or address 
a 
Jense or o 
schedule altered, GP contacted 
Check to varify appropriate dispensing 
With customer 
i surgery/general practitioner 
home 
Check to varify appropriate prescribing 
I Age of child 
Check on the tvoe of item required 
Code t 
31 
32 
33 
34 
35 
g 36 
Frequency$ 
3 
8 
1 
4 
2 
2 
37 34 
38 6 
39 § 
40 6 
41 2 
42 5 
ctitioner 
they prescribe an 
scellaneous 
ne spoon 
ovinq the top from a bottle 
43 1 
44 
45 1 
46 1 
47 § 
48 3 
New code=Combination of 
49 
previous 
=1 
codes 
7 
Frequency 
50 =1 
+ 
+8 
2 
1 
52 =1 + 17 1 
53 = 1 26 
54 = 1 + 1 
55 =1 + 26 +48 1 
5 1 32 
7 = + 
2 
58 =1 + 37 8 
60 =3 + 37 +40 
1 
61 =5 +17 1 
62 =5 + 28 1 
63 = 7 
64 = 
+ 19 1 
65 =8 + 37 1 
66 = 11 +17 1 
67- = 11 +19 2 
68 = 13 + 37 1 
69 = 17 +27 2 
70 = 17 + 37 2 
7 11 = 22 + 37 
72 = 32 + 37 +38 73 = 34 +37 
1 
Notes 
*= Algorithm for supply for the 3519 POls. 
t= Code used to identify supply as topics of discussion. This was necessary as discussion coded 
as 249 included more than one topic. 
t= Matching frequency of individual topics of supply for each code. Only direct or indirect 
conversation between CPs and POls are included. A total of 454 topics were noted during 
discussions with CPs. 
§= Two cases excluded, the first was where the CP attempted to contact a home to verify the 
accuracy of dispensing but was unsuccessful, the second was physical help rather than 
advice, verbal or non-verbal. 
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Table 69 
Dependence of advice on supply 
Variable analysed for dependence* 
Independent PMA No PMA n Chi-Squa re Significance 
variablet 
(A) Total 
Supply 114 340 
Expected value 61.0 393.0 
No supply 359 2706 
Expected value 412.0 2653.0 3519 59.85614 0.00000 
(B) Proactive 
Supply 83 178 
Expected value 61.4 199.6 
No supply 276 988 
Expected value 297.6 966.4 1525 11.38845 0.00074 
(C) Reactive 
Supply 31 162 
Expected value 11.0 182.0 
No supply 83 1718 
Expected value 103.0 1698.0 1994 40.32651 0.00000 
(D) Duplication 
Duplication 56 399 
Expected value 61.2 393.8 
No duplication 417 2647 
Expected value 441.8 2652.2 3519 0.47072 0.49265 
(E) 
Duplication 20 82 
Expected value 13.7 88.3 
No duplication 453 2964 
Expected value 459.3 
.. 
2957.7 3519 2.90909 0.08808 
Notes 
= The dependent variable, advice is given the x axis for ease of display, 
t= Table [A] is an overview of associations of the 473 cases of prescription medication and the 
proportion which included information on supply. Tables [B] and [C] control for type. Table [D] 
considers the possible influence of duplication on the first association. Finally, table [E] 
considers the 102 cases where duplication was linked to supply and associations with advice. 
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APPENDIX 4 SUBMISSIONS AND PAPERS 
A4.1 Submission on the future role of community pharmaceutical services 
SUBMISSION TO THE JOINT WORKING PARTY ON THE FUTURE ROLE OF 
COMMUNITY PHARMACEUTICAL SERVICES 
From 
Mr David Gerrett - Assistant Director, Medicines Research Unit 
of the 
Southern Derbyshire Health Authority working in collaboration with the Derbyshire College of 
Higher Education and the 
Nottingham University, Department of Administrative Science and Social Policy. 
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SUBMISSION OF EVIDENCE TO CORROBORATE A PROPOSAL ON THE FUTURE 
ROLE OF COMMUNITY PHARMACEUTICAL SERVICES 
The information contained in this submission will be presented as part of a Doctoral thesis 
and later papers. It is copyright protected for the Southern Derbyshire Health Authority, 
Medicines Research Unit and Nottingham University and is provided for confidential 
consideration only by the Joint Working Party. 
PROPOSAL 
It is proposed that NHS community pharmaceutical services might be developed by 
additionally remunerating "proactive" pharmacist who actively seek to provide prescription 
medication advice. 
INTRODUCTION 
The Joint Working Party (JWP) have been given the remit of "considering ways in which the 
NHS community Pharmaceutical services might be developed to increase their contribution 
to health care; and to make recommend ations". I 
This submission provides information on the activities of 20 community pharmacists 
concerning prescription medication advice (PMA). Fundamentally, the results of the study 
indicate community pharmacists can be considered either "proactive" seeking to advise on 
prescription medication or "reactive" responding to requests for information from customers. 
It may be helpful in examining the above proposal and the original research in this 
submission for the JWP to consider whether prescription medication advice (PMA) provided 
by community pharmacist is an appropriately remunerated "core activity" or an expanded 
role. This has an implication on the implementation of the proposal. 
A portion of the remuneration for community pharmacies is based on surveys which 
determine the professional fee. The calculation includes the time taken advising customers 
on prescription medication as part of dispensing activity. Although, the exact contribution of 
PMA activity to remuneration is unknown, this implies that the Government considers such 
advice to be a "core activity" for which remuneration is forthcoming. The JWP should 
consider whether changes in the present structure are warrented If a proportion of 
pharmacists are providing significantly greater service without specific remuneration. 
On the other hand, considering PMA as an expanded role activity may: 
(1) Require altering the remuneration survey methodology to 'free' resources; 
(2) Imply that community pharmacy, being historically linked to traders without a specific 
mandate to provide PMA, has developed an "extended role" including the provision 
of advice on prescription medication which should be openly recognised and suitably 
remunerated; and, 
(3) Enable use of the precedent set by the remuneration of community pharmacist for 
providing advice to residential homes to be used in negotiating payment for PMA. 
In summary, community pharmacists may be identified as "proactive" or "reactive" and 
differentially remunerated. The following pages provide evidence for the existence of two 
'types' of pharmacists. Also, that both 'types' of pharmacists appear to have a similar role in 
providing PMA; thus, the debate is not about quality or content but quantity of activity and 
whether to differentially remuneration. 
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EVIDENCE FOR THE ROLE OF THE COMMUNITY PHARMACIST AS ADVISORS ON 
PRESCRIPTION MEDICATION. 
Methodology 
The technique of simultaneously recording the subject-pharmacist interactions concerning 
prescription medication both on tape and on paper was piloted. A radio-microphone and 
transmitter were attached to the pharmacist and appropriate discussions recorded on tape 
from the receiver which was situated with the researcher. The researcher was discreetly 
positioned to observe the interaction without becoming involved. A form for recording details 
of the interaction was developed and experience gained in collecting the required 
information with minimal disruption of the normal activities of the pharmacy. 
Twenty-seven pharmacies were randomly chosen from the 105 listed with the Derbyshire 
Family Practitioner Committee on the 11th April, 1988. Three'Boots'. pharmacies were 
chosen, however, use of the chosen methodology was not permitted by their superintendent 
management and they were excluded from the study. The twenty four remaining pharmacies 
were approached individually by the researcher, given a protocol and a verbal summary of 
the study objectives and methodology. Twenty pharmacies agreed to participate. The 
experimental design required two periods of research, each of up to three days, on the same 
days of the week and, where possible, not more than two weeks apart. Pharmacies were 
randomly chosen to display a poster advertising their services as advisors on prescription 
medication on the first or second visit. The pharmacist and dispensary staff were the same 
on both occasions. The protocol required, were possible, for 74 potential pharmacy-subject 
interactions during each visit. Patients were notified about the study by the display of a 
self-explanatory poster, no attempt being made by the pharmacist to conceal the 
microphone. The names and addresses of patients were noted only for the purpose of 
identifying duplication, earmarking conversations and assigning social status indicators. 
Prescription details were noted and both a written account and recording taken of every 
discussion concerning prescription medication. Specific details on the pharmacy premises 
and labelling practices and non-pharmacy staff were recorded on a separate sheet. 
Pharmacist participating in the study will remain anonymous. 
A case was a possible interaction between pharmacist and subject. The subject was the 
individual presenting the prescription. Prescription medication advice was related to 
prescriptions, subjects and individual drugs. 
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Results Quantitative Evaluation 
A total of 3,519 cases over 69 days between June 1988 and February 1989 were recorded. 
Each day of the week was equally represented. Graph G1* indicates the similarity of the 
6072 dispensed preparations in therapeutic class to National figures. Appendix lt gives 
definitions of the therapeutic classes involved. 
There was no significant difference (p>0.05) in the provision or request for prescription 
medication advice relating to display of the poster. Combining the data for both visits, 
prescription medication advice was associated with 473 cases. 
Graph G2$ indicates the frequency that a dispensed preparation is associated with PMA in 
four previously validated categories by therapeutic class. A dispensed preparation may be 
associated with more than one category of PMA; thus G2 indicates the extent to which a 
therapeutic class of dispensed preparation is associated with a particular category. Graph 
G3§ highlights frequencies of the specific categories shown in graph G2. 
Considering the 6817 "preparation events" recorded, 562 occasions included PMA activity, 
graph G4.11 A'preparation event' refers to discussion on one or more categories of PMA 
whether dispensed or not and including over-the-counter advice on prescribed medication. A 
subject may discuss several preparations, each discussion recorded as an event; thus, the 
graph represents the extent to which individual pharmacist discuss prescribed preparations 
no matter what the category of PMA and provides an index of PMA activity. 
This same order was then applied to graph 5, ¶ dispensed prescriptions whose addresses 
were within the boundary of the Southern Derbyshire Health Authority and which were 
associated with any category of PMA. The total activity is related to whether any category of 
PMA for individual prescriptions was subiect initiated. Subjects may initiate discussion on 
more than one prescription; thus, the graph is indicative of subject initiating activity for 
prescriptions between pharmacists ordered as providers of PMA. The graph indicates the 
existence of two 'types' of pharmacist 'proactive' and 'reactive' and that 'reactive' pharmacist 
(with one exception) are associated with less PMA activity. However, this is valid only if the 
fraction of PMA initiated by subjects is constant between the two 'types'. 
The chi-square test for independence found no significant difference for the frequency of 
subject initiated discussion between the two types of pharmacists (chi-square 0.09937, 
DF=1, n=171/3151, p=0.7526, Yates correction applied). As subjects initiate a similar 
percentage of requests for PMA the difference in frequency of provision of PMA between the 
two types must be due to pharmacists actively providing unrequested advice. 
r° 
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Results Qualitative Evaluation 
Introduction 
Having provided quantitative evidence for the two 'types' of pharmacists, the question 
remains whether there are differences in the content of PMA. 
Evaluation of the role of the community pharmacist as providers of PMA was undertaken 
using matrix analysis of the two'types'. The methodology relies on progressively refining the 
context and content of discussion using a matrix pattern to derive overall patterns of 
activity. 2 
Although analysis of the four categories of discussion describes the complete role of the 
study community pharmacist as advisors on prescription medication, it may be sufficient to 
provide one category in detail to indicate the depth and range of interactions concerning 
PMA. The full analysis would be made available if requested. If the JWP considers the 
qualitative evaluation of the activities or roles of community pharmacists concerning the 
"side-effects", this will serve to exemplify the range of interaction between pharmacist and 
subject. It will provide evidence of consistant features of discussion between the two 'types' 
and a basis for discussion concerning the remuneration of this service in terms of quantity 
not quality. 
Qualitative evaluation of discussion concerning "side-effects". 
Cases of interactions concerning "side-effects" of drugs, may be placed in a qualitative 
matrix of poster and type, figure 1. Appendix 2 lists the data after the first stage of reduction 
and is provided for confirmation of the methodology and conclusions. 
Figure 1. 
Design of qualitative matrix for'type' of pharmacist and whether the poster 
advertising a PMA service was displayed. 
Posters 
Type 
u 
Displayed Not displayed 
Proactive CELL A CELL B 
Pharmacist 
Reactive CELL C- CELL D 
Pharmacist 
From these cells common themes of discussion emerge which represent overall activity for 
community pharmacist in a particular area. 
For the cells A-D. common themes included: 
Short "robot-like" monologues by the pharmacist informing of possible side-effect, 
usually drowsiness or gastric upset as part of the additional labelling 
recommendation for the drug; 
Examples 
Cell A: Case number 413 ".. they; they will cause drowsiness, so no alcohol and be 
careful driving" 
Cell B: Case number 1345 "they might make her feel a little bit sleepy" 
Cell C: Case number 832 "It um.. might make him a bit dopey" 
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Cell D: No cases recorded. 
Use by the pharmacist of side-effects, usually gastric, to increase the likelihood of 
compliance with direction; 
Examples 
Cell A: Case number 3789 "sip it otherwise you might feel sick" 
Cell B: Case number 349 "Sometimes people have trouble with them irritating the 
stomach then... then they space them out" 
Cell C: Case number 787 "after food otherwise they'll give you a very bad er 
indigestion" 
Cell D: Case number 870 "if you take them on an empty stomach, they do tend to 
make you a bit sickly" 
Confirmation by the pharmacist of a link between medication and side-effects; and, 
Examples 
Cell A: Case number 193 "Yeah, it does say it can make you a bit sleepy" 
Cell B: Case number 3649 "Yeah, they can have that effect" 
Cell C: Case number 2899 "Drowsiness is quite Iikely.... yes" 
Cell D: Case number 2510 "It's harmless, yes... won't do you any harm" 
Pharmacists socialising subjects to be wary of specific side-effects of drugs which 
have implications on everyday activity. 
Examples (subjects statements) 
Cell A: Case number 193 
Cell B: Case number 1387 
Cell C: Case number 3467 
"He's not fit to drive reallyl" 
"Be alright driving won't you? " 
"Driving isn't affected is it? ". 
Cell D: No examples of subject initiated discussion 
Having identified commoner themes for the cells a qualitative matrix of poster and type for 
unique discussion on "side-effects" is constructed, figure 2**. By reading down rows and 
across columns statements concerning the qualitative differences of discussion on PMA 
between 'types' of pharmacist and the display of the poster can be made. 
For example, 'reactive' pharmacist, as expected, are asked for specific details on side 
effects rather than volunteer advice. They often provide PMA on "side-effects" in a supply 
setting and appear not to get involved in discussion on steroids (reactive pharmacist 
dispensed 17 steroid items, proactive 26). However, both 'types' are keen to recommend the 
general medical practitioner if patient compliance is an issue or the subject shows anxiety 
over possible "side-effects". 
Although not quantitatively significant, the frequency of discussion on side-effects was 
greater when the poster was displayed. It appeared that more complicated interactions 
concerning side-effects were entered into with the poster displayed although this could be an 
artifact of the limited numbers of interactions. 
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In summary, cases of interactions between the community pharmacist and the subject were 
recorded in 1988/89. Graph G1* indicates that similar numbers and therapeutic classes of 
drugs were dispensed. As no significant difference was found in the frequency of PMA 
between a baseline and when a poster was displayed the data was aggregated to 477 cases 
of PMA. The frequency that a dispensed preparation is associated with PMA is shown in 
graph G2$ and the specific categories of PMA highlighted in graph G3§. The extent to which 
individual pharmacist discuss prescribed preparations no matter what the category of PMA is 
provided in graph G4$ which gives an index of PMA activity. The same order of activity 
when graphed as the percentage of PMA which was subject initiated, graph G5¶ reveals two 
"types" of community pharmacist which are labelled 'proactive' and 'reactive'. 
In oder to describe the variety of PMA activity undertaken by different 'types' of community 
pharmacists, qualitative evaluation of their respective roles for one category, "side-effects" is 
provided. It was demonstrated that pharmacists appear to have common themes of PMA 
concerning "side-effects". Although some differences are noted, these may be due to the 
limited numbers of cases. Analysis of the remaining three categories revealed little 
difference in the PMA role undertaken by the two 'types' of pharmacist. 
From the evidence submitted, or requested, it can be shown that community pharmacists' 
role in providing PMA is essentially consistent; however, some are'proactive' and seek to 
educated subjects about prescription medication without prompting while others respond to 
requests for advice. 
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THE FUTURE ROLE OF THE COMMUNITY PHARMACIST AS ADVISORS ON 
PRESCRIPTION MEDICATION. 
This submission contains evidence developed using social science techniques which may 
appear, at first, "non-scientific". The validity of such methods is part of a continuing 
academic debate in which "The caricature of qualitative research is that it is "soft" whereas 
quantitative research is "hard"; qualitative researcher call quantitative researchers 
"number-crunchers", and the riposte of the latter is that the former are mere "navel-gazers". 3 
However, if the JWP were only to consider graphs G2$ and G3§, the "hard" data, the 
inexorable conclusion would be that, compared to the number of preparations dispensed, a 
small almost Insignificant proportion are associated with PMA and then with reiterating the 
directions concerning antibiotics. Discussion might then introduce complicating factors for 
which figures are simply not available; such as as the proportion of repeat prescriptions and 
the number of dispensed preparations which actually require a pharmacists' intervention. 
This would serve to cloud the central issue of whether community pharmacist are providing a 
PMA service to the community and what, if any, remuneration should be forthcoming. Thus, 
in order to fully appreciate the nature of the PMA role of community pharmacists, a 
combination of quantitative and qualitative methodologies is useful. 
In this necessarily short report I have concentrated on providing evidence for the role of 
community pharmacists as advisors on prescription medication. The essence of this role 
appears consistent, but may be divided quantitatively into two sections based on who 
initiates the discussion, pharmacist or subject. Pharmacists always respond to requests for 
PMA; however, it seems an anomaly that all are similarly remunerated when clearly certain 
individuals are more actively promoting prescription medication education. By additionally 
remunerating "proactive" pharmacists it may be possible to increase the overall activity in 
this area, the remit of the Joint Working Party. 
It Is my considered opinion that differential remuneration Is appropriate given that community 
pharmacists currenty receive payment for providing PMA. If changes are envisaged then the 
following questions and comments might be born in mind: 
(1) Can a universal method for determining 'types' of pharmacist be developed? 
(1.1) Community pharmacists might be surveyed to indicate their perceived activity In 
providing PMA. Those that purport to be 'prospective' advisors on PMA could be 
additionally remunerated on the understanding that their activity would be subject to 
evaluation by administration of test problems. 
(2) What would be the effect on the community pharmacist, the profession and the 
general public of such changes? 
(2.1) The Social Science literature on the professions Is Instructive in highlighting Issues 
which the JWP may consider debating. 
Considering the trait theory of the professions Pharmacy Is Indeed a profession .4 
One of the major tenants is that the 'professional' Is not money orientated "and will put the 
client's interests before his own" also that "standard are homogeneous throughout the 
profession. 5 If it were common knowledge that pharmacists were paid for providing PMA and 
that there were two 'types' of community pharmacist, this would be incompatible with the 
concept of pharmacy as a profession. In addition, the professional label and societies 
expectations of a professional may be one of the major forces Influencing community 
pharmacists to resist all temptations to ethical or technical lapses. In other words, 
professional status Is Important as a motivator for individuals, by paying them for a service 
you could in fact insult their ideals which may have a detrementory effect overall. If the JWP 
consider it viable to appropriately remunerate community pharmacists for providing PMA 
then the views of the profession should be sought to ascertain the level of support for this 
approach. 
(3) Would differential remuneration increase PMA activity? 
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(3.1) There is an underlying assumption in the proposal that remuneration will prompt 
conversion of community pharmacist from being 'reactive' to 'pro active'. It would be 
incumbent on the management of such a scheme to monitor this aspect. 
Submitted 21st February, 1991 
Mr David Gerrett - Assistant Director, Medicines Research Unit 
(Social Sciences / Drug Abuse / 
Community Research) 
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Notes 
*= Figurel 1, page 38, related to table 48 columns 4 and 5. 
t= Table, Drug Master Index 94 reproduced. 
$=A graph of the frequency of prescription medication in categories of advice by 
therapeutic class. Similar to figure 20, page 127. 
The frequency of prescription medication in categories. Similar to figure 21 page 
128. 
q= The frequency of preparation events and those including PMA by community 
pharmacist. Similar to figure 17, page 120. 
The same as the previous graph only using ward data including a graphical 
representation of the proactive and reactive divide based on subject requests for 
advice. 
**= Table 57, page 271 reproduced. 
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A4.2 Patients' advisory requirements for prescribed medication 
Presented as an oral communication at the 7th Social Pharmacy Workshop, Egham, Surrey 
1992 (26-27 July). Published in the Workshop abstracts page 30.147 
Perceived advisory requirements for prescribed medication 
David Gerrett, Medicines Research Unit, Institute for Health and Community Studies, 
Western Road, Derby UK. 
Published research consistently supports patients' perceived need for a broad range 
of information on prescribed medication, However, either the data collection method 
was not stated or findings have been based on respondents' selections from 
predetermined categories. This study was conducted with the aim of developing 
categories of prescription related information individuals who present prescriptions at 
a dispensary feel they should be aware of. The following question was asked on a 
prepiloted form; "Please describe what you feel you should know about prescription 
medication by writing short concise sentences or words in the five spaces below". 
Potential respondents were randomly selected from those presenting to the 
Derbyshire Royal Infirmary's Pharmacy Department from the 25th to the 27th April, 
1988 inclusive. The author gave a brief verbal account of the objectives of the study 
to each potential respondent. Of the 102 respondents, 13 were physically unable to 
write or were illiterate, but could understand and respond to questions when given a 
verbal presentation. Seventeen respondents were excluded as they; asked probing 
questions (2), could not understand the questions (2), had no thoughts on the matter 
(5), couldn't see and were unwilling to respond verbally (4), were illiterate and could 
not understand English (3), or were under 16 years of age (1). Exclusion was 
independent of gender, age, city or country address, or prescription ownership. 
analysis of the 166 responses from the remaining 85 respondents revealed the 
following four discrete non-supply categories of advice when responses were allowed 
to group themselves into general topics or themes: 'side effects', including advice on 
potential harm (40 respondents); 'what is prescribed', the drug's identification 
intended purpose and mechanism of action (35); 'what to do with it', directions, and 
pharmaceutical requirements (28); and, 'specific problems', Interactions where 
alcohol was identified, and other Interactions, precautions and contraindications (18). 
Trends (chi-square test, Yates' correction, p<0.1) were shown for females to have 
responses categorised under'side effects' and 'what Is prescribed'. Also for younger 
respondents to include 'side effects' as a desired category of advice (Mann-Whitney 
test, p<0.1). Clearly many Individuals, who pharmacists have the opportunity of 
advising, perceive a need for Information on 'side effects'. No previous study had 
noted such high levels of perceived need. This may reflect the unique open method 
of data collection used. Further research Is required to substantiate these results on a 
larger and more representative sample. 
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A4.3 Pharmacists' advisory requirements for prescribed medication 
Presented as an oral communication at the Residentail symposium: Progress in Practice. 
Blackpool: United Kingdom Clinical Pharmacy Association, 1993: 25-7.14B 
An investigation of the information on prescribed medication 
pharmacists perceive patients should be told 
Gerrett D. 
Pharmacy Academic Practice Unit, University of Derby, 
Mickleover, Derby, DE3 5GX. 
Introduction 
Researchers considering the role patients perceive for community pharmacists as 
advisors on prescription medication consistently conclude, first, that such a role 
exists and, second, that advising on side effects should be more of a priority (1 2). 
Community pharmacists have been observed providing such information and being 
asked for advice (3). In addition, they have been mandated by General Medical 
Practitioners as advisors on prescription medication with specific note of their role 
informing patients on side effects (4). Clearly, community pharmacists are seen as 
legitimate sources of prescription medication information for patients. Their active 
involvement is increasingly necessary given the unsatisfactory state of knowledge 
about prescription medicines by the general public (5) and patients (2). Two 
problems exist with the current state of research in this area. First, researchers, 
rather than patients or pharmacists, have themselves predetermined the categories 
which represent topics for advice. Second, pharmacists have not been asked what 
topics of advice they feel should be given to patients. The aim of this study was to 
develop and quantify categories of prescription related information pharmacists feel 
patients should be aware of. 
Method 
The sample frame included the 229 pharmacists known on the 26th February 1988 
to be members of The Derbyshire Branch of the RPSGB (The Branch). A pack 
consisting of a covering letter, pre-piloted questionnaire and a return stamped self- 
addressed envelope was distributed by The Branch in the April 1988 mailing to each 
of its members. The form was confidential and anonymous. Pharmacists responded 
to the question "Please describe what you feel patients should know about 
prescriptions or prescription medication by writing short concise sentences or words 
in the five spaces below". It is assumed that there is a common understanding 
between pharmacists for the use of words and sentences submitted. 
Simple content analysis was used to associate like words and sentences into 
discrete topics. These were then aggregated to produce distinct categories for 
advice. The numbers of pharmacists providing responses in each category formed 
the basis of subsequent quantitative analysis. 
Results 
Fifteen respondents were excluded, seven involved In piloting, four who responded 
but were undergraduates and four who provided incomplete details. Of 
25 
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the remaining 214 pharmacists, 81 (38%) replied with the single mailing. The 
response rate was high for a single mailing but limits generalisation of the results to 
those pharmacists who were motivated to provide their perceptions of appropriate 
advice. 
Excluding information on supply, three discrete areas of prescription medication 
advice could be identified. Use of the words "interactions", "precautions" 
"contraindications" or sentences providing examples of such advice were aggregated 
under the title of 'specific problems'. The number of unique responses with the sole 
descriptor of "side effects" singled out this topic from 'specific problems' and lead to 
related sub category 'side effects'. Words and sentences describing drug 
identification or intended purpose and mechanism of action as topics of advice were 
grouped under the heading of 'what is prescribed'. Finally, directions for physically 
taking, using or storing prescribed drug therapy were listed under the title 'what to do 
with it'. A further category, comprising 10% of the total response, contained 
statements implying an attitude to medication rather topics of advice pharmacist felt 
should be provided to patients. The number of respondents with responses in the 
above discrete categories is shown in the table below. 
Category of response Sub category Number 
respondents 
fn=81) 
'Specific problems' 
(excluding side effects) 32 (39.5%) 
'Side effects' 55 (67.9%) 
4 
. 
6% 
Respondents' experience in community, hospital, industry and academic branches of 
pharmacy summed to 1377 years of which 72% was in community practice. The 
number of pharmacists who gave responses in the above categories were tested for 
relationships with the demographic variables age, gender, pharmacy experience, and 
the branch of pharmacy in which respondents currently practised. The only 
significant relationship was a dependence for inclusion of 'side effects' as a topic for 
advice by younger respondents (Mann-Whitney test, mean rank 49.96 for 26 cases, 
36.76 for 55 cases, n=81, Z=-2.3571,2-tailed p=0.0184). 
Discussion 
Using an open question, pharmacists have identified three major categories of 
advice which they felt should be provided to patients. This study validates these 
three categories as variables for further research. Clearly, a case may be made for 
incorporation of 'side effects' as a topic into the generic category 'specific problems'. 
However, this may be an oversimplification. 
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In summary, there is a consensus for motivated pharmacists in varying branches of 
practice to feel patients should be advised of topics which may be described by the 
headings 'what to do with if, 'what is prescribed' and 'specific problems'. That 
relatively large numbers of patients and younger pharmacists perceive the provision 
of information on side effects to be a necessary element of drug therapy advice 
highlights this topic as a necessary sub category for investigation. 
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